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Knowledge is a dynamic human process to justify our personal belief in pursuit of the truth. 
The intellectual output of any organisation is reliant upon the individual people within that 
organisation. Despite the eminent role of personal knowledge in organisations, personal 
knowledge management and measurement have received little attention, particularly in 
pharmaceutical manufacturing.  The pharmaceutical industry is one of the pillars of the global 
economy and a knowledge-intensive sector where knowledge is described as the second 
product after medicines. The need of measurement to achieve effective management is not a 
new concept in management literature.  This study offers an explanatory framework for 
personal knowledge, its underlying constructs and observed measures in the pharmaceutical 
manufacturing context. 
 
Following a sequential mixed method research (MMR) design, the researcher developed a 
measurement framework based on the thematic analysis of fifteen semi-structured interviews 
with industry experts and considering the extant academic and regulatory literature. A survey 
of 190 practitioners from the pharmaceutical manufacturing sector enabled quantitative testing 
and validation of the proposed models utilising confirmatory factor analysis. The 
pharmaceutical personal knowledge framework was the fruit of a comprehensive study to 
explain and measure the manifestations of personal knowledge in pharmaceutical 
organisations.  
 
The proposed framework identifies 41 personal knowledge measures reflecting six latent 
factors and the underlying personal knowledge. The hypothesised factors include: regulatory 
awareness, performance, wisdom, organisational understanding, mastership of product and 
process besides communication and networking skills. In order to enhance the applicability 
and flexibility of the measurement framework, an abbreviated 15-item form of the original 
framework was developed. The abbreviated pharmaceutical personal knowledge (2P-K) 
framework demonstrated superior model fit, better accuracy and reliability. 
 
The research results reveal that over 80% of the participant pharmaceutical organisations had 
a form of structured KM system. However, less than 30% integrated KM with corporate 
strategies suggesting that KM is still in the early stages of development in the pharmaceutical 
industry.  Also, personal knowledge measurement is still a subjective practice and 
predominately an informal process.  The 2P-K framework offers researchers and scholars a 
theoretically grounded original model for measuring personal knowledge. Also, it offers a basis 
for a personal knowledge measurement scale (2P-K-S) in the pharmaceutical manufacturing 
context. 
 
Finally, the study had some limitations. The framework survey relied on self-ratings. This 
might pose a risk of social desirability bias and Dunning–Kruger effect. Consequently, a 360-
degree survey was suggested to achieve accurate assessments. Also, the model was developed 
and tested in an industry-specific context. A comparative study in similar manufacturing 
industries (e.g. chemical industries) is recommended to assess the validity of the current model 
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Background 
By the end of the twentieth century, the notion of managing knowledge had evolved at the 
corporate level as organisations acknowledged the need to leverage and exploit their 
knowledge resources  (Carmeli & Tishler, 2004). Knowledge Management (KM) is considered 
a vital organisational function and a key source of sustainable competitive advantage 
(Anatolievna Molodchik et al., 2014). While KM is concerned with the use of technology and 
management processes for effective management of organisational knowledge, personal 
knowledge management (PKM) helps the individual be more effective in the personal, 
organisational and social environment (Pauleen & Gorman, 2010). PKM illustrates the 
knowledge workers’ endeavour to use knowledge to support their day-to-day activities through 
problem-solving and learning practices (Hine et al., 2008). However, the value of PKM is not 
just limited to the individual level as the combination of both PKM and Organisational 
Knowledge Management (OKM)  can lead to a more effective management of knowledge 
across the whole organisation (Kassim et al., 2018). 
Moreover, the economic impact of KM within the organisation and its influence on financial 
performance and market competitiveness has been evident (Andreeva & Kianto, 2012). The 
recognition of the fundamental role of knowledge in value creation spawned the concept of the 
Knowledge Economy, making it one of the pillars of contemporary management thinking 
(Roberts, 2009). This made KM a predominant field within the business and management 
landscape for both researchers and practitioners (Moustaghfir & Schiuma, 2013). In the 
pharmaceutical industry, knowledge is described as the second product after medicines 
(Riddell & Goodman, 2014) making it an important part of the contemporary knowledge 
economy. The pharmaceutical industry is not only a knowledge-intensive industry but also a 
leading economic partner with huge investments in innovation and research. According to the 
European Federation of Pharmaceutical Industries and Associations (EFPIA), the 
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Pharmaceutical industry employs more than 700,000 employees in Europe, 16% of them 
working in pharmaceutical R&D. It was the preeminent sector regarding R&D intensity and 
expenditure as a percentage of net sales (14.4%) in 2014 followed by software & computer 
services (10.1%) and technology hardware & equipment (8.0%) (EFPIA, 2015, 2016). It is also 
considered the top investing sector in R&D according to the Industrial R&D Investment 
Scoreboard in both US and EU (EU, 2015). More than 19% of total business R&D expenditure 
worldwide comes from the pharmaceutical and biotechnology sector (EFPIA, 2018). In 2016 
alone, the European pharmaceutical sector invested over 34 billion euros in R&D to counteract 
the wild competition with its rivals from the US and emerging economies (EFPIA, 2018). 
This research represents a study of the personal knowledge measurement in the 
pharmaceutical manufacturing context. The research aims to address the identified knowledge 
gaps in both the theory and application of KM and measurement as explained in the next 
section.   
 
Research rationale 
This section presents the rationale for the research. It outlines the apparent need to measure 
the personal knowledge of knowledge workers, the lack of research to date, the potential 
contribution to knowledge and finally the motives for selection of the pharmaceutical 
manufacturing as a context for this study. 
 The duality of the organisational knowledge and personal knowledge was pointed out in 
several studies arguing that they are distinct but interdependent (Bhatt, 2002; Chatti, 2012; 
Gang & Yi, 2009; Hine et al., 2008). It has been argued that a successful PKM would result in 
an improved utilisation of personal knowledge and effective social exchange of knowledge at 
individual employee level (Razmerita et al., 2009). The OKM integrates a variety of individual 
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knowledge bases for more efficient performance. That is to say, the intellectual output of any 
organisation is reliant upon the individual people within that organisation (Hine et al., 2008).  
Furthermore, individual participation is important for successful KM in any organisation. 
One of the explanations is the notion that knowledge is personal by its nature (Chatti, 2012; 
Vladova et al., 2016). The philosophical foundations of knowledge view the person as a 
legitimate participant of KM (Rechberg & Syed, 2014). In knowledge creation literature, 
Nonaka’s SECI model acknowledged the role of socialisation and personal interactions for 
knowledge creation (Nonaka & Takeuchi, 1995). Nonaka emphasised the human and personal 
nature of knowledge as he described it as: “a dynamic human process of justifying personal 
belief toward the truth” (Nonaka et al., 2000). Bhatt (2002) affirms that knowledge monitoring 
and control is challenging for organisations. The organisation internalises only a part of the 
generated knowledge while the rest is internalised by individuals. Thus, capturing and 
codifying knowledge won’t help if the organisation failed to identify who can find and interpret 
this knowledge or to maintain the social networks required to get the work done (Parise et al., 
2006). 
Despite this eminent role of personal knowledge in organisations, the research on personal 
knowledge is quite scant. Cranefield & Prusak (2016) argues that our knowledge on individual 
approaches to KM is incomplete as little is known on how individual employees handle 
knowledge-related problems. The personal knowledge has so far received little attention by 
KM scholars in contrast to the organisational knowledge.  Although the organisational 
knowledge has been the focus of KM scholars, a proper explanation of individual-knowledge 
relationships is missing from KM literature (Tom H Davenport, 2016; K. Wright, 2005).  PKM 
is a relatively new topic that emerged in the recent years to manage knowledge efficiently 
(Gang & Yi, 2009).  Pauleen & Gorman (2010) confirms that little conceptual or empirical 
research has been carried out in the field of personal knowledge (Pauleen & Gorman, 
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2010).  KM literature traditionally explored KM  efforts of organisations and neglected to study 
how knowledge workers leverage their knowledge at the individual or personal level (Kassim 
et al., 2018). This growing need to manage personal knowledge is transforming KM from 
organisation-centric to worker-centric with more attention to the personal knowledge of 
individuals (Jarrahi et al., 2019).  
Knowledge measurement is not an exception from the lack of attention to personal 
knowledge. Whereas several models (e.g. Tobin’s Q (Tobin, 1969), Skandia Navigator 
(Edvinsson, 1997) and the IC Rating (Jacobsen et al., 2005)) offer a method to quantify 
knowledge assets within the organisation (Ragab & Arisha, 2013a), the extant literature 
provides little or no way to measure the personal knowledge of individual employees. The need 
of measurement to achieve effective management is not a new concept in management. Since 
Peter Drucker coined what is known as Management by Objectives (MBO), managers have 
adopted several measures for key organisational objectives leading to the notion that “If it can’t 
be measured, it can’t be managed” (Dumay & Rooney, 2011; Greenwood, 1981).  
The current study addresses this theoretical gap and proposes a framework to explain and 
measure the personal knowledge of individual employees enabling organisations to identify 
knowledge holders. As knowledge is context-specific that depends on a particular time and 
space (Hoe, 2006; Nikkhah et al., 2018; Nonaka et al., 2000; Vladova et al., 2016), the 
pharmaceutical manufacturing was chosen as the context for this study. The pharmaceutical 
industry is a knowledge-intensive sector, however, this sector has not received adequate 
attention from KM scholars. According to a Scientometric review carried out by the author of 
over 500 KM articles in 17 different industries, less than 1% of the reviewed research articles 
had empirical applications in the pharmaceutical industry (Ramy et al., 2018).   
It is worth noting that personal knowledge receives high consideration in pharmaceutical 
regulations. Pharmaceutical personnel are required to have adequate knowledge before 
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engaging in any manufacturing task (Volume 4: Good Manufacturing Practice Annex 6, 2010; 
WHO, 2005, 2014). The increasing business and regulatory pressures for managing knowledge 
make the ability to locate and visualise this valuable abstract resource within organisations 
vitally important. In addition, Pauleen and Gorman (2010) found that the effective management 
of personal knowledge leads to effective OKM. In other words, the identification of knowledge 
holders can enable management to utilise their knowledge to achieve organisational objectives. 
Moreover, effective measurement of personal knowledge could provide solid evidence that the 
organisation has the necessary knowledge capabilities to meet its regulatory commitments.  
In 2008, the ICH Q.10 pharmaceutical standard introduced KM as an enabler to the 
Pharmaceutical Quality System (PQS). Product and process knowledge is required to be 
managed throughout the product life cycle including the transfer of product and process 
knowledge between development and manufacturing as well as within or between 
manufacturing sites to achieve product realisation. This knowledge forms the basis for the 
manufacturing process, control strategy, process validation approach, and ongoing product 
improvement. KM is believed to facilitate continual improvement, the establishment of a state 
of control, and achievement of product realisation (ICH, 2009). The World Health Organisation 
(WHO) demands a science-based understanding of the KM process and Quality Risk 
Management (QRM) to support their quality decisions and regulatory commitments (WHO, 
2013). Similarly, the US Food and Drug Administration (FDA) encourages process 
understanding and KM initiatives for preventing and detecting data integrity issues (FDA, 
2016c). However, current guidelines provide flexible principles rather than rigid frameworks 
for KM (WHO, 2011b). Hence, the development of better understanding of the personal 
knowledge in the pharmaceutical industry would assist the progress and the implementation of 
the regulatory expectations based on a bottom-up KM approach.  
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Consequently,  in the absence of effective KM policies, Knowledge loss is a growing risk 
for business (Jennex, 2014). The author assumes that the lack of personal knowledge 
measurement frameworks would hinder the early identification of knowledge holders before 
they leave or retire. Warnings of the potentially catastrophic effect of the retirement of baby 
boomers and the subsequent knowledge loss have concerned both academics and practitioners 
(Trugman‐Nikol, 2011). The research-based pharmaceutical industry is one of the main high-
tech employers in Europe and globally. It employes a significant portion of knowledge workers 
in Europe making this industry a barrier against “brain drain” from the European continent 
(EFPIA, 2018). In 2013, the Pharma Engagement survey conducted by Randstad - a 
multinational human resource consulting firm -  showed that 37% of respondents from the 
pharmaceutical sector intend to leave their job and move to other employers in the next six 
months (Randstad, 2013) confirming the fears of the loss of knowledge holders in this 
particular sector. 
 
Research Aim and Questions  
A research question is a fundamental element of research work, serving to narrow down the 
focus of the study and therefore, must be clear and well-formulated (Bryman, 2015). This 
research encompasses one major research question to address the overarching  research aim: 
o RQ: How is the personal knowledge conceptualised and measured in the 
pharmaceutical manufacturing context? 
The study seeks to examine the Personal Knowledge (PK) measurement in the under-
researched context of pharmaceutical manufacturing. The following represents the research 
aim: 
Exploration, development and validation of a personal knowledge measurement 
framework in the pharmaceutical manufacturing context. 
CHAPTER 1: Introduction 
 1-8 
Research Objectives 
Objective 1 Gain an in-depth understanding of the current practices of the personal knowledge 
management and measurement focusing on the pharmaceutical manufacturing context.  
 
This objective is tackled in two phases of this study: the literature review and the exploratory 
interviews. A literature review is needed to provide the necessary awareness and ability to 
interpret the published knowledge. It enables the researcher to identify potential contradictions 
and address the gaps in the existing theories (Jesson et al., 2011). Both quantitative and 
qualitative approaches are used in this thesis to identify and map the growing research trends 
in the PKM and knowledge measurement. This review provides an in-depth understanding of 
the existing theories and frameworks that have been developed by previous researchers.  
As the study adopts an industry-specific context, the review included a contextual chapter 
to review the KM literature in the pharmaceutical industry and explore the regulatory 
expectations. The pharmaceutical industry is a highly regulated industry (Calnan et al., 2018). 
KM is recently seen as a better way for proactively managing patient risk and making better 
risk-based decisions. Historically, and up until the release of the ICH Q, 8, 9, and 10 standards, 
pharmaceutical regulators paid more attention towards science and risk-based approaches for 
drug manufacturing and control. Concepts such as “science” or “product/process 
understanding” routinely replaced the word “knowledge” (Calnan et al., 2018). In 2008,  the 
International Conference on Harmonization (ICH) described KM along with quality risk 
management as the enablers of pharmaceutical quality systems (ICH, 2008).  
Moreover, the WHO dedicated a special annex (TRS 961 Annex 7) for technology transfer 
in pharmaceutical manufacturing (WHO, 2011b). Similarly, several international regulatory 
bodies issued regulations for managing and regulating knowledge and ensuring its 
communication and transfer (e.g. FDA, 2016; WHO, 2016). As the proposed measurement 
framework is designed to work in the pharmaceutical industry, the review of all relevant 
regulatory guidelines is necessary to understand the regulatory expectations of authorities and 
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compare it with the current practices. The study addresses the gap between regulatory 
requirements (regulators) on one hand and KM research (academics) and application on the 
other (practitioners). 
Finally, the researcher’s objective of the exploratory phase is to discover the current 
practices and unveil the underlying truth or the inner character of the phenomena under study. 
The study combines the knowledge extracted from literature with primary data collected from 
industry experts to draw a clear picture of KM practices in pharmaceutical manufacturing with 
a particular focus on personal knowledge measurement. This picture reflects not only the in-
field interpretations of regulatory guidelines about KM but also the level of maturity of KM in 
the pharmaceutical industry. It also assesses the value of the personal knowledge measurement 
among knowledge holders in the pharmaceutical sector. 
 
Objective 2 The development of a personal knowledge measurement framework for knowledge 
workers in the pharmaceutical manufacturing context. 
 
Identification and critical analysis of the extant frameworks is a necessary step that proceeds 
the framework development phase. This step outlines the commonalities that can be identified 
as well as the gaps to be addressed. As the  study of the personal knowledge is a relatively new 
field of research (Cranefield & Prusak, 2016), particularly in the pharmaceutical industry, both 
primary data collected during the exploratory study, along with learnings from previous models 
are utilised to develop a new personal knowledge measurement framework for the 
pharmaceutical manufacturing sector. The developed framework offers an explanation of the 
different elements and manifestations of personal knowledge in the featured context. 
During the exploratory phase, the main constructs of the measurement framework are 
identified and refined to build the main constructs of the measurement framework. The next 
step is testing of the proposed constructs in the validation phase. The study sheds light on 
knowledge measurement process in KM literature. An abductive approach is taken where the 
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researcher engages both the extant literature with the exploratory study findings in what is 
known as “dialectal shuttling” (Bryman & Bell, 2015) to develop the measurement framework. 
The developed model would be tested in the subsequent deductive phase. 
 
Objective 3 Validate and optimise the proposed PK measurement framework in the 
pharmaceutical manufacturing sector.  
 
Representing the final phase of the empirical study, the conceptual framework, developed 
during the abductive phase, is tested and validated through a survey of a suitable sample of 
practitioners from the pharmaceutical industry. After the identification of the factors 
underlying the personal knowledge, Confirmatory Factor Analysis (CFA) is employed to test 
and optimise the proposed framework. CFA is a widely-used statistical tool in the 
organisational sciences (Crede & Harms, 2019). CFA is a technique of Structural Equation 
Modelling (SEM) with a particular focus on the analysis and measurement of priori 
measurement models. This means that the number of measures and their relationship with the 
underlying factors must be specified before analysis (Kline, 2015).  
At the end of the validation phase, the proposed framework would be assessed for its 
applicability within the pharmaceutical manufacturing sector. More details about the validation 
process are included in chapter four. 
 
Operational Defintions 
Knowledge:  can be defined in this report as “a dynamic human process of justifying personal 
belief toward the truth” (Nonaka et al., 2000). 
Knowledge context: is the circumstances in which knowledge is produced, transferred, and 
applied (Lisciandra & Herfeld, 2019). This research is conducted in the pharmaceutical 
manufacturing context. 
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Knowledge workers: are those workers who think for a living and their main capital is their 
knowledge (Thomas H Davenport, 2005). In this report it refers to the qualified employees 
(e.g. chemists, pharmacists, biologists and engineers) working in the pharmaceutical 
manufacturing in technical roles. 
Manufacturing: According to the WHO technical report (Series 986, Annex 2), manufacturing 
is defined as “all operations of purchase of materials and products, production, quality control, 
release, storage and distribution of pharmaceutical products, and the related controls” (WHO, 
2014). 
Measurement is the act of collecting data to quantify the value of a business metric (tangible 
or intangible) (Evans & Lindsay, 2013). 
Personal Knowledge (PK): this term is used within this report to refer to the knowledge held 
be individuals. PK and individual knowledge (IK) are used interchangeably in this report.  
 
Report Layout 
The outline of this report is comprised of eight chapters as follows: 
1. Chapter One introduces the research project and its objectives and outlines the structure of 
the thesis. 
2.  Chapter Two is a comprehensive review of the theories of the Personal Knowledge, PKM 
and knowledge measurement frameworks. This is the main literature review chapter of the 
thesis. 
3. Chapter Three presents a contextual chapter that reviews KM in the pharmaceutical 
industry. It also focuses on the regulatory expectations of the different regulatory authorities 
regarding KM. Different knowledge processes and themes are classified in a comprehensive 
taxonomy and the main approaches for developing knowledge assessment measures are 
identified. 
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4. Chapter Four describes the research methodology adopted to address the research 
questions. Based on the critical realistic stance of the research, the mixed-method research 
design is discussed and justified for its ability to achieve the research objectives in an inclusive 
manner. A research plan of five distinct stages is detailed by elucidating the aims, methods and 
techniques used in each stage. 
5. Chapter Five investigates conceptualisations of personal knowledge and the current status 
of knowledge measurement in pharmaceutical organisations. This chapter encompasses a 
thematic analysis of a set of interviews conducted with a number of pharmaceutical industry 
experts. Thematic analysis is utilised at this stage for data analysis and the interpretation of key 
patterns and associations. The conceptual framework is developed at the end of this chapter in 
light of the current literature and the primary data. 
6. Chapter Six presents the results of the quantitative phase. The conceptual model is tested 
in a suitable sample of pharmaceutical practitioners.  The collected data is used to validate and 
optimise the proposed models using confirmatory factor analysis. 
7. Chapter Seven is the discussion chapter where the findings are critically examined and 
relevant literature is consulted. Moreover, the theoretical and practical implications of the 
research are approached. Limitations and future research opportunities are tackled at this 
chapter. 
8. Chapter Eight is where the conclusion of the research and the anticipated contribution to 
knowledge are presented. 
Summary and Conclusion 
The first chapter introduces the research phenomena and provides an overview of the 
research rationale, aims, research questions, research objectives, operational definitions and 
the thesis layout. The next chapter will demonstrate the PK and knowledge measurement 
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Introduction 
Research in “knowledge” is as old as humankind. Over centuries and millennia, 
philosophers were concerned with the search for the ontological interpretations of the word 
“knowledge” (Zaidan, 2012). Epistemology is a stand-alone branch of philosophy concerned 
solely with the theory of knowledge (Lehrer, 2018). In his dialogue with Socrates and 
Theaetetus, Plato introduced his definition of knowledge which is commonly translated as 
“Justified true belief”.  In spite of the criticism of Plato’s classic definition (e.g. Gettier, 1963), 
it is still widely accepted (Rechberg & Syed, 2014). According to this definition, a person can 
claim he/she knows that (P) only if that (P) is true because false knowledge is not possible. 
He/she also believes that (P) and this belief is justified.  In other words, “There is objective 
knowledge if there is a body of propositions which are true and which it is rational to believe” 
(Dawson, 1950).  
Knowledge is a social process (Edwards, 2015a; Sense, 2007). It is worth noting that, the 
western epistemology often demonstrates a static non-human view of knowledge. This 
understanding fails to address the social and context-specific nature of knowledge. If 
knowledge loses its context, it is nothing more than information.  This leads to a definition of 
knowledge as “a dynamic human process of justifying personal belief toward the truth” 
(Nonaka et al., 2000). Knowledge is a state of conscious contact of the person with reality 
(Zagzebski, 2017). It can be also presented as information, professional insights, values, 
experience and context (Thomas H Davenport & Prusak, 1998). Knowledge also implies 
having a special competence, acquaintance with someone or something as well as the 
recognition of something as information (Lehrer, 2018). To make matters more complicated, 
13 distinguishable uses of the phrase ‘to know’  were outlined by Mingers (2008) emphasising 
the notion that there is no one form of “knowledge”. In this dilemma of definitions, the highly 
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cited definition by Nonaka, Toyama and Konno (2000)  is the adopted definition of knowledge 
throughout this report as it magnifies the humanistic and personal nature of knowledge. 
In the last decades, the growing interests in information science and bibliographic materials 
contributed to the emergence of joint frameworks for data, information, knowledge and 
wisdom to explain the underlying connections (Bernstein, 2011). One of the commonly 
accepted illustrations for the interrelationships between data, information, knowledge and 
wisdom is “Knowledge pyramid” or “DIKW hierarchy” (Ackoff, 1989). Wilson’s processing 
hierarchy is another illustration of the knowledge pyramid incorporating decision and action 
as the ultimate purpose of knowledge (Edwards, 2015b; Wilson, 1996). However, inaccurately 
defining data, information and knowledge by each other presented a logical fallacy in the form 
of circular definitions (Liew, 2013). For the purpose of this research, data can be defined as a 
stream of raw facts or simply a flow of events and/or transactions that can be captured by 
organisational systems (Laudon & Laudon, 2016). In order to generate information from this 
data, data must be processed and organised into categories which are meaningful and useful to 
users.   Knowledge can be extracted from the generated data in the form of patterns, contexts 
or rules. The collective capability of applying knowledge to solve problems is called “wisdom” 
which includes when, where and how to apply knowledge (Laudon & Laudon, 2016). At the 
economic level, knowledge is distinguished from other resources within the organisation by 
non-excludability and non-exhaustibility and consequently a higher risk of knowledge 
spillover to competitors who did not share the cost of knowledge creation (Arrow, 1962; 
Audretsch & Keilbach, 2007). Arrow (1962) emphasised that in the absence of legal protection 
to propriety information, it cannot simply be sold as a commodity in an open market. While 
full monopoly can offer the needed protection, it would ultimately lead to inefficient allocation 
and exploitation of information resources (Arrow, 1962). The ability of an organisation to 
incorporate and utilise the transferred knowledge to create value is known as the Absorptive 
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Capacity (ACAP) (Carayannis, 2012). However, the success in exploiting the transferred 
knowledge is a function of prior knowledge of the organisation as it is necessary to evaluate 
the acquired knowledge and to use it effectively. The prior knowledge includes (but not limited 
to) basic skills, languages and awareness of modern technologies (Cohen & Levinthal, 1990). 
In the next sections, the researcher will explore the prevalent trends of personal knowledge 
and knowledge measurement literature. This review is deemed to provide a working definition 
of personal knowledge, to outline the main processes of PKM and to review the prominent 
knowledge measurement efforts. 
 
Knowledge and Personal Knowledge  
Personal knowledge can be understood as skills, talents and expertise necessary to handle 
many situations. It allows the person to solve personal and organisational problems and 
consequently to access new markets and to use new technologies that need specialised expertise 
(Tajedini et al., 2018). Personal knowledge is particularly concerned with knowledge held by 
an individual employee in an organisation in contrast to the collective knowledge held 
commonly by a group (Chua, 2002; Hoe, 2006). 
Personal knowledge is not only raw data but a complex spectrum of talents, innate abilities, 
insights, facts, connections and experiences that generates human decisions, insights and ideas 
(McLaughlin & Stankosky, 2010). It can refer also to the legitimate and personal beliefs of an 
individual that enable him/her to respond to problems rapidly without the application of 
predetermined rules (Tajedini et al., 2018). It is acquired from our memories, documents, 
intuitions, personal contacts, books or learning from other colleagues (Razmerita, Sudzina, et 
al., 2009a). 
The relationship between knowledge and individuals has been discussed by several scholars. 
Knowledge is argued to be personal as it is stored in people’s head, created and embodied in a 
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person, applied or even misused by a person (Wright, 2005). Similarly, Davenport and Prusak 
emphasised that knowledge is created and applied in the mind of the knower ( cited in 
Razmerita, Sudzina and Kirchner, 2009).  By the same token, knowledge is inherently personal 
as all knowledge is in a way or another tacit or intertwined with tacit knowledge which is 
personal (Chatti, 2012). While knowledge can be “computerised”, this is considered as “a 
shadow knowledge” (Völkel & Haller, 2009) as most of the critical organisational knowledge 
remains in the minds of people (D. G. Pauleen & Gorman, 2010).  
However, some scholars defend the subjective nature of personal knowledge.  From this 
perspective, knowledge is personal as people interpret information differently and adopt 
different ways of reasoning (Razmerita, Sudzina, et al., 2009a). The researcher advocates a 
realist understanding of human knowledge where the knowledge has an objective reality 
independent of the person (Popper, 1966).  Similarly, Polanyi (1962) referred to the same 
controversy as the words “Personal” and “knowledge” might sound contradicting. He argued 
although true knowledge is universal, impersonal and objective, the apparent contradiction can 
be resolved by modifying the conception of knowledge. The personal participation of the 
knower in all acts of understanding does not make our knowing subjective as comprehension 
is not an arbitrary passive experience. Knowing is objective as it creates a contact with a hidden 
reality (Polanyi, 1962). In fact, knowledge is created, used and shared among persons in a 
dynamic human process to justify true personal beliefs (Nonaka et al., 2000; Nonaka & 
Takeuchi, 1995). The proposed understanding is that personal or human nature of knowledge 
does not contradict the objective reality of knowledge as it is only related to the generation and 
transfer dynamic processes, not the reality of what we know.  The knowing process is an active 
comprehension of things known that utilises certain skills (Polanyi, 1962) these skills are 
owned by the human. 
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The extant literature makes a distinction between two types of knowledge: personal and 
organisational knowledge. The ISO 9001:2015 standard defines the organisational knowledge 
as the organisation-specific information, gained by experience, shared and used to achieve the 
organisational goals.  Although the OKM is a must for any organisation seeking a competitive 
edge, personal knowledge is the essential core of KM (Zhang, 2009). The identification of 
personal knowledge is not only a personal responsibility but also an organisational one 
(Tajedini et al., 2018). However, it seems difficult to convince traditional companies by the 
value of personal knowledge for the success of OKM (Pauleen & Gorman, 2010). By the same 
token, the use of technology for OKM is insufficient for successful KM as the core knowledge 
assets reside in people (Zhang, 2009). Knowledge can be articulated in the formal business 
processes and patents but creative and innovative tacit knowledge is held by individuals 
(Pauleen & Gorman, 2010). It is believed that the bottom-up approach for PKM would reduce 
friction and mistrust associated with the traditional top-down KM (McLaughlin & Stankosky, 
2010).  From this understanding, PKM is not about self-promotion, but instead about making 
employees more effective in the organisation (Agnihotri & Troutt, 2009; Mittelmann, 2016). 
PKM is the path for successful KM in the organisation as a whole (D. G. Pauleen & Gorman, 
2010).  
Indeed, the idea of managing PK is intertwined with Drucker’s concept of “knowledge 
worker” (Drucker, 1999). A person holding mission-critical knowledge who uses knowledge 
to solve problems and make decisions is described as a knowledge worker (Mittelmann, 2016; 
Razmerita, Sudzina, et al., 2009a). A successful knowledge worker needs to develop critical 
thinking, problem solving, creativeness and decision making skills (Agnihotri & Troutt, 2009). 
In addition, effective communication, ability to learn, the ability for physical and virtual 
collaboration, critical thinking, digital skills and managing information in a particular context 
are recommended skills for a knowledge worker (Mittelmann, 2016). Those individual skills 
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are influenced by education and work experience (Wright, 2005) where the role of experience 
can be easily realised by comparing experienced and novice workers (Beijaard et al., 2000). 
PKM focuses on how people become knowledge workers in the organisation (Pauleen, 2009).  
Moreover, the nature of employment of knowledge workers is changing because a life-long 
job is no longer the norm (McLaughlin & Stankosky, 2010) and dramatic changes in the future 
of employment have taken place in response to  Information and  Communications Technology 
(ICT) breakthroughs that allow the computerisation of job tasks (Schmitt, 2016). In response 
to that, the knowledge worker has to act as a personal knowledge entrepreneur and engage in 
lifelong learning to stay competitive in the jobs’ market (Jarrahi et al., 2019; McLaughlin & 
Stankosky, 2010).  Last but not least, the performance (of a knowledge worker) is a proxy 
indicator of his/her knowledge and experience as it is continuously assessed through social 
interactions (Wright, 2005). This consorts with the common understanding of knowledge as a 
capacity to act and is being associated with human actions (Iazzolino & Laise, 2013; Nonaka 
& Takeuchi, 1995).  
Knowledge provides the power that managers need to overcome business challenges, shape 
and enhance performance. It can be either declarative/explicit knowledge (easy to be 
articulated and coded) or performative knowledge that can also be described as tacit (Spender 
& Marr, 2006). Tacit knowledge is context-specific, acquired through personal experience or 
internalisation and would reside within people rather than any physical media or information 
system (Hoe, 2006; Hsiao & Huang, 2019). Knowledge can be also classified as (1) context-
specific knowledge, about a specific setting, team or organisation; (2) technology-specific, e.g. 
programming knowledge; (3) a combination of both (Nikkhah et al., 2018). A similar 
classification of knowledge is made between the knowledge privately owned by the 
organization and the public knowledge which isn’t proprietary to any particular organization 
e.g. industry and occupational best practices (Hoe, 2006). Millar, Demaid and Quintas (1997) 
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suggested five types of knowledge: know-what, know-why, know-how, know-who and 
experiential knowledge overlapping with all other types. Similarly, Rechberg and Syed (2014) 
presented three dimensions of knowledge: practical knowledge acquired by doing things, 
emotional knowledge important for decision-making process and finally situational knowledge 
gained through experiences. A more comprehensive framework of knowledge and its 
representation is proposed by Mingers (2008) who distinguished between four forms of 
knowledge as follow: 
I. Propositional knowledge: it is merely related to common sense, direct perception, 
receipt of information and communication with others i.e. know-what.   
II. Experiential knowledge: received from previous individual experiences. 
III. Performative knowledge: usually involves some kind of physical motor skills or 
performance. It is about the know-how. 
IV. Epistemological knowledge: it is to know-why through formal or scientific methods 
of discovery. 
Early KM models illustrated knowledge as a thing or object that can be captured, stored and 
reused as managing information was the real focus rather than managing knowledge (Chatti, 
2012). Knowledge nowadays is mobile, global and difficult to contain (McLaughlin & 
Stankosky, 2010). Moreover, tens of frameworks describe KM processes and activities. A 
qualitative and quantitative content analysis of a total of 160 KM frameworks concluded six 
basic categories of KM processes: use, identify, create, acquire, share and store (Heisig, 2009). 
Other taxonomies included more activities such as refine and forget (Edwards, 2015a) or 
securing knowledge (Van der Spek & Spijkervet, 1997).  A review of 119 KM frameworks 
from around the world identified four contextual success factors that influence knowledge in 
the organisation: human factors (culture, people and leadership), organizational factors 
(structures and processes), information technology, as well as management (strategy and 
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control) (Schmitt, 2015). Similarly, several processes are recognised specifically for the PKM. 
Jones (2009) suggests problem-solving, exploring and learning as core processes for PKM. 
PKM implied also the collection, absorption and innovative use of knowledge (Liu et al., 2017). 
PKM is often presented as a set of skills for problem-solving and decision making. These skills 
are (1) retrieving information; (2) evaluating/assessing information; (3) organising 
information; (4) analysing information; (5) presenting information; (6) securing information; 
and (7) collaborating around information (Agnihotri & Troutt, 2009). It is noteworthy that 
problem-solving requires self-talk and/or engagement with a group (Jones, 2009) which 
supports the personal and social nature of knowledge. Pauleen and Gorman (2010) summarise 
PKM strategy in the following activities: management, lifelong learning, communication and 
interpersonal skills, use of technology, forecasting and anticipating. 
In today’s complex environment, knowledge workers are responsible for solving the non-
standardised organisational problems using their knowledge and experience (Mittelmann, 
2016). Solving problems outside of expertise was associated with limited performance and lack 
of confidence (Wright, 2005) confirming the value of experience in the decision-making 
process. Non-routine problems require ‘extensive conscious thinking’ which allow workers to 
identify and close gaps in knowledge or in other words to learn. It entails the critical thinking 
and iterations of deductive and inductive reasoning (Wright, 2005). This requires them to 
develop certain types of information-oriented skills such as critical thinking, innovation, 
flexibility, creativity, decision making and secured sharing (Agnihotri & Troutt, 2009; 
Mittelmann, 2016). Also, experience facilitates the effective recall, use or combination of 
relevant information to solve a problem in different contexts (Beijaard et al., 2000). The 
process of problem-solving can be envisaged as a process of sense-making where tacit 
knowledge is applied in a social and continuous manner and utilising person’s experience and 
worldviews. Effective problem-solving demands team building and collaboration and 
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interaction skills to make the right decision (Wright, 2005). Such higher-level skills in PKM 
have been traditionally called “wisdom” (Pauleen & Gorman, 2010). 
Communication and networking is another basic element in PKM including perception, 
intuition, expression, visualization, interpretation and design (Pauleen & Gorman, 2010). It is 
a must-have skill particularly in the modern virtual world of self-employment (McLaughlin & 
Stankosky, 2010). However, the organisational focus must be on the individual rather than the 
social networks and technology (Völkel & Haller, 2009). More recent studies focus on the 
human element or in other words the personal and cultural dimension of KM (Sense, 2007).  
For instance, Personal Knowledge Network (PKN), as distinct from the traditional view of 
PKM,  considers knowledge a continuous creation of personal networks (Chatti, 2012).  Unlike 
the (inter-)organizational networks that are assembled for the duration of a specific project, 
personal networks develop gradually and remain beyond the project boundaries (Grabher & 
Ibert, 2006). Those external personal knowledge networks refer to knowledge interactions 
between individuals in different organisations, who know each other personally and interact 
formally and informally beyond the official work duties. The strength of such networks can 
influence the knowledge sourcing process and can imply a trade-off between maintaining a 
high number of weak ties versus few strong ties (Huber, 2013). In contrast to common notion, 
studies reveal that local contacts are not socially and cognitively closer than non-local contacts. 
Essentially, the social proximity can be maintained over spatial distances (Huber, 2012). It is 
worth noting that social networking usually results in  “know-who” type of knowledge (Jarrahi 
et al., 2019). The “know-who” is a form of tacit knowledge that is difficult to find in firm’s 
yellow pages but rather in more fluid personal interactions (Grabher & Ibert, 2006). 
The personal knowledge identification is crucial for a successful implementation of KM in 
organizations since personal knowledge identification is not a personal concern but rather an 
organizational one necessary for optimal and efficient knowledge application (Tajedini et al., 
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2018). One effective approach to manage personal knowledge is to locate the workers with 
particular knowledge (Gang & Yi, 2009). This agrees with the notion that it is impossible to 
manage assets that are not measured (McLaughlin & Stankosky, 2010). However, finding 
personal knowledge can be a big challenge within the organisation. According to some studies, 
knowledge workers are unable to locate their own documents (rather than others’ knowledge)  
in 50% of the cases (Agnihotri & Troutt, 2009). The awareness of personal knowledge would 
lead to the identification of skills and experiences that the individual needs to perform tasks 
and consequently improve his/her performance (Tajedini et al., 2018). The self-managing of 
personal knowledge is a characteristic for knowledge workers as work tasks and challenges are 
continuously changing (Völkel & Haller, 2009).  
Several approaches were adopted by organisations to find knowledge such as codification, 
knowledge mapping, network analysis and Personal Knowledge Registration (PKR) 
(Haraldsdottir et al., 2018). PKR is the registration process of personal (employees’) 
information into a central database to generate an overview of knowledge embedded in the 
staff that allow management to look for and find valuable knowledge about their employees 
(e.g. education; language, information technology, writing or mentoring skills; participation in 
courses and conferences; teaching experience, former work experience and communication 
skills). However, the incoherent (or not updated) registration of employee’s personal 
knowledge on automated PKR systems limits its value for the organisation (Haraldsdottir & 
Gunnlaugsdottir, 2018). A proper knowledge culture would facilitate access, storage and 
update of knowledge that has a potential value for the organisation. Without an efficient 
extraction process of the identified and organised knowledge, the organisation would fail to 
utilise this knowledge and might fall into knowledge forgetting (Tajedini et al., 2018).  
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Figure 2-1 Personal Knowledge Review Themes 
Finally, knowledge management must be distinguished from Human Resource Management 
(HRM). In fact, effective HR practices are considered as enablers for a successful KM in the 
organisation (Currie & Kerrin, 2003; Jimenez-Jimenez & Sanz-Valle, 2013; Klumpp et al., 
2013).  Knowledge oriented HRM practices are deemed to encourage knowledge dissemination 
and re-use (Jimenez-Jimenez & Sanz-Valle, 2013). At the same time, without the proper 
knowledge, HRM won’t make the right decisions (Arun Kumar, 2016). Similarly, there is often 
a confusion between Human Capital (HC) and HRM which is concerned with the management 
of HC,  and the former which is the blend of unique attributes of employees  (Chrysler-Fox & 
Roodt, 2014). HC plays a mediator role between HR practices and performance (P. M. Wright 
& Mcmahan, 2011). It combines knowledge, skills, experiences and individual capabilities of 
employees and management (Agostini & Nosella, 2017). The value of HC comes from its direct 
impact on organisational performance. HC can have a positive impact on a company’s RC due 
to the skills and competencies of employees that are believed to enhance the firm’s reputation 
and attract new collaborations. Together with structural capital, it is also believed to enhance 
innovation and strategic renewal (Agostini & Nosella, 2017; Vidotto et al., 2017).  
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Figure 2-2 HRM and KM 
Adapted from Kumar (2016) 
 
Knowledge Measurement 
A literature review is a critical analysis of a published body of knowledge to interpret what 
is known about a research field and to identify gaps in the existing knowledge (Jafari & 
Kaufman, 2006; Jesson et al., 2011). A review of “knowledge measurement” frameworks was 
found necessary to understand the meaning of measurement in KM context. First, a review 
protocol was created. A set of review questions and search strings (Table 2-1) were developed 
after a brainstorming session in order to outline the frames of the review process as follows: 
a. What are the current trends of knowledge measurement in business literature? 
b. How is knowledge measured at an organisational, group and individual level? 
The inclusion criteria included English-written, refereed articles, from peer-reviewed 
journals in business and management field. A total of 138 articles were collected from TU 
Dublin library electronic databases “TU Dublin Summon”. TU Dublin Summon is a search 
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collections include but not limited to: Emerald Insight, Science Direct, Sage Journals Online 
and Scopus together with tens of other resources in different fields (DIT, 2018). Last but not 
least, references in the found articles were further examined to find more relevant papers that 
would contribute to the review even if not fulfilling the inclusion criteria e.g. not from the 
mentioned databases, not journal article, etc. The search results were sorted based on relevance 
to the search strings and manually filtered according to the inclusion criteria. The following 
are the main themes in the reviewed literature. 
Table 2-1 Search Strings 
Concept Search string (s) 
Intellectual capital 
intellectual capital in 
pharmaceutical 
IC in pharmaceutical 
Human capital  
human capital/ determinants human capital /pharmaceutical 
human capital/measurement Human capital/ assessment 
Relational capital 
relational capital determinants relational capital/ assessment 




knowledge/ measurement / 
pharmaceutical 
IC/ measurement 






elements of individual knowledge 
individual knowledge assessment 
Intangible assets measurement /intangible assets / pharmaceutical 
Pharmaceutical 
knowledge 
Pharmaceutical knowledge  
Areas of expertise/pharmaceutical 
Measuring Talent Talent/Measurement talent/ assessment 
 
2.3.1 Measuring knowledge at the organisational and group level: 
 
The literature has highlighted that the organisations that employ skilful, knowledgeable and 
innovative employees and at the same time develop good infrastructures and systems are 
performing better (Chahal & Bakshi, 2016). What’s more, it has been argued that effective 
management of IC, in general, has a positive influence on business performance (Sharabati et 
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al., 2010).This may explain the growing attention towards intellectual capital in academia and 
industry (Chahal & Bakshi, 2016). The history of intellectual capital research includes 
prominent scholars who developed and introduced this area of research. In the eighties, Karl-
Eric Sveiby introduced the concept of intangible assets to management in Northern Europe and 
Scandinavia. Thomas Stewart followed in 1997 with his popular book “Intellectual Capital: 
The New Wealth of Nations” in 1997. This was accompanied by contribution from a number 
of brilliant minds proposing new accounting practices this time to measure and manage firms’ 
intangible assets e.g. Kaplan & Norton‘s Balanced Scorecard approach in 1996, and Sveiby & 
Edvinsson’s Intellectual Capital methods in 1997 (De Beer & Barnes, 2003).  
Indeed, the world’s modern economy has transformed from an economy of tangible assets 
to a new order where intangible resources such as knowledge and competencies are prevailing.  
With the aid of ICT, knowledge is increasingly recognized as a commodity where the 
knowledge agents have grown to global levels (Dumay, 2009). The measurement of IC at an 
organisational level requires monetary metrics which are repeatable and quantifiable that did 
not exist in the traditional accounting practices. Instead, broad terms such as “goodwill” have 
been used to refer to IC. Goodwill is not exactly the IC although it includes it in addition to 
other intangible assets. The need to measure intensifies when an organisation is involved in a 
merger, information alliance or even issuing shares. For instance, Watson-Wyatt, one of the 
biggest HR consulting companies, referred to the relationship between human capital within 
the company and its financial performance.  In order to reflect the value of the company-owned 
IC on its stock price, IC must be valued and disclosed (De Beer & Barnes, 2003).   
On the other hand, a firm’s intellectual capital can be classified into organisational or 
structural capital, human capital and relational capital. The Human Capital (HC) includes 
individual knowledge, skills, abilities, attitudes and due to its weight in literature, it will be 
discussed in more details in a separate section. Structural Capital is the component which 
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remains within the organisation when employees leave e.g. patents, networks, procedures and 
management processes. Relational or Customer Capital refers to external relationships with 
third parties of relevance to business life such as customers and vendors. Examples for that 
may include brand, customer loyalty, distributions channels, favourable contracts (Bueno et 
al., 2014; De Beer & Barnes, 2003; Keong Choong, 2008). While human capital can be 
assessed based on management and HR capabilities, structural capital reflects the innovation 
and internal process capabilities. However, networking capabilities and reputation are 
indicators of relational capital of a firm (Anatolievna Molodchik et al., 2014). The 
measurement of relational capital indirectly protects firm’s relationships with its stakeholders 
not to be lost to market rivals (Hosseini & Owlia, 2016).  
Despite the famous maxim “If it can’t be measured, it can’t be managed”, IC measurement 
is still a controversial discipline. Edward Deming considered running a company on visible 
numbers only as a deadly sin. He argued that important things could not be measured as they 
are either unknown beforehand to the observer or their importance has not been yet established 
(Deming, 1982). However, measurement is a potential enabler to control, evaluate and improve 
processes (Ahmed et al., 2006). While it is relatively easy to describe the IC qualitatively, a 
quantitative measurement is a big challenge for any organisation. Measurement is traditionally 
defined as “the assignment of numerals to the properties of objects or events according to 
rules” (Bandalos, 2018). The main issue with the measurement of social phenomena is its 
dependence on proxies and assumptions. It is not as accurate as applied science either (Sveiby, 
2010). Measurement is required but as part of the IC reporting process not to be confused with 
other intangible assets in the balance sheet. The development of an accounting framework for 
IC is an ongoing journey for academics and practitioners with no one answer for the dispute 
between accounting and narratives of IC mobilisation (Dumay & Rooney, 2011). Albeit 
numerous frameworks were developed over the last two decades for IC measurement, it is 
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incompletely implemented. Few companies have implemented these frameworks, and fewer 
reported any benefit. Even worse, some leading companies in the development and 
implementation of IC measurement, such as Skandia, have abandoned the whole initiative 
(Serena Chiucchi, 2013). 
The general concept of IC valuation that any excess value over the company’s book value 
can be truly attributed to its intellectual assets (Bramhandkar et al., 2007). The four main 
approaches for valuation of knowledge assets in accounting and management literature are:  
• A scorecard describing and not necessarily measuring the value of intellectual 
assets through a set of both financial and non-financial indicators. 
• IC expense-investment methods that measure certain IC expenses as a proxy 
indicator of IC investment and knowledge capital earnings,  
• Assessing the overall influence of interactions among IC components within the 
organisation generally through the gap between market and book value, 
• Finally, the measurement of knowledge per individual and using it to calculate the 
aggregate IC per the whole organisation (Forte et al., 2017).  
Kianto et al. (2018) highlight four critical themes that should be better 
understood about knowledge for any successful IC measurement model: multi-
dimensionality, human agency and action, contextuality, as well as temporality and 
dynamics. Discounted cash flow was also considered an evaluative tool for 
measuring intangible assets (Russell, 2016a). However, financial measures of IC 
has been long criticised for obscuring where the problem exists and what should be 
done to solve it (Kannan & Aulbur, 2004). It is worth noting that the concept of IC 
measurement was also expanded to cover entire geographic regions rather than 
organisations as a proxy for the regional value creation dynamics (Schiuma et al., 
2008).   
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Generally speaking, four main methodologies have been developed for organisational 
knowledge measurement:  
a. Financial methods: utilising financial models to calculate company’s IC value  e.g. 
Tobin’s Q and Economic Value Added; 
b.  IC methods: splitting company value to smaller categories through IC classification, 
development of quantitative metrics and financial valuation e.g. the Skandia navigator ; 
c.  Human capital methods: considering human capital as a key component of IC e.g. HR 
scorecard and Human Capital Index (HCI); 
d. Performance methods: focusing on the impact on knowledge on performance perhaps 
through statistics on KM systems’ use and effectiveness (Matoskova, 2016).  The 
following is an overview of the major measurement frameworks of the organisational 
IC. 
Financial methods 
These methods measure the amount of IC in the organisation utilising accounting 
information from the balance sheet and the stock prices (Matoskova, 2016). One of the leading 
approaches is Tobin’s Q (Tobin, 1969). Tobin’s Q uses the market-to-book ratio (MTB) to 
evaluate the company’s intangible assets. It can also support investment decisions where the 
higher Q value discloses an intangible advantage for the rival company (Sveiby, 2010). Tobin’s 
Q replaces book value with the replacement cost of tangible assets in the MTB ratio (Forte et 
al., 2017). However, like other methods that utilised MTB ratio, Tobin’s Q method was 
criticised for being reflective to changes of the stock market rather than be a robust measure of 
IC (Ragab & Arisha, 2013). 
Human Resource Costing and Accounting (HRCA) is a process of measuring the cost and 
investments as well as quantifying the economic value of people in the organisation (Biswas, 
2013).   IC is estimated as the ratio of the contribution of human assets in the organisation to 
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their capitalised salary expenditures (Sveiby, 2010). The framework was criticised for the lack 
of reliability and dependence on a multitude of assumptions e.g. service life and forecasted 
revenues (Ragab & Arisha, 2013).  
Economic Value Added (EVA) is determined by deducting the sum of operating expenses, 
taxes and capital charges from the net revenue (Matoskova, 2016). EVA is a modified form 
from Market Value Added (MVA) model. In contrast, MVA quantifies the gap between what 
investors spent since the start-up of the company and the current value of their shares (Bontis, 
2001).  The unsupported assumption that an increase in EVA is a proxy indicator of the 
effective management of IC in an organisation makes the reliability of the measurement 
method questionable (Ragab & Arisha, 2013). Ante Pulic argues that the traditional 
performance measurement methods ( e.g. EVA) are not suitable to measure the IC performance 
as they do not really show how much value has been created (Pulic, 2000). 
Similarly, the technology broker evaluates the company’s IC through the diagnostic analysis 
of 20 questions followed by a specific audit questionnaire (Bontis, 2001).  It defines IC as the 
sum of four elements: market assets, human-centred assets, intellectual property assets and 
infrastructure assets (Sveiby, 2010). 
 Value Added Intellectual Coefficient (VAIC) introduced by Pulic (2000) as a methodology 
to measure the IC based on the concept of added value for knowledge-based organisations.  
Knowledge was traditionally used to increase the physical productivity. Now, the productivity 
of Intellectual work is the priority.  From this perspective, IC is not a collection of assets, but 
a set of knowledge workers who have the capability of transforming and incorporating 
knowledge into product and service that create value (Iazzolino & Laise, 2013). VAIC 
measures how much and how efficiently IC and capital employed add value employing: (1) 
capital employed; (2) human capital; and (3) structural capital (Sveiby, 2010). The value added 
is the value created per time unit by the knowledge workers. Thus, the Value Added Income 
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Statement can be usefully employed for measuring the value creation in a knowledge 
organization. The main criticism of this model is the mono-criterial vision of the firm 
performance measurement (Iazzolino & Laise, 2013).  Moreover, in a recent study employing 
VAIC as a measure of efficiency in the Islamic banking sector of Malaysia, VAIC failed to 
establish a consistent correlation with performance and productivity  (Aziz & Hashim, 2017). 
Finally, a measurement framework was proposed by Clausen and Hirth (2016) to examine the 
impact of intangibles on the firm’s value. The tool employs intangible-driven earnings to assess 
the intangibles value. Traditional proxies for intangible intensity such as R&D spending, R&D 
stock and number of patents were used to validate the measure (Clausen & Hirth, 2016).  
Scorecard methods 
Scorecard methods are based on non-financial measures of IC that are reported in a 
scorecard or a graph (Matoskova, 2016). Balanced Score Card (BSC) integrates 
multidimensional financial, customer; internal process, and learning perspectives where the 
measures for each perspective are  directed by the strategic objectives of the firm (Tuan, 2012). 
However, BSC neither measure the knowledge nor provide a direct link to KM (Ragab & 
Arisha, 2013b). 
Skandia Value Scheme and Skandia Navigator are other attempts to measure the IC led by 
the Swedish insurance company, Skandia. The tool involves numerical indicators that provide 
a balanced overview of financial and non-financial dimensions. The Navigator acted as a 
planning and follow up tool as well as for the individual performance appraisal (Edvinsson, 
1997). The tool has found its way to other enterprises e.g. Dow Chemical inspired by Skandia’s 
multidimensional conceptualisation of organisational value (Bontis, 2001).  The navigator 
consists of 164 indicators covering five components: (1) financial; (2) customer; (3) process; 
(4) renewal and development; and (5) human. It is worth noting that Skandia has stopped 
issuing its IC report (Sveiby, 2010).  IC Rating TM is an extension of the Skandia Navigator 
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model incorporating measures from the Intangible Assets Monitor; rating efficiency, renewal 
and risk that has found its way to consulting companies. 
Intangible Asset Monitor (IAM) measures four modes of creating value from three forms of 
intangible assets: People’s competence (education and experience), Internal Structure (the 
organisation, management, legal structure, R&D, software) and External Structure (brands, 
customer, supplier relations). The management is required to consider the organisational 
strategic objectives during the selection of IC indicators (Matoskova, 2016; Sveiby, 2010). The 
model has been criticised for being formatted for internal reporting and lacking a quantitative 
(overall) figure for IC (Ragab & Arisha, 2013). Likewise, Intangible Assets statement is an IC 
measuring framework for the public sector based on the IAM with Indicators of: growth, 
renovation, efficiency and stability (Sveiby, 2010) 
Value Chain Scoreboard is a  matrix of non-financial indicators assembled into three classes 
according to the innovation cycle: Discovery/Learning, Implementation, Commercialization 
(Sveiby, 2010). However, the model and indicators might not fit for all organisations (Ragab 
& Arisha, 2013). 
The IC-Index was first developed by Goran Roos at Intellectual Capital Services Ltd. Then 
shortly adopted by Skandia in its 1997 IC annual report. Since then, the model has been 
endorsed by other firms (Roos et al., 1997). The IC-Index consolidates multidimensional 
indicators in one index as a second-generation model. Thus, the changes in the index score are 
correlated with changes in the firm’s market valuation  (Sveiby, 2010). The model provides a 
managerial advantage as it avoids having a long list of individual indicators that need to be 
compared and investigated (Bontis, 2001). On the other hand, the discrepancy between IC-
Index and the market value over the long term outlined that the tool might be flawed and not 
reliable. Moreover, the model showed a limited ability to compare IC among different 
organisations (Ragab & Arisha, 2013). 
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ICU Report is an IC measurement framework designed for the higher education sector. It 
consists of three components as follow: (1) Vision of the institution, (2) Summary of intangible 
resources and activities, (3) System of indicators (Sveiby, 2010). The adopted indicators are 
classified into human, organisational and relational capital indicators. The main contribution 
of ICU is presenting IC information in a single document with homogeneous language and 
criteria. However, few shortcomings have been found.  For instance, some indicators require a 
further clarification and the synergies between teaching and research needs to be highlighted 
(Sáchez et al., 2009). Last but not least, Pirozzi and Ferulano (2016) proposed an integrated IC 
and leadership measurement model for healthcare organisations. The proposed framework 
assesses the performance based on the organizational, citizen-user/customer, human resources 
and social responsibility results. Also, the new integrated model facilitates the measurement of 
IC and financial/non-financial performance in a single measurement system. However, the 
framework is limited to healthcare non-profit organisations (NPOs) and application outside 
this sector may imply further modifications (Pirozzi & Ferulano, 2016). 
Knowledge Management Evaluation Methods  
This section can be seen as complementary to the IC measurement process. As investments 
in knowledge management dramatically increased, the need to formally track and capture the 
knowledge developments within organisations is growing too.  Knowledge maturity level 
reflects the capabilities within the organisation and how it influences the KM processes  
(Khatibian et al., 2010). Maturity assessment frameworks can be also seen as an internal 
benchmarking that motivate businesses to embrace successful KM practice allowing strengths 
to be shared and consolidated. Furthermore, they can be an enabler for product and process 
understanding and continuous improvement with a direct effect on quality, innovation and 
employees’ development (Jochem et al., 2011). KM can be also presented as an approach to 
achieve corporate sustainability. This implies the implementation of a methodological 
CHAPTER 2:  Personal Knowledge and Knowledge Measurement 
 2-35 
approach for managing knowledge. That is to say, KM maturity models enable corporate 
sustainability through providing the necessary structure for assessment and benchmarking 
which in turn facilitate continuous improvement and enhance stakeholder value (Robinson et 
al., 2006). 
Several models were developed in order to evaluate the level of maturity of KM practices 
within organisations. Many of the proposed models adopt the Capability Maturity Model 
(CMM) proposed by Carnegie Mellon University (Oliva, 2014). Jochem, Geers and Heinze 
(2011) proposed five levels of maturity of KM based on knowledge use and renewal. These 
levels of maturity include either: initial with non-formal characters, repeated implementing 
proactive initiatives, defined with formally established processes, managed with quality-driven 
designs and finally optimised showing a sustainable knowledge-intensive process.  KM 
lifecycle within the organisation inspired business researcher to develop more models where 
the history of KM within the organisation predicts futures KM activities. For instance, an 
organisation’s lack of awareness of the need for KM qualifies it to stage zero on the KM 
maturity scale. The first stage of the KM lifecycle implies awareness but lack of actions to 
implement KM. The organisation is qualified to stage two of maturity when it is actively 
implementing knowledge management but not part of the organisation-wide strategy. It is more 
like isolated silos. The last stage of maturity is reached when KM becomes a part of the 
organisational strategy and routinely reviewed (Edwards et al., 2005). Similarly, STEPS 
framework offered a KM maturity roadmap passing through five stages: start-up, take-off, 
expansion, progression and sustainability (Robinson et al., 2006).  
Whereas previous models ignored the role of knowledge culture, Oliva (2014) implicitly 
outlined the role of culture oriented towards knowledge creation as well as the use of 
knowledge. Based on this understanding, his model distinguished between four levels of 
maturity: insufficient, structured, oriented and integrative. Last but not least, APQC’s levels of 
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KM Maturity SM is a diagnostic tool helping KM practitioners assess their KM programs. It 
consists of five levels starting from initiate, develop, standardise, optimise and finally innovate 
(Hubert & Lemons, 2017).  
On the other hand, KM performance methods measure the impact of knowledge. These 
methods can be classified into financial, non-financial and survey-based methods. The 
financial performance measures employ financial metrics to assess the performance of KM 
system such as stock process, profitability and ROI (Matoskova, 2016). A study of over 700 
Flemish manufacturing and service firms reveals an indirect positive impact of KM on the 
financial performance that  surpasses the KM implementation costs over the long term (Andries 
& Wastyn, 2012). 
Non -Financial methods evaluate the KM outcomes based on the responses to interviews or 
surveys. Thus, it depends on the respondent’s judgement and their perception of KM 
(Matoskova, 2016). Choy, Yew and Lin (2006) propose 38 metrics for measuring KM 
outcomes that can be classified into five categories as follow: (1) systematic knowledge 
activities; (2) employee development; (3) customer satisfaction; (4) good external relationship; 
and (5) organisational success. Other non-financial indicators are suggested such as increase 
in sales, reduction in cycle time or the number of complaints. However, the assumed correlation 
between these measures and KM effectiveness might not be established in all cases (Ragab & 
Arisha, 2013). Some of the performance methods focus on evaluating the performance of 
particular systems e.g. electronic knowledge repositories or electronic communities of practice 
(Matoskova, 2016).  
Evaluation of the success in some KM processes such as knowledge creation and knowledge 
sharing is another approach for KM performance measurement. In their study in the banking 
sector, Shih, Chang and Lin (2010) emphasise on the role of knowledge creation in the 
accumulation of human capital which in turn positively impact both structural and customer 
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capital. Likewise, a total of 914 survey responses from 14 Korean organisations were utilised 
to develop and validate a reliable and valid psychometric measurement model on 
organizational knowledge conversion and creation practices (Song et al., 2012). Knowledge 
creation is generally measured through monitoring the undertaken initiatives towards the 
generation of new ideas, new ideas that elaborate existing knowledge and the knowledge 
incorporated into new products (Mitchell & Boyle, 2010). 
The measurement of knowledge sharing can take the form of hard data measures such as the 
frequency of length of something (number of personal postings or contributions to meetings), 
as well as via surveys that examine the willingness to share knowledge and the underlying 
factors (Matoskova, 2016).  Wang (2013) developed a 20-item scale for knowledge sharing in 
Chinese cultural context based on knowledge donating measures and knowledge collecting 
measures (Wang, 2013). A similar study in the public sector (Dubai Police Force) used a 5-
point Likert scale to measure the attitude towards knowledge sharing, willingness to share 
knowledge, trust, organisational structure, leadership, reward, time, and information 
technology (Seba et al., 2012). Social network analysis (SNA) is concerned with knowledge 
diffusion at the group level. This includes network density analysis ( the number of actual links 
per network over the overall number of possible links) and average number of downward links 
(the span of control) (Matoskova, 2016). Su, Yang and Zhang (2017) have adopted a weighted 
network and knowledge diffusion efficiency measurement approach.  The new approach 
examined network topological parameters, knowledge collaboration level and knowledge 
collaboration relationship strength and has proved superior to traditional unweighted or 
subjective methods. 
Human Capital (HC) measurement 
HC can be understood through three key dimensions: knowledge either from training, 
education, experience or personal development; abilities as a way of doing things and 
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behaviours that lead individuals to do their tasks via mental models, paradigms and beliefs 
(Martín-de-Castro et al., 2011). To that end, Mehralian, et al. (2013) suggested three main 
indicators of HC in the Pharmaceutical sector: learning and education; experience and 
expertise; and innovation and creation. Human Capital Value Metric (HCVM) proposed wages 
as a proxy indicator of employee value assuming that qualified employees bring value above 
and beyond his/her wage (Bukowitz et al., 2004). A review of the major models in the last 60 
years revealed that the key indicators of HC in the organisation are talent, education, 
experience, knowledge, skills, attitudes, creativity and leadership (Vidotto et al., 2017).  
Regardless of the apparent significance of HC for business progress and its popularity in 
academic research, there are few consistent frameworks dedicated to measure it (Bukowitz et 
al., 2004; Mehralian et al., 2013b; Vidotto et al., 2017) which rarely provide any financial 
justification for investments in HC (Cantrell et al., 2006).  
Furthermore, the diversity of HC scales sheds light on the context-specific nature of HC 
measurement.  Having said that, the most appreciated measures for HC are those identifying 
the performance levers and evaluating HC contributions to the organisational value (Baron, 
2011; Robinson, 2009). Furthermore, company strategy was found to influence their choice of 
HC measures. For instance, innovation measures are more employed in differentiation-oriented 
firms, and efficiency measures are preferred in companies following a cost-leadership  strategy 
(Gates & Langevin, 2010). 
Vidotto et al. (2017) proposed a HC measurement framework relying upon three factors: 
leadership and motivation; qualifications; as well as satisfaction and creativity. Another scale 
from the Indian banking sector chose competence, creativity, manager’s attitude and staff 
attitude as dimensions of HC in addition to other dimensions describing RC and SC (Chahal & 
Bakshi, 2016). Family firms displayed some unique intangibles characterising their HC 
including leadership, self-motivation, entrepreneurship, feeling of membership, emotional 
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family component, creativity, skills, knowledge acquired from family members and knowledge 
owned by non-family members (Claver-Cortés et al., 2015). Watson Wyatt’s Human Capital 
Index® is another attempt to assess the HC based on five dimensions: rewards and 
accountability; workplace; recruiting and retention excellence; communication integrity; HR 
service technologies (Watson Wyatt, 2001). 
The British Civil Aviation Authority (CAA) developed a balanced scorecard to measure the 
HC based on three bases: external customer perception of CAA’s performance, achievement 
of objectives and assessment of staff expertise. The proposed measures included strategic 
performance measures, outcome measures (e.g. turnover rates, absence rate), operational data 
(e.g. number of training days) and workforce data (e.g. headcount, demographics). However, 
the adoption of CAA approach for HC measurement is challenging because of the time required 
for data collection and analysis (Robinson, 2009). Other studies distinguished between project-
based organisations in comparison with traditional businesses of repetitive operations as the 
temporary nature of projects implies different HC measures (Demartini & Paoloni, 2011). 
Proxy measures were also utilised as rough assessment tools of HC (Wright & Mcmahan, 
2011).  These diverse approaches advocate the context- specific nature of HC measurement as 
previously argued  by Robinson (2009) and Baron (2011). Regarding the design of the HC 
measurement tool, Massingham, Nguyen and Massingham (2011) advocated 360-degree peer 
review to minimise the bias associated with self-reporting assessments. 
Talent is typically noted as part of HC. Employees who have unique capabilities and possess 
a high value for their organisations are called “talents” (Nijs et al., 2014). Many organisations 
identify groups of high-potential talents (talent pools) through structured, semi-structured or 
even informal procedures. The identification includes a nomination process followed by an 
additional assessment of the nominees, e.g. leadership competency rating (Silzer & Church, 
2010). Despite that the global talent measurement market is expanding (over US$3 billion per 
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annum), talent measurement is a sophisticated process and many firms lack the necessary 
expertise to measure it (Bell, 2013; Nijs et al., 2014).  
2.3.2 Measure Knowledge at Individual Knowledge: 
While HC describes the knowledge within a group or the whole organisation, measurement 
of personal knowledge focuses on the knowledge of individual employees. Individual 
employees are envisaged as key players in knowledge management and development 
(Rechberg & Syed, 2014). However, the individual versus the collective distinction of HC is 
an arguable topic. On the one hand, macro-level scholars argue that HC is the aggregate of 
knowledge, skills and experiences owned by individuals. They argue that knowledge is scale-
free; it applies similarly either at an individual or organisation level (Faucher et al., 2008). On 
the other hand, psychologists and micro-level scholars advocate the synergistic effect of the 
aggregate of individuals, i.e. the unit-level knowledge is more (can be less) than the sum of 
each (Wright & Mcmahan, 2011).  Measures such as the replacement cost of tangible assets 
(Tobin, 1969), market share (Edvinsson, 1997)  or retention excellence (Watson Wyatt, 2001) 
are not suitable predictors of knowledge at the individual level. Taking into consideration the 
definition of knowledge as “a justified true belief”, the review of the IC measures in the above 
section (2.3.1) demonstrate that many of the employed metrics are not knowledge measures 
(e.g. market share, customers lost, IT expenses in Skandia Navigator). This supports the notion 
that the measures of the organisational knowledge and IC are not always accurate measures for 
the personal knowledge of individuals which in turn urge the need to develop specialised 
models for individuals. 
Davenport (1999) has envisaged an individual employee as a human capital investor who 
can invest his knowledge and gain profits. A high level of education (as a measure of 
knowledge) was associated with higher earnings (Davenport, 1999). Similarly, Schultz (1961) 
affirms that differences in earnings correspond closely to differences in education suggesting 
that one is the result of the other (Schultz, 1961). Yet the research on personal knowledge 
CHAPTER 2:  Personal Knowledge and Knowledge Measurement 
 2-41 
measurement is relatively scarce and measurement scales are considerably few. Measurement 
of Individual Knowledge (Mink) framework (Ragab and Arisha, 2013b) suggests ten individual 
knowledge indicators (IKI) in the organisational context: education, training, experience, IT 
literacy, business communications, business process interactions, personal network 
performance, creativity and financial indicators. It can be a tool for both internal monitoring 
and/or external presentation (Arisha & Ragab, 2013).  A standardised test can be another 
approach to measure knowledge at the individual level. However, this method is criticised by 
being limited only to the explicit knowledge component (Matoskova, 2016) in addition to the 
complexity of finding the right answers for the questions (Borgatti & Carboni, 2007). In order 
to overcome the latter problem,  Borgatti and Carboni (2007) proposed a consensus method 
that analyses the pattern of agreement among participants to a knowledge quiz.  
A situational Judgement Test (SJT) is another technique for measuring personal knowledge.  
SJT consists of a set of situations within certain professional context. In order to solve or react 
in these situations, the individual is supposed to possess certain knowledge. However, these 
methods were criticised for fakability and bias (Matoskova, 2016). Peeters and Lievens (2005) 
examined the impact of faking on the incremental validity of SJT in a sample of college 
students. The study found that faking significantly impacts SJT validity where students selected 
the more favourable responses to achieve higher scores (Peeters & Lievens, 2005). Finally yet 
importantly, know-how form of knowledge (performative knowledge), which is predominately 
tacit and acquired through experience, is generally evaluated via practical testing (e.g. success 
or failure in riding a bike and to which level) (Mingers, 2008). 
On the other hand, performance appraisal refers to the organisational HRM activities to 
assess employees, improve their performance, develop their competencies and justify 
rewarding (Fletcher, 2001). This process is often used to allocate bonuses, merit pay, employee 
promotions based on the periodic assessment.  The outcome has a direct impact on the 
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organisation and economy, such as the distribution of wages, who leads organizations, and who 
is laid off (Cappelli & Conyon, 2018). Different measures of performance are adopted 
including objective indicators (e.g. the number of units produced), subjective measures (e.g. 
relationship with customers) or a combination of objective and subjective measures. While 
objective measures are simple and standardised, they are not suitable to assess multitasking 
jobs. Subjective measures are flexible and comprehensive but they depend on the evaluator’s 
judgement (Bayo-Moriones et al., 2019).  
The performance measurement can take the form of self-assessment, feedback from co-
workers and customers or a direct assessment by manager(s) (Lloyd, 2009). Performance 
appraisal is apparently not a knowledge measurement process. Cappelli and Conyon (2018) 
argue that appraisal score is not a reflection of the employee’s initial human capital at the 
recruitment stage but it informs about the variance of his/her performance over time. However, 
knowledge is acquired over a longer period of time through individual processes such as direct 
experience and lifelong learning (Hoe, 2006; Mingers, 2008). Unlike performance appraisal, 
knowledge measurement aims to identify and allocate knowledge assets, benchmarking against 
other companies and monitoring the development of the firm’s IC overtime (Matoskova, 2016). 
Moreover, while performance appraisal is a standard practice in nearly all organisations (Ward, 
1997), the literature review reflects a sporadic implementation of different knowledge 
measurement approaches.  
 
Summary and Conclusion 
Measurement is a popular topic in KM literature; nevertheless, most of the measurement 
literature address the organisational level at macro-level. Either measurement of IC, HC or 
maturity models focus on the knowledge of the group, the whole organisation and sometimes 
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the entire region or society. Despite the growing interest in the PKM, relatively few studies 
focus on the personal knowledge of individuals in the organisational context, and even fewer 
aim to objectively measure it. Few papers in KM provided categorisation and anatomy of 
knowledge forms and its truth, e.g. Millar, Demaid and Quintas (1997) and Mingers (2008), 
but neither utilised this for identifying knowledge holders. The need to measure knowledge 
and identify knowledge holders is justified at both macro and micro-level. The context-specific 
nature of knowledge justifies the need to customise the measurement frameworks to one or a 
group of similar industries to avoid validity problems. This highlights an urgent need to 
develop a measurement framework considering the nature of the pharmaceutical industry. As 
knowledge measurement process is context-specific, as previously mentioned, chapter five (the 
exploratory study) will provide more insights about current measurement practices, the level 
of KM maturity, components of personal knowledge and the significance of its measurement 
from practitioners’ perspective within the pharmaceutical industry. 
In the next contextual chapter, the researcher will explore the prevalent trends of KM in the 
pharmaceutical industry with a focus on the personal knowledge. The regulatory expectations 
of the main global regulatory bodies are critically reviewed and compared with the trending 
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Introduction 
The acknowledgement of knowledge as a pivotal strategic resource in the current smart 
economy has impelled considerable organisational change in knowledge management (KM), 
where organisations endeavour to exploit their intellectual assets to drive value creation. This 
progressive movement by individuals and organisations to manage their intellectual assets 
developed into KM (Davenport & Völpel, 2001). The pharmaceutical industry is not an 
exception of this trend, not only as a knowledge-intensive industry but also as a leading 
economic partner with transcendent investments in innovation and research. According to the 
European Federation of Pharmaceutical Industries and Associations (EFPIA), the 
Pharmaceutical industry employs more than 750,000 employees in Europe, 16% of them 
working in pharmaceutical Research and Development (R&D). It was the preeminent sector 
regarding R&D intensity and expenditure as a percentage of net sales (15%) in 2016 followed 
by software & computer services (10.6%) and technology hardware & equipment (8.4%) 
(EFPIA, 2018). The pharmaceuticals and biotechnology sectors are among the top investing 
sector in R&D worldwide  according to the Industrial R&D Investment Scoreboard (European 
Commision, 2018). 
It comes as no surprise that major pharmaceutical regulatory authorities have realized the 
significance of KM. International Council for Harmonisation (ICH) recommends the 
management of drug and process knowledge from development and up to product 
discontinuation as an enabler of effective quality management systems. On the other hand, 
technology transfer between development and manufacturing, and within or between 
manufacturing sites is considered as an integral part of new drug product realisation (WHO, 
2011b). From this perspective, KM creates the basis for the manufacturing process, control 
strategy, process validation approach, and ongoing continual improvement (ICH, 2009). Food 
and Drug Administration (FDA) has paid close attention in successive guidelines to the 
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management of Electronic Records along with its efforts to enhance data integrity in 
pharmaceutical premises ensuring delivery of safe, effective and quality product to the patient  
(FDA, 2003, 2016b). 
Thus, as knowledge is another core product of the pharmaceutical industry (Riddell & 
Goodman, 2014), managing stocks and flows of knowledge in this sector emerges as a key 
economic and regulatory objective as well as a growing area of academic research. 
Nonetheless, some knowledge-intensive industries such as pharmaceuticals have not received 
adequate attention in industry-specific publications (Ramy et al., 2017).  With few other review 
articles surveying the applications of KM in specific fields (e.g. construction industry (Walker, 
2016), energy sector (Edwards, 2008) and public sector (Massaro et al., 2015), this contextual 
chapter comes as a comprehensive industry-specific systematic review of KM research within 
the pharmaceutical sector identifying key themes, addressing extant research gaps, assessing 
regulatory expectations, and providing an overview of the progress of KM with a particular 
focus on the role of PK.  
 
3.1.1 Systematic Review Questions 
A comprehensive, unbiased search is considered as one of the crucial differences between 
a traditional narrative review and a systematic review. Moreover, traditional reviews suffer 
from lack of thoroughness, inconsistency and bias by researchers that they are not always 
undertaken as a genuine piece of investigatory science (Jesson et al., 2011; Tranfield et al., 
2003). For this reason, the author committed to systematic review techniques in order to 
synthesize a reliable and enhanced knowledge stock as will be clarified in the methodology 
section. Several research papers in the field of KM have followed systematic review 
methodology as the basis of the review process for example: Costa and Monteiro (2014), 
Klammer and Gueldenberg (2016), and Massaro et al.  (2016). These papers were also taken 
into consideration while developing the review protocol. 
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In order to develop a systematic review, the author developed a set of research questions 
and a review protocol in the early stages of the review. The review questions are developed to 
achieve the first research objective and to gain an in-depth understanding of KM practices in 
the pharmaceutical manufacturing context. The proposed questions are believed to develop the 
researcher’s collective understanding of the field which is a pre-condition for doing good 
empirical research (Boote & Beile, 2005). Also, those questions are critical to the systematic 
review as the other aspects of the process flow from it (Tranfield et al., 2003). The questions 
embody a mixture of quantitative and qualitative review aspects. They are designed to provide 
a comprehensive overview where both the academic literature and industry-specific regulations 
are reviewed. Regarding the questions structure, questions are organized as a major question, 
followed by thorough minor questions. 
Q.1 How is the KM literature in pharmaceutical/biopharmaceutical industry developing? 
1.1. Which knowledge processes/ themes are predominantly studied by current research? Or 
what is the focus of KM process research in the pharmaceutical industry? 
1.2.What are the recent trends in co-authorship distribution and author affiliations? 
1.3.Which countries are leading in this track? 
1.4.Which department or function was more represented in pharma industry KM research?  
1.5.What are the most utilized research and data collection methods in pharmaceutical 
industry KM research?  
Q 2. What is the significance of the identified academic research themes from a regulatory 
perspective? Or What are the expectations of regulatory agencies with regard to the identified 
academic research themes? 
Q 3. What is the future of KM research within the pharmaceutical industry?  
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3.1.2 Review Methodology 
The high expectations of improving the quality of reviews through well-defined 
methodologies led to the development of systematic review protocols (Jesson et al., 2011). 
Systematic review protocol encompasses specific research questions, the population that is the 
focus of the study, the search strategy and terms for identification of the relevant studies. 
Studies that meet all inclusion criteria and manifest none of the exclusion criteria needs to be 
integrated into the review (Davies & Crombie, 1998; Tranfield et al., 2003). 
The author commenced his review by identifying the research questions. These questions 
are deemed to construct the pillars of the whole literature review (Jesson et al., 2011; Tranfield 
et al., 2003). After refining the review questions, the timeframe of review is set to be the last 
twenty years (1996-2016). This period represents the prosperous period of KM research (Ma 
& Yu, 2010; M. A. F. Ragab & Arisha, 2013). Furthermore, the timeframe took into account 
the relative novelty of online KM journals. According to Serenko & Bontis (2013) ranking of 
the KM journals, the top ranked four KM journals ( JKM, KMRP, IJKM and JIC) have been 
published online only since 1997, 2003, 2005 and 2000 respectively.  
The criteria for inclusion comprise peer-reviewed electronic business journals in the English 
language retrieved from the Emerald Insight and Science Direct database as the top KM 
journals are published on them e.g. Journal of Knowledge Management (JKM) and Journal of 
Intellectual Capital (JIC) (Serenko & Bontis, 2017). Peer reviewed journals are favoured 
because they are quality assured (Jesson et al., 2011). Search strings were synthesised from the 
top ranked keywords in two comprehensive keyword analysis studies in the KM discipline: 
Fteimi and Lehner in (2016) along with Ribière and Walter in (2013). Thus, potential search 
strings were enumerated based on relevance (Table 3-1). The list was updated during the search 
process. It was meant not to tightly plan the review process as this may inhibit researchers’ 
capacity to explore, discover and develop ideas (Tranfield et al., 2003).  
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Table 3-1 Review Search Strings List 
KM in pharmaceutical Knowledge sharing in 
pharmaceutical 
Knowledge creation in 
pharmaceutical 
Biotechnology knowledge Data mining in 
pharmaceutical 




knowledge measurement in 
pharmaceutical 
Knowledge transfer in 
pharmaceutical industry   
Articles that appeared in the research results were manually checked for relevance through 
title, keywords and abstract analysis. After the exclusion of duplicates, articles were screened 
against the inclusion and exclusion criteria by reviewing the titles and abstracts (Pati & 
Lorusso, 2018). If the pharmaceutical or biopharmaceutical industry was not the research 
field/sample, the article was excluded. Articles which cannot be classified under knowledge 
management research domain were also excluded. The exclusion criteria covered editorials, 
unpublished works and/or journals that do not have online domains (Table 3-2).  
Table 3-2 Inclusion and exclusion criteria 
Inclusion criteria Exclusion criteria 
KM theories and processes Not related to KM 
With applications in pharmaceutical industry Applied exclusively in other industries 
Peer reviewed journal articles Editorials and position papers  
In English language Articles that use languages other than 
English 
Published online between 1996 and 2016 From journals that don’t have online 
domains and unpublished work. 
 
A full-text assessment followed where the full-text articles were scrutinised to assess 
relevance to the review questions. The retained articles addressed a KM related topic 
exclusively in the field of pharmaceutical industry or in conjunction with other industries.  To 
mitigate the risk of bias of the reviewed studies  (Moher et al., 2015), 141 eligible articles were 
quality- assessed for the clarity of research objectives, adequacy of description of the data 
collection methods and finally the link between data, results and conclusion as advised by 
Kitchenham and Charters (2007). Four articles were excluded at this stage due to ambiguous 
methodology and irrelevance to the pharmaceutical industry. Ultimately, 137 articles were 
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retained for analysis after application of inclusion/exclusion criteria and quality assessment. A 
limited number of non-business journal papers (e.g. medical journals) and papers identified by 
cross-referencing citations were included during the review process (Figure 3-1).  
 
After acknowledgement of main themes and processes in KM literature; the identified 
themes were scrutinised in the regulatory guidelines of five major regulatory bodies. The 
reviewer collected all the published guidelines for the pharmaceutical industry on the official 
websites of World Health Organisation (WHO), FDA, ICH, The Pharmaceutical Inspection 
Convention and Pharmaceutical Inspection Co-operation Scheme (jointly referred to as PIC/S) 
and EudraLex- European Union (EU) Legislation. At the end, 128 guidelines were searched 
for KM related topics in light of the identified themes from the academic literature review. The 
Records identified through 
database searching (n=2046) 
Additional records identified 
through other sources (n=18) 
Records after duplicates removed 
(n= 1359) 
Records after titles 
and abstract screening  
(n= 141) 
Records excluded  
(n= 1218) 
Full-text articles 
assessed for eligibility 
and quality (n= 141) 



































excluded with reasons 
(n= 4) 
Figure 3-1 Systematic review process -PRISMA flow diagram (Moher et al., 2015) 
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analysis recognises the significance of research themes from regulatory perspective as well as 




Initially, findings indicate that KM in the Pharmaceutical industry has become a well-
established academic research area. Authorship trends show that approximately 93% of articles 
are published by academic researchers, while the remaining 7% are the product of practitioner 
work. A significant increase in collaborative research is also evident, as the number of co-
authored papers has increased from 62% to 85% over the past ten years. In order to identify 
the leading countries in the KM field, the relative contributions of 36 countries whose papers 
were included in this review are traced and ranked using the Equal Credit counting method 
(Chua and Cousins 2002; Lowry et al. 2007). The USA and UK were ranked highest with 
regards to productivity (18% and 11% respectively of all reviewed articles); followed by Iran 
(7%), Australia (7%) and India (6%) as shown in (Figure 3-2). It is worth nothing that country 
contribution in this research addresses the country of residence of the author not necessarily 
where the research was carried out. 
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Figure 3-2 Country Productivity 
From a functional perspective, more than 60% of the articles do not specify the particular 
department where the study was conducted. Among articles which do specify the function 
under study, 83% fall within pharmaceutical development and innovation functions in contrast 
to only 8% in production, 4% in sales and 4% in the supply chain. It is worth noting that 72 % 
of the reviewed papers were conducted exclusively in the pharmaceutical industry.  
In terms of Methodology, only 29% of the articles are literature review papers; while over 
70% are empirical studies employing one or more data collection methods, e.g. surveys (29%), 
case studies (10%) and interviews (17%) (Figure 3-3). 
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Research Themes 
 A hybrid method of quantitative keyword analysis and qualitative thematic analysis was 
proposed to identify the common research topics or themes. Over 20 concepts were used to 
code the articles according to the prevalent research theme. The most frequent themes and 
keywords (after exclusion of generic keywords, e.g. knowledge management, pharmaceutical, 
etc.) are presented in (Table 3-3). More than 20% of the reviewed papers included “Intellectual 
Capital” as the most frequently used keyword. Innovation, Knowledge Sharing and Knowledge 
Transfer come in the second, the third and the fourth rank respectively regarding keyword/ 
research theme frequency.  
Table 3-3 Themes and Keyword Analysis 
Rank Themes & K. 
processes 
Frequency Keywords Frequency 
1 Intellectual Capital 29 Intellectual Capital 27 
2 Innovation 25 Innovation 18 
3 Knowledge Transfer 14 Knowledge Sharing  10 
4 Knowledge Sharing 13 Knowledge Transfer 10 
5 Organisational 
Performance 12 New Product Development 9 
6 Organisational Culture 12 Research and Development 9 
7 Intellectual Property 10 Intangible Assets 8 
8 Knowledge Creation 9 Organizational Learning 7 
9 New Product 
Development 6 Organizational Culture 5 
10 Organisational 
Learning 6 Project Management 5 
The identified themes and keywords offer a birds-eye view of the KM landscape through a 
taxonomy of KM research in the pharmaceutical industry providing researchers with a map of 
the current literature and insights into future research. The paper presents a classification of 
KM publications into six areas: knowledge sharing and technology transfer, Intellectual 
Property Protection (IPP), knowledge measurement and Intellectual capital (IC) reporting, 
innovation and knowledge creation, organisational knowledge culture and structure as well as 
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pharmaceutical firm performance (Figure 3-4).  Table 3-4 presents the key articles under each 
of the featured themes. 
 



















































How IC Influences 
Performance
KM Strategies
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Table 3-4 Key articles under the featured themes 





(Yang et al., 2014); (Iwasa & Odagiri, 2004); (Boasson & Boasson, 2015); 
(Allarakhia & Walsh, 2011); (Sternitzke, 2010); (Kale & Little, 2005); 
(Hohberger, 2016); (Chávez & Víquez, 2015); (Russell, 2016a); (L. Bollen 
et al., 2005) 
Pharmaceutical 
Firm Performance 
(J.-K. Wang et al., 2006); (Mehralian et al., 2016); (Rémy Magnier-
Watanabe & Senoo, 2008); (Rémy Magnier-Watanabe & Senoo, 2010); 
(Rémy Magnier-Watanabe et al., 2011); (Remy Magnier-Watanabe & 
Senoo, 2009); (Lindner & Wald, 2011); (Guzman, 2008); (J. Evans & 






(Vishnu & Kumar Gupta, 2014); (Tahvanainen & Hermans, 2005); 
(SubbaNarasimha et al., 2003); (Singh & Kansal, 2011); (A.-A. A. Sharabati 
et al., 2010); (Palacios-Marques & Garrigos-Simon, 2003); (Pal & Soriya, 
2012); Narula2016; Naidenova2013; (Mehralian, Rasekh, et al., 2013); 
(Mehralian, Rasekh, et al., 2013); (Kamath, 2008); (Y.-C. Huang & Wu, 
2010); (Hine et al., 2008); (Ghosh & Mondal, 2009); (Erickson & Rothberg, 
2009); (Chizari et al., 2016); (L. Bollen et al., 2005); (Boekestein, 2006); 
(Boekestein, 2009); (Abhayawansa & Azim, 2014); (Sydler et al., 2014); 
(Russell, 2016b); (Rossi et al., 2015); (Nito, 2005); (Mehralian et al., 2012); 




(Wakefield, 2005); (Styhre et al., 2008); (Qureshi & Evans, 2015); (Akhavan 
et al., 2015); (Pedroso & Nakano, 2009); (Mets, 2006); (Lilleoere & Hansen, 
2011); (Lawson & Potter, 2012); (Hemmert, 2004); (Gray et al., 2011); 
(Dooley & Kirk, 2007); (Delaney, 1999); (Criscuolo, 2005); (Coradi et al., 
2015); (Chávez & Víquez, 2015); (Brachos et al., 2007); (Bourouni et al., 
2015); (Azan & Huber Sutter, 2010); (Allen et al., 2016); (Santos, 2003); 
(Mohan et al., 2007); (Malik, 2012); (Iwasa & Odagiri, 2004); (Filieri et al., 




(Mehralian et al., 2012); (Malik, 2012); (Kim et al., 2014); (Vishnu & Gupta, 
2014); (SubbaNarasimha et al., 2003); (A.-A. A. Sharabati et al., 2010); (Pal 
& Soriya, 2012); (Kamath, 2008); (Garcia Morales et al., 2008); (L. Bollen 




(Terziovski & Morgan, 2006); (Styhre et al., 2002); (Sternitzke, 2010); 
(Standing & Kiniti, 2011); (Sharma & Goswami, 2009); (Roth, 2003); (C. 
Parisi & Hockerts, 2008); (Palacios-Marqués et al., 2016); (O’Dwyer et al., 
2015); (Nightingale, 2000); (Mehralian et al., 2014); (Lowman et al., 2012); 
(Lauto & Valentin, 2016); (Kneller, 2003); (Khemka & Gautam, 2010); 
(Kazadi et al., 2015); Kale2005; Huang2011; Hohberger2016; (Herrmann & 
Peine, 2011); (van Geenhuizen & Reyes-Gonzalez, 2007); (Gassmann & 
Reepmeyer, 2005); (Garcia Morales et al., 2008); (Filieri et al., 2014); (Chen 
et al., 2008); (Chang et al., 2007); (Cardinal & Hatfield, 2000); (Styhre et al., 
2008); (Mets, 2006); (Lowman et al., 2012); (Lauto & Valentin, 2016); 
(Kazadi et al., 2015); (Gassmann & Reepmeyer, 2005); (Cardinal & Hatfield, 
2000); (Boasson & Boasson, 2015); (Mohan et al., 2007) 
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Publication years 
The review shows that the majority of included articles have been published between 2004 
and 2016 as shown in (Table 3-5). 



















































































































1996       1 1 
1997       1 1 
1998       1 1 
1999    1    1 
2000      3 1 4 
2001         
2002      1 1 2 
2003   2 1 1 2 1 7 
2004 1   2   5 8 
2005 2 1 3 2 1 3 5 17 
2006  1 1 1  2 2 7 
2007    4  3 4 11 
2008  3 2 1 2 4 9 21 
2009  1 4 1  1 3 10 
2010 1 1 2 1 1 2 2 10 
2011 1 2 2 2  3 3 13 
2012  1 2 2 3 2 1 11 
2013   3 1   3 7 
2014 1 1 4 1 2 2 4 15 
2015 2  1 6  4 3 16 
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Knowledge Sharing (KS) and Technology Transfer: 
More than 19% of the reviewed articles addressed knowledge sharing and transfer 
signifying that Knowledge transfer (KT) holds a special significance in the Pharmaceutical 
industry.  Knowledge transfer (KT) and sharing are the fundamental knowledge processes and 
the leading research topic in KM/IC publications (Ramy et al. 2017). While World Health 
Organisation (WHO) dedicated Annex 7 of Technical Report Series no.961 to discuss 
dynamics and controls of process/technology transfer occurring at some stage in the life-cycle 
of most products in the pharma industry (WHO, 2011b), the real significance of KS comes 
from the fact that it is the component that facilitates continuous knowledge creation (Akhavan 
et al., 2012) and is a key driver of long-term success in a knowledge-intensive organisation 
(Coradi et al., 2015). Accordingly, enablers and deterrents of knowledge sharing come to the 
focus of the field studies in various industrial domains. Within the pharmaceutical context, a 
thorough investigation by Qureshi and Evans (2015) identifies nine categories of deterrents 
which are classified as either structural barriers, cultural barriers, or managerial barriers. 
Structural factors include lack of physical proximity and the associated high cost of KS as well 
as IT infrastructure limitations. Cultural factors encompass knowledge-hiding, the lack of 
socialisation, the lack of trust, the organisational politics and the non-educational mindset as a 
pure commercial drive dominates the interactions within the pharmaceutical organisation. 
Additionally, poor leadership and time pressure are classified as managerial barriers for KS. 
Conversely, documentation, education and training, reading standard operating procedures, 
recognition of work, meetings, seminars and conferences, staff updates and voluntary 
mentoring are identified as intra-organisational knowledge sharing mechanisms in pharma 
(Qureshi & Evans, 2015). Although the perceived loss of knowledge power, the perceived 
reputation enhancement, and the perceived enjoyment in helping others as well as social ties 
and trust can influence employees’ attitude towards KS (Akhavan et al., 2015); empirical 
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evidence indicates that trust, motivation to transfer knowledge, management support and 
learning orientation are crucial for the effectiveness of knowledge transfer and innovation 
(Brachos et al., 2007). As enablers and deterrents for KS are found not to be the same for 
everyone within the pharmaceutical firm, the diverse nature of roles in this industry needs to 
be considered in any knowledge sharing initiatives within the organisation. For example, 
scientists and technicians in R&D present different views and practices regarding their 
perception of the enablers/barriers. Indeed, reinforcing the KS enablers to leverage knowledge 
among pharmaceutical R&D professionals would potentially accelerate the innovation process 
and thus decrease new products’ time to market and consequently reduce cost (Lilleoere & 
Hansen 2011).  
Also, Knowledge Networks (KN) are increasingly considered vital channels to achieve 
strategic objectives in project-based organisations particularly the pharma R&D (Bourouni et 
al., 2015; Mohan et al., 2007). The structural indexing and knowledge dictionaries can identify 
knowledge agents and evaluate intra-organisational knowledge sharing. Enhancing knowledge 
flow among development phases can be crucial to shortening the product to market timing. 
Indeed, structural indexing contributes to KT through the identification of members who 
actively share knowledge and evaluation of the degree of knowledge sharing as well 
(Wakefield, 2005). 
As physical proximity is one of the suggested barriers for Knowledge Sharing and 
Technology Transfer (Lilleoere & Hansen, 2011), several studies handle this topic in the 
pharma explicitly. For instance, studies conducted in the R&D department of the multinational 
drug manufacturer Novartis reveal that the co-location of dispersed project teams increases 
face-to-face communications leading to a faster and more precise flow of personal knowledge. 
In the same study multi-space work areas were found to simulate knowledge creation SECI 
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model (Nonaka & Takeuchi, 1995) by enabling socialisation, externalisation and combination 
of knowledge (Boutellier & Ullman, 2008; Coradi et al., 2015).  
On a macro scale, an equally significant aspect of inter-organisational KS is geographic 
distribution. Higher quality risk can accompany offshore manufacturing due to challenges of 
KT from headquarters (Gray et al., 2011). The location of the pharmaceutical firm is found to 
influence the intensity of communication between different firms but not innovation. 
Relocation (e.g. into industry clusters) and expensive real estate investments can be replaced 
by enhancing the social connections through technology (Allen et al., 2016; van Geenhuizen 
& Reyes-Gonzalez, 2007). However, it has been argued that having an R&D laboratory near 
corporate headquarters can enhance new drug productivity as proximity is necessary for the 
integration of R&D with other functions and strategic goals for product innovation (Cardinal 
& Hatfield, 2000).  
It was also found that pharmaceutical firms often cite more patents from other 
geographically close firms. An elaborate analysis of US pharmaceutical patent citations 
between 1963 and 1999 affirmed that 37% of cited firms are less than one mile away from the 
citing firm and more than 50% are within 50 miles apart or 26% if we excluded self-citations. 
Further, a positive relationship was found in the same study between patent quality and 
geographic proximity to other knowledge-intensive institutions and activities (Boasson & 
Boasson, 2015). In order to overcome geographic proximity challenges, researcher mobility 
within the R&D networks is the commonly adopted approach. Whereas the use of international 
assignments is limited to the transfer of project-specific knowledge, building social relations 
between researchers through assignments was found to increase KT and reduce inter-unit 
attrition as well (Criscuolo, 2005; Iwasa & Odagiri, 2004). 
Intellectual Propriety Protection (IPP): 
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There is no industry where firms build their competitive advantage more closely to IPP than 
the pharmaceutical industry. However,  in response to dramatic transitions in bioscience and 
computational chemistry, biopharmaceutical companies commence newer approaches for 
managing their IP and innovation including open access, closed pool, exclusive and non-
exclusive licensing (Allarakhia & Walsh, 2011). Although exclusive licensing is more 
preferred in the pharmaceutical industry (2:1), the findings support the notion that non-
exclusive licensing contributes more to the overall firm’s performance. This can be explained 
by the increase in the organisational knowledge exchange, decrease the cost of knowledge 
transaction, and the value of increased use of knowledge returns to the innovator through non-
exclusive links. Moreover, non-exclusive licensing provides a strategic advantage to the 
company and reduces market uncertainty by decreasing competition. The organisational 
performance was measured in terms of efficiencies of sales and  Human Capital (HC) in 
addition to Return on Asset (ROA) and Return on Investment (ROI) (Malik, 2012).    
The significance of IP for the pharmaceutical industry comes from the notion that patents 
are used as a proxy indicator for knowledge creation (Nerkar, 2003). Also, patent citation 
studies in pharma exploit patent-related data to estimate the quality of innovation, diffusion of 
knowledge and geographic localisation of knowledge (Chávez & Víquez, 2015). For this 
reason, patents can affirm the firm’s value and market performance. Association between 
company value, reported intangible assets and R&D capitals have been found to exist (Russell, 
2016b).  
In a highly dynamic global economy, enforcing IP protection laws implies significant 
economic costs (Mazzoleni & Nelson, 1998). Considering the importance of IPP as an 
incentive for innovation in advanced countries where there is both a superior scientific and 
technological infrastructure and a rich market for new drug products, WHO was conscious of 
the challenges that can face developing countries due to IPP regulations (WHO, 2006a).  For 
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instance, from 1990 onwards, innovative Indian pharmaceutical firms targeted generic market 
in advanced countries which enforced them to comply with IPP regulations not only for the 
product but also for processes.  Indian firms are facing challenges due to changes in patent law 
and the development of new technologies, particularly in the biotechnology field.  Since 1995, 
a progressive increase in R&D budgets has been observed in order to build the required 
knowledge bases in addition to hiring experienced scientists and targeting retiring post-
graduates from overseas universities. Moreover, building research networks with overseas 
research institutes has emerged as a key mechanism for knowledge acquisition (Kale & Little, 
2005). 
Knowledge Measurement and IC Disclosure: 
Empirical evidence supports the notion that the nature and value of knowledge assets differ 
from one industry to another with a direct impact on investment decisions. By using Tobin’s 
Q model for knowledge measurement, it is noticed that not only the level of intellectual capital 
(IC) and competitive intelligence are both higher in consumer industries (such as 
pharmaceuticals) in comparison to business to business industries, but also investments in 
knowledge assets are less promising in business markets (Erickson & Rothberg, 2009). 
Measurement of pharmaceutical IC at the organisational level relies on the identification of 
most relevant constructs or indicators in each industry. According to a Delphi study in the 
pharmaceutical and telecommunication sectors, the management experience and technical 
knowledge are on the top of the HC indicators in pharma (Palacios-Marques & Garrigos-
Simon, 2003).  
Regarding structural capital, organisational culture, the ratio of investment in R&D and the 
number of R&D projects are the highest priority indicators. Additionally, mutual trust with 
customers and their satisfaction are the highest priority RC indicators in comparison to the co-
authorship with academic centres (Mehralian et al., 2013). However, the disclosure of IC in the 
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balance sheet (BS) is still a measurement barrier and an opportunity for improvement in the 
pharmaceutical industry, particularly in developing countries. In studies of IC disclosure in top 
pharma companies in India and Bangladesh, the computed figures of IC show that the 
enormous value of IC remains unreported in BS. This highlights that the lack of standardised 
accounting guidelines on this vital asset results in unreporting of resources of billions in firm’s 
annual reports which impacts their performance in the stock market (Abhayawansa & Azim, 
2014; Singh & Kansal, 2011).  
Intellectual capital is widely adopted as a predictor for firm’s profitability in the 
pharmaceutical sector and the intangible asset capitalisation is associated with firm’s market 
value (Sydler et al., 2014). Healthcare patents perform both disclosure and signalling functions; 
reflecting firm’s innovative capabilities and enhancing the capacity to raise necessary start-up 
capital (WHO, 2006a). However, no significant relationship was observed either between IC 
and productivity or market valuation. Also, it was found that Market to Book (MB) and Return 
on Asset (ROA) are significantly correlated with IC. While Return on Equity (ROE) in pharma 
is double the ROE in less knowledge-focused industries such as textile (i.e. the investors are 
getting more return on their shareholder equity), ROA is nearly equal for both. A better 
understanding of IC may enhance the profitability and the productivity of companies (Pal & 
Soriya, 2012). Likewise, in the pharmaceutical sector in Iran and India, two comparable studies 
found that the performance of IC can explain profitability but not productivity or market 
valuation (Ghosh & Mondal, 2009; Kamath, 2008). However, this argument is subject to 
controversy as companies which generate more profits are able to invest more in IC (Naidenova 
& Parshakov, 2013).  
Merger and Acquisition (M&A) can be used as a cost-effective way to gain access to new 
product platforms, technologies and patents. Traditional pharmaceutical companies with 
depleted research pipelines but sufficient cash can acquire innovative biotech firms as a source 
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of new products (Rossi et al., 2015). A study of the influence of M&A on the total value of the 
pharmaceutical company acquired revealed that the total value of the companies in 135 
acquisition situations under investigation have increased approximately 6 times on acquisition. 
This increase is mainly attributed to knowledge related intangible assets and goodwill which 
substantially overlap with IC. The Pharma companies which are not being acquired are 
potentially undervalued because of intangible assets underestimation under current accounting 
systems (Boekestein, 2009). 
Research, Innovation and knowledge creation (KC): 
The emergence of new discoveries in the twenty-first century will urge Pharmaceutical 
manufacturing to employ innovation and cutting edge knowledge and technology as ways of 
doing business (FDA, 2004b). Genetics, bioinformatics, High-Throughput Screening (HTS) 
and in-silico simulation have allowed pharmaceutical research to exploit economies of scale 
and economies of speed in drugs experimentation and development. Nowadays, 
pharmaceutical industries do not typically fit to the classic economy of scales theories as they 
transformed into R&D intensive rather than production intensive. In other words, the industry 
has become more dependent on patents rather than production volumes to secure profits. Due 
to the low success rates for drugs under development (two drugs of every 10,000 synthesised 
substances will become a marketable medicine), long development time (up to 10 years) as 
well as high cost for drug development (€ 1,926 million) (EFPIA, 2018), the increase of success 
rates and development speed would substantially reduce the development cost and avoid late 
costly failures (Gassmann & Reepmeyer, 2005; Nightingale, 2000).  
The Pharmaceutical industry, more than other industries, is dependent on scientific advances 
developed in the public sector particularly in basic sciences. It was found that following a basic 
science patent, at least 19 research publications and 23 additional patents are filed. If the 
innovation is of radical type and associated with a market breakthrough, additional patents are 
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expected to be filed earlier (Sternitzke, 2010).  Historically, the role of the public sector in drug 
discovery was limited to basic research to elucidate the basic pathological mechanisms. 
However, this role has significantly expanded in the biotechnology era (Stevens et al., 2011). 
For example, the preliminary evaluation of innovation expenditure structure of the Estonian 
biotechnology sector reflects the prominent role of public fund, which is estimated to be more 
than 80% of the total budget. In spite of that, the low level of R&D expenses in Estonian biotech 
companies (15.7% compared to revenues) against 60% in Europe and 45.7% in the USA 
reflects the challenges facing emerging countries in the biotechnology industry (Mets, 2006). 
In contrast with publicly funded drug research model in EU and US universities, it is noticed 
that drug discovery in Japanese companies occurs predominately in-house which may be no 
longer compatible with the global competitiveness (Kneller, 2003). In Ireland, governmental 
investment in research and innovation is a strategy to compensate the loss of its old competitive 
mandate of low-cost manufacturing capabilities by the emergence of new competitors 
(O’Dwyer et al., 2015). Thus, the collaboration between industry and universities provides 
local competitive capabilities to solve industry problems in Multinational Enterprises (MNE) 
subsidiaries without the need to refer problems back to head offices (O’Dwyer et al., 2015). 
In such a complex R&D environment, information sharing and intrinsic motivation are 
recognized as important drivers for organizational creativity (Sundgren et al., 2005); there is a 
significant influence of knowledge transfer on firm innovative capability (r= 0.893) too 
(Palacios-Marqués et al., 2016). As the bulk costs of R&D comes from the clinical phases, 
sharing knowledge and experiences coming from terminated projects would be of high 
significance too. Knowledge facilitators in clinical trials play an outstanding role in promoting 
knowledge sharing. (Styhre et al., 2008). Knowledge facilitator plays a catalyst role in KC and 
sharing by raising the level of trust between members of organisations and building a care 
climate (Roth, 2003). Evidently, KC process has a direct positive impact on HC which in turn 
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has a positive significant impact on both structural and relational capital (RC) (Mehralian et 
al., 2014).  
The surveyed literature highlights some of the dynamics of innovation within pharma 
organisations. Management support, design of effective policies and effective management of 
knowledge are found indispensable if the organisation wants to adopt an innovative 
environment. Additionally, Job satisfaction explains up to 25% of the variance in innovation 
regression models (Khemka & Gautam, 2010). Transformational leadership shows a positive 
relationship with innovation (Garcia-Morales et al., 2008). Both information and organisation 
capital play a mediating role in the impact of HC on innovation. Also, a significant positive 
relationship has been established between organisation capital and innovation confirming the 
remarkable role of intangible assets in generation and enhancement of innovative capabilities 
(Huang et al., 2011).  Wikis and Innovation contests are used in pharma to leverage collective 
intelligence and enhance innovation in large companies (Lauto & Valentin, 2016; Standing & 
Kiniti, 2011). Conversely, outsourcing of R&D and clinical studies for new product 
development (NPD), combined with lack of integration among outsourced clinical research 
organisations (CRO) and the associated knowledge losses as well as regulatory delays create 
innovation risks (Lowman et al., 2012). Meanwhile, FDA warned from the threats of broad 
interpretations of 21 CFR part 11 (electronic records and electronic signatures) on innovation 
and technological advances without any benefit for patient health (FDA, 2003).  
Knowledge Culture and Organisational Structure: 
The American FDA encourages management to implement quality systems and procedures 
that support a communicative organisational culture. Under such quality systems, knowledge 
communication is promoted through the creation of a work culture that appreciates employee 
suggestions and uses them for continual improvement (FDA, 2006). Specific beliefs and 
knowledge-related values can be sources of competitive advantages in pharma. For instance, 
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values such as love, care and trust contribute significantly to the firm’s performance and 
knowledge creation (Magnier-Watanabe & Senoo, 2009).  For similar reason, the know-how 
or technical skills are not as important success factors as tacit knowledge sources held by 
knowledge workers (Styhre, Roth and Ingelgrd, 2002; Magnier-Watanabe and Senoo, 2009). 
Knowledge culture is a way of organizational life that empowers people to create, share and 
use knowledge for the good of the organisation (Oliver & Kandadi, 2006). In the 
pharmaceutical industry, knowledge culture is believed to compensate for the lack of 
organisation memory in temporary project teams where ICT alone has a limited value. Factors 
like the support of informal communication, tolerance towards mistakes,  positive project 
culture and commitment of top management significantly contribute to open knowledge 
transfer within and/or between projects (Lindner & Wald, 2011). Similarly, Evans and Brooks 
(2005) argued that just providing new technology in order to facilitate collaborative practices 
does not necessarily create a more collaborative culture in pharmaceutical supply chain 
environment (J. Evans & Brooks, 2005). Organisation memory held by ageing workers can be 
transferred to the younger workers through bridges of socialisation and adequate organisational 
climate to facilitate circulation of tacit knowledge (Ebrahimi et al., 2008).  
The organisational characteristics of pharmaceutical firms such as structure and strategy 
affect knowledge acquisition activities including knowledge storage, diffusion and application 
where the national culture must also be considered (Magnier-Watanabe & Senoo, 2008). In 
fact, the organisational characteristics can have even more influence over KM than the national 
culture (Rémy Magnier-Watanabe & Senoo, 2010). In the pharma industry, open culture where 
employees are able to raise questions and feel at ease explains 31% of the variance in four 
modes of SECI process compared to only 16% for the bureaucratic culture (Magnier-Watanabe 
et al., 2011). In pharmaceutical R&D, bureaucratic culture has a negative impact on knowledge 
workers’ job satisfaction while innovative or supportive culture positively influence them 
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(Bigliardi et al., 2012). Wang (2006) claims that the information culture, excessively concerned 
about financial costs and technical compatibility of KM systems, can ultimately be hostile 
towards KM implementation. Moreover, the Knowledge sharing and externalisation of tacit 
knowledge can also be limited by intra-organisational political constrains (Wang, 2006) . 
Pharmaceutical Firm Performance: 
Human and Relational Capital is deemed to positively impact business performance 
(Sharabati et al., 2010). Several empirical studies have underlined this paradigm utilising either 
ROA/ return on sales (ROS) as performance measures (Vishnu & Gupta, 2014); whereas,  
Value Added Intellectual Coefficient (VAIC) (Chizari et al., 2016) or generation of new patents 
were used as proxies for technical knowledge of firms (SubbaNarasimha et al., 2003). Bollen, 
Vergauwen and Schnieders (2005) argue that each of the three components of IC individually 
and collectively influences firm performance. By way of illustration, in spite of the direct 
relationship of HC and firm performance, it offers little value without appropriate Structural 
Capital (SC). At the same time, HC is necessary for the proper formation of SC and RC (Bollen 
et al., 2005). In contrast, Vishnu and Gupta (2014) research in Indian pharmaceutical firms 
denies the relationship between RC and performance. Meanwhile, IC performance (particularly 
the physical capital) and firm profitability not productivity or market valuation are thought to 
be related (Mehralian et al., 2012). KM performance is considered as a predictor of superior 
financial performance in terms of higher profit ratios (ROA, ROS) and lower cost ratios 
(OPEX) (Holsapple & Wu, 2011).  
The literature revealed that KM strategies influence organisational performance in the 
pharmaceutical industry (Kim et al., 2014). Four types of KM strategies are identified in the 
literature: external/internal codification strategy and internal/ external personalisation strategy. 
Information system maturity in the pharmaceutical firm, as well as knowledge intensity, would 
be the determinants for the most effective KM strategy (Kim et al., 2014). Also, integrating 
CHAPTER 3:  Knowledge Management in the Pharmaceutical Industry 
 3-68 
external and internal knowledge sources has increased the probability of obtaining higher level 
of organisational performance.  However, the internal organisational tensions between the 
tacit-oriented and explicit-oriented strategies, which are difficult to reconcile, would negatively 
impact the performance. (Choi et al., 2008). 
 
Regulatory Insights 
In order to understand KM from the pharmaceutical regulators’ perspective, the researcher 
conducted a thorough review of KM requirements in 128 Good Practices (GxP) quality 
guidelines. The review revealed a slightly different pattern of interests and expectations in 
comparison with the academic business journals (Figure 3-5). 
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An overview of the current thinking and expectations of key regulatory bodies regarding 
KM is presented as follow: 
ICH 
 From the previous review sections, KM expresses a considerable level of maturity as an 
academic research field in the pharmaceutical industry. Despite that, Calnan et al. (2018) 
suggest that KM shows less mature roles at industry level which might hinder the achievement 
of ICH Q10 desired state. Whereas Quality Risk Management (QRM) is assigned a full ICH 
guideline (i.e., ICH Q9), KM received less attention by regulatory agencies (Rathore et al., 
2017). This section and the following highlights the major KM requirements as explained by 
regulators.   
For instance, ICH Q10 considers KM together with QRM as the enablers of its effective 
implementation throughout the product lifecycle. Proper implementation of these guidelines 
can facilitate innovation and continual improvement and strengthen the link between 
pharmaceutical development and manufacturing activities. It summarises the goal behind the 
technology transfer process in pharmaceutical firms in the transfer of product and process 
knowledge between development and manufacturing, and within or between manufacturing 
sites to achieve product realisation. In fact, one of the objectives of ICH Q10 is to facilitate 
continual improvements, identify the appropriate product and process improvement as well as 
innovation. Last but not least, ICH Q10 suggests monitoring of all innovations that might 
enhance QMS (ICH, 2008).  
Other ICH guidelines refers sporadically to KM with a focus on KS/KT. ICH Q9 suggested 
the need for further studies related to technology transfer should be assessed through QRM 
(ICH, 2005). ICH Q11 endorses the management and sharing of product/process related 
knowledge throughout product lifecycle including knowledge related to drug substance and its 
manufacturing process.  
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It is argued that this enhances the manufacturing process and establish a control strategy 
especially in cases of product ownership changes (e.g. through acquisition). Suggested sources 
of drug knowledge include but are not limited to process development activities, technology 
transfer activities to internal sites and contract manufacturers, process validation studies over 
the lifecycle of the drug substance, and change management activities (ICH, 2012).
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WHO 
For the purpose of earlier detection of potential problems, WHO guidelines pay close 
attention to regulatory harmonisation and participation in information (e.g.  from inspections 
and clinical studies) sharing networks among regulatory agencies with special considerations 
to confidentiality and intellectual property issues e.g. (WHO, 1999, 2003, 2017). WHO works 
towards provision of high assurance of quality, efficacy and safety of drugs. Parallel efforts are 
exerted to contain escalating costs of drug prices by minimizing duplication of inspection 
activities through: better networking, improved information sharing, enhanced collaboration, 
increased mutual trust and confidence. The organization help manufacturers actively 
collaborate in information sharing among national, regional and international inspection 
authorities (WHO, 1999). WHO efforts are also directed towards the collaboration among 
Pharmacopeias through work-sharing and harmonisation in accordance with Good 
Pharmacopoeial Practices (GPhP) (WHO, 2006b). Information sharing efforts with the 
European Directorate for the Quality of Medicines & Healthcare (EDQM) extends to 
certification programs (WHO, 1999). Risk communication and sharing risk-related knowledge 
are also addressed in WHO guidelines (WHO, 2013). Finally yet importantly, sharing public 
alerts and warning alerts for imported drugs or medical devices can prevent similar faulty 
products from being exported to other markets (WHO, 2017). 
WHO identifies the technology transfer (including process knowledge and product 
development history) as the middle stage in the drug lifecycle where GMP regulations must 
apply (WHO, 2013, 2014). The organisation requires validation of the process of data transfer 
(WHO, 2016). Whenever the transfer involves analytical methods, it is required to conduct this 
validation by the development department before the transfer to manufacturing quality control. 
Periodic checks are necessary to ensure the accuracy and reliability of the process (WHO, 
2006c). As a general requirement, mechanisms should be addressed to facilitate the transfer of 
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information not only between manufacturers and customers but also to the relevant regulatory 
bodies (WHO, 2010b). 
With regard to IPP, the International Medical Products Anti-Counterfeiting Taskforce 
(IMPACT) is led by WHO, where the focal point is public health protection from the 
implications of counterfeiting (WHO, 1999). The ever-changing business strategies and their 
accompanying intra- and intercompany transfers of technology obliged The WHO Expert 
Committee on Specifications for Pharmaceutical Preparations in its 42nd report to assign a 
special guideline to address this issue (TRS 961 Annex 7). However, this guideline is meant to 
be a flexible framework rather than a rigid technology transfer guidance. Although a 
multifunctional team is proposed to manage the transfer process, it is affirmed to be under the 
umbrella of a quality system (WHO, 2011b). 
WHO requires pharmaceutical manufacturers to build their quality decisions and regulatory 
commitments on science-based understanding of the process and QRM which can offer greater 
freedom of how to comply, hence enhances innovation (WHO, 2013). Development of quality 
culture in the pharmaceutical organisation is believed to improve transparency about failures 
and ensure good data management strategies are in place. Besides, data integrity and protection 
occupied a featured position in WHO regulations. Pharmaceutical firms are expected to 
develop appropriate tools and strategies for the management of data integrity risks based upon 
their own GxP activities, technologies and processes (WHO, 2016). 
EU GMP 
EU Guidelines for Good Manufacturing Practices (EudraLex) has adopted  Good 
Documentation Practices as an enabling tool for knowledge management throughout different 
stages of product lifecycle (EudraLex, 2015). Similar to WHO, PIC/S and ICH 
recommendations, the guidelines encourage agents, brokers, distributors, repackers or 
relabellers to share regulatory and quality information with the manufacturers and customers 
(EudraLex, 2004; ICH, 2000; PIC/S, 2017; WHO, 2010a). EudraLex requires analytical 
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method transfer protocol (EudraLex, 2006) with no explicit transfer framework as in WHO 
TRS961 Annex 7. However, it confirmed the coverage of technology transfer by cGMP 
regulations as a part of product lifecycle (EudraLex, 2011). 
FDA 
FDA pays special attention to process understanding and knowledge management as 
effective strategies for preventing and detecting data integrity issues (FDA, 2016c). On the 
other hand, FDA accentuates the knowledge sharing and transfer in contract manufacturing as 
explained in the quality agreement (FDA, 2016a). The agency highlights the role of senior 
management in the creation of communicative organisational culture as a tool for improving 
knowledge sharing and communication in addition to cross-functional groups to share ideas 
for improvement purposes (FDA, 2006). 
In addition, FDA commends the role other knowledge processes such as data acquisition and 
accumulation over the lifecycle as an important way for continuous improvement which in turn 
can facilitate the scientific communication with the agency (FDA, 2004a). Similarly, following 
process validation FDA guidelines would support process improvement and innovation 
(Services & FDA, 2011). 
PIC/S 
In response to the increasingly complex global supply chains in the pharma industry, PIC/S 
facilitates voluntary inspection data-sharing between member authorities. This is deemed to 
enable risk-based assessment of the need to carry out inspections based on shared confidence 
in inspected firms (PIC/S, 2011b). It has not escaped our notice that data sharing and transfer 
in PIC/S guides is focused on inspection data rather than knowledge created in pharmaceutical 
firms. The statute of the International Medicinal Inspectorates Database (IMID), which aims 
at establishing a database of GMP inspections carried out (or to be carried out) by IMID 
participating Regulatory Authorities, was adopted by PIC/S to reduce the number of 
duplicative inspections (PIC/S, 2012). The PIC/S committee is cooperating with other global 
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agencies such as WHO, EMA, the ICMRA (International Coalition of Medicines Regulatory 
Authorities) and United Nations Children's Fund (UNICEF) with regard to training and sharing 
of inspections’ information (PIC/S, 2011a, 2015, 2016b; WHO, 2003). 
The data integrity is essential for the successful implementation of GMP, as such, the 
requirements for good data management are embedded in the current PIC/S guidelines to 
GMP/GDP for Medicinal products. Good data management practices (GDMP) are envisaged 
as fundamental enabler for the integrity of the generated data. The manufacturer or distributor 
undergoing inspection is required to enforce GDMP that ensure the accuracy, completeness 
and reliability of data. (PIC/S, 2016a). Moreover, the suggested expansion of the scope of QMS 
to the development phase is presumed to facilitate innovation and continual improvement and 
build up the link between pharmaceutical development and manufacturing activities (PIC/S, 
2017).  
The data lifecycle (from generation through to discard at the end of retention period) is also 
featured in GMP guidelines including cross-boundaries data transfer emphasising the 
relationship with the product lifecycle. In case of computerised systems, interfaces should be 
assessed and addressed during computer system validation to guarantee the correct, accurate 
and complete transfer of data (PIC/S, 2016a, 2017). Risk review should be considered 
especially for supply chains and outsourced activities to assess the extent of data integrity 
controls required (PIC/S, 2016a). It is noteworthy that PIC/S  has repeatedly warned of 
inappropriate interpretation of guidelines making them barriers to technical innovation or the 
pursuit of excellence (e.g.PIC/S, 2011c). 
Organisational culture and behaviour are a complementary part of the effective data 
governance system when combined with an understanding of data criticality, data risk and data 
lifecycle. The value behind this appears in the empowerment of employees to report failures 
and opportunities for improvement. This reduces the incentive to falsify, alter or delete data 
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(PIC/S, 2016a). GMP inspectors have to be sensitive to the effects of organisational culture 
and structure on the organisation behaviour where data reporting differs between open and 
close cultures. In order to ensure data integrity within the pharmaceutical organisation, 
appropriate values, believes, thinking and behaviours need to be demonstrated consistently by 
management, team leaders and quality personnel (PIC/S, 2016a). 
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Table 3-6 Regulatory insights into Knowledge Management 
KM Theme EU GMP ICH FDA WHO 




N/A ICH Q9 on quality risk 
management (4.5.); ICH Q9 
on quality risk management. 
(II.3); ICH Good 
Manufacturing Practice Guide 
for Active Pharmaceutical 
Ingredients Q7 (17.60);ICH 
Q11 - Development and 
Manufacture of Drug 
Substances (9);ICH Quality 
Risk Management Q9 
(II.3.);ICH pharmaceutical 
quality system Q10 
(1.6.1);ICH pharmaceutical 
quality system Q10 (3.1.2) 
FDA Guidance for Industry: 
Contract Manufacturing 
Arrangements for Drugs: 
Quality Agreements (1.e.); 
FDA Guidance for Industry: 
Contract Manufacturing 
Arrangements for Drugs : 
Quality Agreements (1.d.); 
FDA Guidance for Industry: 
Contract Manufacturing 
Arrangements for Drugs : 
Quality Agreements (1.e.); 
FDA Guidance for Industry: 
Quality Systems Approach to 
Pharmaceutical CGMP 
Regulations (3);CFR Title 21 
Part 820 Quality System 
Regulations 
WHO TRS 1003 Annex 4  
(4.1.1.2.);WHO TRS 996 Annex 
4 (1.1.);WHO TR S 996 Annex 
1 (4);WHO TRS1003 Annex 4 
(1.5.);WHO TRS 953 
(2.1.3.);WHO TRS 953 
(2.1.9);WHO TRS 953 
(2.1.13);WHO TRS 953 
(8.1);WHO TRS 953 
(8.1.1);WHO TRS 953 
(17);WHO TRS 1003 Annex 4  
(4.2.4.3.);WHO TRS 1003 
Annex 4  (4.4.);WHO TRS 981 
Annex 2 (1.1.);WHO TRS 981 
Annex 2 (glossary);WHO TRS 
961 Annex 7;WHO TRS 957 
Annex 2 (17.60);WHO TRS996 
Annex 5 (7.6.);WHO TRS996 
Annex 5 (Appendix 1);WHO 
TRS 973 Annex 4 (1.4.);WHO 
TRS 973 Annex 4 (3.3.);WHO 
TRS 986 Annex 2 (1.4.);WHO 
TRS 986 Annex 2  (7.17);WHO  
TRS 981 Annex 2 (1.2.);WHO 
TRS957 Annex 5 (14.11);WHO 
TRS 953  (8.2.) 
IPP N/A N/A N/A WHO TRS1003 Annex 4 (1.6.); 
WHO TRS 953 (2.1.7., 2.1.11) 

























Knowledge Measurement and 
IC Disclosure 
EudraLex Annex 15: 
Qualification and 
Validation 
ICH pharmaceutical quality 
system Q10 (2.8.) 
 
FDA Guidance for Industry: 
PAT: A Framework for 
Innovative Pharmaceutical 
Development, Manufacturing, 
and Quality Assurance (1.d.) 
WHO TRS 961 Annex 7 (1.4) 
 
Research, Innovation and 
Knowledge Creation 
N/A ICH Q11 - (3.1.3.); ICH Q10 
(Glossary); ICH Q10 (1.1); 
ICH Q10 (1.5.3.); ICH Q10 
(1.6.); ICH Q10 (1.6.1.); ICH 
Q10 (3.2.3.); 
ICH Q10 (4.2.b); 
FDA Guidance for Industry: 
Part 11, Electronic Records; 
Electronic Signatures - Scope 
and Application (III.B.); FDA 
Guidance for Industry: 
Process Validation: General 
Principles and Practices 
(1);FDA Guidance for 
Industry: Data Integrity and 
Compliance With CGMP 
(Draft) (III.1.c) 
WHO TRS 981 Annex 2 (1.1) 
Knowledge Culture N/A N/A FDA Guidance for Industry: 
Quality Systems Approach to 
Pharmaceutical CGMP 
Regulations (B.2.) 
WHO TRS 996 Annex 5 (1.4.) 
 
Pharmaceutical    Firm 
Performance  
N/A N/A N/A Knowledge strategies:  
WHO TRS 996 Annex 5 (1.4., 
5.4., 5.5.,7.5.) 
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Discussion and Implications: 
The pharmaceutical industry  is not only one of knowledge-intensive sectors, but also an 
industry  with a direct effect on health promotion (Mehralian et al., 2016). It comprises distinct 
characters making pharmaceutical knowledge management a unique process. Being research-
intensive, highly innovative and a great source of IC (Kamath, 2008), building networks of 
R&D personnel with research institutions, providing ultimate protection of IP rights, having 
high influence of political, legal and administrative factors on technology acquisition 
(Hemmert, 2004),  achieving a high level of maturity in project management (Wakefield, 
2005), involving suppliers in product development activities (Lawson & Potter, 2012), 
involving collaborative research with universities and governments (Dooley & Kirk, 2007), 
presenting sophisticated drug discovery and development systems (Criscuolo, 2005), facing 
challenges of regulated prescription drugs (Pedroso & Nakano, 2009), being one of the fast-
growing economic sector (Singh & Kansal, 2011), together with huge economic productivity 
and high number of employees (Bigliardi et al., 2012) are some of reasons for choice of the 
pharmaceutical industry as the empirical research field of many articles in KM literature. 
Nevertheless, 28% of the reviewed articles included mixed samples from different industries. 
This might be attributed to selection of convenience sample of knowledge-intensive companies 
without an industry-specific research scope. 
Based on an in-depth review of the literature, key trends emerged. Domination of academic 
authorship (93% of authors) along with 20% increase in co-authorship reflect the academic 
maturity of the research area. Participation of practitioners is relatively limited (7%) in spite of 
the colossal investments in KM by pharma companies (Riddell & Goodman, 2014). This also 
supports Calnan et al. (2018) argument that the role which “knowledge” plays in the 
pharmaceutical industry is still immature and disabling the ICH Q 10 desired pharmaceutical 
quality system. This argument has also been made in other sectors e.g. public sector KM 
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publications (Massaro et al., 2015). This can also accentuate what has been described by Ragab 
and Arisha (2013) as a theory-practice gap in KM literature in general. 
Furthermore, the review found that the UK and USA are responsible for nearly one third of 
publications within the review period. This supports the findings of Ramy et al. (2017) which 
underline the prevalent contribution of North America, Western Europe, and Australia in KM 
publications. However, a compelling interest in KM has been recognized in Iranian, Indian and 
Taiwanese academic institutions reflecting the future role of emerging economies in pharma 
industry. Since R&D is considered the key space for knowledge creation (Ingelgård et al., 
2002; Parisi et al., 2006), most of the studies ignored other functions (e.g. manufacturing, sales 
or quality) or other sources of knowledge in a pharmaceutical organisation (e.g. process 
validation studies; manufacturing experience, continual improvement, and change 
management activities). However, from a regulatory perspective, managing the knowledge 
throughout commercialisation and manufacturing phases until product discontinuation is 
believed to be as important as managing drug development knowledge (ICH, 2009).  
Taxonomical analysis of literature affirms six main knowledge processes/ themes 
extensively covered by researchers in the pharmaceutical industry.  
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Publication years 
The review shows that the majority of included articles have been published between 2004 
and 2016 as shown in (Table 3-5). 



















































































































1996       1 1 
1997       1 1 
1998       1 1 
1999    1    1 
2000      3 1 4 
2001         
2002      1 1 2 
2003   2 1 1 2 1 7 
2004 1   2   5 8 
2005 2 1 3 2 1 3 5 17 
2006  1 1 1  2 2 7 
2007    4  3 4 11 
2008  3 2 1 2 4 9 21 
2009  1 4 1  1 3 10 
2010 1 1 2 1 1 2 2 10 
2011 1 2 2 2  3 3 13 
2012  1 2 2 3 2 1 11 
2013   3 1   3 7 
2014 1 1 4 1 2 2 4 15 
2015 2  1 6  4 3 16 
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 In spite of that, the research in some other potential areas is relatively scarce (e.g. PKM, 
knowledge acquisition, knowledge integration). The reviewer observed an overemphasis on 
the OKM while the PK received little attention in the reviewed literature. Only two out of 19 
subthemes (Figure 3-6) have approached the personal dimension of knowledge. Conversely, 
IC is the most frequently used keyword and research theme in pharmaceutical KM literature. 
As a part of company intangible capital, patent-related keywords (e.g. patent citation, analysis, 
research, count, etc.) are mentioned 10 times in the review pool reflecting the importance of IP 
rights (structural capital) as a research subject. All the knowledge measurement articles were 
dedicated for the IC measurement and disclosure.  
 
Figure 3-6 Personal versus organisational knowledge presentation in the reviewed literature  
(black shading= personal knowledge; white shading= organisational knowledge; grey 
shading= mixed) 
 
The influence of pharmaceutical IC on profitability, productivity and market value is 
addressed in several papers (e.g. Pal and Soriya, 2012). Pharmaceutical IC reporting in BS 
suffers from inconsistency and lack of standardised guidelines. Indeed, this phenomena is not 
exclusive to the pharmaceutical industry and was highlighted in other industries (Ragab & 
Arisha, 2013). Yet, Intellectual Capital, knowledge measurement or disclosure are not 
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in pharma companies, regulatory publications focus on knowledge transfer after 
product/process acquisition or data acquisition during product lifecycle (FDA, 2004a). 
Although KM is explicitly required in ICH Q10 1.6.1.(ICH, 2008), regulatory authorities didn’t 
address either measurement or disclosure of IC. With poor reporting and disclosure of IC in 
pharma (Abhayawansa & Azim, 2014), further research is needed to induce industry-specific 
measurement frameworks not only at the organisational IC level but also at the personal 
knowledge level. 
Barriers and enablers of KS, as well as impact of co-location and geographic proximity on 
knowledge sharing in the pharmaceutical facilities, are thoroughly studied in academic 
literature and partially covered by the regulatory requirements to support a communicative 
culture. No doubt, the return on investments in KS can be manifested in the creation of new 
knowledge (Lilleoere & Hansen, 2011) and evading knowledge loss from pharmaceutical 
organisation. Use of KS enablers, non-exclusive licensing, networks as well as workspace 
designs and co-locations is believed to enhance the flow of knowledge and accelerate the drug 
development phase. Technology transfer and method/process transfer are regulated practices 
under pharmaceutical quality systems (ICH, 2009; WHO, 2011b); case studies or empirical 
research is quite limited in this area.  
Governmental role in innovation, either through the outputs of basic science or public 
funding of growing industry R&D, is emphasised in the literature. Collaboration between 
industry and universities as well as overseas research centres is found crucial for advances in 
global competitiveness in the pharma industry. Dynamics of innovation as managed by the 
Triple Helix model can be a meticulous explication of this phenomenon (Etzkowitz & 
Leydesdorff, 2000; Leydesdorff & Meyer, 2006). When the FDA announced the 
Pharmaceutical CGMPs for the twenty-first Century in 2006; corrective actions, innovation 
and continuous improvement were considered as three complementary improvement 
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approaches in Pharmaceutical Manufacturing (FDA, 2004b). However, only innovation has 
received considerable attention in the surveyed literature. It is worth noting that the term 
“creation” was mainly used by the regulators to signify creation of data and/or electronic 
records (FDA, 2016b). 
The review explored the role of pharmaceutical organisational culture and structure in 
knowledge management. The review highlighted the notion that some values are found to be 
associated with the prosperity of knowledge within workspace (Magnier-Watanabe & Senoo, 
2009) and new technology is not able alone to bring about a successful KM system (Chatzkel, 
2007). The KM performance of the company was found in general related to its market 
performance. Yet, the organisational performance was not considered by any of the five 
regulatory bodies.  
 
Summary and Conclusion 
The pharmaceutical sector is one of the pillars of the world’s economy. A significant 
proportion of its value lies in intellectual assets generated through a continuous innovation 
process and lengthy product development cycles within a strict regulatory environment. The 
purpose of this chapter is to present an inclusive review of Knowledge Management processes 
in the pharmaceutical industry with a focus on key regulatory concerns.  
The review identified a range of knowledge processes that were investigated in the 
pharmaceutical context and highlights their role in the organisation. The academic empirical 
research within the pharmaceutical industry partially addresses the regulatory concerns. 
Regulatory bodies require KM across the product lifecycle and outline the role of the individual 
as a holder of knowledge, meanwhile, the KM scholars focus on the organisational rather than 
the PKM (bottom-up) approaches. Also, the findings indicate that prior KM studies focused on 
the pharmaceutical development and innovation activities, ignoring other ICH Q10 suggested 
CHAPTER 3: Knowledge Management in the Pharmaceutical Industry  
 3-84 
sources of pharmaceutical knowledge such as pharmaceutical manufacturing. In this dilemma, 
the industry practitioners refrain from serious contribution to academic research. This supports 
the notion that knowledge management in the pharmaceutical industry is still a growing 
research area, particularly in manufacturing (non-research) functions. This study attempts to 
address this theory and practice gap by developing a framework for the identification and 
measurement of personal knowledge in the pharmaceutical manufacturing context. 
Chapter five is dedicated to the exploratory study in the pharmaceutical industry. The 
proposed measurement framework is developed in light of the exploratory study findings and 
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Background 
This study can be understood in light of Kothari's (2004) definition of research as an 
academic activity that comprises definition and redefinition of problems; it can take the form 
of an original contribution to the existing stock of knowledge through the formulation or 
generalisation of a theory (Kothari, 2004). The research is undertaken to discover things in a 
systematic way and thereby increase knowledge. The “systematic way” declares that the 
research must be based on logical relationships, not just beliefs (Saunders et al., 2008).  The 
need for research reflects a state of incomplete knowledge or unanswered questions in many 
science disciplines. It is also related to the compulsive need for growth experienced by Homo 
Sapiens which drive humanity to endless requirements of increased performance in all aspects 
of life (Remenyi et al., 1998). Also, the research is motivated by the identified research problem 
and the highlighted gaps as outlined in the previous chapters.  
It is clear that the good research should be capable of generating dependable data. This can 
be achieved by following the structure of the scientific method which leads to a desirable, 
decision-oriented research (Blumberg et al., 2014). This chapter outlines the researcher’s 
approach to meet the criteria of good research at all the stages of this study. Although the choice 
of appropriate data collection techniques and analysis procedure is important for any research 
(Figure 4-1), issues underlying this choice should be considered by the researcher (Saunders et 
al., 2008). This chapter discusses the research philosophies and approaches relevant to this 
study. It provides explicit justification of the adopted methodologies, strategies, time horizon 
and highlights their impact on the research process. It also outlines the research design, the 
research plan and the ethical considerations of the study.  
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Figure 4-1 The Research Onion (Saunders et al., 2008) 
 Research philosophy 
Ontology defines the nature of the social reality upon which the research is based. It is the 
recommended starting point for any research (Grix, 2003).  Two main ontological positions are 
recognised in the academic literature: objectivism and subjectivism (constructivism) (Bryman 
& Bell, 2015). Objectivism is an ontological approach that assumes the reality exists external 
to social actors’ minds. In contrast, the subjectivism suggests that the social reality is the 
creation of the social actor and consequently, it is in a continual state of revision. It also implies 
the existence of multiple realities (Saunders et al., 2016). Popper (1966) advocates that human 
knowledge is objective and impersonal where people are not only theory producing but also a 
consumer of others’ theories whether in science, religion or even poetical myths. Popper’s 
objective knowledge is independent of the person’s subjective belief, in other words, it can be 
understood without submerging in the subjective minds of people (Tell, 2004).  
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This objective understanding of knowledge is in line with the researcher’s proposition of 
the personal knowledge of pharmaceutical manufacturing employees. According to the law of 
contradiction (one of the three fundamental laws of logic), two contradictory prepositions 
cannot both be right or in other words for all propositions P, it is impossible for both P and not 
P to be true (Encyclopedia Britannica, 2019). As previously explained, knowledge is a justified 
true belief. This definition implies that knowledge must always be true as false knowledge is 
impossible (Hunt, 2003).  Therefore, the research adopts the single objective reality position 
as multiple realities (subjectivism) would inevitably lead to a contradiction. The research thus 
adopts that it is not possible to measure and compare the knowledge unless it is objective and 
where external standards (not from the social actor mind) are used to evaluate the generated 
knowledge (Tell, 2004). 
Epistemology is the theory of knowledge or simply the possible ways of gaining knowledge 
of social reality (Grix, 2003). The modern western epistemology recognises two great 
epistemological traditions: Rationalism and Empiricism. While Rationalism claims that true 
knowledge is the product of mental processing rather than sensory experience, Empiricism 
limits true knowledge to sensory experiences (Nonaka & Takeuchi, 1995). Similarly, two main 
paradigms are recognised in social science research which have their roots in the 20th–century 
philosophical thinking: quantitative and qualitative paradigms. The quantitative paradigm is 
also known as the positivist, the traditional or the empiricist paradigm (Creswell, 1994). 
Positivism is adapted from natural science. It has three basic principles: objectivism, value-free 
research, and research independence (Blumberg et al., 2014). In a positivist view of the world, 
the research adopts the philosophical stance of a natural scientist where only observable 
phenomena produce credible data (Saunders et al., 2008). It also proposes a nomothetic 
epistemological approach with existent regularities and law-like generalisations in social 
settings (Easton, 2010).  However, as explained by Sveiby (2010), the measurement of a social 
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phenomenon (e.g. the personal knowledge) depends on proxies and assumptions which make 
it less accurate than measurement in the applied science settings (Sveiby, 2010). For this 
reason, the positivist paradigm is not appropriate for this study. Furthermore, the conclusive 
theory testing within social science is complicated by diversity, complexity and changing 
nature of organisations as well as the element of personal volition in human behaviour 
(Cusumano et al., 2008). 
In contrast, the interpretivist approach advocates a value-laden nature of the study. The 
interpretivist describes reality as subjective and multiple as the social actors interact with their 
research outcomes (Creswell, 1994). Interpretivism appeared as a criticism of the application 
of the scientific model to the study of social phenomena. Whereas the positivist aims to explain 
human behaviour, the interpretivist aims to understand it (Bryman & Bell, 2015). 
Interpretivism exploits the heritage of Phenomenology (Saunders et al., 2008).  From this 
perspective, each situation is perceived in a unique way as a function of circumstances and 
involved individuals. In other words, research is not independent of the researcher, but it is an 
intrinsic part of it (Remenyi et al., 1998).  
For pragmatism, an idea is true if it is useful and has practical consequences or simply if it 
works (Gray, 2013).  Accordingly, there may be multiple realities as no single viewpoint 
furnishes the complete picture (Saunders & Tosey, 2013).  In other words, only concepts that 
support actions are connected to the matter in hand. This can be described as a reconciliation 
between subjectivism and objectivism (Saunders et al., 2016). According to  Gray (2013) 
pragmatism has become popular in recent decades as it provides an epistemological 
justification for the use of mixed methods research (MMR). MMR is that type of research in 
which a researcher join qualitative and quantitative research techniques to achieve breadth and 
depth of understanding and corroboration (Schoonenboom & Johnson, 2017). However, the 
pragmatist position underestimates the role of the philosophical assumptions in the appropriate 
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exploitation of research methods (Maxwell & Mittapalli, 2010). The idea of multiple realities 
was found incompatible with the researcher’s perspective of knowledge as both objective and 
intransitive. Due to this ontological disagreement, both interpretivism and pragmatism 
philosophies were excluded. 
Realism as a research philosophy shares the principles of Positivism and Interpretivism 
(Blumberg et al., 2014).  Similar to positivism, it argues that social sciences can apply the same 
principles of data collection and interpretation as natural science. It also endorses the view of 
external reality to scientists’ minds. There are two major forms of Realism. Direct or Naïve 
Realist believes reality can be accurately understood via the aid of our sensory experiences and 
thus are deemed superficial  (Bryman & Bell, 2015). Conversely, Critical Realism (CR) 
emerged as a response to increasing critique to Positivism that dominated the early decades of 
the 20th-century and was strongly associated with the British Philosopher Roy Bhaskar.  
Bhaskar confirms that the world is structured, differentiated and changing (Danermark et al., 
2002).  
Unlike Naïve Realist, Critical Realist differentiates between the objects under research, and 
the terms used for their description. While the former positivist approach works well in the 
natural science context where it is possible to measure reality in controllable systems, this 
seldom happens in social science. Critical Realist claims that our knowledge of the world is 
fallible where conditions and social relations affect our perception. In spite that the world is 
socially constructed from a Critical Realist perspective, it is not entirely so (Easton, 2010).  It 
is argued that reality already exists independent of our perceptions, but it is impossible to attain 
a “God’s eye point of view” purely independent of any particular viewpoint (Maxwell & 
Mittapalli, 2010). The self-contradiction of Naïve Objectivism and Relativism comes from the 
fact that in their more radical forms they entail that it is meaningless to search for general 
knowledge. Critical Realism keeps the reality existing independently of our knowledge. It 
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considers the facts theory-dependent but not theory-determined (Danermark et al., 2002). For 
a critical realist, the reality is both independent of humans and stratified : the real, the actual 
and the empirical (Mingers, 2004). 
The Researcher assumes that personal knowledge must have an objective nature 
independently existing and external to social actors. This assumption is found necessary to 
measure and compare employee’s individual knowledge in an objective way. Also, 
measurement error and biases are inevitable and need to be considered. The study design meets 
the critical realist assumptions by offering an explanation for the observed organisational 
events through understanding the underlying latent causes which in turn would reveal the deep 
social structure behind them (Saunders et al., 2016). 
 
Research Approach 
As emphasised in chapter one, a key objective of this research is to understand the structure 
behind the personal knowledge of knowledge workers in the pharmaceutical manufacturing 
organisation then exploit this understanding to develop and validate a measurement framework. 
To achieve this, three reasoning approaches are frequently encountered in literature: induction, 
abduction and deduction. Induction is a theory-building approach. Through the analysis of 
collected data, a theory is formulated (Saunders et al., 2008). However, the inductive argument 
doesn’t build high strength in the relationships between premises and results; so it cannot be 
generalised as a conclusion is seen only as a hypothesis (Blumberg et al., 2014). In other terms, 
the truth of premises is not a guarantee of the truth of the conclusion (Schechter, 2013). 
As this research topic is relatively new, limited literature and few frameworks explain the 
dynamics of personal knowledge, particularly in the pharmaceutical manufacturing context 
(Ramy et al., 2018). This suggested that the study commences with an exploratory phase. 
During this phase 15 interviews with pharmaceutical industry experts were conducted to 
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explore the current practices and provide more understanding of literature observations 
(including regulatory literature). The discovered themes and structures of knowledge within 
the pharmaceutical sector were further compared with evidence from the extant literature. The 
new explanations are integrated to build the research hypotheses and the proposed framework. 
This back-and-forth movement between induction and deduction is termed “abduction” where 
new ideas are generated from the combination of both (M. Saunders et al., 2016). Similarly, 
Bryman and Bell (2015) call the process of back-and-forth engagement with the social world 
and literature “dialectal shuttling”. Abduction can also be described as a process of forming 
concrete explanatory hypotheses (Denecker et al., 1996) and inference to the best explanation 
or interpretation of data (Ketokivi & Mantere, 2010). Moreover, the critical realist method is 
deemed to be abductive as it moves from experiences in the empirical domain to the underlying 
structures in the reality domain (Mingers, 2004). As will be detailed later, this study adopts 
Mixed Methods Research (MMR) to address the research problem by combining inductive and 
deductive reasoning through abductive thinking (Creswell & Clark, 2018). 
On the other hand, deductive theory exploits the available body of knowledge and relevant 
theoretical ideas to deduce a hypothesis (or hypotheses) that can be subjected to testing 
(Bryman, 2015). Therefore, the truth of the conclusion in deduction is dependent on the input 
propositions (premises) conditional that the reasoning is made without mistakes (Schechter, 
2013). .Deduction can be seen as the mirror image of induction. Whereas the induction uses 
data to build a new theory, the deduction completes the cycle by using data to test the theory 
(Eisenhardt & Graebner, 2007). The deductive approach demonstrates a highly structured rigid 
methodology. The problem under study should be reduced to the simplest elements through 
the process of Reductionism. However, the prominent feature of the deduction is 
Generalisation when applied on a sufficient sample (Saunders et al., 2008).  In pursuance of 
validating the proposed framework, the deductive approach is suggested. The researcher 
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deductively tests the model (hypotheses) developed from the exploratory phase in the following 
explanatory phase. Abduction and deduction reasoning are sequentially used in research 
through what can be described as the double movement of reflective thought. Abduction 
proceeds by observing a fact then during the course of scrutinising (back-and-forth movement) 
the reason behind it, hypotheses are generated. Deduction comes after to test the capabilities 
of proposed hypotheses to explain the observed fact (Blumberg et al., 2014). Combining both 
approaches can be represented in (Figure 4-2). As a side note, there is no rigid division between 
the different reasoning approaches and it is common to combine more than one approach at 
one stage of the study (Saunders et al., 2016). 
 
Figure 4-2 Combining Abduction and deduction 
Research Strategy 
In critical realism philosophy, the researcher uses either or both quantitative and qualitative 
data to explore not only what is immediately experienced but also the structures and 
relationships that lie beneath (Saunders & Tosey, 2013). While quantitative research explores 
the relationship between variables to validate objective theories, qualitative research help 
discover how people interpret social or human phenomena (Creswell, 2014). This study adopts 
Mixed Methods Research (MMR) techniques. The exploratory phase utilises qualitative semi-
structured interviews followed by quantitative surveys in the explanatory phase. In case of 
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learn about the studied phenomena, theories and variables and then to follow up with a 
quantitative study to validate the exploratory findings as the mixed method is the ideal 
approach in such situations (Creswell & Clark, 2011). From a critical realist perspective, 
quantitative methods (e.g. factor analysis) are employed in the deductive phase to confirm the 
underlying structures of the latent variable “the personal knowledge” and to validate the 
developed explanations from the qualitative phase (Mingers, 2004). 
MMR design can be realised in two main philosophical positions: critical realism and 
pragmatism (Saunders et al., 2016).  Indeed, critical realism provides philosophical and 
epistemological assumptions not only compatible with both qualitative and quantitative 
research methods but also leverage the cooperation between them. MMR gains an advantage 
from combining the benefits of qualitative and quantitative approaches which enable more 
solid conclusions that wouldn’t be possible by any of them alone (Maxwell & Mittapalli, 2010). 
Mixed methods are also deemed to provide the required dialogue between different 
perspectives to deepen rather than triangulate the understanding of the research phenomenon 
(Maxwell & Mittapalli, 2010). This research couples both a qualitative exploratory phase 
(semi-structured interviews) to understand and explain the manifestations of personal 
knowledge in the pharmaceutical organisation and a quantitative validation phase (survey) that 
deductively test the proposed relations in the research phenomena and understand the 
underlying factors.  
 
Research Scope and Time Horizon 
This study takes an industry specific approach where the pharmaceutical manufacturing is 
the research field. According to EudraLex guidelines volume 4, pharmaceutical manufacture 
can be defined as “All operations of purchase of materials and products, production, quality 
control, release, storage, distribution of medicinal products and the related controls” 
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(European Commission (b), 2017). From this perspective, the study explores the personal 
knowledge of all technical employees (knowledge workers) in the following functions: 
▪ Warehousing. 
▪ Formulation, filling, tabletting, primary packaging, etc. 
▪ Secondary packaging. 
▪ Quality Assurance. 
▪ Quality Control. 
▪ Technical services. 
Due to the similarities and overlap among manufacturing functions, only manufacture-
related technical jobs were considered during the framework development. The following 
support functions are considered out of the scope of this study: 
▪ Research and Development (R&D) 
▪ Sales 
▪ Marketing 
▪ Procurement and logistics. 
▪ Human Resource (HR) 
▪ Occupational Health and Safety (HSE) 
▪ Facilities, Utilities, Machines, Equipment (FUME) and maintenance engineers. 
▪ Other supporting services. 
While longitudinal studies allow researchers to study changes and development as he/she 
observes people or events over time with control over the studied variables (Saunders et al., 
2008), this study adopts a cross-sectional time horizon where the data collection relies on 
organised collections or snapshots at a particular time (Saunders & Tosey, 2013). 
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Research Design 
In MMR, data is collected and analysed utilising both quantitative and qualitative 
methodological paradigms.  Quantitative and qualitative methods can be either concurrent 
(conducted in parallel) or sequential (one dependent on the other) as in this research (Creswell 
& Clark, 2018). It is believed that this combination offers more advantages for the research 
rather than the use of any single methodology (Čížek, 2009). The purpose of the sequential 
MMR in this study (QUAL QUAN) is the development of the hypotheses (model) by 
the qualitative techniques that would be confirmed quantitatively in the next phase 
(Schoonenboom & Johnson, 2017).  It is important to mention that this research adopts equal-
status mixed methods research (QUAL QUAN) where qualitative and quantitative 
elements share the same value and weight and are continuously interacting (Schoonenboom & 
Johnson, 2017). 
The first phase of this study is an extensive literature review for relevant academic and 
regulatory literature (Figure 4-3). This is followed by 15 interviews (qualitative) with a selected 
group of pharmaceutical industry experts. Thematic analysis is adopted to identify key themes 
and relations (Braun & Clarke, 2006). The ultimate goal of this phase is to abductively develop 
concrete hypotheses, explaining the personal knowledge, in the form of a conceptual 
framework.  
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Figure 4-3 Research Design 
The subsequent phase is the validation phase employing quantitative techniques. The data 
obtained through the survey are analysed to evaluate and confirm the underlying factors of the 
personal knowledge using confirmatory factor analysis. 
 
Research Plan 
It was once recorded that Benjamin Franklin said “by failing to prepare, you are preparing 
to fail”. In order to answer the research questions and achieve the subsequent objectives, a 
detailed plan was prepared.  The research plan consists of an exploratory study, framework 
development and framework testing/validation. In the following sections, each stage of the plan 
will be explained in further details.  
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The exploratory study 
This stage is seen as an extension and a complementary component to the previous stage. 
There are three ways to conduct an exploratory study: reviewing relevant literature, 
interviewing experts and conducting focus groups (Saunders et al., 2008). The focus group 
method was excluded as it was technically impossible to join geographically dispersed industry 
experts (in 9 countries) together in one session.  Both the literature review and semi-structured 
interviews were employed instead.  A related point to consider, the exploratory stage is not 
subsequent to the literature review phase. Both phases are interacting and engaged together and 
abductively leading to the framework development. Chapter five is dedicated to the findings 
of the exploratory study.  
 
(i) Interviews  
 Interviews are one of the most commonly used data collection tool in the social sciences 
(Brinkmann, 2014) and are considered a good subjective exploratory tool rather than an 
objective scientific hypothesis testing tool (Kvale & Brinkmann, 2009). An interview is a 
verbal exchange where the interviewer gains insights and understanding of the interviewee’s 
experiences, opinions, predictions and processes (Rowley, 2012). It can be also defined as a 
purposeful conversation where the interviewee responds to interviewer’s concise questions by 
providing reliable data, relevant to research objectives. It is either structured, unstructured or 
semi-structured (M. Saunders et al., 2016).  Structured interviews follow a rigid structure and 
highly standardised techniques. On the other hand, unstructured interview pursues a free and 
flexible style for questioning as no predetermined questions are required (Kothari, 2004). As a 
midway between the previously mentioned forms of interviews, semi-structured interviews 
show some level of predetermined structure but maintain flexibility in addressing interview 
topics too (Longhurst, 2010). They were chosen for the exploratory study as a tool for 
understanding what is happening in relation to specific research (Saunders et al., 2008). It is 
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clear that a well-crafted interview can achieve objectivity in the sense of being unbiased and 
free from prejudice. By the same token, reliability can be attained once leading questions were 
ruled out during interviews. This is deemed to enhance the consistency and the trustworthiness 
of research (Kvale & Brinkmann, 2009).  
Interviews can also be classified into face-to-face interviews, telephone interviews and 
internet-mediated (Saunders et al., 2016). Both face-to-face and electronic (internet-mediated) 
interviews were employed according to the geographic location of the participant. Face-to-face 
interviews were limited to only one interviewee who was based in Dublin. For internet-
mediated interviews, several social media tools were used based on convenience including 
Facebook messenger, WhatsApp and Skype. Camtasia Studio 8, a professional desktop 
recording and video editing software, was utilised for recording the online interviews and 
facilitate any necessary sound editing. 
Table 4-1 Semi-structured interview themes 
Theme Rationale Research Objective 
Practitioners definition of 
Knowledge 
The introductory question, ice-
breaking 
Objective 1 
Establishment of KM in industry Reflects the extent of KM adoption in 
the industry 
Objective 1 
The significance of knowledge in 
pharma 
To know the value of KM from the 
subject’s perspective.  Prepare for the 
next question about  
Knowledge  measurement 
Objective 1 
KM Maturity To explore the status of KM in the 
company 
Objective 1 
Individual Knowledge Assessment To examine the importance of IK 
assessment, guides to the following 
question 
Objective 2 
Elements of Individual Knowledge To identify parameters for framework 
design 
Objective 2 
Framework Application Explore the usability of the proposed 
framework  
Objective 2 
The interview design started by identifying the key themes to be covered during the 
interview process (Table 4-1). Later, a group of questions were suggested below each of the 
ten interview themes. Both interview questions and themes were developed drawing on the 
identified theory gaps and reflecting the research objectives (Rowley, 2012). The included 
questions were not obligatory and the interviewer was allowed to rephrase them as required or 
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add necessary probing questions. The researcher utilised open end questions to explore the 
industry practices and provide suitable answers for the relevant research questions. As an 
ethical commitment, the interviewer avoided any guiding enquiries in the course of interviews 
and kept a neutral position. Probing questions are also used to clarify the answers and explore 
the new topics opened by the interviewees. Those questions were non-directive such as “can 
you elaborate?” or “can you give some examples?”.  Active listening was practiced to allow 
the interviewees to freely express their opinions. The interview themes along with the 
suggested questions were reviewed by the researcher and the supervisors for clarity and 
grammatical accuracy. Examples of the utilised question are represented in (Table 4-2). 
Table 4-2 Suggested Interview Questions 
How to explore the theme (a suggested question) Theme 
1. How do you understand/define the word “knowledge” in the pharmaceutical 
industry context?  






2. Do you think knowledge management is a well-established domain within 
the pharmaceutical industry? 
• If yes, please elaborate. 
• If no, please explain. 
Establishment 
of KM in 
industry 
3. In your own opinion, is there a need to better manage knowledge across the 
product lifecycle within the pharmaceutical sector? 
• Please explain your answer with some examples of where more effective 





4. Does your organisation currently have a strategy for knowledge 
management?  
• If yes, please elaborate. 
• If no, please explain. 
5. Has your organisation adopted any specific initiative to promote knowledge 
management practices (e.g. knowledge sharing platforms, social networks, 
Wikis, etc.)?  
• If yes, please elaborate. 
• If no, please explain. 
KM Maturity 
6. Do you think it is important to assess/ measure the knowledge of individual 
employees? Please justify. 
7. Does your organisation attempt to evaluate individual knowledge of 
employees?  
• If yes, please elaborate. 
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How to explore the theme (a suggested question) Theme 
Tip: you can skip Q.7. if the answer to Q.6. is “yes” and the subject explained their 
method of assessment. 
8. Are you able to evaluate and compare the individual knowledge of your 
employees? 
•  If yes, how do you evaluate their knowledge?  
• If no, why not? 
9. What are the main knowledge aspects you need to evaluate in your 
employees? 




10. If you had a tool to measure and compare individual knowledge of your 
employees, would this offer any value to the pharmaceutical industry from a 




At the beginning of each interview, the basic demographic information about the participant 
and his/her organisation was collected. Demographic information included: country of 
residence, organisation type, the approximate number of employees, product category 
(conventional, devices, biologics, etc.), ownership of the organisation, job title and participant 
function or department. These data are obtained to aid the interpretation of the collected data 
and the discovered trends. It was also used to establish a good rapport with the interviewee 
before starting with the questions. After the collection of the demographic data, questions on 
the interview themes followed. Every question was considered to set the context for the 
following question (Rowley, 2012). The review of the relevant regulatory guidelines (chapter 
three) did not provide a comprehensive definition of knowledge for practitioners. The first 
theme introduced the knowledge concept to the interviewees and collected their insights within 
the pharmaceutical manufacturing context. The literature outlines that KM is a well-established 
academic domain (Ramy et al., 2018) and a regulatory requirement (ICH, 2008).  
Understanding the degree of establishment of KM in the industry practices was the focus of 
the second theme. The significance of knowledge is examined and the current efforts for KM 
are assessed in the next theme. The fourth interview theme focuses on KM maturity in the 
pharmaceutical organisation. Jochem, Geers and Heinze (2011) describe KM maturity based 
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on knowledge use and renewal. The interviewer probed the KM strategies, processes and 
initiatives taking place in the pharmaceutical organisations to assess KM maturity and the level 
of KM standardisation.  The fifth and sixth themes explore the understudied area of personal 
knowledge measurement and identify the current processes for identifying knowledge holders 
(if any). The interviewees then were asked to assess the value of the measurement framework 
to understand the practical implications of the study. 
The recorded interviews were saved as MP4 files and were uploaded to a private channel 
on YouTube.com for automatic transcription. The YouTube account is managed by the same 
DIT google account and has the same security features. The account is password protected and 
private (not publicly broadcasted). The automatic transcription features in Youtube.com 
facilitated the preliminary transcription of the recorded interviews. However, it was followed 
by a manual quality check to ensure the accuracy of the transcription. 
 
(ii) Interview pre-testing (Pilot interviews)  
Pilot interviews were conducted with four volunteers from Technological University Dublin 
(formerly Dublin Institute of Technology) in March 2018. The aim of the pilot interviews was 
to ensure the clarity and coherence of interview questions as well as to familiarize the 
interviewer with questioning and probing activities needed during the course of the interview. 
The selection of the pilot interviewees is based on convenience and findings are not included 
in the data analysis phase. All participants spoke fluent English and had an academic affiliation 
(three PhD candidates and one lecturer in the College of Business). Despite that they did not 
have relevant industrial experience, they were able to assess the clarity of the language and the 
logical flow of the questions. It was also an opportunity to familiarise the interviewer with the 
interview themes before the commencement of research interviews.  
The pilot interviews were recorded for two reasons: first to ensure the reliability of the used 
recording devices before the beginning of the research interviews (quality check); second to 
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provide a reference to the recommendations as well as the learned lessons from the pilot 
interviews. However, the pilot interviews were not transcribed as it was found unnecessary and 
hand notes were sufficient at this stage. Notes taken during the pilot interviews helped refine 
the questions and avert any potential misunderstanding. All interviews (including pilot 
interviewees) were conducted in English. It was assumed that English is a commonly used 
language in the pharmaceutical sector (including the pharmaceutical international regulatory 
agencies) and all the selected interviewees spoke English fluently.  
 
(iii) Interview sampling and selection 
Sampling is the examination of a representative group from the entire population. The 
purpose of which is to gain an understanding of the characters of the population through testing 
a sample (Lucey & Lucey, 2002). The selected sample should represent the attributes of the 
population; hence, it is called a “representative sample” (Bryman & Bell, 2015). The 
population targeted in the exploratory study was industry experts who have long experience in 
the pharmaceutical manufacturing industry. As defined in section 4.5, this includes production, 
quality and technical services related functions. This would include senior and middle 
managers, directors as well as industry consultants. The pharmaceutical industry is controlled 
by internationally-harmonised regulations (FDA, 2020).  Due to the global nature of the 
pharmaceutical industry, there was no restriction on the country of the participant. 
Furthermore, the sample includes participant from multinational enterprises as well as domestic 
organisations of different sizes. This provided a bird’s eye view of the current practices in the 
pharmaceutical industry. Sampling techniques are categorised as either probability or non-
probability sampling. In the probability methods, every member of the sample has a known 
and equal chance of being selected. In contrast, the researcher deliberately selects participants 
in non-probability sampling based on specific criteria or convenience (Saunders et al., 2016). 
Table 4-3 provides a summary description of the main sampling techniques.  
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Table 4-3 Sampling techniques Adapted from Kothari (2004) 
Sampling Technique Description 




Probability sampling where all the members of the 
population have an equal chance of being selected. 
Systematic sampling Random selection of every nth element until the full sample 
is collected. 
Stratified sampling To obtain a random sample from a non-homogeneous 
population. 
Quota sampling Fixed sample size. Cost-efficient. 
Cluster sampling Grouping the population then selecting a cluster as a 
sample. 
Multi-stage sampling For big inquiries over a large geographical area. 
Sequential sampling Based on a complex mathematical sampling plan.  
 
As the researcher focused on the main functions in the manufacturing sector, non-
probability deliberate sampling is applied for sample selection. The non-probability sampling 
approach is considered the most practical approach for exploratory studies (Saunders et al., 
2008).  A purposive sample that represents all the key functions in the pharmaceutical 
manufacturing is assumed to be suitable to this stage of research where senior managers and 
experts are targeted as a source of data (Figure 4-4).  
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Figure 4-4 Decision map for selection of non-probability sample (Saunders et al., 2008) 
Note:  The selected path is in colour 
 
In purposive sampling, the interviewer deliberately selects the participants out of the 
population (i.e. not randomly selected). The sample is considered a form of judgement 
sampling rather than a random sampling technique. Purposive samples are quite common in 
qualitative studies where the researcher’s main concern is to develop hypotheses rather than 
generalising findings over wider populations (Kothari, 2004). Although formal generalisations 
are overvalued as the only source of knowledge and development, it is often possible to 
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generalise based on strategically selected critical case study as an alternative or supplemental 
approach. Strategic case selection supports the assumption that if it is valid for this case, it is 
valid for all (or many) cases. This can be attributed to the nature of social science and its 
tendency to offer concrete context-dependent knowledge rather than general context-
independent theories (Flyvbjerg, 2011).  
Regarding sample size, there is no consensus on the suitable sample size for qualitative 
research. However, 12 interviews are the recommended sample size providing that it is 
collected from a homogenous population (Rowley, 2012; Saunders et al., 2016). All the 
interview candidates not only belong to the same industry but also to complementary functions 
(production, technical services and quality) that share pre-requisite qualifications. WHO 
requires scientific education in chemical, pharmaceutical and biomedical disciplines for key 
personnel supervising pharmaceutical manufacturing and quality activities (WHO, 2011a). 
Data saturation is suggested also to determine the acceptable sample size (Saunders et al., 
2016). Data saturation is achieved when new interviews bring little or no new ideas (Saunders 
et al., 2008). For reasons above, the study population is considered homogeneous, covering all 
key functions in the pharmaceutical manufacturing industry and the sample size is determined 
to be 15 interviews or until data saturation whichever is more. After 15 interviews, the 
researcher concluded that data saturation has been achieved and no more interviews are 
required. 
 
(iv) Thematic analysis 
All interviews were transcribed and uploaded to NVIVO 12 for Mac software. NVIVO is a 
Computer- Assisted Qualitative Data Analysis Software (CAQDAS) that was used during the 
qualitative phase of this study. It provides a powerful tool for data classification, analysis and 
visualisation. It organises, stores and retrieves data in several formats helping the researcher 
find hidden connections (NVIVO, 2018). After a preliminary transcription using YouTube 
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automatic captioning, the researcher completed the transcription of his own interviews to 
ensure the accuracy of the transcription and to familiarize himself with the content. Transcripts 
along with the researcher’s notes during interviews constituted the data corpus for the 
qualitative study. Three stages of interview analysis are followed: coding, condensation and 
interpretation (Kvale & Brinkmann, 2009).  
The “code” in qualitative research is a word or short phrase that assigns a summative 
meaning for a piece of data (Saldaña, 2015). The researcher utilises several coding techniques 
in this study including in-vivo, process, descriptive, structural and focused coding to analyse 
the data over several cycles. To identify the underlying patterns and structures of the research 
phenomena hidden within the interview data, thematic analysis was chosen. Thematic analysis 
can be described as a process to identify and analyse themes in qualitative data. This can also 
examine the underlying ideas and assumptions contained in the latent themes (Maguire & 
Delahunt, 2017). The research adopted the six-phases of thematic analysis (Figure 4-5) 
following the guidelines of Braun and Clarke (2006) as well as the six-steps practical guide by  
Maguire and Delahunt (2017).  
 






3. Searching for 
themes
4. Reviewing themes
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 The analysis included six steps or stages as follow: 
Step 1: become familiar with the data: 
This phase is considered a preparation for the next coding phases. As explained above, the 
researcher personally interviewed the selected cases and conducted the transcription himself. 
Before starting the coding process, at least one more check of the transcript including proof 
reading and grammar check. This repeated review (at least four times) enabled the researcher 
to familiarise himself with the data corpus so as to have a holistic understanding of the aspects 
of interviews.  
At this stage, all the transcripts were uploaded to NVIVO 12 Mac version, the Computer 
Assisted Qualitative Data Analysis software (CAQDAS) in this study. All transcripts and 
NVIVO files were saved, and backup copies were saved on a private cloud (Google Drive).  
 
Step 2: generating initial codes: 
The study is exploratory and followed an open coding system, i.e. there weren’t any pre-set 
codes from literature (Maguire & Delahunt, 2017). Several types of codes were utilised 
throughout the thematic analysis process. In the first coding cycle, the process started with a 
structural coding to split the data corpus into ten segments, i.e. one for each main question. 
Despite that structural codes overlapped in the second coding cycle, it was found necessary to 
link the generated in vivo, process and descriptive codes to the proper context in the first cycle. 
In vivo coding emphasises on the actual spoken words by the interview participants. It is a 
useful way to understand stories and experiences in the participant’s own words (Manning, 
2017). Process codes use the gerund to describe or refer to a certain activity or process in the 
interview (Saldaña, 2015).  Descriptive codes describe the patterns in the data set (Maguire & 
Delahunt, 2017). With all these types of codes, the researcher embraced a splitter approach 
generating over 716 codes in the first cycle (Figure 4-6). The coded data could be a single 
phrase, a sentence or a group of sentences. Stated thus, the coding process is speculated as a 
CHAPTER 4: Research Methodology 
 4-109 
part of data analysis where data is aligned in meaningful groups (Braun & Clarke, 2006).  
 
Figure 4-6 A screenshot showing a sample of initial codes in NVIVO (the first coding cycle) 
 
Step 3: searching for themes 
The theme is a patterned response that reflects a meaning within the data set (Braun & 
Clarke, 2006). The goal of the thematic analysis is to discover the hidden patterns or themes in 
data so as to address the research questions (Maguire & Delahunt, 2017). The second coding 
cycle inspected the relations and patterns as they appear in the data corpus. Focused coding 
was employed at this stage of assembling related codes under one category. Focused coding is 
a second coding cycle technique which is led by a dominant theme. It recodes the data set to 
investigate the recurrent patterns and layers of meaning (Saldaña, 2015). This process needs 
further reading and back-and-forth scanning of the interviews’ transcripts. Focused codes 
evolved to meaningful themes after two more cycles of coding. Initial themes were developed 
based on researcher understanding of the analysed phenomena as explained by the 
pharmaceutical industry practitioners. Using NVIVO 12 for Mac, the researcher was able to 
assemble codes (called nodes in NVIVO) to create initial themes or categories that can be easily 
revised in the next cycles. This enabled the researcher to speculate on the possible patterns and 
themes in the provided data.  
Forty-six categories were recognised within the first coding cycle and were used as a basis 
for the initial themes. The preliminary themes are summarized in (Figure 4-7). The themes are 
sorted by the number of interviews that manipulated each theme (colour coded in the tree-map). 
Also, the size of each field in the tree-map reflects the sum of instances where underlying codes 
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are used. This was considered as a quantitative measure of the relative significance of the 
generated themes. 
CHAPTER 4: Research Methodology 
 4-111 
 
Figure 4-7 Preliminary Categories
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Step 4: Review themes 
Initial themes that were generated in the previous phase in the codes section of NVIVO 12 
were further reviewed and refined. In order to facilitate the review of themes, mind maps were 
adopted.  The mind map is an effective and widely used data visualisation format that was used 
to represent the identified themes and the underlying codes (Figure 4-8).  It consists of a central 
image surrounded by a radial diagram that represents the different connections among the 
portions of the illustrated information. It is considered an efficient personal learning tool to 
develop individual solutions and memorable results (Eppler & Usi, 2006). The main themes 
identified at this stage are knowledge maturity, understanding knowledge, the value of 
knowledge measurement, knowledge dynamics, industry practice (in relation to the personal 
knowledge measurement), training, regulatory knowledge, experience, behavioural specialism, 
learning and education, performance, technical knowledge, wisdom and organisational 
specialism. 
It is worth noting that the last nine themes are directly associated with the individual 
employee knowledge (personal knowledge) that was further refined in (Figure 4-9). The first 
five themes were more concerned with current KM practices in the pharmaceutical 
organisations as will be discussed in detail in the next sections.  Following the 
recommendations of Maguire and Delahunt (2017), a special miscellaneous category was 
created to include codes that didn’t fit under any suitable theme. 
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Figure 4-8 Revised themes 
 
At this step, the researcher re-examined the generated themes closely from the last phase. 
Themes are deemed to show coherence and at the same time are distinct from each other 
(Maguire & Delahunt, 2017). The data and codes associated with each theme were investigated 
for relevance. As a result, some of the initial codes were changed and new codes were added. 
The naming of some themes was revised to describe the underlying data more accurately. 
Redundant themes were merged. Several initial themes were renamed or re-categorised as 
subthemes under a more general theme.  The forty-six preliminary themes and subthemes 
evolved to 14 revised themes plus a miscellaneous category (Figure 4-8). As personal 
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knowledge is the focus of this study, key themes and subthemes of personal knowledge are 
further refined as shown in Figure 4-9. 
 
Figure 4-9 The Personal knowledge Themes-Revised  
 
Step 5: Define themes 
As a final refinement of the captured themes, the researcher combines themes that sound too 
similar to be independent themes. Some underlying subthemes and even codes were also 
moved to a more relevant place on the mind map. At this phase, the final themes and subthemes 
are appointed and the underlying interactions are illustrated in the form of a thematic map 
(Figure 4-10). It is noteworthy that two academic researchers with experience in qualitative 
methods were invited to check the classifications and coding. This practice is argued to reduce 
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potential bias in the data interpretation (Rowley, 2012). All their recommendations were taken 
into consideration during data analysis.  
The first theme in the thematic map (Figure 4-10) is training, learning and education that 
was regarded by interviewees as source of employee knowledge in the pharmaceutical 
organisation. This included the knowledge of foreign languages that facilitates communication 
and understanding of regulatory requirements especially in the multinational work 
environment (80% of the sample). Training was considered as the second angle in the 
knowledge base. Both adherences to training as well as training effectiveness were seen as a 
determinant of knowledge acquired from training. It is worth noting that respondents did not 
differentiate between assessing knowledge stock and assessing knowledge acquired after 
specific training. Moreover, relevant experience in a similar function, as well as involvement 
in pertinent projects, has been argued to be necessary to build employee knowledge. 
The outcome of knowledge was repeatedly perceived by the interviewed managers as the 
main indicator of knowledge. The performative knowledge theme included the Know-How 
manifestations of knowledge. The product and process understanding theme refers to the 
comprehension of the particulars of processes and products. It implies also the deep 
understanding of the basic science base (including know-why). This dimension describes also 
employee’s familiarity with modern manufacturing technologies. The organisational 
understanding theme means employee’s understanding of the prevalent culture, company 
values and the behaviours that fit within a certain work environment. Strategic goals and 
organisational policies are another part of employee’s knowledge about the organisation. The 
interviewees also referred to knowledge about weakness points and historical failures that have 
been encountered. Wisdom theme comprises taking the right decision, critical thinking and 
creative problem-solving skills. Finally, communication and networking theme encompasses 
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those skills that the interviewees endorsed their role for the flow of knowledge and integration 
within the organisation. 
 
Figure 4-10 Thematic Map 
Step 6: Writing-up 
The findings of the thematic analysis are reported in the next chapter (chapter five) and will 
be used to develop the conceptual framework. The comprehensive discussion of the thematic 
analysis findings in light of the extant literature is presented in chapter five. 
 
 Framework development 
The development of the research framework is based on abduction and theoretical re-
description of the components of the research phenomenon. This encompasses theories about 
the social structures and underlying relations united with conceptual thinking. This also reflects 
how these components appeared and the related causal mechanism (Raduescu et al., 2009). It 
is worth noting it is a back-and-forth movement between the literature review and thematic 
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analysis rather than an independent stage. Framework development will be presented in details 
at the end of the exploratory study chapter. 
 
Framework optimisation and validation 
 
After the theoretical grounding of the framework, the next stage is to test and validate the 
proposed relationships deductively. This stage represents the explanatory study where the 
relations and underlying factors that explain employee’s knowledge are examined. Explanatory 
research uses data to test theories that have been already grounded and conceptualised 
including cause-and-effect relationships (Saunders et al., 2008). Mixed methods implied an 
integration between both open-ended qualitative data and close-ended quantitative responses 
e.g. questionnaires (Creswell, 2014). The survey is the selected strategy at this stage. Self-




The questionnaire is a data collection instrument where participants are asked to respond to 
the same set of questions. It could be self-completed or completed through assistance, e.g. face-
to-face or telephone (Saunders et al., 2016). It is a quite common technique when the targeted 
sample is large (Kothari, 2004). The self-completion interviews are argued to be less costly to 
administer, less time consuming, free from interviewer effects, less variable and more 
convenient for participants (Bryman & Bell, 2015). Self-completion questionnaires are the 
method of choice for data collection at this stage. Regarding the delivery of the questionnaires 
to the participants (Figure 4-11), web-questionnaire was the selected delivery media.  
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Figure 4-11 Types of questionnaires- Adapted from Saunders, Lewis and Thornhill (2016) 
Note: The selected pathway is highlighted in yellow. 
 
Web questionnaires are often recommended when the research population have ready access 
to the internet  (Kaplowitz et al., 2004) as it provides high confidence that the right person has 
responded. The method is also argued to result in a reasonable response rate among large 
samples (Saunders et al., 2016). Moreover, Google forms is the adopted survey tool. This tool 
is deemed to provide a high level of security and confidentiality as it is password protected and 
linked to TU Dublin (formerly Dublin Institute of Technology) email system. One more feature 
is the possibility of making critical questions obligatory or “required” to ensure they are not 
missed by any of the participants. Screening questions were added at the beginning of the 
survey to ensure that only relevant participants would participate in the survey. For instance, if 
the respondent has no experience in the pharmaceutical manufacturing or occupies a support 
or administrative role (e.g. accounting), he/she will be prompted to submit the form before 
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(ii) Questionnaire design 
The questionnaire is generally divided into two sections. The first section is concerned with 
the key demographic data such as education, function, position, experience of the participants 
and data on the level of KM maturity in the participant’s organisation. The second section is 
designed assess each of the identified personal knowledge indicators of the proposed model 
(on a Likert scale of seven). One on Likert scale means “not at all” while seven signifies that 
the respondent agrees to a great extent with the provided statement. The questions are designed 
to test the hypothesised theoretical framework using confirmatory factor analysis (CFA) 
statistics as described in the next section. 
 
(iii) Confirmatory Factor Analysis 
Structural Equation Modelling (SEM) is a powerful statistical modelling technique 
combining Confirmatory Factor Analysis (CFA), regression models and complex path models. 
It is concerned with latent factors imbedded in theoretical constructs. The argument behind 
factor analysis is that the covariances between a set of observed indicators can be explained by 
a smaller number of underlying latent factors (Hox & Bechger, 1998). Latent variables can 
only be measured indirectly through a set of observed indicators (Skrondal & Rabe-Hesketh, 
2007). Observed indicators can be broadly classified into two principal forms: effect 
(reflective) and causal (formative) indicators (Bollen & Bauldry, 2011). Observed variables 
can also be called measures or manifests. They are graphically represented by a square or 
rectangle (Figure 4-12).  
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Figure 4-12- Structural Equation Model 
In contrast, unobserved (latent) variables are known as constructs or latent factors and are 
commonly illustrated as circles or ovals. Measurement component is depicted graphically by a 
thin line and structural component by using bolded lines (Schreiber et al., 2006). Also, Figure 
4-12 shows the measurement errors (e) or residuals in circles. Unlike the latent factors, 
residual’s effect is associated with only one measured variable (Bollen & Bauldry, 2011). In 
summary, SEM quantitatively tests a proposed theoretical model hypothesised by a researcher 
outlining how observed indicators define underlying factors and how these factors are related 
(Schumacker, 2010). Personal knowledge is a latent variable that cannot be directly measured 
in the organisational context; instead, the underlying factors, as well as the observed indicators 
(that can be empirically evaluated as a measure of PK), are explained through CFA. SEM is 
deemed to provide a quantitative explanation of the theoretically grounded PK measurement 
model hence provides the required validation of the research hypotheses. 
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(iv) Pilot Study 
As a final stage of questionnaire development, the researcher conducted a pilot study before 
distributing the survey. The pilot study is a pre-testing of the questionnaire that can reveal 
weaknesses (if any) and provides an opportunity to fix them (Kothari, 2004). The aim of the 
pilot study was to ensure the clarity and the logical flow of the survey questions and to test the 
electronic forms in practice.  In line with Saunders et al. (2016) recommendations, a non- 
probability purposive sample was adopted. A total of 14 respondents provided informative 
feedback and suggestions that were considered sufficient for serving the pilot study. The 
sample included ten practitioners with different levels of experience in pharmaceutical 
manufacturing. Table 4-4 provides an overview of the selected pilot study sample. In addition, 
four academics with experience in quantitative techniques and research methods have 
participated in the pilot study.  
The researcher contacted every participant individually and explained to him/her the 
purpose of this study and the expected time required to complete the questionnaire. Each 
participant was asked to provide feedback by filling special fields at the end of each section of 
the questionnaire. All respondents consented to take part in the study before starting the survey. 
Ethical considerations (highlighted in section 4.8.  at the end of the study) were adopted at all 
the stages of the research including the pilot study. The researcher reviewed the individual 
feedback and edited the survey in response.  The received feedback was generally positive and 
helpful. Few corrections in the questionnaire wording were made in light of the pilot study. 
Also, the screening questions wording was revised due to confusion between R&D and 
technical services among some participants. Last but not least, although the researcher 
personally contacted 27 pharmaceutical knowledge workers, only 14 agreed to participate in 
the pilot study. Therefore, the researcher anticipated a low response rate from the surveyed 
population. 
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Table 4-4 Participants in the pilot study 
 Job title/level Affiliation Country 
1.  Lecturer Academic Ireland 
2.  Lecturer Academic Ireland 
3.  Director Technical Services China 
4.  Supervisor QC Egypt 
5.  Specialist QA Egypt 
6.  Specialist QC Egypt 
7.  Specialist QA Egypt 
8.  PhD candidate Academic Ireland 
9.  PhD candidate Academic Ireland 
10.  Manager Production Egypt 
11.  Manager QA/QC UK 
12.  Manager Production Egypt 
13.  Manager QA Egypt 
14.  Manager Technical Service- QC Egypt 
 
(v) Sample size 
The targeted population at this stage is the knowledge workers in the pharmaceutical 
manufacturing sector. Employees from the production, technical services, warehouse, quality 
control (QC) and quality assurance (QA) functions are exclusively chosen for the sample. As 
mentioned previously, the knowledge workers within these functions share the basic 
qualifications and might have occupied previous positions in one or more of these departments 
as shown from the profiles of the interviewees (Table 5-1). The sample is not limited to one 
country as pharmaceutical product and process knowledge and regulations are assumed to be 
global. 
In SEM and CFA, the sample size is an important determinant of stability of parameter 
estimates. However, a review of the statistical literature reveals that there is no consensus on 
the minimum sample size. For example, a sample of three to 20 responses per variable are the 
widely accepted sampling rule (Bandalos, 2018; Mundfrom et al., 2005). It is worth noting that 
the accepted sample size is also dependent on the developed framework, factor loading (level 
of communality) and the number of observed variables per factor.  The greater the variables 
to factors ratio (at least three to four) and the higher the level of communality, the smaller the 
minimum sample size that is required (Bandalos, 2018; Schreiber et al., 2006). Computer 
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simulation studies of Mundfrom et al. (2005) suggested a minimum sample size of 150 to 180 
conditioned that the variables-to-factors ratio is at least 7 even in the case of low communality. 
Kline (2011) proposes 200 cases as the typical sample size in SEM studies based on the median 
sample size in published articles in this field.  As the variables-to-factors ratio in the proposed 
framework is close to 7 (
41
6
= 6.8333), a sample size of 180 cases is considered the minimum 
threshold for this study. At the end of the survey period, the researcher received 190 valid 
responses. 
 
Sample structure and collection 
Due to the lack of a complete sample frame, it was found impossible to conduct a simple 
random sampling. The researcher considered several options in order to collect a representative 
sample of the pharmaceutical manufacturing sector including panel survey companies and 
business mailing list brokers. However, none of them provided appropriate solutions. Cluster 
sampling was considered a suitable alternative as it is possible to create a comprehensive list 
of pharmaceutical factories in one country rather than the list of manufacturing professionals. 
Cluster sample is recommended when it is impractical or impossible to create an inclusive 
sample frame for all the elements of the population (Creswell, 2014).  
In cluster sampling, the whole population is divided into groups called clusters, then a 
randomly selected cluster(s) is used as the final sample (Taherdoost, 2016). Cluster sampling 
can be one-stage where all the members of the randomly selected clusters are surveyed or may 
be two-stage where the elements in the chosen clusters are randomly sampled (Žmuk, 2016). 
As the researcher had no control over the survey distribution within the participating 
organisations and due to confidentiality precautions that prevented the full access to full 
employee lists, two-stage cluster sampling was found suitable for data collection. As the 
researcher worked for 10 years in the Egyptian pharmaceutical sector and developed a wide 
network of contacts, Egypt was chosen to commence cluster sampling. It’s worth noting that 
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Egypt is among the largest pharmaceutical manufacturers and consumers in Africa and the 
Middle East with a market value of EGP 35.6 billion (expected to exceed EGP48 billion by 
2020) (Gage Consulting, 2017).  
The researcher initially reached out to a random sample of 50 Egyptian pharmaceutical 
manufacturing firms sourced from Egyptian yellow pages websites and verified individually 
by checking the company website. Contact was made with senior or middle management from 
one of the target functions of the research. A rapport was developed, and each contact was 
asked to distribute the survey to 10 appropriate respondents in their firm. Follow up emails 
were used to encourage participation. A total of 150 responses were received at the end of the 
survey period. 
The research also reached out to contacts within TU Dublin, the school of chemical and 
pharmaceutical sciences who supported the distribution of the survey to three part-time 
master’s programmes in which students commonly have current or prior experience in the 
manufacturing sector: 
a. MSc of Pharmaceutical validation technology. 
b. MSc of Pharmaceutical quality Assurance and Regulation 
c. MSc of Pharmaceutical quality assurance & biotechnology 
A total of 18 responses were received within three weeks and after sending a reminder email 
in week two. The researcher also used social media and popular pharmaceutical forums on 
LinkedIn to communicate with pharmaceutical manufacturing professionals worldwide. The 
following are the key forums that were used in this study: 
• PIC/S GMP Industry Forum (15,277 members). 
• Pharmaceutical Microbiology (25,790 members). 
• Pharmaceutical Discussion Group (18,795 members). 
• Quality Assurance, GMP and ICH Guidelines (76,110 members). 
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• ISPE Ireland Affiliate (557 members). 
• Global Pharmaceutical Contract manufacturing (861 members).  
At the end of the survey period, only 22 responses have been received through these forums 
from six continents as shown in Figure 4-13.  
 
Figure 4-13 Response per country from social media sample 
Maximisation of response 
Self-completed electronic questionnaires can provide reasonable response rates (especially 
when distributed within organisations) (Saunders et al., 2008). Nevertheless, some measures 
are found necessary to maximise the response rate. Studies reveal that in populations with ready 
access to the internet, a web survey with a mailed advance notice has a comparable response 
rate to hard-copy mail survey (Kaplowitz et al., 2004).  For this reason, the survey email is 
accompanied by a pre-contact letter. This letter confirms the confidentiality of the shared data 
and their exclusive use in research. The cover letter highlights the main objectives of the 
research and the affiliation of the researcher as well as contact details. Furthermore, the mail is 
personalised (by identifying the title and name of the contact person) using mail merge or 
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manually as applicable. Last but not least, follow up emails were sent once after ten days to 
two weeks after the initial contact to ensure the maximum response. 
Regarding the design and language, the researcher uses a clear language, avoids jargons and 
uncommon vocabulary. All readability and clarity features are examined during the pilot 
testing of the questionnaire. Literature suggests the use of incentives to enhance the response 
rate (Faria & Dickinson, 1995; Lorenzi et al., 1988). As an incentive to complete the survey, 
the participants were informed that the researcher will donate $1 (one US dollar) per completed 
survey for the Egyptian National Cancer Institute - Cairo (http://www.nci.cu.edu.eg/).  The 
Egyptian National Cancer Institute is a governmental organisation affiliated to Cairo 
University. After the collection of 150 responses, a copy of the donation receipt was posted on 
the researcher LinkedIn page as evidence of payment (as promised).  
The average response rate for the questionnaire was 18-30% (global vs locally distributed 
in Egypt) which is a reasonable response from an internet-mediated questionnaire (Saunders et 
al., 2008). However, it was observed that the promised contribution to charity had an 
insignificant effect on response rate. This goes in line with previous studies where personal 
cash incentives (e.g. lottery) significantly increased mail survey returns in comparison with 
promises of charity contributions  (Furse & Stewart, 1982; Hubbard & Little, 2015). It was 
argued that charity donation is usually associated with philanthropy and might look for some 
potential participants as an improper incentive for taking part in a research survey (Pedersen & 
Nielsen, 2016). Similarly, a comprehensive review of 1607 academic articles published 
between 2000 and 2005 found that the use of incentives is not correlated with the response rate 
(Baruch & Holtom, 2008). 
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Ethical Considerations and the Researcher’s Role 
Ethics are the principles of right and wrong that individual rely on for making choices and 
taking decisions (Laudon & Laudon, 2016). The research has to follow certain standards of 
behaviour to manage his/her relationship with research stakeholders (Saunders et al., 2016). 
Four ethical issues are commonly encountered in research: harm to participants, informed 
consent, invasion of privacy and deception (Bryman & Bell, 2015). The researcher 
acknowledges the research ethics as the top priority through all the stages of this research. All 
research participants are adults (over 18 years old) with no apparent mental or psychological 
illness that can influence their free will. In addition, informed consent was obtained at all data 
collection phases. Before data collection, all participants either in interviews or surveys were 
clearly informed of the purpose of this study and that all the provided information are used 
only for research purpose. For interviews, subjects’ names and their companies were removed 
during the transcription process.  
Moreover, the final copy of each interview transcript is sent to the participant for a final 
quality check and to have a second chance to opt out of the interview process if needed.  
Leading questions are strictly avoided ensuring the objectivity and reliability of the collected 
data. This guarantees higher consistency as well as trustworthiness of data (Kvale & 
Brinkmann, 2009). To avoid any stress of psychological harm for interviewees, they were 
informed at the beginning that they have the right to end the interview at any stage or to refuse 
to answer any question. The anonymity and confidentiality are also secured for all the survey 
data. Finally, the author ensured a high level of integrity during the reporting of research 
findings and accurately referenced all cited authors.   
It is noteworthy that the researcher is a pharmacist with more than 10 years of experience 
in the pharmaceutical manufacturing industry. He held several roles in the quality assurance 
and technical services. This included managerial and non-managerial roles. This long 
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experience is believed to familiarise the author with the industry operations, terminology and 
regulations. The author also utilised his personal network to recruit the interviewed experts 
from different functions. Also, personal contacts facilitated the distribution of the questionnaire 
within the identified clusters. This was deemed inevitable to have access to employees within 
the pharmaceutical manufacturing organisations.  Having a practical experience avoids the 
difficulty of failing to understand the terms and abbreviations commonly encountered in the 
pharmaceutical industry. In addition, familiarity with the different manufacturing and 
management processes enabled him to synthesise suitable probing questions during interviews.  
However, from a critical realist understanding, the researcher believes that the objective 
reality cannot be measured with certainty as our perception is influenced by conditions and 
social factors (Easton, 2010). The critical realism’s reality is also stratified and we deal only 
with outermost level “ the empirical” (Mingers, 2004). Hence, the reality is not simply what 
can be empirically perceived as proposed by the positivist. Developing explanatory theories 
that help identify causal mechanism driving the social events would definitely take us closer to 
the reality (Fletcher, 2017).  The author employed MMR in order to combine both the 
qualitative and quantitative techniques to enhance the credibility and integrity of research 
finding (Schoonenboom & Johnson, 2017). This combination of different methods, following 
structured analysis methodology and deductively comparing the findings with extant literature 
is deemed to reduce the researcher’s bias during data collection and analysis. Also, the 
researcher utilised the data to explain the underlying social structure (causal mechanisms) 
behind the personal knowledge (reality). The developed framework of causal factors from the 
QUAL phase was further tested in a bigger sample of pharmaceutical knowledge workers using 
CFA where the interference of the researcher became minimum.  
CHAPTER 4: Research Methodology 
 4-129 
Dissemination of Research Findings 
The dissemination of the research findings is planned at each milestone. Two literature 
review papers have been published in the Knowledge Management Research and Practice 
(KMRP) Journal. KMRP is one of the key peer-reviewed journals in the KM field. Available 
online since 2003, KMRP is the first KM journal to gain an impact factor (Thomson Reuters, 
2015). Moreover, KMRP was placed third in 2008 then the second in 2013, according to expert 
survey rankings conducted on a sample of 25 key KM journals (Serenko & Bontis, 2013). In 
addition, a Scientometric review paper has been presented in the 12th International Forum on 
Knowledge Asset Dynamics (IFKAD) highlighting the major trends in KM research. The 
empirical study findings are deemed to be published in a KM peer reviewed journal. A 
measurement framework or scale for industrial application is another expected outcome from 
this study. 
Furthermore, the researcher was invited to speak about his early findings in the National 
Pharmaceutical and Life Science Expo in 2018 and 2019. This was another opportunity to 
disseminate the research findings and obtain direct feedback from industry practitioners. It is 
noteworthy that the National Pharmaceutical and Life Science Expo is an annual meeting of 
over 1000 senior managers and speakers from the pharmaceutical and life-sciences sector. It 
provides a platform to disseminate the latest research updates, best industry practices and the 
most innovative technology solutions (Premier, 2019). 
Write-up: Presenting Research Results 
Proper reporting of a research is of ultimate importance for the reader to judge the adequacy 
of the research methods and findings. This implies a proper layout of the research thesis to 
include: A) preliminary pages; B) the main text and C) the end matter (Kothari, 2004). The 
primary part includes all the tables of content, figures and lists of tables. This part also includes 
the abstract, the acknowledgements and the declaration. The main text of the thesis consists of 
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eight chapters that include the literature review, research methodology, exploratory and 
explanatory studies, discussions and conclusions. The final part includes references and 
appendices. 
 
Summary and Conclusion 
This chapter provides an explanation and a justification of the research methodology in this 
dissertation. It outlines the adopted paradigm, the research paradigm, the research strategy, the 
scope and the data collections methods. A detailed research plan describes the research journey 
from literature review until data analysis and conclusion. The next chapter is the first part of 
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Introduction 
The aim of exploratory studies is to understand the research phenomena as we explore what 
happens in the field (Gray, 2013). In other terms, a researcher endeavours to familiarise himself 
with a certain phenomenon and formulate his hypotheses (Kothari, 2004).  This familiarity can 
be achieved via a literature review and/or communications with industry experts through 
interviews or focus groups (Saunders et al., 2008). After the extensive literature review in 
chapter two and three, the exploratory research was undertaken to portray the common 
practices in the pharmaceutical industry regarding personal knowledge management and 
measurement. The exploratory study would also examine, in the next sections, the KM maturity 
in the pharmaceutical manufacturing sector. At the end of this chapter, the conceptual 
framework will be developed and presented. 
 
Interviews 
In order to explore the current understanding of the “knowledge” and its management 
practices among the pharmaceutical industry practitioners, a set of semi-structured interviews 
were conducted with a selected sample from the pharmaceutical industry experts. The 
interviews were intended to define the dimensions of the personal knowledge taking into 
consideration the special nature of pharmaceutical manufacturing. A non-probability sample 
was considered the most practical choice at the exploratory stage (Saunders et al., 2008). 
Detailed justification of sampling techniques is described in the methodology chapter (chapter 
four).  
A total of 15 semi-structured interviews were conducted with senior managers from 
different functions in the pharmaceutical industry. Interviews were conducted over the period 
from March to September 2018. Interviewees were recruited from the researcher’s industrial 
network, LinkedIn and by direct invitations during industry related exhibition (the National 
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Pharma & Life Sciences Expo 2018). Over 29 candidates were suggested for the purposive 
sample. All the nominated managers comply with the inclusion criteria as mentioned in chapter 
three (4.7). Furthermore, a ranking system of three levels was utilised to define the priority and 
relevance of each candidate to the inclusion criteria. Managers who had a superior rank or score 
(i.e. rank one) were given the priority in the interviewing process. This ranking was based on 
the position in the organisation and the relevance of experience either the single or multi-
functional experience (Table 5-1). 
Table 5-1 Interview list 
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The sample covered several organisations in nine countries (Figure 5-1) from domestic 
(private), governmental and multinational sectors in order to shed light on the different KM 
practices including knowledge measurement where applicable. Eighty percent of the 
participants are affiliated to multinational companies. The average organisation size is 355 
employees (Max =1200; Min= 7). One-third of these organisations are mainly producing 
biologics and vaccines. Another third described their experience to be in the conventional 
pharmaceuticals. The rest of the sample is affiliated to organisations producing a mixture of 
biologics and conventional products as well as medical devices.  The median length of 
interviews is 28 min 2 sec (maximum length= 38 min 36 sec; minimum length= 17 min 47 
sec). The interviewees represented a broad range of expertise. Fifty-three percent of the 
participants were affiliated with the quality unit as a core experience. Production, technical 
services, logistics, KM consultancy and IT were also represented in the sample. The final 
sample was intended to cover the key technical functions of the pharmaceutical manufacture 
with a special focus on the quality unit.  The researcher assumed that quality managers would 
always be familiar with any KM initiative in their organisations where KM is mentioned in 
quality guidelines and seen as the enabler for the pharmaceutical quality system (ICH, 2009; 
WHO, 2011b). Last but foremost, 93% of the interviewees are currently affiliated to 
manufacturing organisations. The research and development participant had also an extensive 
manufacturing experience. 
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Figure 5-1 Interviews by country map 
Understanding knowledge from the Practitioners’ Perspective 
During the course of interviews, knowledge was described from different angles. 
Interviewees offered different definitions of knowledge that varied between broad or narrow 
descriptions. From the narrow perspective, employee knowledge was portrayed as 
multidisciplinary, job-related, depending on department or having a special definition for every 
industry and perhaps for every area within the same industry. On the other hand, other 
interviewees provided broader definitions. For instance, subject 12 defined knowledge as:  
“A very abstract concept. Knowledge ...it is a collective understanding 
based on practices and experiences that have been developed over the 
years through execution and implementation".  
It was also described as “a wide definition” and “a diversified aspect” by subjects two and 
three respectively. The offered definitions are in line with knowledge definitions in literature 
where it is gained over time by direct experience and lifelong learning (Hoe, 2006; John 
Mingers, 2008). Davenport and Prusak (1998) proposed a similar definition of knowledge as a 
fluid mix of experience, values, contextual information and expert insights. However, the 
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preliminary definition of knowledge by interviewees limits sources of knowledge to the direct 
experience or learning by doing. 
Participants described two types of knowledge: one that can be found in written documents 
or drawings “explicit knowledge” and another type which is difficult to articulate “tacit 
knowledge”. The tacit knowledge is not written, but employees can use it to solve problems 
(Polanyi, 1966). Moreover, attempts to code the tacit knowledge were recognised. Subject one 
referred to an initiative to articulate tacit knowledge in his organisation: 
“We have programs like after-action reviews where we try to articulate the 
learning from every experience.” 
There was an emphasis on the importance of the flow of this tacit knowledge throughout the 
organisation.  Subject 11 explained how current policies of incentivising knowledge holders 
indirectly encourage knowledge hoarding in the form of Subject Matter Experts (SME’s). 
Alternatively, the interviewee suggests that firms should spend more efforts to establish a 
knowledge sharing environment and offer the appropriate incentives to maintain this.  
By the same token, there was a consensus among the participants that there is a need to 
leverage knowledge to improve operations. They elaborated that the efficient use of knowledge 
could entail a reduction of process cost, optimum utilisation of equipment, decrease time and 
efforts associated with operations, a better understanding of products and effective 
implementation of the pharmaceutical quality systems. Subject 11 referred to the ICH Q10 
description of KM as an enabler of the pharmaceutical quality systems.  
 
Knowledge Maturity in Pharmaceutical firms 
This study documented several KM initiatives within the participants’ organisations. All 
interviewees mentioned one or more attempts to capture, leverage or share knowledge in their 
workplace. These initiatives are argued to overcome (or decrease) the impact of the five main 
barriers to KM success in organisations i.e. inefficient communication, lack of sharing culture, 
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lack of competence, lack of incentive and lack of interest from the employee (Oliva, 2014). 
Some of these initiatives were voluntary actions, while others had a formal firm-wide nature. 
For instance, ‘after-action reviews’ were used to learn about specific situations, articulate the 
acquired knowledge in the form of learned lessons and reuse the learned lessons in the future. 
The interviewees employed document management systems as a secure and reliable method of 
document retention and control. Other initiatives took the form of a social event for knowledge 
sharing.  Knowledge sharing sessions were one of these events to facilitate an informal meeting 
of staff where they are encouraged to exchange knowledge about the problems they face. 
Subject 7 explained his experience with “Lunch and Learning” initiative: 
“something like knowledge sharing lunch when we have once per two 
weeks… we gather together for lunch and some of the colleagues… one of 
the colleagues can present something related to his area of experience… 
his or her area of knowledge to the rest of the team so that they also gain 
the knowledge and understanding of this topic from the SME who is 
presenting this during lunch time... is something like informal or less 
formal knowledge exchange and this is on the level of the small teams and 
groups” 
Alternatively, the interviews showed that virtual communities and expert finder platforms 
were used to facilitate knowledge exchange. However, one drawback of this approach is its 
over-reliance on employee participation (Levy, 2009). The interviewee outlined the 
significance of regular updates of employee profiles to get the full benefit from this repository. 
This step was quite challenging for the organisation to find effective ways to incentivise 
employees to stay active on these platforms. Also, the study found that company-owned social 
networks were adopted to facilitate knowledge exchange among employees. These networks 
were a simulation of Facebook or LinkedIn but exclusively within the company. They were 
used for internal job posting, search for talents, expertise locator or to cover social events within 
companies, e.g. a visit of the vice president. Microsoft Teams, SharePoint and Yammer are 
examples of the widely used applications in this area. 
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In contrast, rudimentary Microsoft Excel spreadsheets were also used to build a knowledge 
map in relation to product history files (explicit knowledge). There were some individual 
initiatives to use free technology to enhance knowledge exchange within small teams. For 
example, subject two explained a personal initiative to use WhatsApp groups to exchange 
regulatory guidelines and scientific articles with his team. This WhatsApp group was also used 
to transfer knowledge to other teams within the same company. He pointed out that “it is not 
the company initiative”. 
Another approach was to provide a platform where employees can search and find useful 
technical resources. It is worth noting that it is not part of the training systems but rather a 
repository of technical resources. Individual employees or groups can contribute to this library 
of technical media (e.g. successful media fill video record) and they can also improve the 
quality of its content. This offered means for knowledge and experience transfer within the 
organisation. Regular conference calls are held where each manufacturing site (in a 
multinational company) present the contributions to this knowledge repository. Apparently, 
this demonstrates a form of Wikis addressed in academic literature (Edwards, 2015a; Jones, 
2009).  Another version of these platforms offered a mobile application. Subject three 
explained one of these applications in the following paragraph: 
“This application on the mobile is user-friendly and can help us a lot get 
knowledge and take lecture at home or in your car... at any place you can 
take your lecture. It is very well selected tool”. 
Supplier Quality Academy was an attempt to transfer knowledge out of the organisation to 
the suppliers. Through this system, it was possible to share sessions or presentations which is 
believed to be useful to the suppliers. It was evident that the use of IT solutions was going in 
parallel with social activities to promote knowledge sharing within these organisations. This 
combination of technology and social initiatives is argued to support the tacit dimension of 
knowledge which can hardly be managed using IT tools ( Chatzkel , 2007). 
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Findings from the interview highlights that KM strategy wasn’t well-defined for most of the 
participants, or they are not aware of its existence. Instead, they mentioned other strategies or 
policies for training, development or patent disclosure. It was also apparent that KM and 
training are sometimes confused among practitioners in the pharmaceutical industry. Subject 
seven assumed that they might have KM strategy but under a different name: 
“No, I didn't hear the exact terminology... KM development but I think it is 
already in practice, but we have different terminology”. 
Despite that, some of the knowledge processes were managed through formal procedures, 
e.g. knowledge transfer. In fact, WHO has dedicated the annex 7 of TRS961 guideline for 
technology transfer. This explains the relative maturity of knowledge transfer for production 
and quality control processes as appeared in the interviews. 
The perception of KM maturity varied among the practitioners. Some described the current 
KM practices as “very immature” as we are on “the very early days” of KM. For others it was 
described as a well-established system. The level of maturity of KM systems was also 
described as “patchy” i.e. it is different from one organisation to another or even among 
departments of the same organisation. Subject 12 clarified his expectations of KM in the 
following paragraph: 
“I think my expectations are a little bit higher for knowledge management. 
I think the pharmaceutical industry has established the first part very well 
which is the instructor-led training, basic foundations to the discipline, 
even highly specialised discipline where they give additional training in 
that aspect is it's very well developed but is it where we need to be? No. I 
think there is a level of knowledge lost through attrition of people's leaving 
the company for retirement or who developed a lot of learning over the 
years that is easily lost because we don't have a way of documenting those 
experiences and sharing learnings.” 
Training is an educational activity. It aims to accumulate knowledge and skills needed for 
better performance of an employee in his/her current role or as a preparation for another 
position within the organisation (Scurtu & Neamtu, 2013). Part of the observed controversy is 
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due to the unclear distinction between training systems and KM in the studied organisations. 
The mechanism of implementing KM away from training is not clear and underdeveloped. 
Also, the participants described a lack of suitable effectiveness checks within the traditional 
training systems. This means there is no guarantee that knowledge is effectively transferred 
after training is completed. They argued that knowledge can be acquired through self-learning 
and employees were allowed to independently interpret what they read on some occasions. 
Another source of confusion is the lack of differentiation between document control systems 
and KM. While these systems can transfer and track changes that happen in processes and 
systems, subject 11 highlighted that organisations expect to have information systems that can 
manage firm’s knowledge in a way similar to electronic document management systems. 
However, almost half of the firm’s knowledge is contained in people’s brains (tacit knowledge) 
while the rest is stored in documents and electronic systems (cited in Liao, 2005). Both training 
and document control were traditionally seen as a compliance activity rather than a knowledge 
transfer process. 
“Traditionally training wasn't seen as a knowledge transfer activity was 
seen as a compliance activity where you have to do X amount of training 
and X amount of qualifications in order to do X amount of tasks”  
Subject 11. 
Moreover, the interviews discovered a high attention to data protection among interviewees. 
Use of data cloud or public servers raised doubts and fears among interviewees. It is believed 
that these doubts about confidentiality and protecting proprietary data might hinder KM 
initiatives in pharmaceutical organisations (Wang, 2006). For instance, subject nine expressed 
his sceptical opinions about the security of social networks as they might rely on public cloud 
computing platforms. In contrast, the fear of reputation damage after a data breach encouraged 
decision makers to enforce data access controls and to adopt information security management 
systems, e.g. ISO 27001. In line with finding from a recent study of Durst & Zieba (2019), 
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those fears portray the participants’ reactions to cybercrimes and other technological risks of 
KM with possible negative consequences on business, reputation and patients’ health. 
 
Knowledge sharing and transfer 
 The interviews shed light on another reason of inefficient flow of knowledge in the 
pharmaceutical organisation. The interviews suggest that employees get their basic training on 
the IT systems by the vendor then each department start coding the knowledge into this new 
repository in its own way, using their own terminology and implementing their taxonomy of 
data. Over time, the organisation ends to a group of individual silos or isolated islands that 
benefits a little form each other’s knowledge. Subject 11 illustrates this situation in the 
following quote:  
“So, you end up with a system that's impenetrable. You've actually created 
locked-in syndrome within the silos because nobody sat down to think 
about how might we architect this forever? So that everyone can have 
access to it and it's not just relying on this tree structure.”  
Similarly, the interviews highlighted a lack of systematic process for knowledge sharing 
and transfer among employees. This often leads to hoarding of knowledge among subject 
matter experts and project managers who see knowledge as power as they are in this position 
because they have something not with everyone. Ultimately, others have little chance to learn 
and when these persons leave, the knowledge loss is quite substantial. The subject 12 
exemplifies this phenomenon in the next paragraph:  
“It is like construction project managers. They maintain their position 
throughout their career as the construction project person because it is a 
positive feedback loop in which they do a project they learn from it so they 
become more careful of doing projects so they're chosen to do more 
projects, and then they learn from that too and become more capable and it 
goes on and on and on until that person requires that information is lost 
they have a continuous influx of people of at different stages of their career 
so that when that happens that when someone does retire he'll have people 
who are at different levels of capability in which they can cover that person 
leaving the company”. 
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It was noted that the knowledge sharing is not often a part of the formal roles and 
responsibilities.  Management doesn’t usually dedicate time (during working hours) to allow 
employees to share their knowledge systematically. These findings supports the lack of 
knowledge management strategy as explained in (5.4 ). 
 
The value of knowledge measurement from the practitioners’ perspective 
The findings of the exploratory study suggest a consensus among the participants on the great 
value of the knowledge measurement. One of the proposed applications of knowledge 
measurement is employee appraisal. Subject three suggests the evaluation of employees not 
only on performance but also on their level of knowledge and how they improve it. He also 
added this could work as a motive for continuous learning. He provided a real example of 
applying this initiative in the scientific office of his company.  However, this does not 
contradict with the delimitation of knowledge measurement and the traditional performance 
appraisal that has been outlined in chapter two. In fact, the design of a performance appraisal 
system can be complex and can involve multiple dimensions (Bayo-Moriones et al., 2019). 
Another suggested value of measurement was to assess the effectiveness of any KM initiative 
within the company on the employees’ knowledge or in other words the return on investment. 
Subject 12 said in that respect: 
“So, yes. This short answer is it would be very helpful for the organisation. 
It would make sure that we don't lose much money in executing initiatives 
and systems that are not helping the organisation in retaining knowledge.” 
The interviewed experts added it could offer a lot of help, especially as a selection criterion 
during the recruitment and retention of employees. It can also predict the outcome of the 
employee based on the level of knowledge he/she holds. It can define the minimum 
requirement for each job. Moreover, it can be used as a way to check the knowledge acquired 
after training or over a certain period. Others referred to the potential impact on business cost 
due to lack of knowledge, e.g. the cost of rework. Similarly, they emphasised that it would save 
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money by retaining knowledge within the organisation.  It was also described as crucial for 
business success and for decision-making process as explained by subject 11: 
“How good we are using what we know as an organization to inform our 
decision-making processes.” 
Embracing Drucker’s Management by Objectives approach (Greenwood, 1981), knowledge 
measurement can drive the development plans of the employees in different functions as 
explained below: 
“I don't want to repeat myself but easy way to see the value would be if I 
have indicator that tell me if my department is much higher than the 
average knowledge or just at the average or below the average. This might 
drive my plans for my people. So, if it is much higher this means I have to 
focus on the execution rather than the knowledge building or the 
awareness. If I am at the average I need to work side by side. If I am much 
lower, it might indicate that I need to change the team to get more 
experienced people or knowledgeable people or to do something to 
leverage the knowledge of the team to be an average of a bit higher.” 
Subject one 
This notion was further highlighted by subject 11. She clarified while an employee might use 
company resources to enhance their CVs rather than obtaining relevant training and 
development, having a comprehensive knowledge measurement and management strategy 
would generate knowledge goals for each employee that can benefit both the employee and the 
organisation. She said also: 
“When you look at the individuals themselves they've got specific goals and 
drivers for their career that are not just linked around “I hope I can get 
that black belt training on Six Sigma next year on my CV […] So, I think a 
tool such as that would be invaluable because again it helps start thinking 
about twisting the coin. It's not about building the CV; it's about enhancing 
the organizational capacity.” 
An additional value of the individual knowledge measurement was to prognosticate 
individual strengths and weaknesses. Subject nine argued that a measurement tool could show 
him/her what is needed for the development of each employee in his area. This can help deploy 
the employees in the right positions and get the best out of them. Subject seven explicate this 
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application of individual knowledge measurement tool in the following: 
“I think if we have a structured tool which can give us an overview, not an 
overview … a deep understanding, strong and fair assessment of the 
amount of knowledge our people or talents have I think this will be 
important in setting how do we deploy these talents and these 
knowledgeable.” 
On the other hand, findings suggest that having a knowledge measurement system in place 
would build trust in the company decisions.  This can provide an advantage during audits or 
inspections. The reason behind this, it would provide the auditors with objective evidence that 
only qualified persons take decisions that might impact patient health. Subject ten clarify this 
notion in the following quote: 
“So, auditor has come into companies and they start looking at 
pharmaceutical development and you know - defining what we had made 
that were made and so on and they start asking questions: why did you 
know if you're doing risk assessments why did you use…? why did you 
come up with these? this risk assessment… how did you come to these 
conclusions and then the obvious question is: are you qualified to actually 
make those decisions? Okay, what's your background?” 
The measurement tool is claimed to influence the whole corporate not only from a quality 
and regulatory perspective but also at the business level. Subject eight argued that this tool 
allows the decision-maker to know who has more knowledge objectively and in turn assign 
new projects and responsibilities to the suitable person. This is deemed to improve the quality 
and business outcome. This supports the notion that the organisational ability to exploit existing 
knowledge is a determent of its success and competitiveness (Matoskova, 2016). By the same 
token, subject 12 speculated that “the aggregates of the individual speak for the performance 
of the site”. As a result, he continued “it starts by individual. If every individual is capable 
consequently the whole organisation is strong and healthy”. The findings suggest that the 
outcome of the personal knowledge measurement can reflect the knowledge level within the 
whole department or even the whole organisation. This also endorses that  HC is a unit-level 
resource and the measurement must be conducted at the individual level (Moliterno & Ployhart, 
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2011). Subject 11 believes that these efforts help link value to knowledge. In turn, when 
decision makers see the contribution of knowledge to value creation, this will build maturity 
in KM practices in the organisation. 
 However, one-third of the interviewed managers referred to some potential barriers hindering 
the systematic measurement of the employee knowledge within their firms.  One of these 
barriers is the availability of alternatives. For instance, it is not always possible to have several 
employees who have the necessary knowledge about a niche product or a particular process. In 
this situation, measuring employee knowledge would offer no more options as the organisation 
might not have the luxury to assign a more knowledgeable worker to support this process. 
Subject 14 mention this barrier in the following quote: 
“If you go to the detailed technical point you don't have the luxury to have 
2. 3, 5 persons able to support in this area […] let's have an example. I have 
now an issue related to XX manufacturing for example. you have a specific 
person, he is educated to support this. He is a global XX steward and he's 
supporting this molecule. So, it won't be helpful anyway if I'm gonna assess 
his knowledge. What else! I don't have options!” 
Similarly, some other firms have a one-year contract of employment policy. This doesn’t 
allow the company to take any corrective actions after knowledge measurement. It might not 
have a formal performance review process either. By the time the organisation takes any action 
based on the measurement process, these employees won’t be there anymore. Subject ten 
asserted:  
“You know by the time you actually take your corrective action the person's 
contract will have expired”. 
In addition, it is not always possible to find a standard or a reference to assess the knowledge 
against (Borgatti & Carboni, 2007). This is quite apparent in innovative and research-related 
activities. The employee is doing a certain task for the first time and nobody knows if this is 
the right way to do it or not. Subject ten demonstrated this in the following quote: 
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“The work we're doing is research and so the samples there has no history 
or no and no one has tested it before. So, we're the first people looking at 
this particular measurement and so it's you know it's there is no 
reference.” 
Poor understanding of the KM and PKM is another barrier to implementation. Interviews 
revealed that management are not always aware of the benefits of the personal knowledge 
measurement and in turn, they might not support such initiatives in their organisations. Indeed,  
the existence of a knowledge-oriented leadership encourages the development and use of KM 
and consequently enhances innovation (Donate & Sánchez de Pablo, 2015). In addition, subject 
11 asserted that management often looks at the employees’ knowledge in a very static way 
where seniority and/or the number of qualifications or certificates are the only ranking criteria 
rather than real capabilities. Based on this understanding, they have a wrong assumption that 
proper knowledge measurement activities have been already in place. 
 
The knowledge measurement practices in the pharmaceutical industry 
Interviewed managers emphasised the regulated nature of the pharmaceutical industry. This 
is coupled with the expectation of high-quality standards in all operations. This also implied a 
need to have the proper knowledge before involvement in any process in such a controlled 
environment (WHO, 2014).  The interviews reveal that the pharmaceutical industry has a 
global nature where practitioners are speaking the same technical language and refer to the 
same global standards. However, some participants argued that albeit there is still a lot to learn 
from other sectors such as automotive, nuclear sector, aeronautics as well as oil and gas in the 
field of KM. According to subject 11, KM is still “immature” in the pharmaceutical industry. 
There is a consensus among the participants that the knowledge measurement practices in 
the pharmaceutical industry are still informal activities. Managers might evaluate the 
knowledge of their subordinates in a qualitative way missing any objective criteria. The process 
is described as a managerial skill which is based on the manager’s personal experience, and it 
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varies from one to another.  
Direct managers can assess the subordinate knowledge through daily interactions and 
performance. Over one third of responses linked the knowledge measurement with the 
recruitment process. During this process, the manager often evaluates the knowledge of the 
applicants through technical questions. Another form of interviews takes place after major 
deviations to ensure that workers hold the required knowledge and can apply it.  The 
operational managers also have open discussions with employees during Gemba walks, and 
this offers another opportunity to assess their level of knowledge qualitatively. However, the 
participants expressed their need to measure the knowledge of their employees in a formal way. 
They are looking for a formal and standardised knowledge scale. This would standardise the 
assessment process. Subject 12 and one respectively emphasised this meaning in the next 
paragraph: 
“Yeah we need to know […] how you know you have a gap if you cannot 
measure. That is why I said we need to be able to measure it.” 
“I don't know the way. I mean if it is true that we have a way to say " in this 
department the collective knowledge of employees hit this bar which might 
be high standard one…this means this gives great confidence that this 
department can make decisions in (desirable) way and if it didn't hit the 
bar or was significantly below this bar it might also indicate that 
something needs to be improved in the knowledge of the organisation so it 
might be a priority to improve.” 
Nevertheless, seven out of 15 interviewees showed scepticism about the possibility of 
having an objective measurement scale of employee’s knowledge. Statements such as “assess, 
I am not sure!”, “you cannot give it a rating” or “I don’t see we can do it” reflects the feelings 
of uncertainty in light of the current practices. 
Talent management can be described as a relatively established process in at least one-third 
of the participating organisations. The process aims to acquire knowledgeable people from the 
market and to retain them in the company (Somaya & Williamson, 2011).  The findings show 
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that talent acquisition starts from the direct manager who nominates the potential talents and 
ends with senior management, e.g. the site head who approves these choices. Talent 
management, in the studied organisations, is also part of the succession planning where talented 
workers are prepared for leading positions. Despite that the talent is not only the knowledge 
but also the skills and abilities (Nijs et al., 2014), subject seven affirmed that knowledge is an 
important part of the talent. He stated:  
“We have a system...the system is supported by IT tool for talent management, and very 
important part of talent management is the knowledge… the person knows, the strengths of 
this person, in which parts this person is very strong, and how can we develop the person in 
this strength knowledge. Further, how can we compensate for the absence of this person in 
case of retirement, lay off, rotation to a different job or whatever?” 
The paragraph above illustrates the management awareness of the significance of 
knowledge loss. People who leave their jobs or retire take their knowledge out of the 
organisation.  This would also increase the turnover cost when the organisation tries to replace 
the lost knowledge holder as subject 14 mentioned below:  
“So, if you for example… if you have a very experienced scientist and for 
some reason, you will lose this person, and this will cost you a lot to get 
somebody else to start over what he used to do.” 
 Forgetting is another mechanism of losing knowledge (Holan & Phillips, 2004; Watanabe 
Wilbert et al., 2019).  The interviews reveal that when the organisation fails to document the 
experiences and to share the learnings, it is usually not possible to avoid repeating the mistakes 
the person who has retired had already faced in the past. Subject matter experts who are retiring 
are seen by participants as another threat to the pharmaceutical organisation. There is still no 
clear process to transfer their knowledge or to systematically document it in a way that allows 
retrieval in the future. 
  Thus, the findings reveals that when knowledge holders leave and the knowledge hasn’t 
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been well documented (or shared), the organisation faces challenges with process and product 
related information especially with legacy products and products acquired from other 
companies. It has been argued that decision-makers would hardly be able to make the right 
decisions, and they could resist any changes as they are not sure about the possible 
consequences. Even wrong decisions can be made due to the lack of knowledge and months 
might be wasted to discover the root causes of the generated problems instead of using the 
current resources for continuous improvement. This supports the notion employees leave the 
organisation with the critical knowledge that supports the business leading to negative impacts 
on productivity, performance and organisational knowledge base (Massingham, 2018; Parise 
et al., 2006). 
In this chaos, the study records some attempts (eight out of 15 interviewees) to plan existing 
resources and human capital. However, the first challenge they have is that it is not always 
possible to identify the knowledge holders. Sometimes management face a particular problem, 
and it needs a certain knowledge to solve it, but it is not possible to know exactly who has this 
knowledge or skill. As there is no formal process for this, it is totally reliant on manager’s 
interactions with his team. Subject ten provide an example of that from his organisation in the 
following quote: 
“For example, if a problem comes in and requires ion chromatography as 
an example, you know, do I know anyone here with Ion chromatography 
experience probably not- maybe just people that I can go and ask about it, 
but I don't know that I have that expertise. We don't do that… hard to do... 
but we should do.”   
Four of the participants referred to the organisational endeavours to plan their Human 
Capital through the identification of knowledge gaps among staff. This process is limited by 
the lack of consist knowledge measurement tool too. This notion was endorsed by subject 12 
as he said:  
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“How do you know you have a gap if you cannot measure? That is why I 
said we need to be able to measure it. You could have a problem with your 
knowledge of your organisation and not know. And the only way to know is 
to measure.” 
 One of the used approaches (in two interviews) is to ensure that each critical area is covered 
by a backup person(s). The backup person holds all the necessary knowledge, and this ensures 
the operation will not be interrupted due to the absence of the needed knowledge holders.  
However, interviewees asserted this approach is not always possible especially with highly 
technical and specialised roles as it is not possible to have a substitute.  
In one of the interviews, the Skills Matrix was introduced as a practical application of both 
human capital planning and backup person allocation.  It was described as an annually used 
tool to assess and manage skills in a function or department. Also, the training and recruitment 
needs are determined based on this matrix. It starts by analysing the process into tasks or steps. 
The matrix consists of two axes. The first is the processes or tasks to be done in a certain unit 
or department. The other axis contains the names of the workers in this area. Each employee 
receives a score from one to five based on his capabilities. If the worker cannot undertake the 
job at all, he/she receives one. He/she receives two or three if they can complete it without 
supervision. The worker receives five when he/she is able not only to undertake the job but 
also to train others on it. Despite that, this scoring is still a subjective activity totally dependent 
on the supervisor or direct manager’s opinion as shown in the next quote from subject eight: 
“It depends on the supervisors’ knowledge and the manager knowledge 
about employees, and this this is built through the experience of the whole 
year, and this matrix is updated. So, of course, you have seen many 
situations during the year that build your knowledge about the employee in 
this task.” 
 
The personal knowledge of the pharmaceutical employee 
The following section illustrates the key antecedents and measures of employee knowledge 
in the pharmaceutical manufacturing sector that have been discovered in the interviews. The 
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interviewed managers explain these measures based on the common practices and their 
industrial experience. Eight main themes and their underlying subthemes are explicitly 
discussed showing the current practices of industry practitioners to assess the personal 
knowledge of individual employees. 
 
5.8.1 Regulatory compliance  
I. Ability to identify compliance gaps 
In such a regulated industry, the ability to understand and interpret regulatory standards to 
identify implementation gaps is seen as a measure of knowledge of regulations. Subject seven 
refer to this in the following paragraph: 
“…understanding and the capability to interpret the quality standards from different bodies 
and from different countries is the key knowledge factor.” 
This ability to interpret the guidelines can be envisaged in employee compliance to these 
regulations in his area and/or his ability to identify implementation gaps (e.g. gap analysis) as 
well. Subject four stated: 
The gaps you put in your final report [..] give us an indication for how 
much you are updated with the new requirements… the main gaps you 
find… 
 
II. Familiarity with relevant regulatory standards 
In addition to employee’s ability to interpret regulatory standards, seven of the interviewed 
managers expressed their concern of their employees’ familiarity with the recent requirements 
or expectations of the regulatory bodies. They emphasised the importance of employee’s 
knowledge of current Good Manufacturing Practices (cGMP) in addition to the internal 
company standards. The knowledge of the latest updates of relevant standards is necessary to 
be able to achieve compliance.  
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“If the reference of the health authorities- we are dealing with- is the ICH or the WHO then 
what are the latest updates in the ICH or WHO (standard) and the level of knowledge you 
have related to this standard.” Subject four 
 
5.8.2 Product and process understanding (mastership) 
I. Finding knowledge (know-where and know-who) 
The ability to find knowledge about the process, product or equipment is one of the 
suggested predictors of his/her personal knowledge. As it is impossible to know everything, 
findings from five interviews show that it is highly appreciated if the employee knows where 
to search to find knowledge. Subject two provide his explication as follow: 
“He shouldn't know the info when I asked him for example but should know 
where to search where to find”. 
The knowledge can be available somewhere in a computer or a server, and it must be 
retrievable to be used. Part of the knowledge lost when a person leaves the organisation is the 
Know-Who (Jennex, 2014; Parise et al., 2006). Thus, besides the need to know where to find 
knowledge, there was an emphasis on the need to know who to go to and who not to go to. In 
other words, another important part of process knowledge would be the knowledge of the “go 
to person” for each process.  
“We'd better if you could just go to someone who had expertise in the area 
or working… does know who to go to, who not to go to”. Subject ten 
Interviews uncovered some of the KM initiatives that facilitated knowledge findings by 
electronic systems such as expertise locators and social networks. Indeed, the existence of 
informal personal networks to connect knowledge holders can compensate for the deficiencies 
of the formal organisational arrangements (Grabher & Ibert, 2006).  
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II.  Working without supervision (Skills Matrix) 
The application of skills matrix to assess the employees’ knowledge about the process is 
explained in detail under (4.8). It relies on the ability to work without direct supervision or 
have the knowledge to train others on a certain task as a proxy indicator of the level of process 
understanding. 
 
III.  Technical knowledge 
Two thirds of the participants advocated that knowledge holder should understand and 
explain the underlying theories of processes, product and equipment in his/her area. 
Understanding of the principles underlying phenomena is described as Know-why (Raghu 
Garud, 1997). This reveals the management concerned with employees’ knowledge in basic 
science and other technical details of formulation and/or analysis. They argued that a 
manufacturing employee must maintain a certain level of knowledge about the scientific 
background of processes and product in addition to full awareness of risks and precautions. 
This includes also the modern technologies employed in manufacturing.  
“.. Even if it is molecule related, or substance 
related or the technology itself about the equipment…” 
Subject 3 
Two of the interviewed managers used technical questions as a knowledge assessment tool 
during the recruitment of their subordinates. The technical questions are related to the part of 
the operations he/she supports. It might be about the analysis techniques, formulation, or 
commissioning and qualification activities. Subject two explains this in the following quote: 
“We ask some questions in our industry for the employee to understand if 
he has a knowledge about our industry, our guidelines, all the rules which 
is covering or which is covering our industry during the normal work.” 
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However, the findings suggest that explicit technical knowledge is more appreciated for 
junior employees and operational managers rather than senior employees as explained by case 
13. 
 
IV. Technical advising 
The interviews revealed a form of technical knowledge sharing among employees. This can 
take the form of formal assignment of a Subject Matter Expert (SME) or Molecule Steward 
based on his/her outstanding process/ product knowledge. Knowledge holder can also be 
informally perceived as “the go-to person” by his/her colleagues. However, the improper use 
of those SME’s and lack for proper incentives for knowledge sharing might lead to knowledge 
hoarding among few of employees who try to protect their knowledge privilege in the 
organisation. Subject 11 clarified this in the following quote: 
“Subject matter expert and then that gives them maybe an extra 10% in 
their pay package or something. So, the incentive for them is actually to 
hoard their knowledge right so they become the expert the go-to person 
rather than the incentive being the other way of identifying where their 
knowledge is where their current knowledge bases what knowledge gaps 
they have and where they might be to fill those and then getting them to 
share that knowledge as part of the incentive package.” 
Finally, knowledge is acquired by participation and involvement (Bakken & Dobbs, 2016) 
were contributing to process design, development and improvement can demonstrate a proxy 
indicator of personal knowledge. 
 
5.8.3 Performative knowledge   
Performative knowledge refers to the skills needed to be able to do something  (Mingers, 
2008). Management used the performance as a predictor for employee knowledge. In other 
words, if the employee holds the required knowledge to do a certain task, management will 
expect superior performance and outcomes out of this task.  Knowledge holders understand the 
process they are responsible for and knows exactly how to do the job from start to end. It is 
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about the know-how of the product or the process. Performance is characterized in terms of 
“efficiency” and “effectiveness” (Ajith Kumar & Ganesh, 2011) as explained in the following 
sections. 
 
I. Achieve the organisational/departmental goals (effectiveness) 
Interviews asserted that knowledge can enable the achievement of firm goals and objectives. 
Knowledge here is assessed through its outcome. Outcome and deliverables are measures of 
employee knowledge.  
" If you need to conduct or to make a specific task you can assess from the 
outcome and the deliverables of this task how much knowledge about this 
task and how much knowledge about the requirements and expectations of 
industry this person has though the deliverables of the task and this is 
entire year of performance" Subject 7. 
Keeping this in mind, subject 9 nominated productivity as another predictor of knowledge. 
Knowledgeable employees are deemed to meet their productivity targets and achieve company 
goals. In other words, deliverables are the result of employee knowledge. On this ground, 
performance reviews measure the contribution of employees over one year including his level 
of knowledge and development plans. It measures if the employee is capable of achieving a 
certain number of goals that have been tightly linked to departmental and organisational goals. 
Performance appraisal was presented as another indicator of personal knowledge in the 
following quote by subject seven: 
“If you are talking about the assessment of knowledge of persons, I think it 
is very core part of the performance review... the semi-annual and annual 
performance review and each employee within the company is assessing 
the amount of knowledge that key participants are having and how much 
knowledge is necessary to perform his job is in place.” 
 
II.  Execution and implementation of tasks (efficiency) 
Management interprets the way employees interact and execute their job as a proxy 
indictor for their knowledge. They referred to these interactions by “day to day 
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activities” and “day to day interactions”. Subject eight explains his approach to assess 
his subordinates’ knowledge: 
“This is not a direct way to (measure knowledge) ... I'm not sitting down 
with an employee just to assess their knowledge... It is observed due to day 
to day work or tasks performed day to day.” 
 The involvement of employees in the execution of different processes, holding proper 
knowledge to improve product or process and the quality of doing this job reflects how much 
knowledge he/she has. This improvement in the performance is summarised by subject two: 
“I believe that people whose knowledge is higher, perform better, perform 
faster."  
 
Timeliness of doing a task was also linked to employee knowledge. If the employee is 
experienced with a certain process, he is expected to be able to do it faster and within the 
planned timeline. This can be explained that the employee can use his/her prior experiences if 
he did a similar job before and in turn would do it faster. 
“It’s more related to the way he is executing his job because the level of 
knowledge you have facilitates the job execution. If you participated before 
in the job, then when you are trying to validate it would be very easy for 
you to execute or to start the protocol or to conclude a report the gaps you 
put in your final report”. 
Another measure of execution and implementation of tasks is the ability to do it right the 
first time. The findings affirm the role that knowledge has to make “doing the job right first 
time” possible. This is illustrated in the following quote from subject two: 
“When this employee, for example, will have this knowledge, he will do the 
right thing, he will take a solid decision, he will do his work right this is a 
reason this is a reason for to know this knowledge.”  
On top of that, doing the job right first time can be also linked to getting reproducible results. 
Knowledgeable employees are argued to maintain the minimum (non-process related) 
variability. This can be verified once the same or nearly the same results are obtained when the 
job is repeated by different persons. In the case of analytical labs, their results can be even 
CHAPTER 5: Exploratory Study 
 5-157 
compared to the results of an experienced analyst or neutral standards. The following quotes 
represent the practitioners’ insights about this point: 
“So, I guess we will consider someone to be successful if they've got 
reproducible results.” Subject ten 
“We need to work more on this part to minimise individual variability.” 
Subject 14 
 
5.8.4 Wisdom, problem-solving and decision making 
Wisdom is the last layer of the knowledge pyramid (Bernstein, 2011). It was used by 
practitioners to describe the judgemental capabilities and the problem-solving capacities of 
employees.  
Making the right decisions 
An important effect of wisdom is the readiness to take critical decisions and use knowledge 
properly (Thomas et al., 2017). Interviewees portrayed knowledge as an enabler of right 
decision making. In addition, the level of maturity in decision making (e.g. the factors 
considered to make a decision) was indicative of the quality of the decision making. One of the 
interviewed senior directors (subject one) outlined how knowledge-based on the understanding 
of company processes and governmental regulations enables “calculated risk-taking” and 
“better decisions”.  Another manager (subject two) explicitly referred to the role of knowledge 
in decision making: 
“…he can take the right decision; this shows that he has a lot of 
knowledge.” 
Subject 12 emphasised the quality of the decision-making process and the need to consider 
the basis upon which the decisions are made. The decision-making skills were presented as a 
‘must-have’ capability for each employee to handle his/her job duties. Starting from 
onboarding training program confirmed this skill. Management knowledge was also seen as 
another enabler to right decision making: 
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"I think better decisions when the management has good knowledge 
...decision-based knowledge can be very effective in taking decisions based 
on knowledge. So, I believe it is a very important tool to be used in taking 
decisions." subject three 
 
Trouble shooting 
Trouble shooting and problem solving were also highlighted by one third of participants as 
a measure of personal knowledge. This was depicted by the ability to close gaps or solve 
problems on daily work. The knowledgeable pharmaceutical employee is believed to be 
familiar with the possible failure modes of his process and possible solutions. This was seen as 
an indicator of knowledge stock and the ability to use this knowledge. 
“Understanding of failure modes that may be present in each analysis…” 
Subject 3 
 It also implies the analytical skills necessary to explore vague situations and come with the 
right solutions. It was even considered a comparative advantage among individual employees. 
“I think this is the knowledge we can assess in employees and compare 
between individuals” subject nine 
Additionally, accumulated experiences about specific types of problems and the most 
effective solutions save both time and effort. Subject ten demonstrated his experience in 
solving client companies’ problems with biologics in the following quote: 
“When a company comes to us with a new problem; it's a new problem for 
them, but it's something that we've seen before. So, we can dip into 
previous work that we've done and kind of look at it and say okay we're 
gonna use that same approach.” 
 
Critical thinking 
 As mentioned before in the previous section, taking the right decision needs both a proper 
use of knowledge and analytical skills. The employees are informally assessed for their ability 
to think critically, apply solid criteria for decision, react well in difficult situations, interpret 
the results and finally come with the right decisions or solutions. They have to illustrate this 
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clear and rationale way to solve work problems. A senior director (subject 12) expressed his 
expectations of his team in the following quote: 
“Basis on which the decisions were made[…] what level of maturity they 
have when they make those decisions what do they factor-in what do they 
not factor-in […] do they underestimate certain things; how do they 
communicate them that information how they communicate that decision; 
are we leaning towards alt conservatism or are we more taking a more 
risky approach that we should? Those are things that I debate through 
today those are the kind of knowledge expectations that I want them to 
reach.” 
 
Applicable and creative solutions 
The fourth element to be considered for problem-solving is the ability to think outside the 
box. Personal knowledge is often reflected as creativity and self-expression (Bhatt, 2002).  
Knowledge was believed to allow employees to introduce new ideas to improve the process or 
product. This can be in the form of business cases or suggestions of improvement initiatives.  
“How he can introduce new ideas to the process or the organisation; how he can present 
business cases or suggestions to improve the process.”   
Subject six 
 
5.8.5 Organisational Understanding  
The findings advocate that the personal knowledge of employee is not limited to the 
technical aspects. Pharmaceutical industry employees are expected to know about their 
organisation mission, vision, operations, functions, culture and values. 
 
Organisational culture 
The first component of organisational understanding is organisational culture and values. 
Culture refers to shared assumptions or values which are learned within organisations to solve 
their adaptation and integration problems (Schein, 2004). The findings show that employees 
need to embrace company values and abide with certain ethical rules. From this perspective, 
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the employee must know what is right and what is wrong within a specific organisational 
context. The code of conduct of every organisation might define some of these values that 
should be promoted among workers. These may include and not limited to integrity, 
transparency, respect for people, etc.  Employees understand the underlying assumptions in 
their organisational culture to take the right decisions. Subject 13 explained the importance of 
company values as shown in this quote: 
“We are calling “Credo”. Credo is our values and one of the very 
important point… law is the values that we are committing our customers 
our consumer. For that, everyone in the company needs to know or have 
knowledge of the credo and have a commitment of this.” 
The employee’s understanding of the organisational jargon and technical terminology is 
indispensable for the proper understanding of the organisational culture and dynamics. 
Nevertheless, this jargon may vary from one manufacturing site to another even within the 
same company. The induction training for new employees introduces those terms to new 
employees as explained by subject 12. 
“So, it is basically to understand the terminologies that are you within the 
company's world worldwide and site-wide.” 
Subject 12 
 
Organisational mission and vision 
Once a new employee joins the pharmaceutical company, he/she commences the necessary 
orientation or induction training about the company. This would include the awareness of key 
operations in addition to the organisational objectives, mission and vision. 
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Understanding his role in the organisation 
Participants pointed out that the employee should be aware of his/her role in the organisation 
along with the relationship with other teams and functions.  Consequently, the employee’s roles 
and relationships would be aligned with the organisational goals and objectives. 
This can be exemplified by this quote from a senior director (subject seven): 
“We assess also the organizational knowledge, how the person 
understands the organisation, how the person understands his position in 
the organisation, how the person understands the correlation between him 
or her and their team with the organization alignment with organizational 
objectives”. 
 
Knowledge about other departments 
The interviewees described other elements of knowledge on the organisation including 
awareness of other operations and activities in other functions particularly in cases of 
partnership or involvement with cross-functional project teams.  
 
Common failures 
This includes familiarity with historical failures and repetitive out of specifications (OOS) 
results. This can be important for understanding the process trends and history of recurrent 
issues. Subject three enumerated several actions that were taken to share this type of knowledge 
among employees through the use of visual management tools. 
“So, we try to make it very simple with pictures just to share the knowledge 
most of the analysts fail in.” 
 
5.8.6 Communication and networking skills 
During the course of interviews, there was repeated emphasis that business is not only in 
need of technical skills but also other social competencies. This agrees with the notion that 
knowledge is not just a thing or a process but it can be envisaged as a personal network (Chatti, 
2012) and knowledge work is increasingly social (Wright, 2005). Engagement with the team, 
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taking the lead, effective communication and motivation of peers are some of the skills 
expected by interviewees from the workforce. To achieve this, certain characters were endorsed 
by interviewed industry experts, e.g. openness and transparency, practical and pragmatic. 
 
Team player 
Certain skills and competencies are expected by the interviewed experts from the 
pharmaceutical employee to undertake his job effectively. The employee needs to work with 
teams, take the required actions and maintain a good relationship with team members. In other 
words, he/she should be a team player who shows high levels of engagement in the assigned 
activities.  
“The main knowledge is what I want to evaluate is the ability to be team 
player” Subject five 
This can be understood in light of the high level of maturity in project management in the 
pharmaceutical firms (Wakefield, 2005) which requires engaged teams. 
 
Leadership, motivation and upward communications 
Participants advised that an employee is required to know how to take the lead in 
organisational initiatives. They stated this type of knowledge or skill is even of more 
significance at the senior level. It implies also the capability to motivate co-workers and team 
members. Participants affirmed that individuals could have a gross impact on team spirit. 
Consequently, they need to know how to manage this.  
On the other hand, interviewed managers required their employees to know the right way 
of dealing with and influencing top management. This comes from their experiences with 
escalation and bottom-up (upward) communications. In other words, they need to know how 
and when to escalate and use this effectively to communicate with or even influence senior 
management.  
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Internal and external network 
The personal network is an important determinant of the flow of knowledge in the 
organisation (Chatti, 2012). This network can be internal or in other words consisting of friends 
from the workplace, perhaps colleagues from the same or different functions. It can also be an 
external network where the employee has access to what is called the communities of practice 
(COP) (Bolisani & Scarso, 2014).  This also requires good communication skills with co-
workers which is necessary for a manufacturing role. These behaviours that signify openness 
and transparency and effective communication are necessary for a successful business. Subject 
11 demonstrates types of behaviours which are appropriate for the manufacturing organisation: 
“We look at behavioral specialisms as well. So that we're looking at the 
types of behaviors that were nominated as being appropriate in our 
organisation and knowledge transfer and sharing would be one of those 
Ummm…you know, openness and transparency and communications and 
things like that.” 
 
 
5.8.7 Learning and education 
 Formal education is still a prerequisite for many pharmaceutical manufacturing roles. 
During recruitment, each role usually specifies the required qualifications. Participants showed 
that it can be even used for comparison between people’s knowledge in the form of “how many 
qualifications do you have?”. Likewise, other participants asserted that certificates can also 
become a prerequisite before getting a promotion or being qualified for certain jobs. 
With regard to training, two sub-themes were discovered: adherence to training and training 
effectiveness. Companies develop training programs, and they expect employees to adhere to 
this program. Completing 100% of the assigned training courses is the expectation.  Companies 
use both internal and external training resources. Interviews revealed also that well-known 
training companies might supply external training. Also, special training and qualification are 
required for critical processes. Training programs start with induction training for new 
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employees. There is periodic training and on the job training. Employees might also be trained 
on historical issues and OOS. Last but not least, training was confused by some participants 
with knowledge sharing or knowledge measurement as shown in the following quotes: 
“When they receive a kind of knowledge sharing or knowledge transfer 
techniques like the training, for example, they need to be assessed for how 
much understanding they get form the training?” Subject seven 
“I think I have answered this question before through the qualification 
training program. I think that is the only way we have to ensure knowledge 
transferred correctly.” Subject eight 
“They need to be assessed for how much understanding they gain from this 
knowledge” Subject seven 
The lack of discrimination between training and knowledge sharing was observed multiple 
times with several participants particularly when they discussed training effectiveness. They 
described how they measure the knowledge acquired by their employees after training through 
training effectiveness checks. The interviewer was aware of this confusion but he didn’t 
interfere not to guide the interviewees and to minimise bias in the results.  In terms of the 
effectiveness criteria, it was primitive and not well-developed for regular training. It was 
described as a simple quiz usually taken after reading the relevant standard operating 
procedure. Then the trainee is required to solve these questions to be certified for that training. 
However, critical tasks have extensive testing under what is called “qualification programs”. 
This includes a quiz, essay, oral discussions, presentation, monitoring programs and 
certification. Subject 13 clarify this in the following quote: 
“I mean if it's something critical to the consumer health, we will have not 
only an SOP it will be like guidance, SOPs, standards plus presentation 
plus you know like quizzes plus certification that this guy has a completed 
the stuff and so on.”  
Similarly, subject eight and 12 respectively added: 
“This is mandatory and oral discussions are not accepted anymore, so we 
have to prove that knowledge transfer is done in a satisfactory manner.”  
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“We do have ways to assess those people and their learning through either 
questions or some kind of assessment that are done depending on the level 
or criticality of the information that being transferred to that person and 
we can very well characterize their level of understanding based on those 
challenges and those questions and those on that assessment.” 
Another type of education highlighted in the interviews includes soft skills and languages 
(e.g. English). In fact, the global regulatory guidelines by WHO, FDA, ICH are published in 
English. Furthermore, multinational companies have employees from different nationalities 
and learning a foreign language can be necessary for communication and knowledge sharing. 
This can explain the value of learning foreign languages in particular the English language. 
The willingness to learn was also seen as an antecedent of knowledge. This was explained 
that people gain knowledge in their areas of interest. Indeed, the ability to assimilate and use 
knowledge (Absorptive Capacity) at an individual or organisational level is dependent on the 
prior knowledge of a closely related discipline (Cohen & Levinthal, 1990). According to this 
notion, if the employee is interested in a particular discipline (e.g. following certain regulatory 
guidelines, reading particular books, communicating with industry experts in this field, etc.), 
this can be an indicator of his knowledge in this field or a similar field. The next quote can 
exemplify this idea from subject one: 
“You can see that the people's interests. So, definitely staff or employees 
who are interested in following annexes or some different ICH chapters or 
looking about those things. This might be an indicator that he is building or 
he fed his knowledge.” 
Likewise, subject six added: 
“you can find someone who always has more knowledge more than at the 
task he is performing at the moment; he always has a need to learn and 
read about the process […] I think this is the way I can manage I can 
assess the knowledge ..can measure the knowledge of the employee.” 
 
5.8.8 Experiential knowledge 
Experiential knowledge refers to personal prior experiences particularly about people, 
places, events or feelings (Mingers, 2008). This type of knowledge was described by 
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interviewees as the knowledge that develops over time. It is usually measured by the years of 
experience or job tenure. Moreover, ICH Q10 outlines the prior knowledge and experiences as 
one of the sources of pharmaceutical knowledge (ICH, 2008). However, relying on seniority, 
length of experience, the number of training courses or qualifications as a sole measure of 
knowledge received a lot of criticism from some participants. It is claimed that pharmaceutical 
organisations are busy measuring the explicit potential causes of knowledge which are not 
always associated with a high level of tacit knowledge. Subject 11 explained the current 
process of assessing or comparing employee knowledge as follow: 
“You know, and very often they tend to be around seniority rather than 
capabilities. you know how many years of experience do you have how 
many qualifications do you have, how many training courses have you been 
on. So, in my experience is still that are our training organizations that 
tend to capture our qualifications and our capabilities… focus more on 
again those explicit outcomes rather than that tacit (knowledge) sharing.” 
 
Moreover, the value of experience is seen related to the level of relevance to the current job. 
Technical jobs have prerequisite requirements of relevant experiences. This means the 
employee spends a certain period doing this job or similar job. The reason behind this, as 
explained by a validation leader in one of the multinational pharmaceutical organisations, the 
level of performance is proportional to the experience. If the employee did a particular job 
before, it would be easier for him to repeat it. Experience facilitates task execution as shown 
below: 
“Because the level of knowledge you have facilitates your job execution if 
you are participated before in the in the job then when you are trying to 
validate it would be very easy for you to execute or to start the protocol or 
to conclude a report on the gaps.” 
The same idea was mentioned by another manager who explained how his team solve 
industry problems for their clients using their experiences and pretested solutions as shown in 
the following quote: 
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“It's a new problem for them, but it's something that we've seen before […] 
we're gonna use that same approach.” Subject ten 
Over and above, interviewees used the experience to differentiate between two types of 
knowledge: explicit knowledge coming from books and documents versus tacit knowledge 
(Polanyi, 1966) acquired by socialisation and experience. 
“You can learn from documents like research or books or something you can get out of a 
library and knowledge based on experience that they have to develop over time.” Subject 12 
 
Framework Development 
This study adopts an abductive approach engaging both of the extant literature and the 
primary data to develop the research framework (Saunders et al., 2016). The outcome of the 
exploratory phase is utilised to develop a measurement framework to identify and measure the 
personal knowledge of the pharmaceutical industry employees. The framework consists of 
observed indicators (measures or manifestations of the personal knowledge) together with the 
underlying latent factors. The proposed framework design is in line with the theoretical 
assumptions of Second-Order Hierarchical Confirmatory Factor Analysis (CFA) (Kline, 2015). 
The proposed framework identifies 41 personal knowledge measures (observed variables) 
reflecting six latent factors describing the main latent variable of the study i.e. the personal 
knowledge of knowledge workers in the pharmaceutical manufacturing. Because knowledge 
and its underlying factors are latent variables that cannot be measured directly (Bollen & 
Lennox, 1984), the research used both primary data from the thematic analysis as well as the 
literature when applicable to define the observed measures of the personal knowledge. The six 
hypothesised factors are: regulatory compliance, performance, wisdom, organisational 
understanding, product and process understanding (mastership) besides communication and 
networking skills (Figure 5-2; Table 5-2). Education, KM maturity of organisation, type of 
organisation, employee experience, training and job level will be studied as controls.  
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The first control is the education level starting from high school and up to PhD level. KM 
maturity included four levels of maturity based on Lotti Oliva (2014) framework. The four 
levels of KM maturity start from the lack of awareness of KM, the lack of formal KM 
processes, isolated implementation of KM to the top level where KM becomes a part of the 
holistic organisation strategy. Type of organisation compared domestic, international and 
multinational enterprises. Employee experience was included as the total number of years in 
the pharmaceutical industry (total experience) and the experience in the current role (current 
experience). Training was basically assessed by the percentage of compliance to the training 
plan. Finally, the job level included five levels starting from the entry-level or student and up 
to senior management. 
 
Figure 5-2 The conceptual framework 
Table 5-2 PK measures and the underlying factors 




Identify compliance gaps/deviations in your area/process R1 
Associate compliance gaps to a specific clause in a standard, 
SOP or a Pharmacopeia 
R2 
Find relevant standards or regulatory guidelines R3 
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Factor Measures Code 
Involved in the development and improvement of standards and 




Locate relevant process and product related information M1 
Carry out assigned responsibilities without supervision M2 
Contribute to the design and development of 
processes/products within your function 
M3 
Train others in relation to your current role M4 
Complete relevant records/forms (including electronic records) 
associated with products or processes in your department 
M5 
Explain to colleagues the scientific basis and precautions of 
processes in your area 
M6 
Explain to colleagues the technology utilised in machinery and 
equipment in your area 
M7 
Are involved in the design, validation, control and continuous 
improvement of products/processes in your function 
M8 
Technical advising (colleagues seeks one’s technical advice) M9 
Wisdom Think critically (clearly and rationally) to solve work problems W1 
Solve daily work problems efficiently 
Other people believe you solve daily work problems efficiently 
W2/W3 
Other people believe you make the right decisions in work W4 





Understanding his role O1 
Familiarity with processes in other departments of the 
organisation. 
O2 
Understand the terminology used in your organisation O3 
Understand the values of your organisation O4 
Understand the vision, mission and goals of your organisation O5 
Abide by the values of your organisation O6 
Explain the historical Out of Specifications (OOS), failures 
and/or any weaknesses in your area 
O7 
Performance Achieve departmental/organisational goals successfully P1 
Play a key role in successful projects in your area P2 
Complete assigned tasks "right first time" P3 
Complete assigned tasks in a consistent manner P4 
Complete assigned tasks on time P5 
Meet or exceed the required targets P6 
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Factor Measures Code 
Achieve a strong positive evaluation in annual appraisal by 




Identify the appropriate person to obtain information relating to 
a specific product/process 
N1 
Communicate effectively with co-workers to get the job done N2 
Communicate effectively with senior management N3 
Motivate others to achieve organisational goals N4 
Lead others to achieve organisational goals N5 
People see you as a team player N6 
have a wide network of contacts within your organisation N7 
have a wide network of contacts outside your organisation 
(pharmaceutical and non-pharmaceutical) 
N8 
 
Summary and Conclusion 
This chapter demonstrated the findings of the exploratory study and the outcomes of the 
thematic analysis. Fifteen interviews were conducted with pharmaceutical industry experts 
from nine countries. The interviews explored the practitioner’s definitions of knowledge and 
how it is managed in the pharmaceutical manufacturing sector. The study shed light on the 
level of KM maturity in the pharmaceutical sector. The chapter discussed the value of the 
personal knowledge measurement for the pharmaceutical firm. Finally, personal knowledge 
measurement practices and indicators were explored and explained. In light of the thematic 
analysis and literature review, the conceptual framework was abductively developed. The next 
chapter is data analysis of the quantitative survey in an attempt to confirm and optimise the 
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Introduction 
This chapter focuses on the analysis of the data obtained from the questionnaire. The design 
and distribution of the questionnaire is outlined in chapter four. In total, 190 valid responses 
were received using Google forms for data collection. The chapter provides the details of the 
respondents and their organisations before focusing attention on the analysis of the framework 
using CFA tools. 
Sample demographics data 
6.2.1 Descriptive statistics 
At the end of the quantitative data collection phase, 190 valid responses were received 
including participants’ self-assessment of their personal knowledge. The questionnaire 
included 41 questions (based on Likert scale) representing the proposed 41 observed indicators 
of personal knowledge. Table 6-1 demonstrates the descriptive statistics of the selected scores 
on Likert scale.  The results show that the selected ratings ranged between 1 and 7. Based on 
sample mode, (5, 6 and 7) were the most selected scores. However, the mean score is positively 
shifted (between 4.9 and 6.2). Sample kurtosis and skewness will be discussed in section 6.3.1 
“data preparation”. 




















































































M1 190 5.6 0.08 5.7 1.1 1.3 2 5 6 6 7 5 6 61 
M2 190 5.6 0.11 5.8 1.5 2.1 1 5 6 7 7 6 7 63 
M3 190 5.5 0.10 5.6 1.4 2.0 1 5 6 7 7 6 7 57 
M4 190 5.9 0.08 6.0 1.1 1.3 2 5 6 7 7 5 6 69 
M5 190 5.8 0.09 5.9 1.2 1.4 1 5 6 7 7 6 6 73 
M6 190 6.0 0.07 6.1 1.0 1.1 2 5 6 7 7 5 6 73 
M7 190 5.7 0.08 5.8 1.1 1.3 1 5 6 7 7 6 6 65 
M8 190 5.6 0.09 5.7 1.2 1.5 1 5 6 7 7 6 6 67 
M9 190 5.8 0.07 5.8 1.0 1.0 2 5 6 6 7 5 6 81 
N1 190 5.7 0.09 5.8 1.2 1.5 1 5 6 7 7 6 7 58 





















































































N2 190 6.0 0.07 6.1 1.0 1.0 1 6 6 7 7 6 6 79 
N3 190 5.9 0.08 6.0 1.0 1.1 2 5 6 7 7 5 6 75 
N4 190 5.7 0.08 5.8 1.1 1.2 2 5 6 6 7 5 6 68 
N5 190 5.8 0.08 5.9 1.1 1.2 1 5 6 7 7 6 6 75 
N6 190 6.0 0.07 6.0 1.0 1.0 2 5 6 7 7 5 6 76 
N7 190 5.9 0.08 6.0 1.1 1.2 2 5 6 7 7 5 6 68 
N8 190 5.6 0.09 5.7 1.3 1.6 2 5 6 7 7 5 6 59 
O1 190 6.2 0.06 6.3 0.9 0.8 3 6 6 7 7 4 7 87 
O2 190 5.8 0.07 5.8 1.0 1.1 2 5 6 7 7 5 5 64 
O3 190 6.1 0.06 6.2 0.9 0.8 3 6 6 7 7 4 6 74 
O4 190 6.0 0.08 6.1 1.0 1.1 3 5 6 7 7 4 7 71 
O5 190 5.7 0.08 5.8 1.2 1.4 1 5 6 7 7 6 6 68 
O6 190 5.7 0.09 5.7 1.2 1.4 1 5 6 7 7 6 6 62 
O7 190 5.4 0.10 5.5 1.3 1.8 1 5 6 6 7 6 5 54 
P1 190 5.9 0.07 5.9 1.0 1.0 1 5 6 7 7 6 6 91 
P2 190 6.0 0.07 6.1 1.0 0.9 3 5 6 7 7 4 6 72 
P3 190 5.8 0.07 5.9 1.0 1.0 3 5 6 7 7 4 6 82 
P4 190 6.0 0.07 6.0 0.9 0.8 3 5 6 7 7 4 6 81 
P5 190 5.9 0.07 6.0 1.0 1.0 1 5 6 7 7 6 6 75 
P6 190 5.9 0.07 6.0 1.0 1.1 2 5 6 7 7 5 6 74 
P7 190 5.9 0.08 6.0 1.2 1.4 1 5 6 7 7 6 6 79 




R2 190 4.9 0.12 5.0 1.7 2.8 1 4 5 6 7 6 6 51 
R3 190 5.7 0.09 5.9 1.3 1.7 2 5 6 7 7 5 7 65 
R4 190 5.7 0.08 5.8 1.1 1.2 1 5 6 7 7 6 6 68 
R5 190 5.5 0.09 5.6 1.3 1.6 1 5 6 6 7 6 6 65 
W1 190 6.0 0.07 6.1 0.9 0.8 2 6 6 7 7 5 6 81 
W2 190 6.0 0.06 6.1 0.9 0.7 3 6 6 7 7 4 6 86 
W3 190 5.9 0.07 6.0 0.9 0.8 3 5 6 7 7 4 6 78 
W4 190 5.9 0.07 5.9 0.9 0.8 3 5 6 7 7 4 6 81 
W5 190 5.1 0.09 5.2 1.3 1.6 1 4 5 6 7 6 5 62 
 
6.2.2 Respondents 
The review of sample statistics shows that more than two-thirds (70%) of respondents are 
males while female respondents represent only 26% of the sample with 4% of respondents 
failing to provide this information. The responses reflect the gender imbalance in the 
manufacturing sector. According to the statistical office of the European Union, males are 
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overrepresented in the manufacturing sector (79%) in comparison to females (Eurostat, 2020). 
The sample also includes 49 responses from quality assurance and 50 responses from quality 
control constituting 52% of all responses. In addition, 40% of responses were from production, 
packaging and technical services. The remainder of respondents is affiliated to other functions 
including supply chain, operation excellence and project management roles (Table 6-2). Figure 
6-1 depicts the level of education of the respondent.  While more than half of the sample 
received at least university education, 73 respondents completed postgraduate studies with ten 
of the respondents hold a PhD degree. 
 
Figure 6-1   Level of Education  
 
Table 6-2 Participating Functions 
 
Frequency Percentage 
Quality Assurance 49 26% 
Production or packaging 39 21% 
Quality Control 50 26% 
Technical services 37 19% 
Other 15 8% 
Total 190  
 
Furthermore, the average length of experience of participants from the manufacturing sector 
ranged from one year and up to 27 years with an average of approximately 10 years (standard 
deviation = 5.314 years). Figure 6-2 depicts the distribution of the number of years of 
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experience of respondents. On average, 72% of the participants’ tenure was at the current 
function. However, only 51% of the tenure was at the current employer. This reflects the mixed 
experiences held by respondents at different functions and different organisations. The sample 
varied also at the depth of experience at one department or function ranging from totally new 
up to 18 years at the same department. 
 
Figure 6-2 A histogram depicting the experience range of respondents 
The sample represented different job levels in the organisation. However, it can be noticed 
that middle and senior managers constitute 39% of the sample (Figure 6-3). This relative over-
representation of managers may be attributed to the design of the two-stage cluster sampling 
where contact persons (can be more than one per organisation), who were selected from 
managers and senior managers, were solely responsible for distributing the survey within their 
organisation. However, some managers provided only a single response per organisation and 
apologised that it is not possible to share the survey link within their organisation due to fear 
of company’s data breach. Another potential reason for the over-representation of managers is 
that the survey was not designed to be distributed to every member of the organisation. 
Operators and technicians were out of the scope of this survey. As a result, the survey was 
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Figure 6-3 Job Level 
As the questionnaire language was in English, it was found necessary for data validity 
purposes to ensure that participants are able to understand the questions and select the most 
accurate answer. Three main language skills were self-assessed by respondents. With regard to 
reading skill, 98.4% of respondents described themselves as intermediate, advanced or native. 
Despite that English reading skill are the most relevant skill required to complete the 
questionnaire properly, other language skills were evaluated too. The survey shows that over 
96% of respondents possess intermediate to advanced speaking and listening skills (Table 6-3). 
Table 6-3 English Language Fluency 
 Reading Speaking Listening 
Beginner 1.6% 1.6% 3.2% 
Intermediate 12.1% 35.8% 27.9% 
Advanced 71.6% 49.4% 55.8% 
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6.2.3 Organisations  
More than half of the participants are affiliated to well established pharmaceutical 
organisations operating for more than 20 years. Conversely, two percent of responses came 
from relatively new firms operating for less than five years (Table 6-4Table 6-4).  
Table 6-4 Age of organisation 
 Frequency Percent 
Less than 5 years 4 2.1 
From 5 to 10 years 22 11.6 
From 11 to 20 years 59 31.1 
From 21 to 50 60 31.6 
More than 50 years 45 23.7 
Total 190  
 
 The European Commission defines small enterprises as an enterprise that employs less than 
50 employees while medium enterprise employs more than 50 but less than 250 (EC, 2003). 
Forty-four respondents were affiliated to medium size enterprises while only 6 worked for 
small enterprises (Table 6-4). Chi-Square test of independence (Table 6-6) revealed a 
significant association between the organisation size and age (Pearson Chi-Square =78.059; 
df=16; P< 0.000).  
 
Table 6-5 Size of organisation 
 Frequency Percent 
Less than 50 employees 6 3.2 
From 50 to 249 employees 44 23.2 
From 250 to 500 employees 33 17.4 
From 500 to 1000 employees 28 14.7 
More than 1000 79 41.6 
Total 190 100.0 
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Table 6-6 Chi-Square Test: Organisation size vs age 
 Value df 
Asymptotic 
Significance (2-sided) 
Pearson Chi-Square 78.059 16 .000 
Likelihood Ratio 88.865 16 .000 
N of Valid Cases 190   
 
 
Figure 6-4 Organisation size vs age 
Four levels of knowledge maturity were recognised among the organisations of participants 
based on  Oliva (2014) framework that identified four levels of KM maturity: insufficient, 
structured, oriented and integrative (Figure 6-5). Approximately one-third of participants’ 
organisations belonged to the structured KM maturity level. Only 18% of respondents referred 
to a lack of awareness of the need to KM in their organisations. Interestingly, Chi-Square test 
of independence showed (Table 6-7) no association between organisational size and the level 
of KM maturity (Pearson Chi-Square= 18.357; df=12; P=0.105). Similarly, the test (Table 6-8) 
demonstrated a lack of association between the organisation age and the level of KM maturity 


















From 250 to 500 employees From 50 to 249 employees From 500 to 1000 employees
Less than 50 employees More than 1000
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Table 6-7 Chi-Square Test: organisation size vs KM maturity 
 Value df 
Asymptotic 
Significance (2-sided) 
Pearson Chi-Square 18.357 12 .105 
Likelihood Ratio 20.171 12 .064 
N of Valid Cases 190   
 
Table 6-8 Chi-Square Test: organisation age vs KM maturity 
 Value df 
Asymptotic 
Significance (2-sided) 
Pearson Chi-Square 19.310 12 .081 
Likelihood Ratio 19.309 12 .081 
N of Valid Cases 190   
 
 
Figure 6-5 KM Maturity levels in the sample organisations 
Forty-nine percent of respondents described their manufactured product as conventional 
pharmaceuticals. Fourteen percent produced biologics and 24% have mixed portfolios. The 





There  is a general lack of
awareness of the need for
knowledge management.
The management is aware of
the importance knowledge
management but  there are






place at some departments
(islands of knowledge) but it
is not part of an
organisation-wide strategy.
Knowledge management is
part of a holistic organisation
strategy and continuously
reviewed by management.
Level of KM Maturity
Insufficient OrientedStructured Integrative
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as medical devices, veterinary product or active pharmaceutical ingredients (API).  It should 
be emphasised that more than 52% of responses were received from multinational and 
international enterprises (Table 6-9). Also, 93.2% of the respondents are affiliated to private 
sector organisations while the remaining 6.8% work for governmental firms. 
Table 6-9 Type of participants’ organisation 
 Frequency Percent 
Multinational or global 100 52.63 % 
International 1 0.53 % 
Domestic/local 89 46.84 % 
Total 190 100.0 % 
 
Finally, almost two-thirds of participants completed more than 80% of their technical and 
GMP training plan at the time of filling the survey (Table 6-10).  
Table 6-10 Compliance to training plan among participants 
 Frequency Percent 
Less than 40% 6 3.2 
40-50% 8 4.2 
51-60% 4 2.1 
61-70% 15 7.9 
71-80% 32 16.8 
81-90% 60 31.6 
More than 90% 65 34.2 
Total 190 100.0 
 
Confirmatory Factor Analysis 
6.3.1 Data preparation 
The data was prepared for further analysis. This included the analysis of missing data, 
outliers, data normality and reliability. Data organisation and coding of the variables was 
required to prepare them for CFA. Variable codes are presented in chapter five (Table 5-2).  
Both SPSS 26 and IBM AMOS 26 were used for data analysis at this stage.  
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Missing data and outliers 
The risk of incomplete surveys or in other words missing data was mitigated by making the 
41 model questions required. However, an initial analysis of the data identified a small 
percentage of missing data (less than 1%) as the first ten responses were received before 
making all the model questions required (not more than one missing response per variable). 
Estimate means and intercepts option in AMOS was selected to compensate the few missed 
entries (less than 1%). No further action was taken. 
Multivariate outliers are cases whose variables show a pattern of values different from other 
cases in the sample. Although there is no consensus on the best action to be taken to deal with 
outliers, multivariate outliers possibly caused by data entry mistakes or random responding can 
be omitted (Bandalos, 2018). Mahalanobis Distance test in SPSS 26 was used to identify 
outliers in the sample. Twelve multivariate outliers were identified in the dataset (P <0.001). 
The researcher chose to compare the model estimation and goodness of fit with and without 
those outliers. A small and insignificant improvement in model fit was observed after omitting 
the outliers from the data. Based on this observation, a decision was made to retain multivariate 
outliers. 
 
Normality of variable distribution 
 One of the basic assumptions of CFA is data normality.  According to the probability 
theory, normal or Gaussian distribution is a type of continuous probability distribution where 
the characteristic bell curve can be defined by the population mean and standard deviation 
(Lucey & Lucey, 2002).  Reporting the skew and kurtosis indices of all continuous variables 
is a recommended practice (Kline, 2011). It has been recommended that the skewness index 
should not exceed | 2.0 |. However, more liberal standards have accepted kurtosis up to | 7.0 | 
(Bandalos, 2018).  
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As outlined in Table 6-11, skewness and kurtosis values are less than | 2.0 | and | 7.0 | 
respectively suggesting acceptable data normality. It is noteworthy that all skewness values are 
negative. This is in line with Dunning-Kruger effect on self-evaluation of personal knowledge 
(Schlösser et al., 2013)  which will be discussed in the next chapter. Last but not least, the data 
presented in the form of a Likert scale from one to seven. The literature suggests a negligible 
bias in parameter estimates can be achieved when the Likert scale is five or more categories as 
the data can be treated as continuous (Bandalos, 2014). 














Statistic Std. Error Statistic Std. Error 
M1 2 7 5.61 1.125 -.660 .176 .230 .351 
M2 1 7 5.61 1.464 -1.161 .176 .811 .351 
M3 1 7 5.49 1.421 -.890 .176 .326 .351 
M4 2 7 5.90 1.134 -1.077 .176 .810 .351 
M5 1 7 5.82 1.201 -1.325 .176 2.160 .351 
M6 2 7 5.97 1.028 -1.058 .176 1.074 .351 
M7 1 7 5.70 1.122 -.885 .176 1.049 .351 
M8 1 7 5.63 1.225 -1.085 .177 1.525 .352 
M9 2 7 5.77 1.010 -1.053 .177 1.952 .352 
N1 1 7 5.68 1.245 -1.005 .177 1.062 .352 
N2 1 7 5.98 1.008 -1.306 .176 2.876 .351 
N3 2 7 5.89 1.041 -.944 .176 .733 .351 
N4 2 7 5.68 1.081 -.916 .176 1.361 .351 
N5 1 7 5.77 1.083 -1.167 .176 2.325 .351 
N6 2 7 5.96 .988 -1.050 .177 1.406 .352 
N7 2 7 5.88 1.097 -1.105 .176 1.392 .351 
N8 2 7 5.55 1.283 -.817 .176 .225 .351 
O1 3 7 6.24 .875 -1.354 .176 2.353 .351 
O2 2 7 5.75 1.027 -.761 .176 1.058 .351 
O3 3 7 6.10 .888 -.793 .176 .143 .351 
O4 3 7 5.97 1.038 -.882 .176 .218 .351 
O5 1 7 5.73 1.163 -1.040 .176 1.350 .351 
O6 1 7 5.65 1.187 -.972 .177 1.378 .352 
O7 1 7 5.42 1.330 -.865 .176 .679 .351 
P1 1 7 5.86 1.000 -1.345 .176 3.314 .351 
P2 3 7 5.98 .970 -.801 .176 .194 .351 
P3 3 7 5.83 .988 -.786 .176 .334 .351 
P4 3 7 5.98 .900 -.674 .176 -.021 .351 
P5 1 7 5.89 1.018 -1.033 .176 1.909 .351 
P6 2 7 5.87 1.031 -.973 .176 1.183 .351 
P7 1 7 5.87 1.171 -1.732 .176 4.314 .351 















Statistic Std. Error Statistic Std. Error 
R1 1 7 5.17 1.527 -.724 .177 -.290 .352 
R2 1 7 4.89 1.672 -.638 .177 -.535 .352 
R3 2 7 5.75 1.289 -1.017 .176 .345 .351 
R4 1 7 5.74 1.082 -.892 .177 1.260 .352 
R5 1 7 5.48 1.274 -1.030 .177 1.442 .352 
W1 2 7 6.04 .908 -1.028 .176 1.674 .351 
W2 3 7 6.04 .863 -.820 .176 .718 .351 
W3 3 7 5.89 .905 -.617 .177 .310 .352 
W4 3 7 5.86 .900 -.608 .177 .336 .352 
W5 1 7 5.13 1.266 -.620 .176 .497 .351 
Reliability 
Cronbach’s alpha α was used to assess instrument reliability. Cronbach's alpha is a widely 
used measure of the reliability of such multi-item indices (Bonett & Wright, 2014; Cronbach, 





A high value of Cronbach's alpha implies a high level of reliability or low response variance. 
On the other hand, a small value may be an indicator of low instrument reliability or can 
indicate that the items do not really measure the same construct (Groves et al., 2004). 
 As pointed out earlier, the number of test items, item interrelatedness and dimensionality 
affect the value of alpha. The commonly acceptable values of alpha range from 0.70 to 0.95 
(Tavakol & Dennick, 2011). The calculation of Cronbach’s alpha coefficients for the different 
factors ranged from 0.738 to 0.886 indicating acceptable internal consistency between 
questions and answers as seen in the table below (Table 6-12). 
Table 6-12 Cronbach's alpha 
Factor Cronbach's Alpha 
Cronbach's Alpha Based 








Performance .881 .886 









6.3.2 Model Specification 
The specified model consists of 41 reflective (effect) indicators (Bollen & Bauldry, 2011) 
and six underlying latent factors creating a second-order hierarchical CFA model. Hierarchical 
models present the hypotheses in such a way that the higher-order factors have a presumed 
direct causal effect on the lower order factors (Kline, 2011).  The relationship between the 
latent variable and the reflective indicators is theoretically grounded based on the conceptual 
framework presented in chapter five and considered as the manifestations of the personal 
knowledge of pharmaceutical manufacturing employees. Each of the 41 observed indicators 
has a unique variance as shown in Figure 6-6.  Unique variance accounts for the measurement 
error or the unreliability in a specific indicator in contrast to the common variance 
(communalities) accounted for the latent variables in the model (Kenny, 2006).  Similarly, each 
latent factor of the first order variables has a residual which accounts for the variance 
unexplained by the higher-order construct (Kline, 2011). Personal knowledge is a latent 
variable that doesn’t have its own observed indicators. Instead, it is indirectly measured by the 
observed indicators measuring the first-order constructs (Byrne, 2016).  
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Figure 6-6 Specified full model one 
For graphical representation, rectangles were used to refer to the observed variables, while 
oval shapes referred to the latent variables. Straight arrows describe the direction of the causal 
relation in the model. IBM Amos 26 offers three methods for model specification: 
programming, graphics and  table interface (Byrne, 2016). Amos Graphics user interface was 
utilised to specify the model instead of the traditional programming (coding) interface. This 
method was found more convenient and poses a lower risk of coding errors. For reasons related 
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to model identification, the researcher constrained the regression path of one observed indicator 
per each of the six first order constructs to the value of one. Because the impact of the latent 
variable (personal knowledge) on the lower order construct and measures is the main interest 
of this study, the researcher constrained the variance of personal knowledge to one leaving the 
second-order factor loadings freely estimated. All measurement error and residual variables 
have a constrained regression coefficient of one. Based on the theoretical background of this 
model, cross loadings are fixed to zero.  
 
6.3.3 Model identification 
Bollen (1989) suggested three conditions for model identification: 
• Three or more observed variables must load on each latent construct. 
• Measurement error variances are not correlated.  
• Each variable loads on one latent construct. 
As shown in the model specification section, all three conditions are met. In CFA, a model 
must be either just identified or over-identified (recommended) but cannot be under-identified. 
In other words, the number of variance/covariance elements must be equal or more than the 
parameter values to be estimated (Bandalos, 2018).  The following formula calculates the 







Where v is the number of observed variables. The total number of variances (41) and 
covariances = 41+861 =902. The number of parameter values to be estimated in this model can 
be enumerated as follow: 
• 41+6 -6 =41 loadings/regression weights for first and second-order variables 
excluding 6 constrained regression weights that have been fixed to one. 
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• 41measurement error variances. 
• 6 residuals variances. 
• 41 intercepts 
For a grand total of distinct parameters to be estimated = (41+41+6+41) = 129 which is less 
than 902 (degrees of freedom = 902-129 = 732). A positive degrees of freedom means that the 
model is over-identified and can be estimated (Byrne, 2016) as will be explained in the next 
section. 
 
6.3.4 Model estimation 
Maximum Likelihood (ML) method was chosen for the model estimation. ML is the default 
estimation algorithm in IBM AMOS 26 with assumptions of continuous and normally 
distributed data. It is a widely used method offering unbiased, consistent, and efficient results 
(Bandalos, 2018). The results of the initial model indicate an average regression weight of 0.7, 
the maximum loading equals 0.95 and the minimum loading is 0.4. However, 94% of the 
loading values are above 0.5 and 55% are above 0.7 which indicates a moderate to high 
correlation with the underlying latent constructs and the latent variable (personal knowledge). 
It is argued that moderate to high correlation is a desirable situation when dealing with effect 
indicators in a model (Bollen & Lennox, 1984) such as the specified model in this study.  
Moreover, all loading values are statistically significant (P< .001) as shown in Table 6-13. 







Performance <--- PK .923 .651 .076 *** 
Regulatory <--- PK .783 .592 .083 *** 
Organisational <--- PK .813 .572 .083 *** 
Network <--- PK .931 .481 .087 *** 
Wisdom <--- PK .946 .585 .087 *** 
Mastership <--- PK .882 .492 .066 *** 
M9 <--- Mastership .554 1.000   








M8 <--- Mastership .524 1.148 .195 *** 
M7 <--- Mastership .677 1.359 .194 *** 
M6 <--- Mastership .748 1.375 .185 *** 
M5 <--- Mastership .678 1.456 .208 *** 
M4 <--- Mastership .771 1.563 .207 *** 
M3 <--- Mastership .703 1.786 .249 *** 
M2 <--- Mastership .580 1.519 .240 *** 
M1 <--- Mastership .583 1.174 .185 *** 
P7 <--- Performance .605 1.000   
P6 <--- Performance .739 1.077 .131 *** 
P5 <--- Performance .690 .993 .127 *** 
P4 <--- Performance .821 1.043 .118 *** 
P3 <--- Performance .716 1.000 .124 *** 
P2 <--- Performance .828 1.135 .128 *** 
P1 <--- Performance .705 .997 .125 *** 
R5 <--- Regulatory .594 1.000   
R4 <--- Regulatory .627 .897 .138 *** 
R3 <--- Regulatory .695 1.182 .171 *** 
R2 <--- Regulatory .563 1.243 .207 *** 
R1 <--- Regulatory .502 1.013 .184 *** 
O7 <--- Organisational .530 1.000   
O6 <--- Organisational .695 1.171 .173 *** 
O5 <--- Organisational .770 1.271 .178 *** 
O4 <--- Organisational .821 1.209 .164 *** 
O3 <--- Organisational .642 .809 .125 *** 
O2 <--- Organisational .592 .863 .140 *** 
O1 <--- Organisational .704 .875 .128 *** 
N8 <--- Network .404 1.000   
N7 <--- Network .670 1.417 .271 *** 
N6 <--- Network .723 1.378 .257 *** 
N5 <--- Network .812 1.696 .305 *** 
N4 <--- Network .767 1.601 .293 *** 
N3 <--- Network .787 1.581 .287 *** 
N2 <--- Network .764 1.485 .272 *** 
N1 <--- Network .454 1.091 .248 *** 
W5 <--- Wisdom .490 1.000   
W4 <--- Wisdom .711 1.032 .161 *** 
W3 <--- Wisdom .714 1.040 .162 *** 
W2 <--- Wisdom .798 1.111 .164 *** 
W1 <--- Wisdom .825 1.208 .176 *** 
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Table 6-14 shows the unique variances (measurement errors and residuals) in the model. It can 
be observed that the variance of the second order latent variable (personal knowledge) has been 
fixed to one. All other variances were left unconstrained. 
Table 6-14 Unique Variances 
Variables Estimate S.E. P Variables Estimate S.E. P 
PK 1.000   20 .708 .086 *** 
Res1 .069 .021 *** 19 .854 .114 *** 
Res2 .074 .023 .001 18 1.903 .221 *** 
Res3 .221 .065 *** 17 1.736 .195 *** 
Res4 .167 .048 *** 28 1.265 .136 *** 
Res5 .036 .015 .018 27 .723 .084 *** 
Res6 .040 .018 .023 26 .548 .068 *** 
9 .702 .076 *** 25 .350 .048 *** 
8 1.081 .116 *** 24 .461 .052 *** 
7 .678 .076 *** 23 .681 .075 *** 
6 .464 .055 *** 22 .384 .045 *** 
5 .775 .087 *** 36 1.369 .143 *** 
4 .519 .063 *** 35 .660 .073 *** 
3 1.015 .116 *** 34 .462 .052 *** 
2 1.415 .154 *** 33 .399 .049 *** 
1 .831 .090 *** 32 .479 .056 *** 
16 .865 .093 *** 31 .409 .049 *** 
15 .480 .055 *** 30 .421 .049 *** 
14 .539 .060 *** 29 1.223 .129 *** 
13 .263 .032 *** 41 1.212 .128 *** 
12 .474 .053 *** 40 .398 .045 *** 
11 .294 .037 *** 39 .399 .046 *** 
10 .500 .056 *** 38 .269 .033 *** 
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Figure 6-7 Model one with unstandardised estimates 
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Figure 6-8 model one with standardised estimates 
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6.3.5 Model testing “goodness of fit”  
The model that well fits the data as explained in the SEM literature should be able to match 
and reproduce the actual covariances among the variables in the study sample (Bandalos, 
2018). A survey of the literature reveals that methodologists have proposed many fit indices. 
Model chi-square (χ2) is one of the most popular indices of the overall model fit. Significant 
chi-square at 0.05 threshold implies a poor model fit. However, this method was criticised for 
being over-sensitive to sample size (Hooper et al., 2008). Table 6-15 shows a significant χ2 test 
results (P< .05) as an indication of poor model fitting (for model one). However, the literature 
shows no consensus on χ2 test as a sole indicator of the overall model fit. In fact, SEM 
researchers emphasised that significant χ2 test results don’t necessarily entail model rejection 
but further exploration in light of the theories underlying the proposed model (Bandalos, 2018; 
Crede & Harms, 2019). In order to mitigate the effect of sample size, the relative or normed 
chi-square (χ2 /DF) was proposed as an alternative to chi-square test where a value of five or 
less indicates good fit (Tabachnick & Fidell, 2007; West et al., 2012). χ2 /DF equals to 2.668 
(Table 6-15). The first row of the table below refers to the model under test (model one), while 
the two rows beneath handles the saturated and the independence models. The independence 
model can be described as a hypothesised model in which the correlations between its variables 
equal to zero. In contrast, the saturated model has the number of parameters to estimate equal 
to the variances and covariances of the observed variables and is the least restricted (Byrne, 
2016). 




χ2 DF P χ2 /DF 
Default model 129 2062.208 773 .000 2.668 
Saturated model 902 .000 0   
Independence model 41 5694.069 861 .000 6.613 
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In addition to χ2, two other popular fit indices were consulted. The root mean square error 
of approximation (RMSEA) (Steiger, 1980)  and the comparative fit index (CFI) (Bentler, 
1990). RMSEA is considered as an error of approximation index that can assess the level of 
model fit in the population. The test assesses the non-centrality parameter which equals zero 
when the model fit is perfect (Kenny, 2006). Literature suggests that RMSEA score between 
0.08 and 0.10 indicates a mediocre fit while scores above 0.10 reflect poor fit. However, it is 
recommended to have an RMSEA score below 0.08 to guarantee a good model fit (Hooper et 
al., 2008). The specified model has a RMSEA score of 0.094 signifying a mediocre model fit. 
Comparative Fit Index (CFI) is a modified version of the normed fit index (NFI) adjusted 
to avoid the underestimation of model fit when the sample size is small (Bentler, 1990). Similar 
to RMSEA, there is no consensus on the cut-off point differentiating good fit from poor fit. In 
general, CFI values closer to 1.0 demonstrates better fit. However, a value of CFI ≥0.90 or 
0.95 is widely recognised as an indicator of a good fit. The CFI value for the model one is 
0.733 suggesting mediocre fit results. 
The model fit indices were recalculated without the 12 outliers identified by Mahalanobis 
distance test as mentioned before. A slight improvement was observed where the RMSEA 
score decreased to 0.09, CFI value increased to 0.758 and chi-square =1874 with df=773 at P< 
0.001. In order to investigate the underlying causes of the modest fit of model one, the next 
section will discuss model alterations that were carried out with a resulting improved model 
fit.  
 
6.3.6 Model respecification / optimisation 
A revised abbreviated model was assessed based on the original model (model one). The 
second model is based on five factors instead of six where the regulatory awareness (having 
the lowest loading) is merged with the Mastership of product and process. The revised model 
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assumed that the regulatory awareness e.g. the ability to identify gaps in the process or system 
is an integral part of product and process understanding. In other words, the awareness of 
specifications and the ability to identify the gaps between the practice and the 
standard/specification is a basic part of the Mastership of the process/product. If an employee 
is unable to identify non-conformances in his/her work area or unaware of them, this may 
reflect a deficiency in his/her product and process knowledge. By the same token, ICH Q10 
emphasises that the corrective actions and preventive actions (CAPA) resulting from the 
investigation of product/process non-conformances should enhance product and process 
understanding (ICH, 2008). 
It is worth noting that all the observed measures in the specified model one are reflective 
indicators which implies that the observed indicators of each factor are interchangeable (Bollen 
& Bauldry, 2011; Kline, 2015). Based on this understanding, interchangeable measures 
showing low loading were omitted and the model was re-estimated. Model two (Figure 6-9) 
below was generated taking a conservative approach through omitting any reflective indicator 
with a loading value ≤ 0.5. It was also considered to maintain three measures per factor as 
required for model identification (Byrne, 2016; Schumacker, 2010). Table 6-15 enumerates 
standardised and unstandardised regression weights of model two. It can be observed that all 
standardised regression weights are greater than 0.63 and significant at P< 0.001. 
Table 6-16 Model two standardised and unstandardised regression weights 






Performance <--- PK .850 .629 .066 *** 
Organisational <--- PK .670 .605 .077 *** 
Network <--- PK .840 .814 .069 *** 
Wisdom <--- PK .954 .545 .061 *** 
Mastership <--- PK .747 .631 .074 *** 
M7 <--- Mastership .754 1.000   
M6 <--- Mastership .844 1.025 .098 *** 
M4 <--- Mastership .717 .961 .104 *** 
P5 <--- Performance .729 1.000   
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P4 <--- Performance .920 1.115 .094 *** 
P3 <--- Performance .769 1.024 .100 *** 
O6 <--- Organisational .763 1.000   
O5 <--- Organisational .822 1.057 .096 *** 
O4 <--- Organisational .860 .986 .087 *** 
N5 <--- Network .897 1.000   
N4 <--- Network .862 .959 .062 *** 
N3 <--- Network .737 .789 .066 *** 
W4 <--- Wisdom .636 1.000   
W2 <--- Wisdom .835 1.259 .137 *** 
W1 <--- Wisdom .844 1.338 .144 *** 
 
Figure 6-9 Respecified model (two) 
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Figure 6-10 Model two standardised estimates 
CHAPTER 6: Quantitative Data Analysis 
 6-197 
 
Figure 6-11 Model two unstandardised estimates 
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Model fit indices were reassessed for the new model showing a significant improvement. 
CFI value for model two equals 0.949 (approx. 0.95), RMSEA value equals 0.074, chi-square 
test result equals 172.32 with df=85 (P< 0.001) and X2/df equals 2.027 (Table 6-16; Table 6-
18).  The revised results suggest a good model fit.  
 
Table 6-17 χ2 Test results for model two 
Model No. of Parameters χ2 DF P χ2 /DF 
Default model 50 172.320 85 .000 2.027 
Saturated model 135 .000 0   
Independence model 15 1820.665 120 .000 15.172 
 
Table 6-18 Unique variances- model two 
 Estimate S.E. P  Estimate S.E. P 
PK 1.000   12 .397 .049 *** 
Res1 .315 .067 *** 27 .586 .077 *** 
Res2 .152 .036 *** 26 .436 .067 *** 
Res4 .448 .085 *** 25 .280 .051 *** 
Res5 .277 .056 *** 33 .228 .043 *** 
Res6 .029 .017 .088 32 .300 .046 *** 
7 .540 .074 *** 31 .492 .058 *** 
6 .303 .057 *** 40 .480 .054 *** 
4 .622 .079 *** 38 .224 .032 *** 
14 .483 .057 *** 37 .235 .035 *** 
13 .124 .032 ***     
 
Table 6-18 presents the unique variances (measurement errors and residuals) in the revised 
model -two. All variances have significant values (P<0.001) except residual 6 associated with 
wisdom construct (P<0.1). Based on the results above, model two is the preferred model with 
superior fit and loading values compared with model one (Table 6-19).  
Table 6-19 Model fit indices of two models 
Model χ2 DF P CFI RMSEA 
One 2062.208 773 .000 0.733 0.094 
Two 172.320 85 .000 0.949 0.074 
CHAPTER 6: Quantitative Data Analysis 
 6-199 
Covariates (controls) 
Covariates are a form of variables in the measurement model to control and minimise 
potential bias in estimating the relationship of latent and observed variables that could happen 
if covariates were not included. However, covariates are not necessarily measures or causes of 
the latent variable (Bollen & Bauldry, 2011). The researcher studied the influence of sample 
demographic data on the estimation and fit of the model one (complete 41 measures) and model 
two (best fit 15 measures). Seven variables extracted from the sample demographic data 
(Education, KM maturity of the organisation, type of organisation, employee experience, 
training and job level) were selected as controls - explained in Section 5.9.  
Table 6-20 Model one: controls loadings 









.054 .057 .075 .444 
















-.069 -.017 .017 .324 
PK <--- Job level -.024 -.028 .082 .731 
 
Table 6-21 Model two: controls loadings 














-.055 -.013 .018 .448 
PK <--- Type of Org -.014 -.015 .078 .846 
PK <--- Job level -.039 -.045 .084 .594 
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.012 .013 .077 .869 
PK <--- KM Maturity .261 .250 .071 *** 
 
Table 6-20 and Table 6-21 illustrate the standardised and unstandardised loadings of the 
described controls. Five out of seven controls showed insignificant relationships in both model 
one and model two. Knowledge management maturity exhibits a weak to moderate positive 
(approx. 0.3) relationship with personal knowledge. This signifies that organisations with well-
developed KM systems attract and retain knowledge holders. The total experience in terms of 
the number of years (job tenure) shows a weak positive relationship at a significance level of 
0.05. Figure 6-12 and Figure 6-13 demonstrate the unstandardised estimates of model one and 
model two with the covariates. A slight reduction in model fit was observed after the 
introduction of the covariates. CFI value for model two equals 0.834, RMSEA value equals 
0.091, chi-square test result equals 2636.519 with df=1074 (P< 0.001) and X2/df equals 2.455. 
CFI value for model one equals 0.694, RMSEA value equals 0.088, chi-square test result equals 
526.351 with df=204 (P< 0.001) and X2/df equals 2.58. This can be attributed to the five 
covariates of the insignificant relationship as well as the limited sample size.  
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Figure 6-12  Unstandardised estimates of model one with covariates 
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Figure 6-13 Unstandardised estimates of model two with covariates  
CHAPTER 6: Quantitative Data Analysis 
 6-203 
Summary and Conclusion 
In this chapter, the researcher analysed the quantitative data extracted from the survey 
responses. Two main phases of data analysis can be distinguished in this chapter: descriptive 
statistics and confirmatory factor analysis. Descriptive statistics aimed at the review of 
respondents’ demographic data to highlight how it represented the targeted population of the 
study.  Thereafter, the developed model of personal knowledge was tested and optimised 
employing CFA tools. CFA encompassed six steps starting by data preparation, model 
specification, model identification, model estimation, model testing of fit then finally model 
optimisation. At the optimisation step, an alternative model was proposed as a modification of 
the original model one. The final model (two) is the preferred model that showed good fit and 
high loadings of all the measures of personal knowledge. Also, the model propounded a 
reasonable number of personal knowledge measures facilitating its potential use as a tool for 
personal knowledge assessment in the organisational context. Finally, the influence of seven 
control variables was assessed where only total experience and KM maturity expressed 
significant weak to moderate relationships with the personal knowledge suggesting that 
organisations with mature KM systems retain and attract knowledge holders. The outcome of 
the quantitative data analysis will be thoroughly discussed and compared to the extant literature 
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 Introduction 
This chapter presents the discussion of the research results that have been demonstrated in 
the previous chapters. The researcher adopted sequential mixed methods research (Creswell & 
Clark, 2018) starting with a qualitative exploratory phase followed by a survey of 
pharmaceutical manufacturing employees to validate the developed framework. The outcome 
of the qualitative phase was the development of a theoretical framework of 41 measures of 
personal knowledge of pharmaceutical manufacturing employee. The model was tested and 
validated using CFA (Schoonenboom & Johnson, 2017) to identify the best fit model 
describing the key manifestations of the personal knowledge in a pharmaceutical 
manufacturing context. 
 
Personal Knowledge Management in the Pharmaceutical Manufacturing 
The researcher received 190 valid responses from more than 50 organisations that presented 
all drug product categories (conventional, biologics, devices, etc.) in multinational and 
domestic corporates and in the private and governmental sectors. The sample was intended to 
cover both genders and all the professional job levels in the organisation and within the 
functions specified in the study scope. The KM maturity of the pharmaceutical organisation 
was explored during the exploratory study as well as during the explanatory phase. The results 
revealed that over 80% of the participant organisations had a form of structured KM system 
and 27% had integrated KM with the corporate strategies. This agrees with the findings of  
(Oliva, 2014) that knowledge management is typically implemented in all major corporates.  
Since 2008, ICH Q10 depicted KM as an enabler of the pharmaceutical quality system 
(ICH, 2008). However, the highest percentage of the surveyed companies are still struggling 
in the second stage of KM maturity where formal KM strategy is not established.  Likewise, 
the qualitative phases addressed several initiatives for knowledge sharing and acquisition that 
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were widely applied in the pharmaceutical industry. The use of information technology was 
commonly adopted as an enabler of KM even though it is not sufficient without a supporting 
culture (Chatzkel, 2007).  Evidence from the qualitative and the quantitative studies points to 
varied levels of KM maturity in the surveyed companies. Also, the survey results agree with 
the qualitative study findings as personal knowledge measurement activities were informal and 
unstructured. Nearly all the interviewed industry experts confirmed the lack of KM strategy in 
their organisations. The Chi-Square test of independence denied any statistically significant 
association between KM maturity and either organisation size or age. These results build on 
existing evidence that the pharmaceutical industry haven’t developed mature KM capabilities 
(Calnan et al., 2018). 
 
Personal Knowledge Measurement 
 A slightly negative skewness (on average -0.96) was observed in all the variables assessed 
by the questionnaire. In other words, the most frequent self-assessment scores are higher than 
the mean and median. Also, the mean was shifted towards the positive side of the scale. This 
shifting was partially attributed to Dunning-Kruger effect (Kruger & Dunning, 1999) and the 
nature of the sample. The Dunning-Kruger effect shows that incompetent people would 
overestimate their capabilities in self-assessments due to their doubled curse being unskilled 
and unaware (Schlösser et al., 2013). The literature suggests that the only intervention to make 
participants more accurate in self-assessments is to educate them to be more competent (Kruger 
& Dunning, 1999).  
However, it is believed that the Dunning-Kruger effect has a limited impact on the results 
of this study aiming to identify personal knowledge measures and the underlying factors rather 
than assessing the actual knowledge of participants. In the organisational context, this kind of 
knowledge measurement should be conducted as a 360-degree survey to minimise the bias due 
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to self-assessment. The other potential factor behind the positive shifting of scoring is the 
relative over representation of middle and senior managers constituting 39% of the sample 
(Figure 6-3). This relative over-representation may be attributed to the design of the two-stage 
cluster sampling as explained in the previous chapter. However, all job levels were represented 
in the surveyed sample. 
 
Testing and validation of PK framework 
Two second-order CFA models were specified and theoretically grounded on the basis of 
the conceptual framework. The initial model included six underlying constructs (first-order) 
while the other model (five-factor model) excluded regulatory awareness as an independent 
construct. Instead, regulatory awareness was either merged with the Mastership of product and 
process. It is worth noting that regulatory awareness had the smallest regression weight in 
relation to personal knowledge. Model two was the optimised model that retained only the 
measures showing the highest loading values and had the best model fit indices. In all models, 
personal knowledge was the second-order latent variable. The revised five-factor model had 
better loading values and model fit indices compared to the six-factor original model (Table 6-
18). 
Model one shows that the regulatory awareness is the underlying construct of five measures of 
personal knowledge: 
• The identification of compliance gaps/deviations in worker’s area/process (R1). 
• The association of compliance gaps to a specific clause in a standard, SOP or a 
Pharmacopeia (R2). 
• Finding relevant standards or regulatory guidelines (R3). 
• Awareness of updates to regulatory standards, specifications and SOPs (R4). 
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• Involvement in the development and improvement of standards and specifications in 
your organisation (R5). 
Although regulatory awareness was a theme fully independent of product and process 
understanding in the thematic analysis study, a closer review of the measures of regulatory 
awareness highlights the communalities. Prior knowledge of product and process 
specifications, standard operating procedure or manufacturing process details is a prerequisite 
for identifying any practice to standard gaps. Moreover, the ICH guidelines accentuated that 
the adopted corrective or preventive actions to address any potential compliance gap should 
enhance product and process understanding (ICH, 2008). 
 
Measures of Personal Knowledge 
The review of measurement models shows medium to high correlation with the underlying 
latent constructs and the personal knowledge (all regression weights above 0.4). In model one 
(which included all the hypothesised measures of personal knowledge), 94% of the loading 
values were above 0.5 and 55% are above 0.7 which indicates a moderate to high correlation 
with the underlying latent constructs and the latent variable. Moreover, the respecified model 
two (five-factor model) showed a noticeable improvement in model fit. Overall, results 
suggest that it can provide efficient, reliable, and valid assessment of the personal 
knowledge. Five factors were identified as the measures of personal knowledge in the 
pharmaceutical manufacturing context as shown in Table 7-1.  
Regarding the applicability of the model in the pharmaceutical sector, three items per factor 
or a total of 15 measures were found to achieve the required balance between reliability and 
speed (see model two). Model two was favoured as it has offered both of these criteria by 
retaining only three measures per each factor and achieving best model fit. Unlike formative 
measures which cause the underlying latent variable, reflective measures are the effect of the 
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underlying latent variable and are known to be interchangeable (Kline, 2015). The 
measurement models used reflective observed variables (measures) to reflect the effect of the 
underlying factors and latent variable (Bollen, 1989). Consequently, reflective measures under 
each of the factors can replace one another.  
To create the abbreviated model two, measures that have shown the highest correlation 
with the underlying factors were retained to create the optimum model (model two). The items 
for the optimised model were chosen balancing concerns for reliability, internal structure, 
and content representativeness (representing the five constructs). For convenience, the 
optimised PK framework (model two) will be referred to as the Pharmaceutical Personal 
Knowledge Framework or the 2P-K Framework. 
Table 7-1 The 2P-K Framework (model two) 
Factor Measures Code 
Mastership of 
product/process  
Train others in relation to your current role M4 
Explain to colleagues the scientific basis and precautions of 
processes in your area 
M6 
Explain to colleagues the technology utilised in machinery and 
equipment in your area 
M7 
Wisdom Think critically (clearly and rationally) to solve work problems W1 
Solve daily work problems efficiently W2 
Other people believe you make the right decisions in work W4 
Organisational 
understanding 
Understand the values of your organisation O4 
Understand the vision, mission and goals of your organisation O5 
Abide by the values of your organisation O6 
Performance Complete assigned tasks "right first time" P3 
Complete assigned tasks in a consistent manner P4 
Complete assigned tasks on time P5 
Network and 
communication 
Communicate effectively with senior management N3 
Motivate others to achieve organisational goals N4 
Lead others to achieve organisational goals N5 
 
7.5.1 Mastership of product and process  
The ICH Q10 presents product and process understanding as the core of KM activities and 
the outcome of applying scientific approaches across the product lifecycle (ICH, 2008). The 
estimation of the 2P-K framework shows regression weights of 0.75, 0.72, 0.84 and 0.75 for 
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the mastership factor and the three observed measures respectively reflecting a moderate to 
high correlation with personal knowledge. In other words, Personal knowledge explains 56% 
(0.752) of variations in the mastership construct. The Mastership of product and process 
knowledge was measured by three items reflecting what can be generally described as technical 
advising. Interviews revealed that knowledgeable workers are not only capable of doing their 
jobs without supervision but also are able to pass their technical knowledge to others. Due to 
the unstructured and subjective nature of tacit knowledge, coaching and mentoring are essential 
to pass it to other employees. This includes the transfer of subjective understanding, know-
how, know-why, job-specific and expert’s knowledge (Mohajan, 2016).  
The transferred knowledge through training can take several forms.  While training can 
simply imply reading (self-study) what has been explicitly articulated in a document. Mentors 
or coaches are often required to transfer the heuristics they unconsciously use (tacit knowledge) 
to perform a certain task in a process (Gorman, 2002). Understanding the underlying theoretical 
and technology basis of product and process is described as the epistemological knowledge 
explaining why things are as they are. This type of knowledge normally goes beyond how 
things happen (performative knowledge) to why they happen (Mingers, 2008). Although 
sharing product and/or process knowledge with co-workers may be limited by factors such as 
personality traits, level of trust and other individual and organisational barriers (Pirozzi & 
Ferulano, 2016; Roos et al., 1997; Sveiby, 2010; Tobin, 1969), the ability to pass technical 
knowledge to others in the form of formal or informal training as well as to explain the 
knowledge beyond certain process can be seen as manifestations of deep knowledge. By the 
same token, Mohajan (2016) enumerated several ways for tacit knowledge transfer including 
but not limited to: training successors, sharing accumulated knowledge from prior role and 
other forms or coaching.  
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7.5.2 Wisdom 
Three manifestations of personal knowledge were categorised as a reflection of the 
underlying latent construct of wisdom: critical thinking, problem-solving and proper decision 
making. The estimation of the 2P-K framework shows regression weights of 0.95, 0.84, 0.84 
and 0.64 for wisdom factor and the three observed measures respectively reflecting a moderate 
to high correlation with personal knowledge. In other words, personal knowledge explains 90% 
(0.952) of variations in the wisdom construct. Wisdom is a special type of judgement that 
requires prior knowledge to critically reflect on and question prevailing mental models 
(Gorman, 2002). Wisdom is depicted as the summit of knowledge hierarchy and as a result of 
the underlying knowledge (Ackoff, 1989). It enables the person to anticipate the long-term 
consequences of his/her actions (Bernstein, 2011). This can be interpreted in the form of a long-
term vision, deep thinking, rationalism and coping with complex uncertain events (Ekmekçi et 
al., 2014). Indeed, multidisciplinary PKM approaches emphasise the use of knowledge for 
effective decision making and problem-solving (Pauleen, 2009; Wright, 2005). Problem-
solving involves understanding of the problem through relevant information, generating 
alternatives and finally judgement or selecting the most appropriate solution (Wright, 2005). 
That is to say, holding the necessary tacit and explicit personal knowledge about the product 
and process is a prerequisite to solving problems which is the core of PKM (Agnihotri & Troutt, 
2009). 
7.5.3 Organisational understanding 
Knowledge workers are expected to use their knowledge to make decisions that affect the 
performance of their organisations (Agnihotri & Troutt, 2009). However, values and contextual 
information are an integral part of knowledge as defined by Davenport & Prusak, (1998). In 
other terms, knowledge workers make their decisions in light of their understanding of their 
organisational culture, values, mission and vision. Three manifestations of personal knowledge 
were presented as a reflection of the underlying latent construct of the organisational 
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understanding: understanding company’s values, understanding its mission, vision & goals and 
finally abiding by these values. The estimation of the 2P-K framework shows regression 
weights of 0.67, 0.86, 0.82 and 0.76 for organisational understanding factor and the three 
observed measures respectively reflecting a moderate to high correlation with personal 
knowledge. That is to say that the personal knowledge explains 45% (0.672) of variations in 
the organisational understanding construct. 
7.5.4 Performance 
The literature suggests that personal knowledge is required for better performance of job 
tasks (Tajedini et al., 2018). By the same token, the interviewed industry experts proposed that 
the personal knowledge of employees can be assessed by the outcome of knowledge i.e. 
performance. Performative knowledge (also called procedural or know-how) is the form of 
practical knowledge, skills and competencies which enables us to do something (Gorman, 
2002; John Mingers, 2008). Hence, it can be evaluated by success to do something. Three 
manifestations of personal knowledge were presented as a reflection of the underlying latent 
construct of performance: completion of a task right first time, in a consistent manner and on 
time. The estimation of the 2P-K framework shows regression weights of 0.72, 0.77, 0.92 
and0.73 for performance construct and the three observed measures respectively reflecting a 
moderate to high correlation with personal knowledge. That is to say, the personal knowledge 
explains 72% (0.852) of variations in the performance construct. Performance can be 
understood as the outcome of job activity within a certain period. It is associated with personal 
knowledge, experience, self-esteem and motivation (Taba et al., 2016). 
 
7.5.5 Network and communication 
The fifth construct in 2P-K framework is the network and communication measures. This 
includes the effective upward communication with senior management, motivation of co-
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workers and leadership to achieve the organisational goals.  Knowledge is not just a thing or a 
process, but rather a personal network (Chatti, 2012). Moreover, knowledge work is 
increasingly depicted as a social activity (Wright, 2005). Personal network in terms of strength 
of ties and the number of contacts was positively related to performance in knowledge-
intensive jobs due to transfer of complex knowledge between contacts (Taba et al., 2016). The 
estimation of the 2P-K framework shows regression weights of 0.84, 0.74, 0.86 and 0.90 for 
the communication construct and the three observed measures respectively reflecting a 
moderate to high correlation with personal knowledge. That is to say that the personal 
knowledge explains 70% (0.84 2) of variations in the communication and networking construct. 
It is important to note that social networking requires “know-who” form of knowledge (Jarrahi 
et al., 2019) which is a predominately tacit knowledge impeded in the fluid personal 
interactions in the organisation  (Grabher & Ibert, 2006). 
 
Controls 
The quantitative study assessed the influence of seven covariates on personal knowledge: 
education level, KM maturity, type of organisation, total experience, current experience, 
training (percentage completed) and Job level. Five out of the seven control showed an 
insignificant relationship with the measurement framework. While KM maturity showed a 
weak to moderate correlation (approx. 0.3) with the personal knowledge, total experience (job 
tenure) was weakly correlated (approx. 0.2) to personal knowledge and its manifestations. The 
results suggest that the surveyed organisations which have developed stronger KM systems 
also employed the most knowledgeable employees. As lifelong employment is no longer the 
norm in modern organisations, continuous learning throughout the career has become the 
responsibility of employees in an ever-changing environment to stay competitive (Thornley et 
al., 2016). It is argued that mature knowledge processes play a potential role in enhancing 
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organisational learning and expanding the learning culture (Chinowsky & Carrillo, 2007; 
Thepthepa & Mitsufuji, 2016). In other terms, this prevalence of learning culture in KM mature 
organisations can justify the association of KM maturity and personal knowledge.   
The job tenure was used as a proxy for employee experience. The available evidence seems 
to suggest that experience is necessary for problem-solving and proper decision making 
(Mittelmann, 2016). The qualitative study showed that prior experiences help employees find 
efficient solutions to problems that had faced the organisation before. The cross relationships 
between the length of experience and the knowledge management maturity at one side and 
personal knowledge at the other side is consistent with the notion that time is crucial for 
knowledge accumulation over a long period through direct experiences and lifelong learning 
(Hoe, 2006; John Mingers, 2008). 
 
Theoretical Implications 
Successful PKM implies better use of the knowledge of individual employees (Razmerita et 
al., 2009b). Therefore, the intellectual output of an organisation is reliant on the personal 
knowledge of its employees (Hine et al., 2008). In order to manage this sort of knowledge 
predominately stored in people’s brain (Thornley et al., 2016), better understanding and 
measurement of the personal knowledge is prescribed. An empirical study of the personnel 
knowledge in the pharmaceutical manufacturing sector resulted in the development of the 
Pharmaceutical Personal Knowledge (2P-K) framework (the abbreviated form of the original 
41-measures model).  Due to the context-specific nature of knowledge (Hoe, 2006; Nikkhah et 
al., 2018; Nonaka et al., 2000; Vladova et al., 2016), the 2P-K framework addressed the 
manifestations of personal knowledge in an industry-specific context. The framework depicted 
five constructs illustrating the key manifestations of the personal knowledge of manufacturing 
personnel. The 2P-K framework offers researchers and scholars a theoretically grounded model 
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for measuring personal knowledge. In order to enhance the applicability of the model, the 
number of measures per construct was reduced to three (15 items in total) by retaining the 
strongest loading variables and the best fit model. Thus, the model offers an opportunity to be 
integrated with future research questionnaires to assess personal knowledge in relation to other 
latent variables using structural equation modelling or similar techniques. 
 
Furthermore, measures of the intellectual capital of organisations such as the replacement 
cost of tangible assets (Tobin, 1969), market share (Edvinsson, 1997) or retention excellence 
(Wyatt, 2001) are argued to be inaccurate measures of the personal knowledge due to potential 
synergism of collective knowledge in organisations (Wright & Mcmahan, 2011).  The 
developed 2P-K framework explored the statistical interrelations of 15 manifestations of 
personal knowledge in industry-specific context and concluded that a positive correlation 
between any two of the five constructs should be attributed to the personal knowledge since 
the underlying constructs have low correlations among them. Unlike classical measures of 










Figure 7-1 The 2P-K Framework 
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(SJT) (Peeters & Lievens, 2005), the study offers an original personal knowledge explanatory 
model supported by the confirmatory factor analysis statistics. 
 
Practical Implications 
The literature reveals that knowledge measurement aims to offer a tool to identify and 
allocate knowledge assets, benchmark against other companies, monitor the development of 
the firm’s HC overtime (Matoskova, 2016). The 2P-K framework can be used as a basis for a 
personal knowledge measurement scale (2P-K-S) in the pharmaceutical manufacturing 
context. The interviews conducted in the exploratory phase with industry experts concluded 
that personal knowledge measurement is reliant on informal subjective activities (if existed). 
In order to develop a quantitative and consistent scale of personal knowledge, the 
Pharmaceutical Personal Knowledge Scale (2P-K-S) was suggested as a practical application 
of 2P-K framework.  
The use of structural techniques for organising decision making such as Analytic Hierarchy 
Process (AHP) (Saaty, 2000) can offer relative weights for each of the five factors underlying 
the personal knowledge latent variable. The AHP allows the use of the experts’ assessments to 
estimate the relative weight of each factor through pair-wise comparisons to achieve a 
consistent judgement (Li et al., 2019). The assigned weights would be customised to the 
relative significance of each of the factors within each organisation.  Whereas Spearman 
developed the general intelligence test using the g-Factor, underlying a set of cognitive 
abilities, as a measure of intelligence (Hally, 2012), the 2P-K scale similarly would measure 
the personal knowledge of manufacturing employees by explaining the common variance of 
the 15 observed measures of knowledge. Although this study relied on self-assessment, 360-
degree feedback is recommended for the organisational application of this framework. The 
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360-degree feedback is a form of multi-ratter assessment where the feedback is received from 
supervisor, peers, subordinates in addition to self-evaluation (Atkins & Wood, 2002). 
The practitioners’ interviews demonstrated a consensus on the value of personal knowledge 
measurement. It suggested that the personal knowledge measurement tool can help employees’ 
appraisal. As the appraisal process can be multidimensional (Bayo-Moriones et al., 2019), 
evaluation of new and current employees can include the level of personal knowledge. This 
might be of particular importance within the learning organisation culture to evaluate the 
effectiveness of training and learning programs. It was also suggested as a way to compare and 
monitor the knowledge of teams or departments in a consistent way where the aggregates of 
personal knowledge echo the collective knowledge of a group (Faucher et al., 2008). The tool 
can also highlight the opportunities for development and weakness points of employees to be 
considered for future development. As previously discussed, personal knowledge is a predictor 
of job performance (Mingers, 2008; Taba et al., 2016). Consequently, awareness of personal 
knowledge is associated with performance improvement (Tajedini et al., 2018).  
Moreover, all manufacturing personnel are required to have the proper training on their job 
responsibilities (WHO, 2014). The identification of knowledge holders within the organisation 
can provide evidence that business and quality decisions are made by those who hold the right 
knowledge.  This is deemed to improve the quality and business outcome by raising the level 
of confidence in the decision-making process. This supports the notion that the organisational 




The research anticipated few limitations of the developed measurement framework. Firstly, 
the proposed measurement framework/scale relies on 360-degree survey to assess the personal 
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knowledge of employees. This requires supervisor, peers and subordinates to develop a certain 
level of awareness of the performance of the assessed employee. In turn, they should encounter 
shared situations, work jointly and share their reflections about daily work problems. The 
qualitative study suggests that is not always possible. Some organisations rely on fixed-term 
contracts to fill certain jobs. In such a case, the limited employment period does not allow 
proper evaluation or corrections. In some other cases, workers might not be part of a team or 
in other words, working solely in a particular processor on a niche product. This is deemed to 
limit the assessor’s capacity to evaluate his/her peers too. If the assessed knowledge is 
associated with a breakthrough product or process, assessors might face difficulties to define 
what the proper outcome or performance reflecting the acquisition of this new knowledge.  
Secondly, the framework validation in this study relied on self-ratings. This might pose a 
risk of social desirability bias. Social desirability bias describes the tendency of respondents to 
choose socially desirable answers rather than the answers which describe their true beliefs 
(Grimm, 2010). Atkins & Wood (2002) criticised the use of self-rating as a reflection of a 
particular competency either by itself or as in aggregation with other ratings from 360-degree 
feedback. In order to minimise the impact of social desirability bias, the researcher resorted to 
the use of a self-administered electronic questionnaire, anonymous survey of practitioners and 
a careful selection of the wording of survey questions (Grimm, 2010). Finally, Dunning Kruger 
effect (Kruger & Dunning, 1999; Schlösser et al., 2013) is another source of bias where 
unskilled generally lack the metacognitive abilities to realise their incompetency.  This agrees 
with the findings of Atkins & Wood (2002) where high performers had less propensity to 
overestimate their performance compared to low-performers who showed lower self-
awareness. For this reason, a 360-degree survey was prescribed for organisational application 
as shown before. 
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Recommendations and future directions 
In order to overcome the limitations of this research, a case study employing the 360-degree 
survey in a pharmaceutical manufacturing organisation is recommended for practical testing of 
the framework. The use of AHP to determine the relative weights of each of the five factors 
would personalise the framework to the priorities of each organisation. Also, the framework 
can be estimated in a bigger sample that includes practitioners from similar manufacturing 
industries such as chemical, food and beverages. 
 Finally, as knowledge is context-specific (Nikkhah et al., 2018), the model was developed and 
tested in an industry-specific context (pharmaceutical manufacturing). However, comparison 
to similar manufacturing industries (e.g. chemical industries) is recommended to assess the 
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Introduction 
Knowledge is a dynamic human process to justify our personal belief in pursuit of the truth 
(Nonaka et al., 2000). Therein, information is processed and stored in people’s mind (Thornley 
et al., 2016). Personal knowledge management and particularly measurement have received 
little attention, particularly in pharmaceutical manufacturing. This study offers an original 
framework for measuring personal knowledge of knowledge workers in pharmaceutical 
manufacturing. The tool has been developed considering the extant literature and guided by 
experts’ insights. The proposed framework has been validated and optimised by surveying 190 
practitioners from the pharmaceutical sector. The following section depicts how the study 
addressed the three research objectives, the contribution to knowledge and finally the author’s 
reflections and conclusion.  
 
Understanding Personal knowledge Management and Measurement 
In order to develop a framework of personal knowledge in the pharmaceutical industry, it 
was important to achieve a deep understanding of the current industry practices and 
predominant theories in the extant literature. Research commenced with a comprehensive 
literature review of the personal knowledge and knowledge measurement theories as well as 
the applications of KM and PKM in pharmaceutical manufacturing. The extant literature 
provided dozens of comprehensive definitions of knowledge at its tacit and explicit dimensions 
such as “a dynamic human process of justifying personal belief toward the truth” (Nonaka et 
al., 2000). In contrast, practitioners’ definitions in the qualitative phase emphasised knowledge 
acquired by doing and experience. Regulatory and industry guidelines were reviewed to 
understand the regulatory expectations and requirements. The review of 137 empirical studies 
revealed a growing interest in KM in the pharmaceutical industry and regulatory endeavours 
to enforce KM across the product lifecycle. The review also provided a literature map that 
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identified six popular themes in KM literature in pharmaceutical industry. Regarding 
knowledge theories, the review identified the dimensions of personal knowledge and key 
knowledge measurement frameworks (Pirozzi & Ferulano, 2016; Roos et al., 1997; Sveiby, 
2010; Tobin, 1969).  
However, as the focus of academic and regulatory literature was set on the organisational 
knowledge management, exploratory interviews with pharmaceutical industry experts were 
necessary to address this knowledge gap by identifying how personal knowledge is assessed in 
the pharmaceutical manufacturing organisations. The thematic analysis of interviews provided 
a thorough analysis of the current KM and PKM practices in pharmaceutical manufacturing. 
The analysis highlighted the measures of personal knowledge adopted in the organisational 
context.  Measurement strategies were predominately subjective and informal. Participants 
emphasised the value and growing need for consistent and formal measures of personal 
knowledge. At the end of the literature review (chapter two and three) and the qualitative study 
(chapter five), the research developed the required understanding of how personal knowledge 
was conceptualised in pharmaceutical industry context (RQ1) and how it is currently measured 
by practitioners (RQ2). 
Finally, the level of KM maturity in the pharmaceutical industry was assessed both in the 
qualitative and quantitative studies. There was an agreement that the levels of implementation 
and maturity of KM practices are not the same in every pharmaceutical organisation. The 
quantitative study findings supported this assumption. While most of the surveyed companies 
had a sort of structured KM system (more than 80%), they were distributed between the four 
levels of maturity (Oliva, 2014) in similar ratios (18%, 32%, 23% and 27%) -RQ3. 
Literature review and the exploratory study paved the road for achieving the first research 
objective: 
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Objective 1 Gain an in-depth understanding of the current practices of the personal knwoledge 
management and measurement focusing on the pharmaceutical manufacturing context.  
 
Development of Personal Knowledge Framework 
Following an abductive reasoning approach, a conceptual framework was developed taking 
into account the exploratory interviews and literature review findings. The thematic analysis 
provided the required insights about research phenomenon from the practitioners’ perspective. 
Developing a theoretically grounded model was a prerequisite for the next phase of framework 
testing and validation. The personal knowledge measurement conceptual framework was 
hypothesised as a second-order model with 41 observed measures. By the end of chapter five 
the second research objective was achieved.  
Objective 2 The development of a personal knowledge measurement framework for 
knowledge workers in the pharmaceutical manufacturing context. 
 
Personal Knowledge Framework Validation and Optimisation 
A survey of 190 manufacturing employees at different job levels was used to achieve the 
third research objective. Confirmatory factor analysis using IBM AMOS 26 was the chosen 
technique to estimate the proposed models and to select the most reliable model that best-fit 
the data with a reasonable number of measures. Model two was the favoured measurement 
framework (2 P-K) that combined both speed and reliability through 15 observed measures of 
personal knowledge with five underlying factors that have shown high loading on the latent 
variable and good model fit. The five underlying factors are: Mastership of product and 
process, wisdom, organisational awareness, communication and networking as well as 
performance. Thus, the third objective was addressed. 
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Objective 3 Validate and optimise the proposed PK measurement framework in the 
pharmaceutical manufacturing sector.  
 
Contribution to knowledge  
8.5.1 Development of the Pharmaceutical Personal Knowledge (2P-K) framework 
 As explained in chapter one, PKM is a relatively new research discipline that has not 
received proper attention (Cranefield & Prusak, 2016). The research offers a theoretically 
grounded and validated framework explicating personal knowledge and its manifestations. As 
knowledge is context-specific (Hoe, 2006; Nikkhah et al., 2018; Nonaka et al., 2000; Vladova 
et al., 2016), pharmaceutical manufacturing was adopted as the context for the development 
and testing of 2P-K framework. Due to the limited knowledge on the measurement strategies 
of personal knowledge particularly in the manufacturing context, the research commenced with 
an exploratory phase. The exploratory phase merged the knowledge available in literature and 
industry guidelines with the experiences of industry experts to deductively develop the 
conceptual framework in the study. 
Thematic analysis was the vessel where knowledge from primary and secondary data 
interacted to hypothesise the measures of personal knowledge and the underlying factors. A 
theoretically grounded framework was a prerequisite for the following testing phase using 
structural equation modelling (Kline, 2011). A quantitative survey of 190 practitioners in the 
pharmaceutical manufacturing was used to test and optimise the proposed models. Finally, the 
2P-K framework was developed to explain personal knowledge through its manifestations in a 
pharmaceutical manufacturing context. 
The developed 2P-K framework provides researchers and scholars in the area of PKM with 
a multifaceted explanation of personal knowledge. The theoretical framework can assist PKM 
CHAPTER 8: Conclusion 
 8-225 
future researches as an indirect tool to measure PK (which is a latent variable) in relation to 
other variables. 
 
8.5.2 A basis for PK measurement instrument in manufacturing  
The study offers a reliable and flexible measurement framework that can be adopted in 
pharmaceutical manufacturing to assess the level of personal knowledge of employees based 
on the manifestations and outcome of knowledge itself. Unlike currently applied subjective 
and informal personal knowledge assessment strategies (as identified in the exploratory study), 
the framework provides the basis for a systematic objective tool to measure personal 
knowledge. However, the use of 360- Degree feedback is recommended to avoid bias due to 
social desirability or Dunning-Kruger effect and consequently achieve accurate results.  
In order to enhance the applicability and flexibility of the framework, the final optimised 
model (2P-K framework) was an abbreviated (15-item) form of the original 41-observed 
variable framework. In addition, the abbreviated framework showed better model fit than the 
original model reflecting its accuracy and reliability. The author anticipates that the proposed 
framework can be applied in organisational context to measure personal knowledge in a way 
similar to Spearman IQ test where the underlying g-Factor (intelligence) is used to explain the 
variances in the cognitive abilities (Hally, 2012). 
 
8.5.3 Taxonomic analysis of KM literature  
KM is a relatively new research discipline with limited applications in the pharmaceutical 
industry (Ramy et al., 2018). This study contributed by developing a taxonomic map (Figure 
3-4) of the predominant themes in the academic journal articles with direct applications in the 
pharmaceutical industry. Similarly, the review of more than 128 pharmaceutical industry and 
regulatory guidelines brought forth a literature map of KM related themes addressed in these 
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guidelines (Figure 3-5). The literature review findings have been published in the Knowledge 
Management Research and Practice (KMRP) Journal.  
 
Summary and Conclusion 
This thesis presents original research to explore and explain the personal knowledge 
management and measurement in literature and practice. After a comprehensive review of 
knowledge measurement theory and application literature, fifteen industry experts were 
interviewed to obtain a greater understanding of personal knowledge management and 
measurement practices. The fruit of that stage was the development of an explanatory 
theoretical framework that describes personal knowledge, knowledge manifestations and the 
underlying factors of those manifestations. The framework was validated and optimised 
through a survey of 190 practitioners from pharmaceutical manufacturing where confirmatory 
factor analysis statistics were applied to test and validate the key measures of the personal 
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In response to an increasing regulatory and business needs for knowledge management across the commercial life 
of the drug product, this survey comes as a part of a comprehensive academic study to develop a knowledge 
assessment scale for pharmaceutical manufacturing employees. It is hoped that the results of this study will 
enhance the ability to identify knowledge assets and enhance decision-making capabilities within the 
pharmaceutical industry. 
The study is conducted by the College of Business,  Technological University Dublin and embracing its research 
ethics. To ensure confidentiality, we will guarantee the anonymity of both participant and company information. 
The survey responses are accessible only by the authorised research team members and the academic supervisor 
Dr. Lorraine Sweeney (lorraine.sweeney@TUDublin.ie). Mindful of your busy schedule, we are kindly inviting you to 
participate in this survey which should only take an average of 15 minutes. Your participation in this survey means 
you consent that your data will be exclusively used for academic research. 
As an incentive to complete this survey, we will donate $1 (one US dollar) per completed survey for the Egyptian 
National Cancer Institute - Cairo (http://www.nci.cu.edu.eg/).
For further enquiries about the survey, kindly contact Ahmed.Ramy@TUDublin.ie.
Thanks for your kind participation
Ahmed Ramy, MSc
PhD Candidate
3S Group, College of business 
TU Dublin  
1.
Mark only one oval.
Support and administration roles (e.g. accounting, IT, HR, Training, admin, etc.).
Manufacturing (e.g. quality, production, warehouse, manufacturing R&D, etc.)
 e Pharmaceutical Personal Knowledge Scale
(2P KS)
 A Personal knowledge Measurement Scale for individual employees in the Pharmaceutical 
Manufacturing sector
*Required
Which one of the following best describes your role in the orgainsation? *




Mark only one oval.
Less than 50 employees
From 50 to 249 employees
From 250 to 500 employees











Mark only one oval.
Less than 5 years
From 5 to 10 years
From 11 to 20 years
From 21 to 50
More than 50 years
Please indicate the approximate size of your organisation (all the sites and affiliates). *
Please indicate the category of drug products manufactured at your organisation/site *
-Choose all that apply
Please indicate the age of your organisation (the whole organisation worldwide) *
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5.

















Please indicate the ownership of your organisation. *
Please indicate the type of your organisation. *
Please indicate your current department or function. *
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8.
Mark only one oval.
Other:














Mark only one oval.
Male
Female
Prefer not to say
Please indicate your current position/title. *
Please indicate the highest level of education you have obtained. *
Please indicate your gender.














Please indicate your total experience in the pharmaceutical manufacturing (in years). *
Out of your total manufacturing experience (previous question), how many years have you
spent in the current department/function? *
Out of your total manufacturing experience , how many years have you spent with the current
employer? *
Please indicate your level of compliance to technical training requirements (including GMP
training) *
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15.
Tick all that apply.
16.
Mark only one oval.
There is a general lack of awareness of the need for knowledge management.
The management is aware of the importance of knowledge management but there are
no or few formal processes for identifying, capturing, sharing, transferring, and applying
knowledge.
Formal knowledge management initiatives take place at some departments (islands
of knowledge) but it is not part of an organisation-wide strategy.




Please indicate the extent to which you are confident that you are able to undertake ( or would 
be able to , if required) the following:
17.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Please indicate your proficiency with English language (reading, speaking and listening) *




Which of the following statement best describes the knowledge management practices in your
organisation: *
Identify compliance gaps/deviations in your area/process. *
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18.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
19.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
20.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
21.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Associate compliance gaps to a specific clause in a standard, SOP or a Pharmacopeia. *
Find relevant standards or regulatory guidelines. *
Locate relevant process and product related information. *
Identify the appropriate person to obtain information relating to a specific product/process. *
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22.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
23.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
24.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
25.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Please indicate the extent to which you are confident that you are able to undertake ( or would be able to , if 
required) the following:
Carry out assigned responsibilities without supervision. *
Contribute to the design and development of processes/products within your function. *
Train others in relation to your current role. *
Complete relevant records/forms (including electronic records) associated with products or
processes in your department. *
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26.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
27.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
28.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
29.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Explain to colleagues the scientific basis and precautions of processes in your area. *
Explain to colleagues the technology utilised in machinery and equipment in your area. *
Achieve departmental/organisational goals successfully *
Play a key role in successful projects in your area. *
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30.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
31.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
32.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
33.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Complete assigned tasks "right first time". *
Complete assigned tasks in a consistent manner. *
Complete assigned tasks on time. *
Meet or exceed the required targets. *
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34.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Please indicate the extent to which you are confident that you are able to undertake ( or would be able to , if 
required) the following:
35.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
36.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
37.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Think critically (clearly and rationally) to solve work problems. *
Communicate effectively with co-workers to get the job done. *
Communicate effectively with senior management. *
Motivate others to achieve organisational goals. *
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38.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
39.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Section three
Please indicate the extent to which you:
40.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
41.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Lead others to achieve organisational goals. *
Solve daily work problems efficiently. *
Understand your role within you organisation. *
Understand processes within other departments in your organisation. *
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42.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
43.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
44.
45.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Understand terminology used in your organisation. *
Understand the values of your organisation. *
Please provide examples of the values of your organisation (at least three):
Understand the vision, mission and goals of your organisation. *
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46.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
47.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
48.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
49.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Abide by the values of your organisation. *
Explain the historical Out of Specifications (OOS), failures and/or any weaknesses in your area.
*
Are aware of updates to regulatory standards, specifications and SOPs. *
Are involved in the development and improvement of standards and specifications in your
organisation. *
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50.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Section four
Please indicate the extent to which:
51.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
52.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
53.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Are involved in the design, validation, control and continuous improvement of
products/processes in your function. *
Other people seek advice or information from you relating to products, processes and systems
(including computer systems). *
Other people believe you solve daily work problems efficiently. *
Other people believe you make the right decisions in work. *
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54.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
55.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
56.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
57.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
Other people see you as a team player. *
Your out of the box suggestions are implemented within your organisation. *
You achieve a strong positive evaluation in annual appraisal by management. *
You have a wide network of contacts within your organisation. *
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58.
Mark only one oval.
Not at all
1 2 3 4 5 6 7
To a great extent
This content is neither created nor endorsed by Google.
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ABSTRACT
The purpose of this paper is to explore the current research trends in Knowledge Management 
(KM) through a scientometric analysis of all literature published in KMRP between 2003 and 2015 
(506 articles). The review framework explores three sets of review questions addressing Research 
Productivity, Research Themes and Methods, and Citation Analysis. The study elucidates wide 
global interest in KM and an increasing trend towards multi-author collaboration. Although more 
than 55 different industries have featured in the journal, certain knowledge-intensive sectors 
remain underrepresented. Country productivity shows few nations taking the lead with an 
interesting correlation between research activity and economic prosperity. Moreover, a growing 
tendency towards empirical methods is observed in contrast to a decrease in literature review 
papers, coupled with a recent rise in articles that integrate KM and Information Technology (IT). 
In terms of citation and influences, few published articles have stood out in the journal’s history. 
This is the first comprehensive scientometric research of KMRP describes the state-of-the-art 
value and provides an outlook of the future.
1. Introduction
Knowledge management (KM) has become a predomi-
nant field within the business and management landscape 
for both researchers and practitioners (Moustaghfir & 
Schiuma, 2013). The recognition of the fundamental 
role of knowledge in value creation spawned the con-
cept of the Knowledge Economy, making it one of the 
pillars of contemporary management thinking (Roberts, 
2009; Weir, Huggins, Schiuma, Lerro, & Prokop, 2010). 
Economic growth is no longer reliant on physical capi-
tal and labour only as established in nineteenth century 
theories, but also on the human capital comprised of 
“knowledge workers” whose innovative capabilities lead 
the advancement of the current “knowledge society” 
(Drucker, 1994). This was highlighted by a 1999 World 
Bank report which provided one of the first compre-
hensive accounts of the emerging role of knowledge in 
economic development through a focus on acquisition, 
application, and transfer of knowledge (World Bank 
Annual Report, 1999). By the end of the twentieth cen-
tury, the notion of managing knowledge had evolved at 
the corporate level as organisations acknowledged the 
need to leverage and exploit their knowledge resources 
(Carmeli & Tishler, 2004). KM is now considered a vital 
organisational function and a key source of sustainable 
competitive advantage (Davenport & Völpel, 2001). On 
the other hand, progressive academic works have also 
established KM as an independent and rich scientific 
discipline. As a research field, KM has witnessed an 
exponential growth rate in publications amounting to 
50% per year, supported by the foundation of a number 
of dedicated KM journals and conferences (Serenko, 
Bontis, Booker, Sadeddin, & Hardie, 2010).
One of the key peer-reviewed journals in the KM 
field is Knowledge Management Research and Practice 
(KMRP). Available online since 2003, KMRP is the first 
KM journal to gain an impact factor (Thomson Reuters, 
2015). Its aim is to provide an outlet for high-quality 
peer-reviewed publications including both academic 
and practical dimensions and the relationship between 
both perspectives. The journal pays particular attention 
to cross disciplinary research, mixtures of techniques, 
and differing schools of thought adopting a broad spec-
trum of publication themes including empirical research 
and case studies as well as conceptual and theoretical 
papers (Springer, 2017). Moreover, KMRP was placed 
third in 2008 then the second in 2013, according to 
expert survey rankings conducted on a sample of 25 key 
KM journals (Serenko & Bontis, 2013a).
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While the KM field continues to grow, reflections on 
literature can allow for more efficient future delibera-
tions on subjects within the discipline, minimise repeti-
tion, and create starting points for further advancements 
in KM theory and practice. This paper provides insights 
into KM research published in the KMRP, which could 
arguably apply to the whole KM domain considering 
that KMRP is a representative example of the wider 
KM literature. To present the work, the paper is divided 
into five sections. Following the introduction, the sec-
ond section offers a brief survey of relevant literature 
and presents the study’s research questions. Section 3 
details the study’s methodology and the development 
of the review framework. Findings are presented and 
analysed in the fourth section, while the final section 
discusses the work’s conclusions and implications for 
future research.
2. Background and research questions
A literature review is a “critical analysis of a segment 
of a published body of knowledge through summary, 
classification, and comparison of prior research studies” 
(Jafari & Kaufman, 2006). It helps to interpret what is 
known about a research field and to identify gaps in the 
existing knowledge (Jesson, Matheson, & Lacey, 2011). 
Several reviews covered KM publications and journals 
using a number of methods over different time peri-
ods. These include but are not be limited to: Citation 
Analysis (Huang, Chen, & Stewart, 2010; Ma & Yu, 
2010; Ribière & Walter, 2013; Serenko & Bontis, 2013a; 
Serenko & Dumay, 2015) Content Analysis (Fteimi & 
Lehner, 2016), Journal Ranking (Serenko & Bontis, 
2009, 2013b), Meta-review (Serenko & Bontis, 2004) 
and Scientometric Analysis, the approach adopted in 
this study (Serenko, Bontis, & Grant, 2009; Serenko et 
al., 2010).
Scientometrics is science about science with distinct 
identity and methodology (Garfield, 2009). The term has 
grown in popularity and recognition in the last decades, 
especially after the founding of the dedicated Journal 
of Scientometrics by Tibor Braun in 1978. It is used to 
describe the study of science including growth, structure, 
interrelationships and productivity of a certain research 
discipline (Hood & Wilson, 2001). Scientometrics por-
trays a comprehensive picture of research activity within 
the field and is able to present existing trends supported 
by quantitative data. In this study, the scientometric 
approach is adopted to investigate three main research 
issues within KMRP during the review timeframe:
(1)  Productivity – Demographic patterns in the 
production of KMRP research;
(2)  Themes and methods – Trends in topics exam-
ined and research tools applied; and
(3)  Citation – Analysis of referencing frequency of 
the journal’s papers.
Accordingly, three groups of research questions were 
formulated to guide the research process as follows.
Research productivity in KMRP
RQ1. What are the dominant trends in authorship 
distribution?
RQ2. What is the prevailing affiliation of KMRP authors 
(Academics vs Practitioners)?
RQ3. Which countries are leading in KM research?
RQ4 . Is there a relationship between a country’s econ-
omy and its contribution to KM research?
RQ5. What is the institutional productivity in the 
journal?
Research themes and methods in KMRP
RQ6. Which research methodologies are most used by 
authors?
RQ7. What are the most popular industrial sectors in 
KM research?
RQ8. What are the main research themes in the journal?
RQ9. What is the degree of integration of Information 
Technology in KM research?
Citation analysis of KMRP
RQ10. Which articles are the most influential in the 
journal’s history?
3. Methodology
The research methodology adopted in this study can be 
summarised in a series of steps. First, the boundaries of 
article selection for analysis were drawn using criteria 
for inclusion and exclusion. This set initially included 
506 articles published in KMRP between the year 2003 
– when the first issue was published – and up to 2015. 
Editorials, position papers, and book reviews were 
excluded from the article list. Accordingly, a total of 344 
peer-reviewed journal articles was retained for analysis, 
while 162 were excluded. Second, the research frame-
work was synthesised in light of previous similar works 
(Fteimi & Lehner, 2016; Serenko & Bontis, 2004; Serenko 
& Dumay, 2015; Serenko et al., 2010). The subsequent 
design allows exploration into the various attributes of 
publications within the selected sample (Table 1).
A pilot review of 10 articles was initially conducted by 
two researchers for validation purposes. The outcomes 
of this exercise led to minor modifications of the frame-
work, and helped identify what the authors refer to as 
grey areas, which are article attributes within the frame-
work that are subjective in nature and can vary according 
to the views of the coder. Grey areas are mainly confined 
to two review parameters: research method and research 
topic where the same article can be classified under more 
than one category within the coding scheme. In such 
cases, the researchers agreed to code the article under the 
most predominant theme then cross-check their results.
68   A. RAMY ET AL.
In the subsequent stage, the articles were mutually 
coded by both researchers. Finally, full analysis of the 
resultant data-set was undertaken to identify patterns. 
When addressing Research Questions 2–5 pertaining to 
Research Productivity, methods utilising credit analysis 
were enacted and the researcher had to select the most 
appropriate method. Authorial credit is generally pro-
vided using one of four methods depicted in Table 2.
The Equal Credit Method was selected because it 
avoids the shortcomings of the three other methods and 
provides mostly unbiased authorial credit. In addition to 
Equal Credit, the Direct Count Method was employed in 
Research Questions 2 and 3 as well and results of both 
methods were compared. It is worth noting that studies 
have suggested that the Direct Count, Author Position, 
and Equal Credit methods can produce similar results, 
particularly when utilising aggregate data (Serenko, 
Cocosila & Turel, 2008).
In addressing Research Question 10 regarding cita-
tion impact of influential KMRP publications, each 
paper’s citation impact index was computed to deter-
mine the single most highly cited article. The most 
commonly used measure is the calculation of the total 
number of citations of each paper since its publication. 
However, according to Holsapple, Johnson, Manakyan, 
and Tanner (1994), the weakness of this method is that 
it does not consider the publication date of the article. 
It will provide the same score to two publications that 
are cited the same number of times even if they are pub-
lished in different years, although the most recent of 
them would have a higher average number of citations 
per year. This suggests that the latter publication has 
had a higher contribution to the field having achieved 
the same number of citations in a shorter time period, 
an aspect which the traditional citation index overlooks. 
To overcome this drawback, Holsapple et al. (1994) pro-
pose the use of Normalised Citation Impact Index (NCII) 
which accounts for the paper’s longevity thus reflecting 
the relative contribution of each article. It is calculated 
by dividing the number of times the article has been 
Table 1. Research framework.
Theme Variables
Productivity •  Number of authors – Single vs. multiple authors
•  Affiliation of author – Academic vs. Practitioner
•  Country of residence – where the author is based, not where the work was conducted
Research method •  Case study
•  Interviews
•  Literature review
•  Modelling tools
•  Surveys
•  Other qualitative – e.g., Focus groups, Delphi, site observation, action research, con-
tent analysis, ethnography
Includes data collection method, more than one can be selected
Research Topic •  Intellectual capital
•  Innovation
•  Organisational learning
•  Culture and Social issues (social capital)
•  Performance management
•  Information system
•  Communities of practice
•  Knowledge measurement
•  Knowledge philosophy/ontology
•  Other knowledge management
•  Knowledge sharing
•  Knowledge transfer
•  Knowledge creation
•  Knowledge process
•  Knowledge acquisition
•  Knowledge exchange
•  Use of knowledge
•  Knowledge audit
•  Other
Most prominent topic in the paper, more than one can be selected
Technology adoption •  Use of Technology (yes/no)
Type of KM Technology:•  Knowledge management system
•  Internet
•  Communication technology
•  Wiki




•  Decision support systems
•  Other
Referencing •  Number of citations from Google Scholar database
•  Keywords
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the contribution of practitioners and academic authors 
and no statistically significant difference is found 
between the results of both methods (p-value = 0.592).
4.3. Country productivity and GDP
In order to identify the leading countries in the KM 
field, the relative contributions of 57 countries whose 
papers are published in the KMRP are traced and ranked 
using both the Equal Credit and Direct Count meth-
ods. Similar results from both methods are obtained 
and the Pareto Principle or “The Law of Vital Few” is 
heavily observed (Pareto, 1971). The majority of pub-
lications originate from roughly 20% of participating 
countries as shown in Figure 3 and Table 4. To confirm 
the findings, the number of citations from each country 
is counted using the NCII method for all the countries. 
The same countries of the highest contribution to the 
journal are found to be on the top of the articles citation 
list. Statistical analysis also revealed a moderate positive 
correlation (0.559) between the country Gross Domestic 
Product (GDP) and contribution to KM research.
4.4. Institutional productivity
When examining institutional productivity, Equal 
Credit is the method of choice for organisations as well. 
Analysis revealed that, to-date, more than 400 unique 
referenced by the number of years the article has been 
available [NCII = Total Citations (count)/Longevity in 
years]. The NCII method is hence adopted in this study 
in order to provide more reliable results. Individual arti-
cle citations obtained from the Google Scholar database 
are used to compute the NCII for each article and pub-
lications are ranked in descending order according to 
their indices.
Finally, author keywords were extracted from the 
review pool using the open-source bibliography refer-
ence software JabRef. Keywords were then electronically 
sorted and counted as a part of trend analysis.
4. Findings
In an attempt to identify the trends within the current 
sample, the analysis results are presented over two time 
periods (2003–2008) and (2009–2015). This format 
helps to highlight the major changes in the nature of 
research work published in the journal over its lifetime.
4.1. Authorship trends
The average number of authors within the sample is 2.28 
authors per paper, however, a growing trend towards 
multi-authored papers is evident. While the average 
paper authorship in the first time period (2003–2008) 
is 1.96 authors per paper, it increased to 2.46 authors 
per paper in the second time period (2009–2015). The 
median number of authors has also increased from two 
to three after 2013 (Table 3). The percentage of single 
authored papers dropped from 40% in 2003–2008 to less 
than 20% in 2009–2015, whereas papers with two, three, 
and four authors witnessed significant increases of 1.5, 
8.5, and 9.8%, respectively, (Figure 1). This confirms the 
findings of Akhavan, Ebrahim, Fetrati, and Pezeshkan 
(2016) who observe a decline in single-authored works 
over time and the emergence of collaboration patterns 
among KM scholars.
4.2. Author affiliations
From an affiliation perspective, more than 90% of 
authors have an academic background and are in direct 
affiliation with educational and/or research institutions 
(Figure 2). The remaining 10% of authors are practition-
ers from service or industrial sectors. Both the Direct 
Count and Equal Credit methods are used to compute 
Table 3. Co-authorship Distribution – Number of Authors.
Year 2003 2004 2005 2006 2007 2008 2009
Mean 1.78 1.93 1.61 2.07 2.32 1.86 2.18
Median 2 2 1 2 2 2 2
Year 2010 2011 2012 2013 2014 2015
Mean 2.34 2.48 2.34 2.48 2.83 2.58








































E.Credit count ( Academic Authors)
E.Credit count ( Practitioner Authors)
Figure 2. Author affiliation.
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mild to moderate increase in published empirical stud-
ies, both quantitative and qualitative, is observed in the 
second review time period (2009–2015) in comparison to 
conceptual models and literature reviews which are prev-
alent in the first review period (Figure 4). Nevertheless, 
modelling tools and frameworks are still the most used 
methodology by KMRP researchers, followed by case 
studies.
4.6. Industrial sectors
Expanding on the findings from the previous section, 
articles were thoroughly surveyed for industries which 
are selected as research fields. While 33% of studies are 
classified as conceptual studies and thus have no indus-
tries, the other two-thirds are conducted in more than 
57 different industries and service sectors. Moreover, 
15% of papers do not specify a single sector used in data 
collection. Instead, a mixture of different businesses is 
used as a non-industry specific convenience sample. This 
is expected since researchers often tend to gather data 
institutions have published articles in the KMRP. The 
noticeable finding is the minimal variation among indi-
vidual contributions of each institution where no sin-
gle institution dominates publications in the journal as 
shown in Table 5 (range = 3.8, standard deviation = 0.65). 
By the same token, the top fifth of contributions comes 
from more than 27 different institutions. It is also noted 
that two-thirds of papers are the product of a single 
institution and 38.6% of the papers are the outcome of 
multi-institutional collaboration. Furthermore, the top 
20% contributors are all academic organisations, which 
coincide with the prevalence of academic authorship as 
previously mentioned.
4.5. Research methods
Research methods can be described as all the data collec-
tion and analysis techniques that are used for conduction 
of research activities to solve research problems (Kothari, 
2004). Nearly half of the articles (47%) utilised a single 
method, while the rest of articles used two or more. A 
Figure 3. Country productivity (equal credit score). 
Source: Authors.
Table 4. Country productivity ranking.
Rank
Equal credit method Direct count method NCII
Country Percentage Country Percentage Country Percentage
1 UK 13.76 UK 12.74 UK 12.92
2 USA 12.37 USA 12.02 USA 12.52
3 Australia 8.13 Spain 7.69 Japan 8.95
4 Spain 7.94 Australia 7.69 Spain 7.67
5 France 5.89 Italy 5.53 Canada 7.49
6 Italy 5.81 France 5.05 Italy 6.74
7 Taiwan 4.93 Canada 4.81 Finland 4.25
8 Canada 4.29 Taiwan 4.09 Germany 4.14
9 Germany 3.91 Germany 3.85 France 4.10
10 Rest of the world 32.95 Rest of the world 36.54 Rest of the world 31.22
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4.7. Research themes
Two approaches are adopted to identify the common 
research themes within the KMRP body of literature. 
First, two researchers qualitatively categorised the papers 
according to their research topic as explained in the 
review framework. A counter review of the same papers 
by the other researcher was used to confirm the cate-
gorisation of each paper under a single theme. In cases 
where researchers coded a paper differently, the article 
was jointly reviewed by both researchers until a classifi-
cation is agreed, or third opinion was sought. Secondly, 
a quantitative keywords analysis is used in parallel in 
order to compare the findings of the thematic analysis.
Results show that 61% of research papers falls within 
five topics; (1) Knowledge Sharing, (2) Intellectual 
from companies in their network and the ones that they 
have access to.
Moreover, research and education institutions are on 
the top of the popularity list. Approximately 12% of the 
studies are conducted either within universities, research 
labs and/or rely on the classroom as a case study. Once 
again, this could be simply attributed to convenience. 
Information and Communication Technologies (ICT), 
Healthcare, and High-Tech firms come in the second, 
third, and fourth places, respectively. Nonetheless, some 
knowledge-intensive industries such as Pharmaceuticals, 
Aerospace, and Energy have not received adequate atten-
tion in industry-specific publications. Table 6 illustrates 
the main industry/service sectors in the articles and their 
relative percentage.
Table 5. Institutional productivity.
Rank Institution Equal credit Percentage Cumulative sum (%)
1 National Technical University of 
Athens
3.999 1.16 1.16
2 University of Sydney 3.999 1.16 2.33
3 Tampere University of Technology 3.998 1.16 3.49
4 Queens University 3.916 1.14 4.63
5 University of Southampton 3.5 1.02 5.64
6 University of Hull 3.166 0.92 6.56
7 National Taiwan Ocean University 3 0.87 7.44
8 Universidad Computense de Madrid 3 0.87 8.31
9 University of Sao Paulo 3 0.87 9.18
10 Politecnico di Milano 2.75 0.80 9.98
11 Hitotsubashi University 2.5 0.73 10.71
12 University of South Australia 2.5 0.73 11.43
13 University of Southern Queensland 2.499 0.73 12.16
14 Kingston University 2.333 0.68 12.84
15 University of Salento 2.333 0.68 13.52
16 University of Sheffield 2.333 0.68 14.19
17 Loughborough University 2.166 0.63 14.82
18 Bangkok University 2 0.58 15.40
19 Edith Cowan University 2 0.58 15.99
20 Politecnico di Bari 2 0.58 16.57
21 Robert Gordon University 2 0.58 17.15
22 Soochow University 2 0.58 17.73
23 University of Akureyri 2 0.58 18.31
24 University of Alicante 2 0.58 18.89
25 University of Castilla La Mancha 2 0.58 19.47
26 University of Melbourne 2 0.58 20.06
27 University of New South Wales 2 0.58 20.64
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thematic analysis outcomes of the previous section. It 
also elucidates the emphasis researchers have placed on 
the knowledge sharing process as a precursor of effec-
tive KM. Whether the objective is spreading best prac-
tice, disseminating innovative ideas, or creating digital 
repositories, sharing knowledge is often at the core of 
KM initiatives.
4.9. KM technology
The role of Information Technology (IT) in KM is widely 
discussed in the literature (Ragab & Arisha, 2013). A 
common view is that KM should not be reduced to a 
solely IT-based project as there is a tacit dimension of 
knowledge which cannot be managed using technolog-
ical tools (Chatzkel, 2007; Schiuma, 1998). IT is rather 
envisaged as an essential KM catalyst and an enabler of 
knowledge sharing processes within and between organ-
isations (Tsui, 2005). This view seems to be reinforced 
by scientometric figures as, overall, 91% of papers did 
not include reference to IT.
However, by contrasting the first review period 
(2003–2008) to the second (2009–2015) in regards to 
discussing technology, an increase from 4.2 to 11.6% 
is observed (Figure 7). This demonstrates a movement 
towards further integration of IT in KM. In this area, the 
Internet, Databases, and Social Media are the most pop-
ular IT solutions within the published papers, a trend 
in tandem with the digital revolution and the explosive 
growth of social networking (Figure 8).
4.10. Citation analysis
By examining citation frequency, three articles stand 
out as the most influential articles in the journal’s his-
tory based on their NCII (Table 7). It is noted that the 
top three articles gained 11.8% of the NCII score for all 
the articles and approximately 80% of citations came 
from the top 144 articles (≈40%). Interestingly, the most 
Capital, (3) Knowledge Creation, (4) Knowledge 
Transfer, and (5) Culture. Some research themes indi-
cate significant growth in the second review time 
period (2009–2015) in comparison to the first period 
(2003–2008). For example, there is a growing interest 
in Intellectual Capital, Knowledge Transfer, Innovation 
and Culture, while issues such as Knowledge Creation, 
Knowledge Measurement, Organisational Learning, 
Information Systems, Communities of Practice have 
received less interest (Figure 5).
4.8. Keyword analysis
A comprehensive keyword analysis of KMRP articles 
between 2003 and 2012 undertaken by Ribière and 
Walter (2013) demonstrate that Knowledge Sharing is 
the most used keyword in the journal. A similar exer-
cise extending until 2015 conducted in this research 
unsurprisingly yielded the same outcome (Figure 6). 
The predominance of Knowledge Sharing as a keyword, 
as well as a research theme, confirms the validity of the 
Table 6. Industrial sectors.
Rank Industry %
1 Multi Sectoral 14.8




6 Civic Society 2.3







14 Metal industry 1.2




19 Other industries 13.1
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capacity of an organisation to create value is tied to its 
ability to identify, manage, and renew its key knowl-
edge assets (Stewart & Ruckdeschel, 1998). The jour-
nal of Knowledge Management Research and Practice 
(KMRP) depicts one of the key scientific outlets that has 
significantly contributed to the development of main 
research streams in the field of KM. KMRP publica-
tions have paid considerable attention to models, tools, 
cited article is authored by renowned KM thinker Ikujiro 
Nonaka and extends on his SECI model (Nonaka, 1994) 
of knowledge creation, which is regarded as one of the 
most seminal and highly-cited theories in the history of 
KM at large, cited 21,360 times.
5. Implications and conclusion
In a global economy of knowledge-intensive nature, KM 
efforts have become a necessity for any organisation to 
survive and prosper (Davenport & Prusak, 1998). The 
Figure 6. Keyword analysis.
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to support the movement towards the development of 
applied KM solutions.
While this study encompasses a multitude of research 
topics, knowledge sharing emerges as the leading choice 
of researchers. Along the same line, knowledge sharing 
technologies (e.g., internet and social media) are the 
leading IT solutions employed to support the KM pro-
cess. The prevalence of the knowledge sharing theme 
elucidates the emphasis researchers have placed on the 
knowledge sharing process as a precursor of effective 
KM. Whether the objective is spreading best practice, 
cultivating and disseminating innovative ideas, or cre-
ating digital repositories, sharing knowledge is often at 
the core of KM initiatives. KM work often focuses on the 
role of knowledge flows among individuals and between 
individuals and the organisation to drive value creation 
(Bolisani & Oltramari, 2012; Schiuma, 2006). It is hence 
not surprising that the most influential article published 
by the journal extends Nonaka’s work on the SECI Model, 
a fundamental theory of knowledge creation and sharing 
antecedents within organisations.
Furthermore, statistical analysis has revealed a cor-
relation between KM research activity and economic 
prosperity as the leading contributing countries are in 
North America, Western Europe, and Australia. The 
link between the focus on knowledge and national 
wealth reinforces the theory established by Drucker 
(1994) in his discussion of the post-Second World 
War (WWII) economic transformations from goods to 
intangibles in what is dubbed today as the Knowledge 
Economy. Nevertheless, from an industry perspective, 
key knowledge-intensive industries remain underrepre-
sented in KM research. This could be considered as an 
opportunity for future researches to direct their efforts 
towards such relatively under-published sectors. The 
fact that most KM research is conducted in education 
and research institutions could be simply attributed to 
convenience. Researchers often find access within their 
own organisations, or in similar academic ones, more 
feasible than the challenge of penetrating new industries 
to obtain data. Unless sectorial comparison is sought, 
limited access could also explain why 15% of authors 
opted to gather data from multiple sectors within the 
same study.
In conclusion, this study provides evidence that the 
field of KM is reaching maturity which poses at least two 
challenges. Firstly, the need to identify key future trends 
of research development in the field, and second, the 
factors, and mechanisms that can support managers in 
translating knowledge into business performance. After 
almost 15 years since the foundation of KMRP by the 
Operations Research Society, the scientometric analysis 
in this study portrays a comprehensive picture of the 
growth, structure, interrelationships, and productivity 
of the published research activities within the journal.
Initially, the study elucidates an increasing trend 
towards multi-author collaboration especially in recent 
years. This posits an indication of the maturity of the KM 
domain where authors develop relationship networks 
and collaborate to overcome the current increasingly 
challenging journal acceptance rates. The findings are 
also in line with the broader bibliometric studies of Metz 
(1989) and Terry (1996) which report a general phe-
nomenon of progressive trends in co-authorship in other 
research disciplines. An additional indicator of maturity 
is represented in the findings of unbiased distribution of 
papers among a wide range of research and professional 
organisations. Over 400 institutions are involved in KM 
research, either in individual or cooperative studies, 
emphasising the growing interests in knowledge-based 
research.
Looking at research methods, there is an increasing 
propensity towards empirical methods in contrast to a 
decrease in literature review studies. This is further sug-
gestive of maturity and an ongoing shift from theory to 
practice where field studies are increasingly undertaken 
to explore KM issues in real-life contexts and collect 
first hand data. This tendency seems to be a general 
trend in the KM field, as indicated by results of similar 
studies. For example, a recent content analysis of the 
proceedings of the European Conference of Knowledge 
Management (ECKM) between 2006 and 2013 revealed 
that model and framework development were the most 
favoured research method followed by case studies and 
questionnaires (Fteimi & Lehner, 2016). With respect 
to the contribution of practitioners, the study reveals 
it is academic authors and institutions who dominate 
publications with the percentage of practitioners aver-
aging around 10% over the years. Despite the apparent 
stability in the percentages of practitioners to academic 
authors in KMRP over the years (Figure 2), other studies 
have shown otherwise. A study by Serenko et al. (2009) 
revealed that the number of practitioners declined from 
approximately one third of all contributors in the late 
1990s to 10% by 2008. These findings suggest an impetus 
to deeper engagement of practitioners in KM research 
Table 7. Highest cited KMRP articles.
Author Title Year NCII
Nonaka, Ikujiro, and Toyama, Ryoko The Knowledge-Creating Theory Revisited: Knowledge Creation as a 
Synthesising Process
2003 77.1
Baskerville, Richard, and Dulipovici, Alina The Theoretical Foundations of Knowledge Management 2006 26.8
Usoro, Abel; Sharratt, Mark W; Tsui, Eric, and Shekhar, Sandhya Trust as an Antecedent to Knowledge Sharing in Virtual Communities 
of Practice
2007 18.8
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Garfield, E. (2009). From the science of science to 
Scientometrics visualizing the history of science with 
HistCite software. Journal of Informetrics, 3(3), 173–179. 
doi:10.1016/j.joi.2009.03.009
Holsapple, C. W., Johnson, L. E., Manakyan, H., & Tanner, J. 
(1994). Business computing research journals: A normalized 
citation analysis. Journal of Management Information Systems, 
11(1), 131–140. doi:10.1080/07421222.1994.11518033
Hood, W. W., & Wilson, C. S. (2001). The literature 
of bibliometrics, and informetrics scientometrics. 
Scientometrics, 52(2), 291–314.
Huang, T.-T. (Andrew), Chen, L., & Stewart, R. A. (2010). 
The moderating effect of knowledge sharing on the 
relationship between manufacturing activities and 
business performance. Knowledge Management Research 
& Practice, 8(4), 285–306. doi:10.1057/kmrp.2010.21
Jafari, A., & Kaufman, C. (2006). Handbook of research on 
ePortfolios. Calgary: Idea Group Inc.
Jesson, J., Matheson, L., & Lacey, F. M. (2011). Doing your 
literature review traditional and systematic techniques. 
Thousand Oaks, CA: Sage.
Kothari, C. R. (2004). Research methodology: Methods & 
techniques. New York, NY: New Age International (P) Ltd. 
doi:10.1017/CBO9781107415324.004
Lowry, P. B., Karuga, G. G., & Richardson, V. J. (2007). 
Assessing leading institutions, faculty, and articles 
in premier information systems research journals. 
Communications of the Association for Information 
Systems, 20(16), 142–203.
Ma, Z., & Yu, K.-H. (2010). Research paradigms of 
contemporary knowledge management studies: 1998–
2007. Journal of Knowledge Management, 14 (2), 175–189. 
doi:10.1108/13673271011032337
Metz, P. (1989). A statistical profile of College and Research 
Libraries. College and Research Libraries, 50(1), 42–47.
Moustaghfir, K., & Schiuma, G. (2013). Knowledge, learning, 
and innovation: Research and perspectives. Journal of 
Knowledge Management, 17(4), 495–510. doi:10.1108/
JKM-04-2013-0141
Nonaka, I. (1994). A dynamic theory of organizational 
knowledge creation. Organization Science, 5(1), 14–37.
Pareto, V. (1971). Manual of political economy. Macmillan.
Ragab, M. A. F., & Arisha, A. (2013). Knowledge management 
and measurement: A critical review. Journal of Knowledge 
Management, 17(6), 873–901. doi:10.1108/JKM-12-2012-
0381
Ribière, V., & Walter, C. (2013). 10 years of KM theory and 
practices. Knowledge Management Research Practice, 
11(1), 4–9. doi:10.1057/kmrp.2012.64
Roberts, J. (2009). The global knowledge economy in 
question. Critical Perspectives on International Business, 
5(4), 285–303. doi:10.1108/17422040911003033
Schiuma, G. (1998). Knowledge codification in industrial 
districts. In Proceeding of the Workshop on SMEs and 
Districts: Hybrid governance forms, knowledge creation and 
technology transfer, Castellanza, (October 2011) (pp. 5–7).
Schiuma, G. (2006). Assessing the value of international 
workers. Measuring Business Excellence. Emerald Group 
Publishing Limited, 10(1), mbe.2006.26710aaf.002. 
doi:10.1108/mbe.2006.26710aaf.002
Serenko, A., & Bontis, N. (2004). Meta-review of knowledge 
management and intellectual capital literature: Citation 
impact and research productivity rankings. Knowledge 
and Process Management, 11(3), 185. doi:10.1002/kpm.203
Serenko, A., & Bontis, N. (2009). Global ranking of 
knowledge management and intellectual capital academic 
journals. Journal of Knowledge Management, 13(1), 4–15. 
doi:10.1108/13673270910931125
need to conduct research of more applied nature. KMRP 
publishes both quantitative and qualitative papers, how-
ever, the discriminating factor to bear in mind is the 
relevance of the contribution to KM practice. Emphasis 
must be placed upon the consideration that while man-
agers are interested in knowledge and its management, 
it is often not for the sake of mere KM theories. Rather, 
their interest is rooted in the need to understand how 
organisational knowledge assets can be translated into 
drivers that positively impact and enhance business 
value creation mechanisms.
Limitation of this study lies in the fact that it encom-
passes only one single journal (i.e., KMRP). While 
KMRP is one of the most established periodic in the 
KM field, exclusion of others does not ensure the gen-
eralisability of findings across wider KM landscape. It 
is, therefore, recommended that a similar review frame-
work would be applied to other KM journals in future 
studies to enable comparison and validation of results 
garnered from this project.
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ABSTRACT
The pharmaceutical sector is one of the pillars of the world’s economy. A significant proportion 
of its value lies in intellectual assets generated through continuous innovation and lengthy 
development cycles within a strictly regulated environment. The purpose of this paper is to 
address the gap between knowledge management (KM) as an expanding academic discipline 
in the pharmaceutical industry and at the same time a growing regulatory expectation. 
A systematic review of 137 refereed KM articles revealed six empirical research themes in the 
pharmaceutical industry. In a subsequent step, the discovered themes and subthemes were 
compared with the extant regulatory expectations as explained in 128 regulatory guidelines. 
Findings shed the light on the gap between academic KM research and the current thinking of 
regulatory bodies. Some regulated knowledge processes were underrepresented in academic 
literature. The paper offers also novel insights and recommendations for future developments 
in academic research, regulations, and/or industry.
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1. Introduction
The acknowledgement of knowledge as a pivotal strate-
gic resource in the current smart economy has impelled 
considerable organisational change. This progressive 
movement by individuals and organisations to manage 
their intellectual assets developed into KM (Davenport 
& Völpel, 2001). The Pharmaceutical industry is not an 
exception to this trend, not only as a knowledge- 
intensive industry but also as a leading economic 
partner with transcendent investments in innovation 
and research. According to European Federation of 
Pharmaceutical Industries and Associations (EFPIA), 
The Pharmaceutical industry employs more than 
750,000 employees in Europe, 16% of them working in 
Pharmaceutical Research and Development (R&D) 
(EFPIA, 2018).
It is not strange that the significance of KM is also 
realised by major pharmaceutical regulatory authori-
ties. International Council for Harmonisation (ICH) 
recommends management of drug and process knowl-
edge from development and up to product disconti-
nuation as an enabler of effective quality management 
systems. From this perspective, KM creates the basis 
for the manufacturing process, control strategy, and 
ongoing continual improvement (ICH, 2009). On the 
other hand, there are some signs of regulatory imma-
turity of KM. The term “knowledge” is relatively new 
in regulatory publications and is routinely replaced by 
indirect words such as “science” or “product/process 
understanding” (Calnan et al., 2018). Moreover, KM 
is seen by ICH only as an enabler of The 
Pharmaceutical quality system (ICH, 2009).
Thus, as knowledge is another core product of 
the pharmaceutical industry (Riddell & Goodman, 
2014), managing stocks and flows of knowledge in 
this sector emerges as a key economic and regula-
tory objective as well as a growing area of academic 
research. Nonetheless, some knowledge-intensive 
industries such as pharmaceuticals have not 
received adequate attention in industry-specific 
publications (Ramy et al., 2017). This paper comes 
as a comprehensive industry-specific systematic 
review of KM literature between the academic 
research and regulatory expectations.
2. Review methodology
The high expectations of improving the quality of 
reviews through well-defined methodologies led to 
the development of systematic review protocols 
(Jesson et al., 2011). Systematic review protocol 
encompasses specific research questions, the popu-
lation that is the focus of the study, the search 
strategy, and terms for identification of the relevant 
studies. Studies that meet all inclusion criteria and 
manifest none of the exclusion criteria need to be 
integrated into the review (Davies & Crombie, 
1998; Tranfield et al., 2003). The authors com-
menced his review by identifying three research 
questions: 
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Q.1 How is the KM literature in pharmaceutical/bio-
pharmaceutical industry developing?
Q 2. What are the expectations of regulatory agencies 
with regard to the identified research themes?
Q 3. What is the future of KM research within the 
pharmaceutical industry?
After refining the review questions, the timeframe of 
review is set to be the last twenty years (1996–2016). 
This time period represents the prosperous period of 
KM research (Ragab and Arisha, 2013a). Furthermore, 
the timeframe took into account the relative novelty of 
online KM journals. According to Serenko and Bontis 
(2013) ranking of the KM journals, the top-ranked 
four KM journals (JKM, KMRP, IJKM, and JIC) have 
been published online only since 1997, 2003, 2005, and 
2000, respectively.
The criteria for inclusion comprise peer-reviewed 
electronic business journals in the English language 
retrieved from Emerald Insight and Science Direct data-
base (Table 1). Pharmaceuticals related search strings in 
the titles, keywords, or abstracts were used to identify 
the relevant articles. Search strings were synthesised by 
combining terms like “pharmaceutical” or “pharmaceu-
tical industry” with the most popular KM keywords 
(such as knowledge sharing, intellectual capital, knowl-
edge transfer, or innovation) extracted from two com-
prehensive keyword analysis studies in the KM 
discipline: Fteimi and Lehner (2016) along with 
Ribière and Walter (2013). After a brainstorming ses-
sion by the authors, potential search strings were 
approved. The list was updated during the search pro-
cess. It was meant not to tightly plan the review process 
as this may inhibit researchers’ capacity to explore, 
discover, and develop ideas (Tranfield et al., 2003).
After the exclusion of duplicates, Articles that 
have been retrieved from the search results were 
screened against the inclusion and exclusion criteria 
by reviewing the titles and abstracts (Pati & 
Lorusso, 2018). A full-text assessment followed 
where the full-text articles were scrutinised to assess 
relevance to the review questions. The retained 
articles addressed a KM related topic exclusively in 
the field of pharmaceutical industry or in conjunc-
tion with other industries. To mitigate the risk of 
bias of the reviewed studies (Moher et al., 2015), 
141 eligible articles were quality-assessed for the 
clarity of research objectives, adequacy of descrip-
tion of the data collection methods and finally the 
link between data, results, and conclusion as 
advised by Kitchenham and Charters (2007). Four 
articles were excluded at this stage due to ambigu-
ous methodology and irrelevance to pharmaceutical 
industry. Ultimately, only 137 articles were retained 
for analysis after application of inclusion/exclusion 
criteria and quality assessment. A limited number of 
non-business journal papers (e.g., medical journals) 
and papers identified through cross-referencing and 
hand searching were included (Figure 1).
After acknowledgement of main themes and pro-
cesses in KM literature; the identified themes were 
scrutinised in the regulatory guidelines of five major 
regulatory bodies. The reviewer collected all the pub-
lished guidelines for pharmaceutical industry on the 
official websites of World Health Organisation 
(WHO), FDA, ICH, The Pharmaceutical Inspection 
Convention and Pharmaceutical Inspection Co- 
operation Scheme (jointly referred to as PIC/S) and 
EudraLex- European Union (EU) Legislation. At the 
end, 128 guidelines were searched for KM related 
topics in light of the identified themes from academic 
literature review. The analysis was meant to recognise 
the significance of research themes from regulatory 




Initially, findings indicate that KM in the Pharma- 
ceutical industry has become a well-established aca-
demic research area. Authorship trends show that 
approximately 93% of articles are published by aca-
demic researchers, while the remaining 7% is the pro-
duct of practitioner work. Over the past ten years, 
a significant increase in collaborative research from 
62% to 85% is also evident. Among the articles which 
do specify the function under study (approx. 40%), 83% 
fall within pharmaceutical development and innovation 
functions in contrast to only 8% in production, 4% in 
sales and 4% in supply chain. In order to identify the 
leading countries in the KM field, the relative contribu-
tions of 36 countries whose papers were included in this 
review are traced and ranked using the Equal Credit 
counting method (Chua & Cousins, 2002; Lowry et al., 
Table 1. Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
KM theories and processes Not related to KM
With applications in pharmaceutical industry Applied exclusively in other industries
Peer reviewed journal articles Editorials and position papers
In English language Articles that use languages other than English
Published online between 1996 and 2016 From journals that don’t have online domains and unpublished work.
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2007). The USA and UK were ranked highest with 
regards to productivity (18% and 11%, respectively, of 
all reviewed articles); followed by Iran (7%), Australia 
(7%) and India (6%). It is worth noting that country 
contribution in this research addresses the country of 
residence of the author not necessarily where the 
research was held (Figure 2).
In terms of methodology, only 29% of the articles 
adopt literature review as the research strategy; while 
over 70% are empirical studies employing one or more 
data collection methods, e.g., surveys (29%), case stu-
dies (10%) and interviews (17%).
3.2. Research themes
A hybrid method of quantitative keyword analysis 
and qualitative thematic analysis is proposed to 
identify the common research topics or themes. The 
most frequent themes and keywords (after exclusion 
of generic keywords, e.g., knowledge management, 
pharmaceutical . . ., etc..) are presented in (Table 2).
The identified themes and keywords offer a birds-eye 
view of the KM landscape. The paper presents 
a classification of KM publications into six areas: knowl-
edge sharing and technology transfer, Intellectual 
Property Protection (IPP), knowledge measurement 
and Intellectual capital (IC) reporting, innovation and 
knowledge creation (KC), organisational knowledge cul-
ture and structure as well as Pharmaceutical firm perfor-
mance (Figure 3). The rest of articles falls in 
miscellaneous category that includes other themes such 
as: organisational learning, knowledge management 
maturity, data mining, etc. Table 3 presents the key 
articles under each of the featured themes.
Records identified through 
database searching (n=2046)
Additional records identified 
through other sources (n=18)
Records after duplicates removed 
(n= 1359)







and quality (n= 141)






















Figure 1. Systematic review process – PRISMA flow diagram (Moher et al., 2015).
Figure 2. Country productivity.
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Table 2. Themes and keyword analysis.
Rank Themes & K. processes Frequency Keywords Frequency
1 Intellectual Capital 29 Intellectual Capital 27
2 Innovation 25 Innovation 18
3 Knowledge Transfer 14 Knowledge Sharing 10
4 Knowledge Sharing 13 Knowledge Transfer 10
5 Organisational Performance 12 New Product Development 9
6 Organisational Culture 12 Research and Development 9
7 Intellectual Property 10 Intangible Assets 8
8 Knowledge Creation 9 Organisational Learning 7
9 New Product Development 6 Organisational Culture 5
10 Organisational Learning 6 Project Management 5
Figure 3. Literature map.
Table 3. Key articles under the featured themes.
Category
Knowledge Sharing and Technology 
Transfer
(Wakefield, 2005); (Styhre et al., 2008); (Qureshi & Evans, 2015); (Akhavan et al., 2015); (Pedroso & Nakano, 2009); 
(Mets, 2006); (Lilleoere & Hansen, 2011); (Lawson & Potter, 2012); (Hemmert, 2004); (Gray et al., 2011); (Dooley 
& Kirk, 2007); (Delaney, 1999); (Criscuolo, 2005); (Coradi et al., 2015); (Chávez & Víquez, 2015); (Brachos et al. 
2007); (Bourouni et al., 2015); (Azan and Huber Sutter 2010); (Allen et al., 2016); (Santos, 2003); (Mohan, Jain, 
and Ramesh 2007); (Malik, 2012); (Iwasa and Odagiri 2004); (Filieri et al. 2014); (Chang, Yeh, and Yeh 2007); 
(Buchel et al. 2013); (Bourouni et al., 2015)
Pharmaceutical Firm Performance (Mehralian et al. 2012); (Malik, 2012); (Kim et al., 2014); (Vishnu & Gupta, 2014); (SubbaNarasimha et al., 2003); 
(Sharabati et al., 2010); (Pal & Soriya, 2012); (Kamath, 2008); (Garcia Morales et al., 2008); (Bollen et al., 2005)
Research, Innovation and 
Knowledge Creation
(Terziovski and Morgan 2006); (Styhre et al., 2002); (Sternitzke, 2010); (Standing and Kiniti 2011); (Sharma and 
Goswami 2009); (Roth, 2003); (Parisi and Hockerts 2008); (Palacios-Marqués, Popa, and Mari 2016); (O’Dwyer 
et al. 2015); (Nightingale, 2000); (Mehralian et al. 2014); (Lowman et al., 2012); (Lauto and Valentin 2016); 
(Kneller, 2003); (Khemka & Gautam, 2010); (Kazadi, Lievens, and Mahr 2015); Kale & Little, 2005; Huang, 2011; 
Hohberger, 2016; (Herrmann and Peine 2011); (van Geenhuizen and Reyes-Gonzalez 2007); (Gassmann & 
Reepmeyer, 2005); (Garcia Morales et al., 2008); (Filieri et al. 2014); (Chen, Jiao, and Zhao 2008); (Chang et al. 
2007); (Cardinal & Hatfield, 2000); (Styhre et al., 2008); (Mets, 2006); (Lowman et al., 2012); (Lauto and Valentin 
2016); (Kazadi et al. 2015); (Gassmann & Reepmeyer, 2005); (Cardinal & Hatfield, 2000); (Boasson and Boasson 
2015); (Mohan et al. 2007)
Intellectual Property Protection (Yang et al. 2014); (Iwasa and Odagiri 2004); (Boasson and Boasson 2015); (Allarakhia & Walsh, 2011); (Sternitzke, 
2010); (Kale and Little 2005); (Hohberger, 2016); (Chávez & Víquez, 2015); (Russell 2016); (Bollen et al., 2005)
Knowledge Culture and 
Organisational Structure
(Wang, Ashleigh, and Meyer 2006); (Mehralian et al., 2016); (Magnier-Watanabe & Senoo, 2008); (Magnier- 
Watanabe & Senoo, 2010); (Magnier-Watanabe et al., 2011); (Magnier-Watanabe & Senoo, 2009); (Lindner & 
Wald, 2011); (Guzman, 2008); (Evans & Brooks, 2005); (Ebrahimi et al., 2008); (Bigliardi et al., 2012); (Filieri et al. 
2014)
Knowledge Measurement and IC 
Disclosure
(Vishnu & Gupta, 2014); (Tahvanainen and Hermans 2005); (SubbaNarasimha et al., 2003); (Singh & Kansal, 2011); 
(Sharabati et al., 2010); (Palacios-Marques & Garrigos-Simon, 2003); (Pal & Soriya, 2012); Narula, 2016; 
Naidenova &Parshakov, 2013; (Mehralian et al. 2013); (Mehralian et al. 2013); (Kamath, 2008); (Huang and Wu 
2010); (Hine, Helmersson, and Mattsson 2008); (Ghosh & Mondal, 2009); (Erickson & Rothberg, 2009); (Hosein 
Chizari et al., 2016); (Bollen et al., 2005); (Boekestein, 2006); (Boekestein, 2009); (Abhayawansa & Azim, 2014); 
(Sydler et al., 2014); (Russell, 2016); (Rossi et al., 2015); (Nito, 2005); (Mehralian et al. 2012); (Mehralian et al. 
2014); (Huang et al., 2011)
4 A. RAMY ET AL.
3.3. Publication years
The review shows that the majority of included articles 
have been published between 2004 and 2016 as shown 
in (Table 4).
3.4. Knowledge Sharing (KS) and technology 
transfer
More than 19% of reviewed articles addressed knowl-
edge sharing and transfer signifying that Knowledge 
transfer (KT) holds a special significance in the 
Pharmaceutical industry. Therefore, the WHO dedi-
cates Annex 7 of Technical Report Series no.961 to 
discuss dynamics and controls of technology transfer 
occurring at some stage in the lifecycle of most pro-
ducts in the pharma industry. However, the real sig-
nificance of KS comes from the fact that it is the 
component that facilitates continuous knowledge 
creation (Akhavan et al., 2012) and is a key driver of 
long-term success in a knowledge-intensive organisa-
tion (Coradi et al., 2015). Accordingly, Qureshi and 
Evans (2015) identify nine categories of deterrents of 
KS in the pharmaceutical organisation. They can be 
broadly classified as either structural barriers, cultural 
barriers, or managerial barriers.
Other studies focused on the attitudes necessary to 
enhance knowledge sharing (Akhavan et al., 2015). 
Also, Knowledge Networks (KN) are increasingly con-
sidered vital channels to achieve strategic objectives in 
project-based organisations particularly Pharma R&D 
(Bourouni et al., 2015). By the same token, structural 
indexing and knowledge dictionaries can identify 
knowledge agents and evaluate intra-organisational 
knowledge sharing. Enhancing knowledge flow 
among R&D stages can be crucial to shorten the pro-
duct to market timing (Wakefield, 2005).
As physical proximity is one of the suggested bar-
riers for Knowledge Sharing and Technology Transfer 
(Lilleoere & Hansen, 2011), several studies handle this 
topic in pharma explicitly. For instance, studies con-
ducted in the R&D department of multinational drug 
manufacturer Novartis reveal that co-location of dis-
persed project teams leads to faster and more precise 
flow of knowledge (Coradi et al., 2015).
On a macro scale, an equally significant aspect of 
inter-organisational KS is geographic distribution. 
Higher quality risk can accompany offshore manufac-
turing due to challenges of KT from headquarters 
(Gray et al., 2011). Pharmaceutical firm location is 
found to influence the intensity of communication 
between different firms but not the innovation. 
Relocation (e.g., into industry clusters) and expensive 
real estate investments can be replaced by enhancing 
the social connections through technology (Allen 
et al., 2016). In spite of that, having an R&D laboratory 
near corporate headquarter enhances new drug pro-
ductivity as proximity is necessary for the integration 
of R&D with other functions (Cardinal & Hatfield, 
2000).
3.5. Intellectual Propriety Protection (IPP)
There is no industry where firms build their competi-
tive advantage more closely to IPP than the pharma-
ceutical industry. However, in response to dramatic 
transitions in bioscience and computational chemis-
try, biopharmaceutical companies commence newer 
approaches for managing their IP and innovation 
including open access, exclusive and non-exclusive 
licencing (Allarakhia & Walsh, 2011). Although the 
exclusive licencing is more preferred in the pharma-
ceutical industry (2:1), non-exclusive licencing pro-
vides a strategic advantage to the company and 























2000 3 1 4
2001
2002 1 1 2
2003 2 1 1 2 1 7
2004 1 2 5 8
2005 2 1 3 2 1 3 5 17
2006 1 1 1 2 2 7
2007 4 3 4 11
2008 3 2 1 2 4 9 21
2009 1 4 1 1 3 10
2010 1 1 2 1 1 2 2 10
2011 1 2 2 2 3 3 13
2012 1 2 2 3 2 1 11
2013 3 1 3 7
2014 1 1 4 1 2 2 4 15
2015 2 1 6 4 3 16
2016 2 1 3 1 4 3 14
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reduces market uncertainty by decreasing competition 
(Malik, 2012).
The real significance of IP for the pharmaceutical 
industry comes from the belief that patents are used as 
a proxy indicator of knowledge creation (Nerkar, 
2003). Also, patent citations studies in pharma exploit 
patent-related data to estimate the quality of innova-
tion, diffusion of knowledge and geographic localisa-
tion of knowledge (Chávez & Víquez, 2015). For this 
reason, patents can affirm firm’s value and market 
performance. Association between company value, 
reported intangible assets and R&D capitals is proven 
(Russell, 2016).
In a highly dynamic global economy, enforcing IP 
protection laws implies significant costs particularly 
on developing economies (Mazzoleni & Nelson, 1998). 
Nevertheless, IPP is an important incentive for inno-
vation in advanced countries enjoying both a superior 
technological infrastructure as well as a rich market 
for new drug (WHO, 2006a).
3.6. Knowledge measurement and IC disclosure
Empirical evidence supports the notion that the nature 
and value of knowledge assets differ from industry to 
another with a direct impact on investment decisions. 
By using Tobin’s Q model for knowledge measurement, 
it is noticed that not only the level of intellectual capital 
(IC) and competitive intelligence are both higher in 
consumer industries (such as pharmaceuticals) in com-
parison to business to business industries, but also 
investments in knowledge assets are more promising 
(Erickson & Rothberg, 2009). Measurement of pharma-
ceutical IC at organisational level relies on the identifi-
cation of most relevant constructs or indicators in each 
industry (Palacios-Marques & Garrigos-Simon, 2003). 
For example, management experience and technical 
knowledge are on the top of HC indicators in pharma. 
Regarding structural capital, organisational culture, the 
ratio of investment in R&D and the number of R&D 
projects are the highest priority indicators. Additionally, 
mutual trust with customers and their satisfaction are 
the highest priority RC indicators (Mehralian et al., 
2013).
However, the disclosure of IC in balance sheet (BS) 
is still a measurement barrier and an opportunity for 
improvement in the pharmaceutical industry, particu-
larly in developing countries. The lack of standardised 
accounting guidelines on this vital asset results in 
unreporting of resources of billions in firm’s annual 
reports with an impact on their performance in the 
stock market (Abhayawansa & Azim, 2014).
Intellectual capital is widely adopted as a predictor 
for firm’s profitability in pharmaceutical sector (Sydler 
et al., 2014). Healthcare patents reflect firm’s innova-
tive capabilities and enhance the capacity to raise 
necessary start-up capital (WHO, 2006a). However, 
no significant relationship was observed either 
between IC and productivity or market valuation 
(Ghosh & Mondal, 2009; Pal & Soriya, 2012). This 
argument is subject to controversy as companies 
which generate more profits are able to invest more 
in IC (Naidenova & Parshakov, 2013).
In the pharmaceutical industry, Merger and 
Acquisition (M&A) is used as a cost-effective way to 
gain access to new product platforms, technologies 
and patents; traditional pharmaceutical companies 
with dried-out research pipelines but sufficient cash 
acquire innovative biotech firm as a source of new 
products (Rossi et al., 2015). M&A can be seen as an 
opportunity to overcome the underestimation of 
intangible assets under current accounting systems in 
pharma companies (Boekestein, 2009).
3.7. Research, innovation, and Knowledge 
Creation (KC)
The emergence of new discoveries in the twenty-first 
century will urge Pharmaceutical manufacturing to 
employ innovation and cutting-edge technology as 
ways of doing business (FDA, 2004b). Nowadays, 
pharmaceutical industries do not typically fit to the 
classic economy of scales theories as they transformed 
into R&D intensive rather than production intensive 
(Gassmann & Reepmeyer, 2005). Pharmaceutical 
industry becomes more than other industries depen-
dent on scientific advances, particularly in basic 
sciences, developed in public sector (Sternitzke, 
2010). Historically, public sector role in drug discov-
ery was limited to basic research to elucidate the basic 
pathological mechanisms. However, this role has sig-
nificantly expanded in the biotechnology era (Stevens 
et al., 2011). In contrast with publically funded drug 
research model in EU and US universities, it is noticed 
that drug discovery in Japanese companies occurs 
predominately in-house which may be no longer com-
patible with global competitiveness (Kneller, 2003).
In such a complex R&D environment, information 
sharing and intrinsic motivation are recognised as 
important drivers for organisational creativity 
(Sundgren et al., 2005). There is a significant influence 
of knowledge transfer on firm innovative capability 
(r = 0.893) too (Palacios-Marqués et al., 2016). As 
the bulk costs of R&D come from the clinical phases, 
sharing knowledge and experiences coming from ter-
minated projects would be of high significance (Styhre 
et al., 2008).
Surveyed literature highlights some of the dynamics of 
innovation within pharma organisation. Management 
support and effective management of knowledge are 
found indispensable if the organisation wants to adopt 
an innovative environment. Additionally, Job satisfaction 
explains up to 25% of the variance in innovation 
regression models (Khemka & Gautam, 2010). 
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Transformational leadership shows a positive relation-
ship with innovation (Garcia Morales et al., 2008). Also, 
a significant positive relationship is established between 
organisation capital and innovation confirming the 
remarkable role of intangible assets in generation and 
enhancement of innovative capabilities (Huang et al., 
2011).
Conversely, outsourcing of R&D and clinical stu-
dies for new product development (NPD) and the 
associated knowledge losses as well as regulatory 
delays create innovation risks (Lowman et al., 2012). 
Likewise, FDA warned from the threats of broad inter-
pretations of 21 CFR part 11 (electronic records and 
electronic signatures) on innovation and technological 
advances without any benefit for patient health (FDA, 
2003).
3.8. Knowledge culture and organisational 
structure
FDA encourages management to implement quality 
systems and procedures that support a communicative 
culture. Under such work culture, employee sugges-
tions are appreciated and used for continual improve-
ment (FDA, 2006). Along the same line, beliefs and 
knowledge-related values (love, care and trust) can be 
potential sources of competitive advantages in pharma 
(Magnier-Watanabe & Senoo, 2009).
Knowledge culture is a way of organisational life that 
empowers people to create, share, and use knowledge 
for the good of the organisation (Oliver & Kandadi, 
2006). In the pharmaceutical industry, knowledge cul-
ture is believed to compensate for the lack of organisa-
tion memory in temporary project teams where 
information Communication Technology (ICT) sys-
tems are not enough alone for ensuring the exchange 
of knowledge (Evans & Brooks, 2005; Lindner & Wald, 
2011). Organisation memory held by ageing workers 
can be transferred to the younger workers through 
bridges of socialisation and adequate organisational 
climate (Ebrahimi et al., 2008).
Organisational characteristics of pharmaceutical 
firm such as structure and strategy affect knowledge 
acquisition activities including knowledge storage, dif-
fusion, and application (Magnier-Watanabe & Senoo, 
2008). In fact, organisational characteristics can have 
even more influence over KM than national culture 
(Magnier-Watanabe & Senoo, 2010). For example, 
open culture where employees can raise questions 
and feel at ease explains 31% of the variance in four 
modes of SECI process compared to only 16% for 
bureaucratic culture (Magnier-Watanabe et al., 
2011). In pharmaceutical R&D, bureaucratic culture 
has a negative impact on knowledge workers’ job 
satisfaction while innovative or supportive culture 
positively influences them (Bigliardi et al., 2012).
3.9. Pharmaceutical firm performance
Human and Relational Capital is deemed to positively 
impact business performance of the pharmaceutical 
firm (Sharabati et al., 2010). Several empirical studies 
have underlined this paradigm utilising either return 
on asset (ROA) as performance measures (Vishnu & 
Gupta, 2014); whereas, Value Added Intellectual 
Coefficient (VAIC) (Chizari et al., 2016) or generation 
of new patents were used as proxies for technical 
knowledge of firms (SubbaNarasimha et al., 2003). 
Even more striking is the fact that each of the three 
components of IC is not only individually related to 
firm performance, but also they collaborate together in 
the way they influence firm performance (Bollen et al., 
2005). KM performance is considered as a predictor of 
superior financial performance in terms of higher 
profit ratios (ROA, ROS) and lower cost ratios 
(OPEX) (Holsapple & Wu, 2011).
KM strategies can influence organisational perfor-
mance in pharma. Information system maturity in the 
pharmaceutical firm as well as knowledge intensity 
would be the determinants for the most effective KM 
strategy (Kim et al., 2014). Internal organisational 
tensions between tacit-oriented and explicit-oriented 
strategies, which are difficult to reconcile, would nega-
tively impact the performance (Choi et al., 2008).
3.10. Regulatory insights
A thorough exploration of KM in 128 Good Practice 
(GxP) quality guidelines (Table 5) has revealed 
a slightly different pattern of interests and expecta-
tions in comparison with the academic business jour-
nals (Figure 4).
An overview of the current thinking and expecta-
tions of key regulatory bodies regarding KM is pre-
sented as follow:
3.11. ICH
From the previous review sections, KM expresses 
a considerable level of maturity as an academic 
research field in the pharmaceutical industry. Despite 
that, KM shows less mature roles at industry level 
which might hinder the achievement of ICH Q10 
desired state (Calnan et al., 2018). KM received mea-
gre attention by regulatory agencies (Rathore et al., 
2017). For instance, ICH Q10 considers KM together 
with QRM as the enablers of its effective implementa-
tion throughout the product lifecycle. Proper imple-
mentation of ICH Q10 guidelines is deemed necessary 
for innovation and continual improvement and 
strengthening the link between pharmaceutical devel-
opment and manufacturing activities. Last but not 
least, ICH Q10 suggests monitoring of all innovations 
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that might enhance QMS (ICH, 2008). Other ICH 
guidelines refer sporadically to KM with a focus on 
KS/KT. ICH Q9 suggested the need for further studies 
related to technology transfer should be assessed 
through QRM (ICH, 2005). ICH Q11 endorses the 
management and sharing of product/process-related 
d knowledge throughout product lifecycle including 
knowledge related to drug substance and its manufac-
turing process. This is supposed to enhance the man-
ufacturing process and establish a control strategy 
especially in cases of product ownership changes.
3.12. WHO
For the purpose of earlier detection of potential pro-
blems, WHO guidelines pay close attention to regula-
tory harmonisation and participation in information 
(e.g., from inspections and clinical studies) sharing 
networks among regulatory agencies with special con-
siderations to confidentiality and intellectual property 
issues (e.g., WHO, 1999, 2003, 2017). Parallel efforts 
are exerted to contain escalating costs of drug prices 
by minimising duplication of inspection activities 
through: better networking, enhanced collaboration, 
and increased mutual trust (WHO, 1999). Information 
sharing efforts with the European Directorate for the 
Quality of Medicines & Healthcare (EDQM) extends 
to certification programmes (WHO, 1999). Risk com-
munication and sharing risk-related knowledge are 
also addressed in WHO guidelines (WHO, 2013). 
Finally yet importantly, sharing public alerts and 
warning alerts for imported drugs or medical devices 
can prevent similar faulty products from being 
exported to other markets (WHO, 2017).
WHO identifies the technology transfer as the mid-
dle stage in the drug lifecycle where GMP regulations 
must apply (WHO, 2013, 2014). The organisation 
requires validation of the process of data transfer 
(WHO, 2016). Whenever the transfer involves analy-
tical methods, it is required to conduct this validation 
by the development before transfer to manufacturing 
quality control. Periodic checks are necessary to 
ensure the accuracy and reliability of the process 
(WHO, 2006b). As a general requirement, mechan-
isms should be addressed to facilitate the transfer of 
information not only between manufacturers and cus-
tomers but also to the relevant regulatory bodies 
(WHO, 2010a).
With regard to IPP, The International Medical 
Products Anti-Counterfeiting Taskforce (IMPACT) 
is led by WHO, where the focal point is public health 
protection from the implications of counterfeiting 
Figure 4. Key themes in regulatory guidelines.
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(WHO, 1999). The ever-changing business strategies 
and their accompanying intra- and intercompany 
transfers of technology obliged the WHO Expert 
Committee on Specifications for Pharmaceutical 
Preparations in its 42nd report to assign a special 
guideline to address this issue (TRS 961 Annexe 7). 
However, this guideline is meant to be a flexible fra-
mework rather than rigid technology transfer gui-
dance. Although a multifunctional team is proposed 
to manage the transfer process, it is affirmed to be 
under the umbrella of a quality system (WHO, 2011).
WHO requires pharmaceutical manufacturers to 
build their quality decisions and regulatory commit-
ments on science-based understanding of the process 
and QRM which can offer a greater freedom of how to 
comply, hence enhances innovation (WHO, 2013). 
Development of quality culture in the pharmaceutical 
organisation is believed to improve transparency 
about failures and ensure good data management 
strategies are in place. Besides, data integrity and pro-
tection occupied a featured position in WHO regula-
tions. Pharmaceutical firms are expected to develop 
appropriate tools and strategies for the management of 
data integrity risks based upon their own GxP activ-
ities, technologies, and processes (WHO, 2016).
3.13. EU GMP
Furthermore, EU Guidelines for Good Manufacturing 
Practices (EudraLex) have adopted Good Docu- 
mentation Practices as an enabling tool for knowledge 
management throughout different stages of product 
lifecycle (EudraLex, 2015). Similar to WHO, PIC/S 
and ICH recommendations, the guidelines encourage 
agents, brokers, distributors, repackers, or relabellers to 
share regulatory and quality information with the man-
ufacturers and customers (EudraLex, 2014; ICH, 2000; 
PIC/S, 2017; WHO, 2010b). EudraLex requires analyti-
cal method transfer protocol (EudraLex, 2006) with no 
explicit transfer framework as in WHO TRS961 Annexe 
7. However, it confirmed the coverage of technology 
transfer by cGMP regulations as a part of product life-
cycle (EudraLex, 2011).
3.14. FDA
FDA pays special attention to process understanding 
and knowledge management as effective strategies 
for preventing and detecting data integrity issues 
(FDA, 2016c). On the other hand, FDA accentuates 
on knowledge sharing and transfer in contract man-
ufacturing as explained in the quality agreement 
(FDA, 2016a). The agency highlights the role of 
senior management in the creation of communica-
tive organisational culture as a tool for improving 
knowledge sharing and communication in addition 
to cross-functional groups to share ideas for 
improvement purposes (FDA, 2006).In addition, 
FDA encourages data acquisition and accumulation 
over the lifecycle as an important way for continuous 
improvement which in turn can facilitate the scien-
tific communication with the agency (FDA, 2004a). 
Similarly, following process validation FDA guide-
lines would support process improvement and inno-
vation (FDA, 2011).
3.15. PIC/S
In response to the increasingly complex global supply 
chains in the pharma industry, PIC/S facilitates voluntary 
inspection data-sharing between member authorities. 
This is deemed to enable risk-based assessment of the 
need for inspections based on shared confidence in 
inspected firms (PIC/S, 2011b). It has not escaped our 
notice that data sharing and transfer in PIC/S guides is 
focused on inspection data rather than knowledge created 
in pharmaceutical firms. The statute of the International 
Medicinal Inspectorates Database (IMID), which aims at 
establishing a database of GMP inspections carried out by 
IMID participating Regulatory Authorities, was adopted 
by PIC/S to reduce the number of duplicative inspections 
(PIC/S, 2012). Besides, the PIC/S committee is cooperat-
ing with other global agencies such as WHO, EMA, 
the ICMRA (International Coalition of Medicines 
Regulatory Authorities) and United Nations Children’s 
Fund (UNICEF) with regard to training and sharing of 
inspections’ information (PIC/S, 2011a, 2015, 2016b; 
WHO, 2003).
Because data integrity is essential for successful 
implementation of GMP, the requirements for good 
data management are embedded in the current PIC/S 
guidelines to GMP/GDP for Medicinal products. 
Good data management practices (GDMP) are envi-
saged as fundamental enabler for the integrity of the 
generated data. The manufacturer or distributor 
undergoing inspection is required to enforce GDMP 
that ensure the accuracy, completeness, and reliability 
of data (PIC/S, 2016a).
The data lifecycle (from generation till discard at 
the end of retention period) is also featured in GMP 
guidelines including data transfer throughout the pro-
duct lifecycle. In case of computerised systems, inter-
faces should be assessed and addressed during 
computer system validation to guarantee the correct, 
accurate, and complete transfer of data (PIC/S, 2016a, 
2017). Risk review should be considered specially for 
supply chains and outsourced activities to assess the 
extent of data integrity controls required (PIC/S, 
2016a). It is noteworthy that PIC/S has repeatedly 
warned of inappropriate interpretation of guidelines 
making them barriers to technical innovation or the 
pursuit of excellence (e.g.PIC/S, 2011c).
10 A. RAMY ET AL.
Organisational culture and behaviour are 
a complementary part of the effective data governance 
system when combined with an understanding of data 
criticality, data risk, and data lifecycle. The value 
behind this appears in the empowerment of employees 
to report failures and opportunities for improvement. 
This reduces the incentive to falsify, alter, or delete 
data (PIC/S, 2016a). GMP inspectors have to be sensi-
tive to the effects of organisational culture and struc-
ture on the organisation behaviour where data 
reporting differs between open and close cultures. In 
order to ensure data integrity within the pharmaceu-
tical organisation, appropriate values, believes, think-
ing and behaviours need to be demonstrated 
consistently by management, team leaders, and quality 
personnel (PIC/S, 2016a).
4. Discussion and implications
The pharmaceutical industry is not only one of the 
knowledge-intensive sectors, but also an industry with 
a direct effect on health promotion (Mehralian et al., 
2016). It comprises distinct characters making phar-
maceutical knowledge management a unique process. 
Being research-intensive, highly innovative and a great 
source of IC (Kamath, 2008), building networks of 
R&D personnel with research institutions, providing 
ultimate protection of IP rights, having high influence 
of political, legal, and administrative factors on tech-
nology acquisition (Hemmert, 2004), achieving high 
level of maturity in project management (Wakefield, 
2005), involving suppliers in product development 
activities (Lawson & Potter, 2012), involving colla-
borative research with universities and governments 
(Dooley & Kirk, 2007), presenting sophisticated drug 
discovery and development systems (Criscuolo, 2005), 
facing challenges of regulated prescription drugs 
(Pedroso & Nakano, 2009), being one of the fast grow-
ing economic sector (Singh & Kansal, 2011), together 
with huge economic productivity and high number of 
employees (Bigliardi et al., 2012) are some of reasons 
for choice of pharmaceutical industry as empirical 
research field in KM literature.
Based on an in-depth review of the literature, few 
trends emerge. Domination of academic authorship 
(93% of authors) and empirical research (>70%) in 36 
countries along with 20% increase in co-authorship 
reflects the academic maturity of the research area. 
Participation of practitioners is relatively limited (7%) in 
spite of the colossal investments in KM by pharma com-
panies (Riddell & Goodman, 2014). This also validates 
the notion that the role which “knowledge” plays in the 
pharmaceutical industry is still immature and disabling 
the ICH Q 10 desired pharmaceutical quality system 
(Calnan et al., 2018). This can also accentuate what has 
been described by M. A. F. Ragab and Arisha (2013) as 
a theory-practice gap in KM literature in general.
Since R&D is considered the key space for knowl-
edge creation (Ingelgård et al., 2002; Parisi et al., 
2006), most of the studies ignored other functions 
(e.g., manufacturing, sales or quality) or other sources 
of knowledge in pharmaceutical organisation (e.g., 
process validation studies; manufacturing experience, 
continual improvement, and change management 
activities). From a regulatory perspective, managing 
the knowledge throughout commercialisation and 
manufacturing phases until product discontinuation 
is supposed to be as important as managing drug 
development knowledge (ICH, 2009).
Taxonomical analysis of literature affirms six main 
knowledge processes/themes extensively covered by 
researchers (Figure 3). In spite of that, the research in 
some other potential areas is relatively scarce (e.g., 
knowledge acquisition). In addition, the current think-
ing of the pharmaceutical regulatory bodies does not 
match the trending themes in business literature. For 
example, technology transfer and method/process 
transfer are regulated practices under pharmaceutical 
quality systems (ICH, 2009; WHO, 2011); case studies 
or empirical research is quite limited in this area.
IC is the most frequently used keyword and 
research theme in pharmaceutical KM literature. The 
influence of pharmaceutical IC on profitability, pro-
ductivity, and market value is addressed in several 
papers (e.g., Pal & Soriya, 2012). Pharmaceutical IC 
reporting in BS suffers from inconsistency and lack of 
standardised guidelines. Yet, Intellectual Capital, 
knowledge measurement or disclosure are not recog-
nised by cGMP guidelines. While M&A implications 
were a subject of academic research in pharma com-
panies, regulatory publications focus on knowledge 
transfer after product/process acquisition or data 
acquisition during product lifecycle (FDA, 2004a).
Although KM at product and process level is 
explicitly required in ICH Q10 1.6.1. (ICH, 2008), 
regulatory authorities did not suggest any framework 
for either measurement or disclosure of IC. With 
poor reporting and disclosure of IC in pharma 
(Abhayawansa & Azim, 2014), further research is 
needed to induce industry-specific measurement fra-
meworks not only at organisational IC level but also 
at the individual knowledge level. As a part of com-
pany intangible capital, patent-related keywords are 
mentioned 10 times in the review pool (e.g., patent 
citation, analysis, research, count, etc.) reflecting the 
importance of IP rights as a research subject.
Governmental role in innovation, either through the 
outputs of basic science or public funding of growing 
industry R&D, is emphasised in the literature. Dynamics 
of innovation as managed by the Triple Helix model can 
be a meticulous explication of this phenomenon 
(Etzkowitz & Leydesdorff, 2000; Leydesdorff & Meyer, 
2006). When the FDA announced the Pharmaceutical 
cGMPs for the Twenty-first Century in 2006; corrective 
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actions, innovation, and continuous improvement were 
considered as three complementary improvement 
approaches in Pharmaceutical Manufacturing (FDA, 
2004b). However, only innovation has received enough 
attention in the surveyed literature. It is worth noting 
that the term “creation” was mainly used by the regula-
tors to signify creation of data and/or electronic records 
(FDA, 2016b).
The review explored the role of pharmaceutical 
organisational culture and structure in knowledge 
management. The review confirmed the notion that 
some values are found to be associated with the pros-
perity of knowledge within workspace (Remy 
Magnier-Watanabe & Senoo, 2009) and a new tech-
nology is not able alone to bring about a successful 
KM system (Chatzkel, 2007). The KM performance of 
the company was found in general related to its mar-
ket performance. Unlike pharmaceutical quality sys-
tem (ICH, 2008), organisational performance as 
a function of its KM practices was not considered by 
any of the four regulatory bodies.
5. Conclusion and limitations of research
According to the pharmaceutical regulatory guidelines, 
personnel must be qualified and knowledgeable with 
functions related to their work activities (FDA, 2006; 
WHO, 2014). It is a requirement to manage product 
and process knowledge throughout the product lifecycle 
(ICH, 2008). However, the academic research interests in 
pharmaceutical knowledge as presented in the extant KM 
literature partially overlap with the regulatory concerns. 
This incomplete overlap offers an opportunity for busi-
ness researchers to design their future work to help 
industry meet regulatory expectations. Regulatory bodies 
recommended knowledge management but did not pro-
vide comprehensive frameworks to manage knowledge of 
pharmaceutical firms at the time industry practitioners 
refrain from serious contribution to academic research. 
This supports the notion that knowledge management in 
pharmaceuticals is still a growing research area, particu-
larly in non-research and development functions.
The review has the limitation of being restricted to 
articles extracted from the Emerald Insight and Science 
Direct databases. Knowledge management conference 
proceeding and other academic portals can be 
explored in future studies. Despite the limitations, 
this paper offers an integrative and comprehensive 
taxonomy of KM literature in an industry-specific 
context that offers valuable insights for future 
research.
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Purpose - The purpose of this paper is to explore the current research trends in
Knowledge Management (KM). To achieve this objective, a scientometric analysis of all
literature published in Knowledge Management Research and Practice (KMRP), a leading
journal, is conducted ranging from the year 2003 to 2015.
Design/Methodology/Approach - A comprehensive literature review framework is
synthesised from previous studies in KM. The analysis is designed based on three sets of
review questions addressing Research Productivity, Research Themes and Methods, in
addition to Citation Analysis. A total of 344 articles are reviewed and coded according to
the adopted framework. To examine research output, Equal Credit and Direct Count
methods are applied to assign authorial credit, while Normalized Citation Impact Index
(NCII) is used for research impact analysis. A qualitative approach is introduced for
thematic and methodological analysis.
2
Practical Implications – The study elucidates an increasing trend towards multi-author
collaboration especially in recent years. The KMRP’s publication list includes more than
400 academic and research institutions showing the wide global interest in KM research.
It also points at no particular dominant institution in the field. More than 50 different
industries are represented in the ranking of sector application. Nevertheless, certain
knowledge-intensive business fields have featured less such as pharmaceuticals and
aerospace. Country productivity shows few nations taking the lead with research
initiatives. Interestingly, statistics reveal a correlation between research activity and
economic prosperity. There is a growing tendency towards empirical methods in contrast
to a drop in literature review papers which is a sign of the field’s maturity. Results have
also demonstrated that there is an increased contribution from practitioners. It is noticed
that there is a recent rise in number of articles that present the integration between KM
and Information Technology (IT). This is a natural trend given the current inconceivable
advances in technology. This study also looked at the most influential publications in the
journal’s history, taking into consideration their issuing date. Finally, insights on the
current status of the KM research landscape is discussed in line with future trends.
Originality/Value - It is the first comprehensive scientometric research of KMRP. The
paper describes the state-of-the-art value and provides an outlook of the future.
Keywords – Scientometric Analysis, KMRP, Knowledge, Knowledge Management,
Intellectual Capital.
1 Introduction
Knowledge management (KM) has become a predominant field within the business and
management landscape for both researchers and practitioners. The recognition of the
fundamental role of knowledge in value creation spawned the concept of the Knowledge
Economy, making it one of the pillars of contemporary management thinking (Roberts,
2009). Economic growth is no longer reliant on physical capital and labour only as
established in nineteenth century theories, but also on the human capital comprised of
“knowledge workers” whose innovative capabilities lead the advancement of the current
“knowledge society” (Drucker, 1994). This was highlighted by a 1999 World Bank report
which provided one of the first comprehensive accounts of the emerging role of
knowledge in economic development through a focus on acquisition, application, and
transfer of knowledge (World Bank Annual Report, 1999). By the end of the twentieth
century, the notion of managing knowledge had evolved at the corporate level as
organisations acknowledged the need to leverage and exploit their knowledge resources
(Carmeli and Tishler, 2004). KM is now considered a vital organisational function and a
key source of sustainable competitive advantage (Davenport and Vo, 2006). On the other
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hand, progressive academic works have also established KM as an independent and rich
scientific discipline. As a research field, KM has witnessed an exponential growth rate in
publications amounting to 50% per year, supported by the founding of a number of
dedicated KM journals and conferences (Serenko et al., 2010).
One of the key peer-reviewed journals in the KM field is Knowledge Management
Research and Practice (KMRP). Available online since 2003, KMRP is the first KM
journal to gain an impact factor (Thomson Reuters, 2015). Its aim is to provide an outlet
for high quality peer reviewed publications, which include articles on all aspects of KM
whether this is academic or in practice. The journal pays particular attention to cross
disciplinary research, mixtures of techniques, and differing schools of thought adopting a
broad spectrum of publication themes including empirical research and case studies as
well as conceptual and theoretical papers (Springer, 2017). Moreover, KMRP was placed
third in 2008 then the second in 2013, according to expert survey rankings conducted on a
sample of 25 key KM journals (Serenko and Bontis, 2013a).
While the KM field continues to grow, reflections on literature can allow for more
efficient future deliberations on subjects within the discipline, minimise repetition, and
create starting points for further advancements in KM theory and practice. This paper
provides insights into KM research published in the KMRP, which could arguably apply
to the whole KM domain considering that KMRP is a representative example of the wider
KM literature. To present the work, the paper is divided into five sections. Following the
introduction, the second section offers a brief survey of relevant literature and presents
the study’s research questions. Section 3 details the study’s methodology and the
development of the review framework. Findings are presented and analysed in the fourth
section, while the final section discusses the work’s conclusions and implications for
future research.
2 Background and Research Questions
A literature review is a “critical analysis of a segment of a published body of
knowledge through summary, classification, and comparison of prior research studies”
(Jafari and Kaufman, 2006). It helps to interpret what is known about a research field and
to identify gaps in the existing knowledge (Jesson et al., 2011). Several reviews covered
KM publications and journals using a number of methods over different time periods.
These include but are not be limited to: Citation Analysis (Huang et al., 2010; Ma and Yu,
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2010; Ribière and Walter, 2013; Serenko and Dumay, 2015) Content Analysis (Fteimi
and Lehner, 2016), Journal Ranking (Serenko and Bontis, 2009, 2013b), Meta-review
(Serenko and Bontis, 2004) and Scientometric Analysis, the approach adopted in this
study (Serenko et al., 2009, 2010).
Scientometrics is science about science with distinct identity and methodology
(Garfield, 2009). The term has grown in popularity and recognition in the last decades,
especially after the founding of the dedicated Journal of Scientometrics by Tibor Braun in
1978. It is used to describe the study of science including growth, structure,
interrelationships, and productivity of a certain research discipline (Hood and Wilson,
2001). Scientometrics portrays a comprehensive picture of research activity within the
field and is able to present existing trends supported by quantitative data. In this study, the
scientometric approach is adopted to investigate three main research issues within KMRP
during the review timeframe:
(1) Productivity - Demographic patterns in the production of KMRP research;
(2) Themes and Methods - Trends in topics examined and research tools applied; and
(3) Citation - Analysis of referencing frequency of the journal’s papers.
Accordingly, three groups of research questions were formulated to guide the research
process as follows:
Research Productivity in KMRP
RQ1. What are the dominant trends in authorship distribution?
RQ2. What is the prevailing affiliation of KMRP authors (Academics vs
Practitioners)?
RQ3. Which countries are leading in KM research?
RQ4. Is there a relationship between a country’s economy and its contribution to KM
research?
RQ5. What is the institutional productivity in the journal?
Research Themes and Methods in KMRP
RQ6. Which research methodologies are most used by authors?
RQ7. What are the most popular industrial sectors in KM research?
RQ8. What are the main research themes in the journal?
RQ9. What is the degree of integration of Information Technology in KM research?
Citation Analysis of KMRP
RQ10.Which articles are the most influential in the journal’s history?
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3 Methodology
The research methodology adopted in this study has a number of steps. First, the
boundaries of article selection for analysis are drawn using criteria for inclusion and
exclusion. This set initially included 506 articles published in KMRP between the year
2003 - when the first issue was published – and up to 2015. Editorials, position papers,
and book reviews are excluded from the article list. Accordingly, a total of 344 articles
are retained for analysis, while 162 are excluded. Second, the research framework is
synthesised in light of previous similar works (Fteimi and Lehner, 2016; Serenko et al.,
2010; Serenko and Bontis, 2004; Serenko and Dumay, 2015) and subsequent design
allows exploration into the various attributes of publications within the selected sample
(Table 1).
Table 1: Research Framework
Theme Variables
Productivity
x Number of authors
x Affiliation of author -Academic vs. Practitioner
x Country of Residence - where the author is based, not where




method, more than one can be
selected





x Other qualitative - Focus groups, Delphi, site observation,
action research, content analysis, ethnography.
Research Topic
Most prominent topic in the





x Culture & Social Issues (Social Capital)
x Performance Management
x Information System
x Communities of Practice
x Knowledge Measurement
x Knowledge Philosophy/Ontology












x Use of Technology (yes/no)
Type of KM Technology:








x Decision support systems
Referencing x Number of citations from Google Scholar database
x Keywords
For cross-validation, coding process has been structured so that each researcher
conducts a round of ten articles before they compare the codes for agreement. The
outcomes of this exercise led to minor modifications of the framework, and helped
identify what the authors refer to as grey areas - article attributes within the framework
that were subjective in nature and could vary according to the views of the coder. For
example, the same article could be classified under more than one category within the
coding scheme. In this case, the authors have agreed to code the article under the most
predominant theme and then cross-check their results. In the third stage, the articles are
mutually coded by both researchers, and results are cross-checked to minimise grey coded
articles. Finally, the full analysis of the resultant dataset is conducted to identify patterns.
When addressing Research Questions 2-5 pertaining to Research Productivity, methods
utilising credit analysis are enacted. Authorial credit is generally provided using one of
four methods depicted in Table 2 below.
Table 2: Methods for Assigning Author Credit
Method Description Example Criticism
Normalised
Page Size
Number of pages is







- Assumes longer papers make
higher contribution.














- Co-authors are sometimes
listed in alphabetical order;
thus those whose names are
earlier in the alphabet are
unjustly favoured.












- Gives advantage to researchers
who co-author numerous














- Avoids the drawbacks of
previous methods.
Adapted from Chua and Cousins (2002) and Lowry et al. (2007)
The Equal Credit Method is selected because it avoids the shortcomings of the three
other methods and provides mostly unbiased authorial credit. In addition to Equal Credit,
the Direct Count Method is employed in Research Questions 2 and 3 as well and results
of both methods were compared. It is worth noting that studies have suggested that the
Direct Count, Author Position, and Equal Credit methods can produce similar results,
particularly when utilising aggregate data (Serenko et al., 2008).
In addressing Research Question 10 regarding citation impact of influential KMRP
publications, each paper’s citation impact index is computed to determine the single most
highly cited article. The most commonly used measure is the calculation of the total
number of citations of each paper since its publication. However, according to Holsapple
et al. (1994), the weakness of this method is that it does not consider the publication date
of the article. It will provide the same score to two publications that are cited the same
number of times even if they are published in different years, although the most recent of
them can have a higher average number of citations per year. This suggests that the latter
publication has had a higher contribution to the field having achieved the same number of
citations in a shorter time period, an aspect which the traditional citation index overlooks.
To overcome this drawback, Holsapple et al. (1994) proposed the use of Normalized
Citation Impact Index (NCII) which accounts for the paper’s longevity thus reflecting the
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relative contribution of each paper. It is calculated by dividing the number of times the
article has been referenced by the number of years the article has been available [NCII =
Total Citations (count) / Longevity in years]. The NCII method is hence adopted in this
study in order to provide more reliable results. Individual article citations obtained from
the Google Scholar database are used to compute the NCII for each article and
publications are ranked in descending order according to their indices.
4 Findings
In an attempt to identify the trends within the current sample, the analysis is presented
over two time periods (2003 – 2008) and (2009 – 2015). This format facilitates in
highlighting the major changes in the nature of research work published in the journal
over its lifetime.
4.1 Authorship Trends
Figure 1: Number of Authors
The average number of authors within the sample was 2.28 authors per paper, however,
a growing trend towards multi-authored papers is evident. While the average paper
authorship in the first time period (2003 – 2008) was 1.96 authors per paper, it increased
to 2.46 authors per paper in the second time period (2008 – 2015). The median number of
authors has also increased from two to three after 2013 (Table 3). The percentage of
single authored papers dropped from 40% in 2003-2008 to less than 20% in 2009-2015,
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whereas papers with two, three, and four authors witnessed significant increases of 1.5%,
8.5%, and 9.8% respectively (Figure 1). This confirms the findings of Akhavan et al.
(2016) who observe a decline in single-authored works over time and the emergence of
collaboration patterns among KM scholars. This is justified by the maturity of the KM
domain where authors develop relationship networks and collaborate to overcome the
current increasingly challenging journal acceptance rates. The findings are also in line
with the broader bibliometric studies of Cline et al. (1979), Metz (1989), Terry (1996)
which report a general phenomenon of progressive trends in co-authorship in other
research disciplines.
Table 3: Co-authorship Distribution - Number of Authors
Year 2003 2004 2005 2006 2007 2008 2009
Mean 1.78 1.93 1.61 2.07 2.32 1.86 2.18
Median 2 2 1 2 2 2 2
Year 2010 2011 2012 2013 2014 2015
Mean 2.34 2.48 2.34 2.48 2.83 2.58
Median 2 2 2 2 3 3
4.2 Author Affiliations
Figure 2: Author Affiliation
From an affiliation perspective, more than 90% of authors have an academic
background and are in direct affiliation with educational and/or research institutions. The
rest of authors are practitioners from service or industry sectors. Both the Direct Count
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and Equal Credit methods are used to compute the contribution of practitioners and
academic authors and no statistically significant difference is found between the results of
both methods (p-value=0.592). Despite the apparent stability in the percentages of
practitioners and academic authors in KMRP over the years (Figure 2), other studies have
shown otherwise. A study by Serenko et al. (2009) revealed that the number of
practitioners decline from approximately one third of all contributors in the late 1990s to
10% by 2008. Their findings suggest that there is room for further engagement of
practitioners in KM research and publication.
4.3 Country Productivity and GDP
Figure 3: Country Productivity
In order to identify the leading countries in the KM field, the relative contributions of
57 countries whose papers were published in the KMRP are traced and ranked using both
the Equal Credit and Direct Count methods. Similar results from both methods are
obtained and the Pareto Principle or “The Law of Vital Few” is heavily observed. The
majority of publications originate from roughly 20% of participating countries as in Table
4 (Pareto, 1971). To confirm the findings, the number of citations from each country is
counted using the NCII method for all the countries. The same countries of the highest
contribution to the journal are found to be on the top of the articles citation list. Moderate
positive correlation (0.559) is discovered between the country Gross Domestic Product
(GDP) and contribution to KM research. This explains the finding that the majority of
leading contributors are in North America, Western Europe, and Australia. The link
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between knowledge and wealth reinforces the theory established by Drucker when he
discussed the post-WWII transformation of the American economy from goods to what
we call today the Knowledge Economy (Drucker, 2011).
Table 4: Country Productivity Ranking
Rank
Equal Credit Method Direct Count Method NCII
Country Percentage Country Percentage Country Percentage
1. UK 13.76% UK 12.74% UK 12.92%
2. USA 12.37% USA 12.02% USA 12.52%
3. Australia 8.13% Spain 7.69% Japan 8.95%
4. Spain 7.94% Australia 7.69% Spain 7.67%
5. France 5.89% Italy 5.53% Canada 7.49%
6. Italy 5.81% France 5.05% Italy 6.74%
7. Taiwan 4.93% Canada 4.81% Finland 4.25%
8. Canada 4.29% Taiwan 4.09% Germany 4.14%
9. Germany 3.91% Germany 3.85% France 4.10%







When examining institutional productivity, Equal Credit is the method of choice for
organisations as well. Analysis revealed that, to-date, more than 400 unique institutions
have published articles in the KMRP. The noticeable finding is the minimal variation
among individual contributions of each institution where no single institution dominated
publications in the journal as shown in Table 5 (range = 3.8, standard deviation = 0.65).
Approximately 20% of contributions come from 27 different institutions which indicates
unbiased distribution of papers between a wide range of research and professional
organisations. It is also noted that two thirds of papers are the product of a single
institution and 38.6% of the papers are the outcome of multi-institutional collaboration.
Furthermore, the top 20% contributors are all academic organisations, which coincides
with the prevalence of academic authorship as previously mentioned.
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Table 5: Institutional Productivity
Rank Institution EqualCredit Percentage Cumulative Sum
1. National Technical University ofAthens 3.999 1.16% 1.16%
2. University of Sydney 3.999 1.16% 2.33%
3. Tampere University of Technology 3.998 1.16% 3.49%
4. Queens University 3.916 1.14% 4.63%
5. University of Southampton 3.5 1.02% 5.64%
6. University of Hull 3.166 0.92% 6.56%
7. National Taiwan Ocean University 3 0.87% 7.44%
8. Universidad Computense de Madrid 3 0.87% 8.31%
9. University of Sao Paulo 3 0.87% 9.18%
10. Politecnico di Milano 2.75 0.80% 9.98%
11. Hitotsubashi University 2.5 0.73% 10.71%
12. University of South Australia 2.5 0.73% 11.43%
13. University of Southern Queensland 2.499 0.73% 12.16%
14. Kingston University 2.333 0.68% 12.84%
15. University of Salento 2.333 0.68% 13.52%
16. University of Sheffield 2.333 0.68% 14.19%
17. Loughborough University 2.166 0.63% 14.82%
18. Bangkok University 2 0.58% 15.40%
19. Edith Cowan University 2 0.58% 15.99%
20. Politecnico di Bari 2 0.58% 16.57%
21. Robert Gordon University 2 0.58% 17.15%
22. Soochow University 2 0.58% 17.73%
23. University of Akureyri 2 0.58% 18.31%
24. University of Alicante 2 0.58% 18.89%
25. University of Castilla La Mancha 2 0.58% 19.47%
26. University of Melbourne 2 0.58% 20.06%
27. University of New South Wales 2 0.58% 20.64%
28. Other 375 unique institutions N/A 79.36% 100
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4.5 Research Methods
Research methods can be described as all the data collection and analysis techniques
that are used for conduction of research activities to solve research problems (Kothari,
2004). Nearly half of the articles (47%) utilised a single method, while the rest of articles
used two or more. A mild to moderate increase in published empirical studies, both
quantitative and qualitative, is observed in the second review time period (2009-2015) in
comparison to conceptual models and literature reviews which are prevalent in the first
review period (Figure 4). Nevertheless, modelling tools and frameworks are still the most
used methodology by KMRP researchers, followed by case studies. This rise in case study
and survey work along with the decline in literature reviews suggests an ongoing shift of
KM research from theory to practice where first hand studies are increasingly held with
knowledge workers to explore knowledge related phenomena in real-life organisational
contexts. This tendency seems to be a general trend in the KM field, as indicated by the
results of other similar studies. For example, a recent content analysis of the proceedings
of the European Conference of Knowledge Management (EKCM) between 2006 and
2013 revealed that model and framework development were the most preferred research
method followed by case studies and questionnaires (Fteimi and Lehner, 2016).
Figure 4: Research Methods
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4.6 Industrial Sectors
Expanding on the findings from the previous section, articles are thoroughly surveyed
for industries which are selected as research fields. While 33% of studies are classified as
conceptual studies and thus have no industries, the other two thirds are conducted in more
than 57 different industries and service sectors. Moreover, 15% of papers do not specify a
single sector used in data collection. Instead, a mixture of different businesses is used as a
convenience sample that is non-industry specific. This is expected since researchers often
tend to gather data from companies in their network and the ones that they have access to.
Moreover, research and education institutions are on the top of the popularity list.
Approximately 12% of the studies are conducted either within universities, research labs
and/or rely on the classroom as a case study. Once again, this could be simply attributed
to convenience. Researchers often find access within their own organisations, or in
similar academic ones, more feasible than the challenge of penetrating new industries to
obtain data. Information and Communication Technologies (ICT), Healthcare, and High-
Tech firms come in the second, third, and fourth level places respectively. Nonetheless,
some knowledge intensive industries such as Pharmaceuticals, Aerospace, and Energy
have not received adequate attention in industry-specific publications. This could be
considered as an opportunity for future researches to direct their efforts towards such
relatively under-published sectors. Table 6 illustrates the main industry/service sectors in
the articles and their relative percentage.
Table 6: Industrial Sectors
Rank Industry % Rank Industry %
1 Multi Sectoral 14.8% 11 Engineering 1.2%
2 Research &Education 11.6% 12 Entertainment 1.2%
3 ICT 8.7% 13 Insurance 1.2%
4 Healthcare 5.2% 14 Metal industry 1.2%
5 Technology 4.1% 15 Oil and Gas 1.2%
6 Civic Society 2.3% 16 Aerospace 0.9%
7 Consulting &Training 2.0% 17 Banking 0.9%
8 Automotive 1.7% 18 Pharmaceuticals 0.9%
9 Unspecified 1.7% 19 Other industries 13.1%
10 Construction 1.2% 20 Conceptual (none) 32.8%
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4.7 Research Themes
Two approaches are adopted to identify the common research themes within the KMRP
body of literature. First, two researchers qualitatively categorised the papers according to
their research topic as explained in the review framework. A counter review of the same
papers by the other researcher is used to confirm the categorisation of each paper under a
single theme. In cases where researchers coded a paper differently, the article is jointly
reviewed by both researchers until a classification is agreed, or third opinion is sought.
Secondly, a quantitative keywords analysis is used in parallel in order to compare the
findings of the thematic analysis.
Results show that 61% of research papers fell under only five topics; (1) Knowledge
Sharing, (2) Intellectual Capital, (3) Knowledge Creation, (4) Knowledge Transfer, and (5)
Culture. Some research themes indicate significant growth in the second review time
period (2009-2015) in comparison to the first period (2003 – 2008). For example, there is
a growing interest in Intellectual Capital, Knowledge Transfer, Innovation and Culture
(Figure 5). Nevertheless, themes such as Knowledge Creation, Organisational Learning,
Information Systems, Communities of Practice (CoP) have received less interest.
Figure 5: Research Themes
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4.8 Keyword Analysis
A comprehensive keyword analysis of KMRP articles between 2003 and 2012
undertaken by Ribière and Walter (2013) demonstrate that Knowledge Sharing is the most
used keyword in the journal. A similar exercise extending until 2015 conducted in this
research unsurprisingly yielded the same outcome. The predominance of Knowledge
Sharing as a keyword, as well as a research theme, confirms the validity of the thematic
analysis outcomes of the previous section. It also elucidates the emphasis researchers
have placed on the knowledge sharing process as a precursor of effective KM. Whether
the objective is spreading best practice, disseminating innovative ideas, or creating digital
repositories, sharing knowledge is often at the core of KM initiatives.
Figure 6: Keyword Analysis
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4.9 KM Technology
The role of Information Technology (IT) in KM is widely discussed in the literature. A
common view is that KM should not be reduced to a solely IT-based project as there is a
tacit dimension of knowledge which cannot be managed using technological tools
(Chatzkel, 2007). IT is rather envisaged as an essential KM catalyst and an enabler of
knowledge sharing processes within and between organisations (Tsui, 2005). This view
seems to be reinforced by scientometric figures as, overall, 91% of papers did not include
reference to IT. However, by contrasting the first review period (2003-2008) to the
second (2009-2015) with regards to discussing technology, an increase from 4.2% to
11.6% is observed indicating a movement towards further integration of IT in KM. In this
area, the Internet, Databases and Social Media were the most popular IT solutions in the
published papers (Figure 8), a trend in tandem with the digital revolution and the
explosive growth of social networking.
Figure 7: Integration of IT in KM Research
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Figure 8: IT Technologies
4.9 Citation Analysis
By examining citation frequency, three articles stood out as the most influential articles
in the journal’s history based on their NCII (Table 7). It is noted that the top three articles
gained 11.8% of the NCII score for all the articles and approximately 80% of citations
came from the top 144 articles (|40%). Interestingly, the most cited article is authored by
renowned KM thinker Ikujiro Nonaka and extends on his SECI model of knowledge
creation, which is regarded as one of the most seminal and highy-cited theories in the
history of KM at large.
Table 7: Highest Cited KMRP Articles
Author Title Year NCII
Nonaka, Ikujiro & Toyama,
Ryoko
The Knowledge-Creating Theory Revisited:





The Theoretical Foundations of Knowledge
Management
2006 26.8
Usoro, Abel; Sharratt, Mark
W; Tsui, Eric & Shekhar,
Sandhya
Trust as an Antecedent to Knowledge
Sharing in Virtual Communities of Practice
2007 18.8
19
5 Discussion and Implications
The journal of Knowledge Management Research and Practice (KMRP) stands for one
of the key scientific outlet in the field of knowledge management and has significantly
contributed to the development of the research streams related to strategic knowledge
management, learning organisation, intellectual capital measurement and management,
and knowledge-based information technologies, just to name few fundamental domains of
investigation.
With the economy and organisations showing increasingly a knowledge-intensive
nature, in today’s business landscape managing knowledge is acknowledged as a
necessary condition to survive and prosper. The ability of an organisation to create value
is tied to its ability to identify, manage and renew the key knowledge assets at the basis of
organisational competences and, in turn, processes affecting company value creation
dynamics. KMRP has contributed to shed light and disclose the functions, factors and
mechanisms characterising knowledge as a resource and source of organisational
competitiveness as well as the processes, models, approaches and tools that can support
managers in translating knowledge into business performance.
After almost 15 years since the foundation of KMRP from Operation Society, this
study proposes a scientometric analysis of the studies published by the journal. This helps
to provide a comprehensive picture and to understand the growth, structure,
interrelationships, and productivity of the published research activities within the field of
managing knowledge.
The study elucidates an increasing trend towards multi-author collaboration especially
in recent years. The KMRP’s publication list includes more than 400 academic and
research institutions showing the wide global interest in KM research. More than 50
different industries are represented in the ranking of sector application, although it is
surprising that certain knowledge-intensive business fields have featured less such as
pharmaceuticals and aerospace. The majority of leading contributors are in North
America, Western Europe and Australia. Interestingly, statistics reveal a correlation
between research activity and economic prosperity. There is a growing tendency towards
empirical methods in contrast to a drop in literature review papers which is a sign of the
field’s maturity. Results have also demonstrated that there is an increased contribution
from practitioners, although there is a dominant position of academia’s contribution. This
denotes the efforts of scholars to set up the foundation of the theory of managing
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knowledge integrating evidences from practice, but at the same time as the field is
progressively becoming more mature it indicates a potential shortcoming related to the
lack of a stronger involvement of practitioners in order to make sure that the research
outputs are relevant to advance the practice as well as for theory building. The study
shows that 61% of research papers fell under only five topics; (1) Knowledge Sharing, (2)
Intellectual Capital, (3) Knowledge Creation, (4) Knowledge Transfer, and (5) Culture. In
particular, the topic of Knowledge Sharing emerges a predominant indicating that it is
considered as one of the key process at the core of managing knowledge, in terms of
spreading best practice, disseminating innovative ideas, or creating digital repositories,
and sharing knowledge. This points out that one of the fundamental reasons for
implementing knowledge management initiatives is related to the need of moving
knowledge from individual to individual, from individual to team and organization, from
organisation to organisation, and from organisation to artefacts. In other words,
knowledge sharing is the key strategic knowledge process to support learning
organisation and the translation of knowledge into organisational and business
performance. In this light it is not surpsising that the modt influnecial article published by
the journal are those focusing on the SECI model of Nonaka and on the antecedents and
factors affecting the knowledge sharing characteristics of an organisation.
Concluding this study provides evidences that the field of knowledge management is
reaching a maturity which poses at least twofold challenges. On the one hand to identify
what are the future key trends of research development in the field, and on the other hand
the need to adopt more empirical based investigation. KMRP publishes both quantitative
and qualitative papers, however the discriminating factor to bear in mind is the relevance
of the contribution. From this point of view we need to remind that managers are
interested to knowledge and its management not for the sake of knowledge and
knowledge management, but because they need to understand how they can translate
organisational knowledge assets into drivers that positively impact and enhance the
business value creation mechanisms.
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Simulation modeling is extensively applied to address hospital challenges. To build the right model, 
unbiased accurate conceptual model has first to be produced. Conventional modeling process requires all 
data and information to be collected by interviews and/or focus groups then collated maually to produce a 
coceptual model before validation. This paper embraces modeling hybridization by introducing process 
mining for conceptual modeling stage in order to enhance the time factor of developing the model and 
equally increase accuracy of the conceptual model.  Patient’s pathways will be generated using data-driven 
approach (i.e. data from an Emergency Department - ED).  The hybrid framework demonstrates the high 
variance in patient pathways and then identify the system bottlenecks. A Dicrete-Event Simulation (DES) 
model is complementing the solution by adding the stochastic layer of the system dynamics. Results show 
that the unblocking of ED outflows by in-patient bed management rather than increasing capacity of the 
ED. 
1 INTRODUCTION 
Health-care management are currently under constant pressure to control rapidly escalating expenses, while 
still responding to growing demands for better patient service levels and safe medical treatment. Addressing 
these challenges requires a thorough understanding of health-care system constraints, which can be an 
overwhelming task, given the high levels of uncertainty and interdependence. Simulation modeling has 
contributed strongly to the understanding of different level of complexity within healthcare processes 
(Arisha and Rashwan 2016). Discrete event simulation (DES), agent-based simulation (ABS), Monte Carlo 
simulation (MCS), and system dynamics (SD) are widely used in healthcare appications (Brailsford et al. 
2009; Katsaliaki and Mustafee 2011). Each of these simulation techniques addresses a particular level of 
complexity within the system. Modelers are often challenged to accurately model the system complexity in 
order to provide managers with effective results resembling reality (Lynch et al. 2014). Research indicated 
that the use of hybrid simulation will improve the capabilities of simulation solutions  (Brailsford 2008; 
Djanatliev and German, 2013; Viana 2014; Zulkepli and Eldabi 2015; Gao et al. (2015). Despite the 
growing number of hybrid simulation studies, there are still a number of challenges that has not been 
addressed adequately. For instance, most reported hybrid simulation cases have attained their findings 
mainly on model implementation phase rather than considering other phases such as conceptual modeling.   
In addition, the human behavior in healthcare processes and activities has always been a challenge for most 
of the simulation approaches (Daellenbach 2001). Therefore, hybrid approach has to extend to reach the    
conceptual modelling (Robinson 2008), data collection, model optimization, analysis and implementation.  
This approach of a hybrid Modeling and Simulation (M&S) study applies various interdisciplinary methods 
in the wider simulation study has been discussed in (Powell and Mustafee 2016). A hybrid M&S study is 
characterized by the use of methods from fields such as Operations Research (OR), Computer Science, 
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Systems Engineering, Information Systems and Distributed Computing; these methods are applied to 
specific stages of a simulation study. 
 Most of the simulation studies develop the process model using documentation, direct system 
observations and interviews with stakeholders and experts (e.g. consultants, nurses…etc.). This manual 
process is time-consuming, and arguably the longest stage of any M&S project. This lengthy process 
significantly affects the validity and effectiveness of the M&S study recommendations. In addition, the 
perception of the actual process is influenced by the experience of the individual studying the system and 
this often results in biased models.  Therefore, it is essential for any successful M&S healthcare study to 
develop conceptual models that are unbiased, reusable, and close reflection of reality in a timely manner. 
To do so, a data-driven process mining approach can be adopted using event logs (van der Aalst 2011). 
Through the application of process mining techniques, healthcare organizations can: discover the actual 
patient pathways that are conducted in reality (Saunders, Makens, and Leblanc 1989); understand the high 
variance in clinical pathways taken by diverse groups of patients; and gain insights into bottlenecks and 
resource utilization (McGregor, Catley, and James 2011; Abo-Hamad 2017). 
 The aim of this research is to introduce a hybrid framework that integrates process mining techniques 
in the conceptual modeling phase. This will minimize the latency between the occurrence of events and 
decision-making. The main objective is to automatically identify patients’ pathway patterns that are 
consistent with the observed dynamic behavior. Hence, a more accurate and unbiased process model for 
patients’ journey is obtained in a timely manner. Using this model then as an input for simulation model 
and for what-if scenario analysis. The proposed framework is tested on a real-world case study of an 
emergency department of one of the leading hospitals in Ireland. 
2 PROPOSED FRAMEWORK 
2.1 Literature Review 
Conceptual modeling has been identified as potentially the most significant stage of any simulation 
study, however, it is the most underestimated aspect (Law 1991). Building a valid and credible model is a 
sophisticated process (Law et al. 2001). Data collection for conceptual model construction can be 
complicated due to confidentiality, security or subjectivity concerns. Although organizations utilize 
procedures to manage its processes, usually procedures are either informal, not documented or entirely 
different from reality (van der Aalst 2012). Process Mining (PM) techniques have emerged to handle the 
discrepancy between what should be done and how processes operate in the real world (Turner et al. 2012). 
The input data of PM is an event log (i.e. dataset of traces). Each trace has a sequence of ordered process 
activities (i.e. events). By utilizing evolutionary computational intelligence techniques (e.g. Artificial 
Neural Networks, Fuzzy logic, and Support Vector Machines), PM can provide an unbiased view of the 
underlying processes based on what is actually happening, and not on subjective views of the system (Maita 
et al. 2015). On the one hand, PM techniques can bridge the gap between data capabilities and process 
modeling analytics. Event logs can be exploited in three main approaches: discovery, conformance, and 
enhancement. In discovery approach, process models are discovered automatically by analyzing event logs 
without using any further information. Conformance process mining can be used to compare an existing 
process model with real life data expressed in event log (van der Aalst 2011). Whereas conformance and 
enhancement techniques can improve current process models through checking conformance, analyzing 
deviations and enriching existing models with conformance-related diagnostics (Centobelli, Converso, and 
Gallo 2015; Rovani et al. 2015).  
The proposed framework in this paper focuses only on the Process Discovery step that studies the event 
log activities and results in the creation of a conceptual model. The Alpha-Algorithm (van der Aalst, 
Weijters, and Maruster 2004), the Fuzzy Miner (Günther and Aalst 2007), and the Heuristic Miner 
(Weijters, van der Aalst, and Medeiros 2006) are the most reported techniques for process discovery. 
Process mining can be considered as a relatively new research discipline with a successful record in 
Abohamad, Ramy, and Arisha 
 
Healthcare applications. A recent extensive literature review (more than 74 articles) conducted by Rojas et 
al. (2016) on the application of process mining in healthcare has identified the research opportunities with 
this area. Interestingly, only one paper in their review has attempted to combine process mining with 
simulation models for an outpatient clinic model (Zhou, Wang, and Li 2014). 
2.2 Proposed Framework 
The proposed hybrid framework consists of three phases; Formulation and Data Analysis, Conceptual 
Modeling, and Model Development (Figure 1). Typically, each hospital department has its own database 
that supported its functions. The database usually contains information on patients and records detailed 
information regarding the journey or movements of patients within the hospital.  Process mining techniques 
usually use a transactional event log data set. Therefore, the “extraction” step in the framework is used to 
construct the event log data set from the raw database. Each row in the transactional event log corresponds 
to an event that was executed in the process. Multiple events are linked together in a process instance or 
case where each case forms a sequence of events—ordered by their timestamp. In contrast, data mining 
techniques uses the raw database directly where each row represents a complete process instance (i.e. 
patient episode). In the conceptual modelling phase, process mining algorithms are used to analyze the 
event log.  
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Figure 1 An overview of the proposed process-mining-based M&S Framework 
Due to the unstructured nature of healthcare process, the selection of the process mining discovery 
algorithm is crucial. The Fuzzy miner (Günther and Aalst 2007) is more suitable for unstructured processes 
and for the purposes of simulation and managerial analysis. Other algorithms such as Alpha-algorithm 
produces a very complicated process models which shows all process details without distinguishing what 
is crucial and what is unnecessary. On the other hand, fuzzy miner algorithm observe complex processes at 
different levels of granularity and provides meaningful abstraction and different views. This is achieved by 
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applying two fundamental metrics: significance and correlation. The significance metric assesses the 
relative importance of a precedence relation between two event classes, i.e. the more often two event classes 
are observed after one another, the more significant their precedence relation. The correlation metrics 
indicates how closely two events (i.e. activities) are following each other. Therefore, fuzzy mining could 
reduce and focus the displayed event classes by applying the two metrics on the discovered process map to 
achieve different levels of aggregation and abstraction. Therefore, various process models of different 
abstraction levels (number of activities and pathways) can be produced. The discovered process models 
combined with the analysis of patients’ records are used in the model development and experimentation 
phase. Depending on the model scope and objective, the model can be implemented using a single 
simulation technique such as Monte Carlo simulation (MCS), discrete event simulation (DES), system 
dynamics (SD) and agent-based simulation (ABS) or a hybrid between these simulation techniques.  
3 CASESTUDY 
3.1 Project Background 
The hospital studied in this paper is an acute public teaching hospital located in North Dublin, Ireland. This 
570-bed hospital includes a 24-hour Emergency Department (ED) which services over 50,000 patients 
annually. The ED is operating at approximately 99% occupancy, according to the task force report in 2007, 
which is an indication of inadequate physical space and infrastructure. This is often aggravated by delays 
in patients transfer to critical care (ICU/HDC) beds. Consequently, the ED is not compliant with volume 
and waiting time targets (6-hour Length of Stay target). A detailed simulation model for the ED was 
developed in (Abo-Hamad and Arisha, 2013), and some improvement strategies were proposed to achieve 
the national target. Although these strategies were effective, the model was not flexible to accommodate 
the constant changes in patient care pathways and to sustain improvement efforts. To overcome these issues, 
the process model of the ED (that was developed manually) should be updated to capture the changes in 
patient flow. Following the manual process of developing and updating the ED process model would take 
6 – 8 weeks. Given the fast changes in healthcare process, by the time the model is completed the process 
model will not be reflective. Therefore, process mining techniques were applied to discover patients' 
pathways from historical data automatically. 
3.2 Dataset  
A real-time patient tracking information system was used to track the patient’s journey within the ED. The 
hospital managers have provided a one-year historical data with anonymous patients' records. The dataset 
was provided in an event log structure with a total of 229,971 event logs representing 40,777 patients. Each 
log in the table represents an event (i.e. one process stage of the patient journey in the ED) with the 
following attributes (patient ID, Triage Category, Presenting Complaint, Date of Birth, Gender, Event ID, 
Tracking Step Name, Tracking Step Date Time, Location, Staff). Events with the same name, patient ID 
and timestamp were removed which resulted in a total of 210,180 records in the ED event log. 
3.3 Patient pathway discovery and analysis 
The event log for patients was analyzed to discover patient’s pathways and to extract statistics on their 
characteristics and types. Upon their arrival, patients are assigned a clinical priority (triage category) 
according to the Manchester Triage System (Cronin 2003). The MTS uses a five-level scale for classifying 
patients according to their care requirements; immediate, very urgent, urgent, standard, and non-urgent. 
Immediate and very urgent patients represent 15%, urgent patients (triage category 3) represent the largest 
group of attendees to the ED annually (59% average), while standard and non-urgent patient 26% of all 
patients. As advised by ED consultants, the analysis of these patients’ groups is critical as each group of 
patients can have a different journey within the ED and hence a different pathway. 
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3.3.1 Patient Pathway Discovery 
The main building block of patient pathways are the activities that patients go through during their journey 
in the ED. Twenty-two different activities within the ED are identified from the event log data. The fuzzy 
miner has then applied on the whole event log to construct the first top-level process map of the overall ED 
(Figure 2a).  
 
Figure 2 The discovered patient flow model of the emergency department 
The resulted complete map is complex and hard to interpret due to the high variances in patients’ 
pathways. This confirms the perception of the complex nature of patient journeys within the ED; there will 
always be patients presenting to the ED with non-standard characteristic that would require the patient to 
follow a different or new care pathway. This complexity is what doctors and nurses deal with daily, and 
make them not believe that system engineering techniques can contribute to help with patient flow 
complexity.  But the fact is that the fuzzy miner allows observing complex processes at different levels of 
granularity by applying two fundamental metrics: significance and correlation. The significance metric 
assesses the relative importance of a precedence relation between two event classes, i.e. the more often two 
event classes are observed after one another, the more significant their precedence relation. On the other 
hand, the correlation metrics indicates how closely two events (i.e. activities) are following each other. 
Therefore, fuzzy mining can reduce and focus the displayed event classes by applying the two metrics on 
the discovered process map to achieve different levels of aggregation and abstraction. Fuzzy process miner 
has therefore applied to the data to show the main highway paths for patients and to hide less frequent paths 
(Figure 2b). The count inside each rectangle (Figure 2) shows how many times an activity has been executed 
(e.g. activity ‘Doctor Seen’ occurred 31,571 times). While, the count on the arc represents the co-occurrence 
frequency between any two activities. For example, the co-occurrence frequency between ‘Doctor Seen’ 
and ‘Referred for Admission’ is 7,205. Due to excluding low frequent paths there are differences between 
the numbers of activities shown on incoming arrows and activity boxes on the process maps. Further 
analysis of this model revealed that there are 1,984 different patient pathway patterns (Table 1).  
a) ED process model with all 
activities and paths 
b) The process model with main 
activities and paths 
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Table 1 Discovered patient pathway patterns 
Pathway Cases Relative frequency Events Step 1 Step 2 Step 3 Step 4 Step 5 Step 6 … 
Step 
13 
1 9374 23% 4 Attended Triaged Doctor Seen Discharged      




Discharged      
3 3264 8% 3 Attended Doctor Seen Discharged 
      
4 3005 7% 3 Attended Triaged Discharged       








































1984 1 0.002% 6 Attended Did Not Answer Triaged 
Referred for 
Opinion Doctor Seen 
Admitted to 




Over 60% of these patterns are one-off path and only 31 patterns account for 80% of ED patients. 
Therefore, the remaining 1,951 patterns, which accounts to 20% of patients, were filtered out in order to 
reflect the common behavior of the ED. However, the filtering process output will depend on the project 
objectives. For example, the one-off paths can be the focus if the project is to investigate the reasons of the 
variations in patients’ flow. The fuzzy miner was applied again on the resulted 31,447 patients to drive final 
top-level process map of the ED (Figure 3). The most followed paths are shown with thick arcs between 
activities. However, the analysis of exceptional pathways (paths with very low frequency) can give deep 
insights for medical professionals regarding the main factors behind these patterns.  
 
Figure 3 The top-level process map of patient pathways   
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3.3.2 Performance and Bottleneck Analysis 
By considering the timestamp of events in the dataset, the ED performance and bottlenecks can be identified 
and analyzed (Figure 4). The number inside the rectangle represents the average activity time while the 
numbers on the arcs represents the waiting time between any two activities. The average length of stay 
(LOS) for all patients from arrival to departure (whether discharged or admitted to the hospital) is 9.1 hours 
which is 3 hours above the national target of 6-h average LOS in Ireland. However, the waiting time for 
admitted patients is 14 hours on average (with an average LOS of 18 hrs). Patients have to wait 3.3 hours 
on average to be seen by a doctor and 5.1 hours afterwards to be discharged from the department. The main 
bottlenecks in the ED are the “Seen by Doctor” and “Patients waiting admission” activities.  
 
Figure 4 Performance analysis of the top-level process map 
To gain a deeper understanding of the process flow of patients and the causes of these bottlenecks, the 
process model was analyzed at a more fine-grained level. The “Triage Category” attribute was used to 
divide patients into three groups; Immediate and very urgent, non-urgent and standard, and urgent patients. 
The process map of each patient group was constructed using the fuzzy miner and pathway patterns that 
reflect the common behavior for each group was analyzed (Figure 5). There are obvious variances in the 
associated pathways for patients with different urgency categorization (i.e. triage). The first patient groups 
(Immediate and Very Urgent) represents 15% of all patients with the majority of them have been admitted 
to the hospital with an average waiting time of 13.7 hrs. for the admission process to be completed (Figure 
5a). While 26% of all patients are Standard and Non Urgent patients whom have a shorter pathway with a 
discharge outcome and 5.1hrs average LOS. The “Did not Answer” activity represents patients who left the 
ED after being triaged without waiting to be investigated by a physician (whether a doctor or advanced 
nurse practitioner) (Figure 5b). Patients leave the ED after being triaged (9.6% of all patients) due to the 
overcrowding of the ED and the prolonged waiting times. 
 






Urgent patients represent almost 60% of all patients with 10.1 hrs average LOS. This group are 
presented to the ED with a wide range of complaints with 27% are referred for admission and the remaining 
are discharged with an average waiting time of 5.2 hrs (Figure 5c). The insights from this analysis enabled 
the ED decision makers to identify the bottlenecks for each group of patients and the challenges that they 
need to address. 
3.3.3 Staff and Resources Analysis 
The department has officially, 12 monitored trolley spaces; 3 of these trolley spaces (resuscitation area) are 
reserved for major trauma and critical care patients. Besides, the ED has an ambulatory car area with a 
capacity of six trolley spaces. Two rapid assessment triage bays and two triage rooms are also provided by 
the ED. As a 24hr department, the ED has eleven nurses during the day and nine nurses at night which 
collectively are divided into six types of nurses; Advanced Nurse Practitioner (ANP), triage nurse, 
resuscitation nurse, respiratory nurse, majors/minors nurse, and healthcare assistant. Physicians (excluding 
the 3 Consultants who provide shop floor cover between 9-5 or 8-8 with 24/7 on-call provision) are divided 
into two types: registrar/specialist registrar and Senior House Officer (SHO). Two types of resources were 
recorded in the eventlog for each record; location and staff type. Therefor resource requirement was 
analyzed for different activities in patients’ pathways (Table 2). The resource analysis gives deep insights 
regarding the gap between the guidelines that should be followed and what is actually happening. For 
example, the triage activity should take place in the triage room by a registered nurse (RGN). However, the 
analysis reveals that 68% this activity takes place in the triage room and 77% of the times is performed by 
the RGN. This is a clear evidence of the overcrowding of the ED and quantify how fare this activity from 
the guidelines. Similarly, the “Doctor seen” activity is performed by SHOs (58%) and registrars (20%) in 
the Majors area in the ED (55%) and in the Resuscitation room (18%). This highlights the actual time spent 
by doctors in this activity and the actual locations where this is happening. These insights helped the ED 
managers to understand the actual allocation of staff and resources within the ED and to identify the gaps 
between best practices and the actual performance. 
 
a) Immediate & Very Urgent                 b) Standard & non-Urgent                                  c) Urgent patients 
Figure 5 Performance Analysis for patients with different Triage Categories 
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Majors Area (9) 6% 55%   65% 57% 71% 72% 
Resuscitation Room (3) 6% 18% 
 
31% 29% 4% 24% 
Ambulatory Care Unit (6) 3% 11% 57% 3% 14% 23% 2% 
Rapid Assessment Triage (2) 17% 9% 
     
Triage Room (2) 68% 
      
ANP: Advanced Nurse Practitioner      SPR: Specialist Registrar 
RGN: Registered General Nurse       SHO: Senior Hospital Officer 
CNM: Clinical Nurse Manager       ADN: Associate Degree in Nursing 
 
3.4 Model Development and Experimentation 
A discrete event simulation model is developed using the discovered process models along with 
analysis of the staff, and resources, and performance (Figure 6).  
 
 
Figure 6 The ED Simulation Model 
The simulation results of the baseline represent runs for one year (Table 3). The results are very close to 
the information extracted from the event log as following: average length of stay (LOS) is 9 hour vs 9.1 
hour, average waiting time for triage is 19.9 min vs 20.6 min, average waiting for first clinical contact either 
by a doctor or ANP is 190.8 mins and 57.5 min vs 198 min and 58.3 min respectively, and percentage of 
patients left without being seen (L.W.B.S) by clinician (due to extended waiting time) is 10% vs 9.6%. 
Accordingly, simulation results have a satisfactory level of inaccuracy and that allows the model to be 
deemed as a valid model for experimentation. Based on the simulation results and process mining outcomes, 
Abohamad, Ramy, and Arisha 
 
the main bottlenecks in the workflow are the “Seen by Doctor” and “Patients waiting admission” activities.  
Therefore, the simulation scenarios tested were the impact of variation in medical staffing (an increase of 
25%), increasing clinical assessment space (an increase of 50%), and finally assessing the impact of 
incorporating a ‘zero-tolerance’ policy regarding exceeding the national 6-hour boarding time. According 
to the ED managers, the goal of the ‘zero-tolerance’ policy is to assess the performance of the ED if the 
average LOS of patients complies with the HSE 6 hour target and to identify the real factors that contribute 
the unacceptable overcrowding status of the ED; inappropriate physical space, insufficient staffing levels, 
or operational difficulties beyond the direct control of the ED. This scenario is implemented in the 
simulation model by dismissing patients from the ED model who are waiting to be admitted to the hospital 
and their LOS exceeds 6 hour. The rationale beyond this is that hospitals can provide a short stay unit, with 
an appropriate capacity, for patients who are waiting to be admitted but there are no available beds in the 
hospital. The simulation results of these scenarios are shown in Table 3.  
Table 3 Simulation results of Baseline and Scenarios 
 
Baseline Scenario 1 +/- (%) Scenario 2 +/- (%) Scenario 3 +/- (%) 
Avg. W. T. Triage (mins) 19.9 19.6 -1% 19.8 0% 20.4 3% 
Avg. W. T. Doctor (mins) 190.8 186.9 -2% 2.5 -99% 12.2 -94% 
Avg. W. T. ANP (mins) 57.5 60.7 6% 65.6 14% 62.5 9% 
Avg. # of Pts in W.R. 13.4 13.1 -2% 1.2 -91% 1.7 -87% 
% of Pts L.W.B.S 10% 9% -3% 0.01% -100% 0.01% -100% 
Avg. LOS Discharged Pts (hrs) 7.5 7.5 -1% 5.2 -30% 4.1 -45% 
Avg. LOS Admitted Pts (hrs) 17.8 17.7 0% 15.9 -11% 2.8 -84% 
Avg. LOS All Pts (hrs) 9.0 9.0 0% 7.0 -23% 3.9 -56% 
 
The simulation model shows that adoption of the cost-neutral scenario 3 has the highest impact on patients 
LOS at every stage, especially among patients who are discharged directly after ED care (45% improvement 
LOS). Furthermore, while scenario 3 improves the LOS of boarders, the more expensive Scenarios 1 and 2 
have negligible impact on ED boarding times. 
4 CONCLUSION 
Hybrid modeling approach is used in this paper to demonstrate the impact of using process mining 
techniques to support the development of simulation models for healthcare applications. Using the 
healthcare information systems, event log data can be generated for patient-care activities and this can feed 
into the analysis process. Process mining approach aims to utilize these event logs in order to find out the 
patients’ pathway patterns that are consistent with the observed dynamic behavior. This process secures a 
more accurate process model for patient treatment paths and provides a better foundation to develop an 
effective simulation model. The proposed framework was tested using a case study of an Emergency 
Department with event logs of 210,000 records. The discovered process model revealed that there are 1,984 
different patient pathway patterns with only 31 patterns account for 80% of ED patients. However, 
infrequent behaviors show variants in clinical pathways, and thus require to be investigated. A more fine-
grained level analysis was also performed for different patient groups to gain better insights on the treatment 
of patients within ED. The average length of stay (LOS) for all patients from arrival to departure (whether 
discharged or admitted to the hospital) is 9.1 hours – 3 hours above the national target of 6 hours average 
LOS in Ireland. However, the waiting time for admitted patients is 14 hours on average (with an average 
LOS of 18 hours). Patients had to wait 3.3 hours on average to be seen by a doctor and 5.1 hours afterwards 
to be discharged from the department. A dicrete-event simulation model is used to implement the 
discovered process models and to examine the impact of potential what-if scenarios. The simulation 
scenarios tested were the impact of variation in medical staffing (an increase of 25%), increasing clinical 
assessment space (an increase of 50%), and finally assessing the impact of incorporating a ‘zero-tolerance’ 
Abohamad, Ramy, and Arisha 
 
policy regarding exceeding the national 6-hour boarding time.The results show that the unblocking of ED 
outflows by in-patient bed management had the highest impact on patients LOS at every stage, especially 
among patients who are discharged directly after ED care (45% improvement LOS) with 87% improvement 
for patients waiting times. Furthermore, the embeded process mining cababilities within the hybrid 
framework resulted in a 85% reduction in the time required to develop conceptual model and equally 
increased its accuracy.  
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